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ABSTRACT
Psychosocial factors are thought to contribute to the long term development of coronary 
artery disease (CAD), to the triggering of cardiac events in people with advanced disease, and to 
adaptation following acute coronary syndromes (ACS). My thesis presents three studies 
addressing different aspects of the relationship between emotional factors and CAD, using 
different methodologies. They focus on the role of negative emotions in vulnerability to 
myocardial ischaemia in daily life, the influence of acute emotional triggers of ACS on long term 
quality of life, and the effect of depression following ACS on a particularly important aspect of 
adaptation, namely return to work.
The first study, called the Silent Ischaemia Study (SIS) investigated 88 out-patients with 
suspected CAD who underwent 24 hour ambulatory electrocardiogram (ECG) monitoring, 
together with saliva sampling and characterisation of daily life by a new method called the Day 
Reconstruction Method (DRM). The results indicated that in patients with definite CAD, 
depressed mood was associated with reduced high frequency and increased low frequency heart 
rate variability (HRV), suggestive of parasympathetic withdrawal. The cortisol slope over the 
day was flatter in more depressed patients with CAD. Episodes of transient ischaemia and/or 
arrhythmia were also associated with increased negative affect, but their incidence was low, 
primarily because most patients were medicated with beta blockers.
The second and third studies derive from the ACCENT (Acute Coronary Syndrome, 
Emotion and Triggers) study, exploring long term adaptation following ACS. Analyses showed 
that the likelihood of returning to work was negatively associated with depression immediately 
following ACS, independently of clinical and demographic factors, and that emotional triggers 
predicted elevated anxiety and poor mental health status at 12 and 36 months independently of 
covariates. In combination, these studies suggest that negative emotional status contribute both 
to the onset of acute cardiac events, and to adaptation following ACS.
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Chapter 1: Introduction
Cardiovascular diseases including coronary artery disease (CAD) are the largest 
cause o f sickness and morbidity, and are the major cause o f premature death and reduced 
quality o f life for citizens o f the European Union. CAD causes 114,000 deaths a year in 
the UK. Whereas mortality from CAD is falling rapidly, morbidity from CAD and other 
heart disease appears to be rising, especially in older groups. In those aged 65 years and 
older, morbidity has risen by a third since the late 1980’s. CAD costs UK healthcare 
£3,500 million per year (British Heart Foundation statistics, 2005).
The term CAD encompasses a wide variety of cardiac diseases ranging from 
angina to myocardial infarction, and to subsequent complications like heart failure. To 
understand how such diseases occur, the pathophysiological changes o f CAD need 
description. The term acute coronary syndrome (ACS) is usually used to describe two 
conditions, either a heart attack that is also known as myocardial infarction (MI), or 
unstable angina (UA). Coronary Heart Disease (CHD) occurs when a cholesterol plaque 
builds up in the walls of the coronary arteries. Over time, this may cause significant 
narrowing o f one or more of the arteries. When the arteries narrow to more than 50 - 
70%, the blood supply beyond the plaque cannot meet the oxygen demand o f the heart 
on exertion. This lack o f oxygen to the heart muscle usually causes chest pain known as 
angina, although about 25% of people will not actually experience pain. When the 
arteries become narrowed, in excess of 90-99%, patients may have angina at rest. This is 
known as unstable angina (UA). A person has an acute myocardial infarction (AMI) or 
heart attack when the flow o f blood through their coronary arteries is reduced to such an 
extent that the heart muscle dies. This often occurs suddenly, when a coronary artery is 
occluded by a blood clot that forms in the artery, because o f the rupture o f one o f these 
plaques. Physical or mental stresses in either daily life, or extreme events such as natural
1
disasters, or bereavement, can be triggers for rupture o f a vulnerable plaque. 
Coaguability increases or vasoconstriction triggers complete the occlusion by thrombosis 
or clot formation.
The risk o f acute coronary syndrome (ACS) is influenced by a range o f factors. 
CAD risk is increased not only by established clinical factors such as hypertension, 
diabetes, and hypercholesterolaemia but also by genetics, lifestyle factors (such as 
smoking, obesity, and alcohol consumption), early life factors, and various psychosocial 
factors. Figure 1.1 illustrates how these various psychosocial factors interact with the 
environment to affect coronary artery disease and the possible biological associated 
pathways. A crucial observation for the research described in this thesis is that 
psychosocial factors are associated both with the long term development o f CAD and 
with the triggering o f acute cardiac events. There is some overlap between the factors 
involved (such as depressed mood), but they may be operating over different time scales 
in the two situations. Additionally, psychosocial factors influence adaptation and quality 
o f life following ACS.
Psychosocial factors, including low socio-economic status, work-related, 
financial and marital stress, low social support, hostility, depression and anxiety, have all 
shown some association with an increased risk o f coronary heart disease in prospective 
cohort studies (Kuper et al., 2002). Poor social support has emerged as a predictor of 
CAD and as an indicator o f poor prognosis in patients with established disease (Berkman 
et al., 1979; Orth-Gomer et al., 2000). Marital stress may be especially predictive of 
poorer coronary outcomes for women (Orth-Gomer et al., 2000; Balog et al., 2003), and 
it has been well documented that cardiovascular and immunological measures increase in 
response to marital conflict (Miller et al., 1999). Associations between these 
psychological and social factors on the one hand and biological indices on the other
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allow identification o f those particularly at risk, although it is difficult to assess the 
direction o f effects in cross-sectional studies (Kuper et al., 2002; Williams et al., 2002; 
Rozanski et al., 1999).
There is considerable evidence that emotional states, particularly negative affect, 
are associated with cardiovascular health outcomes. A variety o f studies shows that 
depression, anxiety and hostility, lead to an increased risk of impaired cardiovascular 
outcomes and higher morbidity and mortality (Frasure-Smith et al., 1993; Frasure-Smith 
et al., 1995; Frasure-Smith et al., 2002; Lesperance et al., 2002; Mayou et al., 2000; Van 
Melle et al., 2004 and Kaufmann et al., 1999). Negative emotions (such as anxiety and 
hostility) may also be related to the risk o f developing CAD (Kawachi, et al., 1994). 
Among psychological factors, depression has shown the most consistent association with 
CAD and particularly with angina (Aromaa et al., 1994; Penninx et al., 1998; Sesso et 
al., 1998). The evidence is less consistent for anxiety, hostility and Type D personality 
traits.
This chapter is divided broadly into four sections. The first section introduces the 
various psychosocial stressors affecting long term CAD development. Since many o f the 
same factors also influence future morbidity in patients with established CAD, this 
literature is also reviewed. Additionally, I have highlighted research that throws light on 
mediating physiological responses. The second section will also examine how 
psychosocial factors, and in particular emotional responses, relate to the acute triggering 
o f cardiac events. The third section examines how these factors relate to adaptation to 
CAD in the long term. The final section will conclude with the proposals for the new 
studies comprising the thesis.
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Figure 1.1 Potential psychosocial pathways influencing both acute and long term  
coronary heart disease
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1.1 Psychosocial factors and the development of cardiovascular disease
The principle research method used to investigate the role of psychosocial factors 
in the development of cardiovascular disease is the prospective observational cohort 
study. This involves measurement of exposure to the potential risk factor (e.g. work 
stress, depression) in a large sample of initially healthy participants. Other risk factors 
(age, gender, smoking, blood pressure, cholesterol, etc.) are measured at the same time. 
The cohort is then followed up for a period of years, during which time some individuals 
will develop CAD. Using multivariate statistics, associations between the psychosocial
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factors and future disease can then be assessed, and the extent to which effects are 
independent o f standard risk factors can be evaluated.
1.1.1 Chronic stressors
1.1.1 1 Work Stress
Studies o f chronic stress and CAD have often focused on work related stressors. 
Two models with respect to work stress and health have been developed to explain the 
possible link; these are the demand-control model and effort-reward imbalance model. 
The job strain model suggests that an adverse job profile is one that is high in 
quantitative demands, in combination with low control over task performance, and this 
limits self efficacy and gives a stressful experience. This has long term deleterious 
effects on cardiovascular health (Karasek et al., 1981; Kuper & Marmot, 2003). These 
effects are enhanced if social support in the work place is lacking and stress related 
disease risks are augmented over increasing exposure time. The second model, called 
the effort -  reward imbalance model, suggests that high efforts (high demands and / or 
high involvement) in the presence of low rewards (low pay, low esteem, few career 
opportunities and / or job insecurity), may have a hazardous effect on CAD risk (Siegrist, 
1996, 2004). Several large prospective studies have found a consistent positive 
association between job strain and cardiovascular disease (CVD) morbidity and mortality 
(Kuper et al., 2003; Theorell et al., 1998), with low control being the most harmful to 
health (Schnall et al., 1994; Bosma et al., 1997, 1998).
Other studies show a significant association between effort-reward imbalance and
CVD indices, including new cardiac events (Siegriest et al., 1990, Siegrist, 1996) and
actual progression on coronary disease development in terms o f atherosclerosis (Lynch et
al., 1997). In the Whitehall II study, Bosma et al. (1998) found that both effort-reward
imbalance in jobs and low job control were independent predictors o f cardiovascular
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outcomes, with a 1.56 -  2.38 greater risk o f new coronary disease over a 5 year follow 
up period. Since then, researchers have combined information from the two job models 
and provided greater estimates o f cardiovascular outcomes.
Recent studies have found a significant association between more generalised 
measures o f work stress and CAD mortality (Matthews & Gump, 2002), as well as job 
insecurity, which is a component o f the effort-reward imbalance model and the incidence 
o f CAD (Lee et al., 2004). On average, job strain and effort reward -  imbalance and 
other job  stressors have consistently predicted adverse cardiac outcomes for men more so 
than for women (Lee et al., 2002; Orth-Gomer et al., 2000). Rosengren et al. (2004) in 
the INTERHLART case control study, which examined the association of a variety of 
psychosocial risk factors with the risk o f an acute Ml in 11,119 cases and 13,648 controls 
from 52 countries, showed that people with a myocardial infarction reported higher 
prevalence o f permanent work stress (Odds Ratio (O.R) 2.14; 99% Confidence Interval 
(C.I) 1.73 -  2.64), after adjusting for age, sex, geographic area and smoking. When 
separate analyses was carried out on men and women, in contrast to men, work stress 
was not associated with acute MI in women (p = 0.06).
The majority o f studies have controlled for potential confounders such as 
physical activity, smoking, body mass index (BMI), and socio-economic position. 
However, it is difficult to eliminate the co-factors associated with both stress exposure 
and physiological functioning. One way o f overcoming this is by longitudinal follow up 
studies o f specific biological mediators. Schnall et al. (1998) followed up 195 men for 3 
years and analysed the relationship with job strain. Results suggested that those who 
reported high job  strain at baseline, but not 3 years later, showed a significant reduction 
in cardiovascular indices such as ambulatory systolic and diastolic pressure, after
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adjustment for age, BMI, smoking and alcohol consumption. This suggested that an 
improvement in chronic stress led to a decline in ambulatory blood pressure.
1.1.1.2 Financial stress
Financial strain is another chronic psychosocial stressor, and like work stress, has 
been associated with increased CAD risk. Perceived financial strain was predictive of 
myocardial infarction and cardiac death in the longitudinal 20 year follow up 
Framingham study o f 749 women aged 45 - 64 years initially free o f coronary disease 
(Eaker et al., 1993). It was also associated with CAD risk in the large epidemiological 
case control INTERHEART study (Rosengren et al., 2004). The literature also 
established that lower socio-economic position as expected, would be associated with 
financial strain as well as with poor residential area (Evans & Steptoe, 2002).
Steptoe et al. (2005) carried out a longitudinal study where the influence of 
changes in financial strain in relation to changes in ambulatory blood pressure and 
salivary cortisol were assessed. Data was analysed from 160 men and women aged 47 - 
59 years at first assessment, in which the variables were repeated 3 years later. Results 
found that systolic blood pressure at 3 years follow up period, was lower in the improved 
financial strain group, than in the worse or no change group (p = 0.029) after adjustment 
for confounders. In addition, the cortisol awakening response was lower in men 
reporting improved financial strain (p=0.048), after adjustment for confounders.
Such studies on longitudinal data extend cross-sectional findings, by showing 
associations between favourable changes in chronic stressors like financial strain and 
reduced cardiovascular and neuroendocrine activation in everyday life.
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1.1.1.3 Care giving stress
Caring for a family member with a chronic illness is generally regarded as a 
chronically stressful process with potentially negative physical health consequences for 
the carer. Informal caregivers are those who are not financially compensated for their 
services. They are usually relatives or friends who give assistance to persons who are 
having difficulties with activities o f daily living due to physical, cognitive, or emotional 
impairments. A meta analysis by Vitaliano et al. (2003) combined results o f 23 studies, 
to compare the health o f caregivers with demographically similar non caregivers, 
examining across 11 health categories, and demonstrated a strong relationship between 
caregiving and stress hormones, antibodies and global reported health.
Chronic stressors, like care giving, are also associated with illness including 
cardiac disease (Cohen et al., 1997) and with disease progression (Everson et al., 1997). 
Caregivers undergo a burden resulting from the physical, psychological, emotional, 
social and financial problems experienced by families caring for impaired older adults 
(George & Gwither, 1986). Caregivers are more likely to be distressed, have clinical 
depression (Schulz et al., 1995) and engage in risky health behaviours. In addition, 
caregivers show other reactions, such as poor sleep, diet and sedentary behaviour 
(Vitaliano et al., 2002). The explanation as to how an increased risk o f CAD may be 
linked to caregivers is two fold. One pathway appears to flow from chronic stressors to 
psychosocial distress and then onto activation o f the hypothalamic - pituitary - axis 
(HPA) releasing cortisol, coupled with activation o f the sympathetic adrenomedullary 
axis from which adrenaline and noradrenaline are secreted (Lovallo et al., 1997; Steptoe 
et al., 2000). These hormones stimulate peripheral activity leading to allostatic load or 
wear and tear from repeated arousal and inefficient control of physiological responses 
(McEwen et al., 2000) which may lead to pathophysiology (Niaura & Goldstein, 1992).
The second pathway is that stress in care giving may trigger risky health behaviours, 
such as excessive smoking. These two pathways may contribute to illness by increasing 
cardiovascular dysregulation (Kannel et al., 1986).
The impact of care giving is influenced by other psychosocial factors. For 
example, high levels o f perceived social support among caregivers predict lower 
metabolic and cardiovascular risk (Vitiliano et al., 2002) and a lower CAD prevalence 
(Niaura & Goldstein, 1992). Two reports from the Nurses Health study show a strong 
association between care giving and incidence o f CAD. Women caring for an ill spouse 
for 9 or more hours a week had almost twice the risk o f incident CAD over 4 years. In 
addition, women who reported high levels o f care giving for even healthy children or 
grandchildren also experienced an increased CAD risk (Lee et al., 2003).
1.1.1.4 Family stress
Another adverse psychosocial factor to influence CAD is family stress. There is 
increasing evidence that family discord and negative non-supportive relationships are 
associated with a heightened physiological stress response, which may contribute to 
CAD over time.
Much o f the literature on marital discord relates to patients who have established 
CAD focusing on endocrinological and immunological correlates (Keicolt-Glaser et al., 
1998), and on cardiovascular reactivity (Smith et al.,1998), as well as follow up studies 
o f such patients focusing on recurrent cardiac events (Orth-Gomer et al., 2000). The 
literature on the association between marital distress and future CAD in initially healthy 
populations at baseline is more limited. In a large sample o f initially healthy but high 
risk men, Matthews and Gump (2002) found that increasing levels o f marital stress was 
associated with an increased risk o f death from CAD.
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A further study by Gallo et al. (2003) studied 393 healthy post menopausal 
women assessing marital status and quality, cardiovascular risk factors. Intima media 
thickness and plaque in carotid arteries and calcification in the coronary arteries o f the 
heart was measured by electron beam computed tomography, as markers o f 
atherosclerotic burden. These women were followed up for three years. The study 
found that women in highly satisfying marriages had the least atherosclerosis in both 
carotid arteries and aorta relative to women in low satisfying marriages.
1.1.2 Social Stressors: Social Support and Social Isolation
This section reviews the literature on the relationship between social relationships 
(namely social support and social isolation) and the long term health outcomes, in 
particular, as relates to cardiovascular disease.
There is much evidence for lack o f social support being a significant 
psychosocial risk factor for CAD (Hemingway & Marmot, 1999; Berkman et al., 1995; 
Orth-Gomer et al., 1993; Kuper et al., 2002). Despite the clear evidence o f a predictive 
association between social support and future CAD, there is ambiguity in precise 
measurement o f social support. Different indicators o f social support and isolation 
produce inconsistent effects (Irvine et al., 1999). Many different indicators o f social 
support and isolation have been used in epidemiological studies, ranging from 
quantitative measures o f network characteristics (membership of a club, marital status) to 
subjective measures o f network support (perceived satisfaction with emotional or 
practical support).
There are several definitions o f types o f support. Briefly, structural support 
refers to the size, type, density and frequency o f the network o f people surrounding an
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individual. A criticism o f measuring support in this way is that the mere structure o f a 
relationship does not necessarily describe the nature o f the relationship. Social 
integration is defined as the participation in a broad range of relationships (Brissette et 
al., 2000) giving a sense o f communality and identification of one’s social roles. Social 
isolation is the flip side o f social integration. It could be viewed that it is the negative 
aspects of the lack o f these social networks, which acts as a psychological stressor and 
increases negative affect due to a sense o f alienation and loneliness. This in turn 
increases neuroendocrine and cardiovascular responses (Uchino et al., 1996), suppresses 
the immune system, (Cohen et al., 1998) and affects health outcome. Functional social 
support refers to a social network’s provision o f psychological and material resources 
intended to benefit the individual’s response to stress (House & Khan, 1985). One has to 
distinguish between functional support actually received, which is limited by its overlap 
with illness, distress or extent o f need, from that of perceived functional support which is 
an individual’s subjective appraisal o f perception o f available support if so needed.
There are several methodological issues related to an examination of the 
relationship between social support and cardiovascular function. These issues, as 
highlighted by Uchino et al. (1996), include assessing multiple functional dimensions of 
support and use o f appropriate statistical controls. Many o f the studies are correlational, 
with discrepancy in the literature due to potentially confounding variables o f socio­
economic status, lack o f control for cardiovascular altering medications (e.g. beta 
blockers), age and gender (Shumaker et al., 1991).
Prospective studies of initially healthy individuals support the notion of social 
support as a predictor o f the onset and progression o f CAD. Kawachi et al. (1996) found 
in a study o f 32,624 US male health professionals that social isolation was related to
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increased cardiovascular disease mortality and deaths but was unrelated to other causes 
o f death.
Orth-Gomer et al. (1993) in a longitudinal community based study, and 
Rosengren et al. (1993), have shown that low perceived emotional support is associated 
with an increased CAD incidence. Several studies have also shown an effect for 
structural support on initial cardiac events (Vogt et al., 1992) and cardiac mortality 
(House et al., 1982). However, other studies have found no significant effects of social 
integration on CAD incidence (Reed et al., 1983). There are mixed findings regarding 
social support and the incidence o f CAD. This may be due to fact that although one may 
have greater social integration this can be accompanied by greater interpersonal 
problems. This is highlighted in a study by Medalie et al. (1976), in which a cohort of 
Israeli men revealed that those with greater social support in terms o f numbers o f ties had 
higher levels o f family problems. This was associated with a greater risk o f angina 
development. A significant inverse association was found between levels o f emotional 
support and extent o f atherosclerosis found by Blumenthal et al. (1987), which suggests 
that it is more the quality and level o f social support than simply the network size that is 
important in cardiac health outcomes. The discrepancy in the findings from these studies 
may be thus due to the variability o f measurement tools used. The majority o f the 
studies show an effect for measures of structural support as predictors o f CAD onset but 
we know little as to the specific dimensions o f structural support used. In addition, few 
studies actually include a measure o f perceived functional support, which limits the 
validity o f conclusions made.
Socio-cultural factors such as gender, socio-economic status, as well as 
psychological factors like depression and personality are potential moderators o f the 
effect o f social support on CAD. Studies investigating gender specific effects o f social
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support suggest being married is more beneficial to health for men in terms of 
cardiovascular morbidity and mortality than for women (Kawachi et al., 1996; Matthews 
& Gump, 2002). Studies investigating socio-economic status give mixed results. 
Vitaliano et al. (2001) found that emotional support, but not tangible support, was 
associated with increased cardiovascular risk for low income patients only.
Low social support often co exists with established depression and both these 
factors have been implicated as predictors of CAD onset and progression. The effects of 
depression significantly interact synergistically with the effects seen with social support 
on CAD outcomes. Frasure-smith et al. (2000) found that high levels o f perceived social 
support buffered the effects o f depression on one year mortality in post AMI patients, 
such that depressed patients with high levels o f social support were not at an increased 
risk relative to the non-depressed patients.
Social support influences health by several mechanisms. Cohen (1988) suggests 
that social support may be beneficial because it protects individuals from the deleterious 
behavioural and the physiological consequences o f stress through two mechanisms: 
stress buffering and main effects. The critical factor in social support as a stress buffer is 
the perception that others will provide appropriate aid (Cohen, 1988; Uchino et al., 1996) 
thus bolstering one’s perceived ability to cope with demands, and thereby lowering the 
stress level (Cohen & Wills, 1985). This in turn dampens the emotional and 
physiological responses to a cardiac event, or alters maladaptive behavioural responses 
(Wills & Cleary, 1996).
Cohen (2004) also suggests that the benefits of social support operate through 
main effects. Individuals who participate in social networks are subject to social controls 
that influence normative health behaviours as well engender feelings of responsibility for 
others and one’s self. In addition, the positive psychological effects from close ties, in
turn directly motivate the individual in healthy practices and behaviours, including 
adherence to medication and lifestyle recommendations e.g. smoking (Doherty et al., 
1983; Hartel et al., 1988).
Studies have indicated that the associations found between social support and 
CAD are linked to plausible physiological pathways. The reactivity hypothesis suggests 
that exaggerated cardiovascular activity to stressors may be a pathogenic mechanism in 
influencing the development o f cardiovascular disorders (Matthews et al., 1986). Higher 
cardiovascular reactivity seen in situations o f low social support (Gerin et al., 1995; 
Kamarck et al., 1995) may translate to gradual elevations in tonic blood pressure across 
an individual’s lifespan (Light et al., 1992). Studies o f conflictual relationships have 
been shown to produce heightened cardiovascular and neuroendocrine responses both in 
the laboratory and ambulatory studies (Holt-Lunstad et al., 2000). Individual differences 
in perceived support and experimental manipulation o f perceived support are associated 
with reduced cardiovascular and neuroendocrine activity to stressors (Kiecolt-Glaser & 
Greenberg, 1984; Cohen et al., 1998; Uchino et al., 1996).
To conclude, despite mixed findings, overall studies show that structural and 
functional social support, social isolation and conflict all have a consistent impact on 
mental and physical health outcomes and especially so with CAD outcomes. However, 
the strongest effects observed are in prognosis post myocardial infarction rather than 
incidence (Seeman et al., 1996).
1.1.3 Negative emotions and cardiovascular health
There has been much research on how negative emotions play a role in the 
aetiology o f cardiovascular disease in the form o f large scale epidemiological studies
(Rozanski et al., 1999). Depression and anxiety predict CAD morbidity and mortality 
after controlling for traditional risk factors (Hemingway & Marmot, 1999; Kubzansky & 
Kawachi, 2000) whereas associations with anger, hostility and personality have more 
mixed findings (Krantz & McCeney, 2002). This section will review the key findings of 
the literature on depression, anxiety, hostility, and anger and the effect on cardiovascular 
disease risk and outcomes and highlight some o f the limitations in the studies to date. I 
will discuss key pathophysiological mechanisms by which these psychosocial factors 
may influence CAD in chapter 2.
1.1.3 1 Depression
Both the presence of depressive disorder defined by clinical interview, and the 
presence o f depressive symptomatology measured by questionnaire scales, has been 
studied as predictors of CAD. The Diagnostic and Statistical Manual of Mental 
Disorders criteria for major depressive disorder include nine criteria and for a diagnosis, 
an individual must have five of them, one o f which must be depressed mood and 
symptoms lasting longer than 2 weeks, which impair daily functioning. Depression is 
not diagnosed in the context of grief, medication or direct physiological effects o f a 
medical illness such as hypothyroidism.
Researchers assess depression with self-report questionnaires like the Beck 
Depression Inventory (Beck et al., 1988) or the Centre for Epidemiological Studies- 
Depression (CES-D) Scale (Radloff, 1977), and some depression reviews (Krantz & 
McCeney, 2002) have also included related but distinct concepts of vital exhaustion (lack 
o f energy, irritability) and hopelessness (no reference to somatic symptoms of 
depression). In the studies of depression and CAD, the clinical manifestations o f CAD 
include both cardiac death and acute coronary syndromes (as established by symptoms
together with ECG or biochemical changes and angina). In the systematic review by 
Hemingway et al. (2001), it is noted that studies that have separated angina from other 
outcomes reported stronger effects of depression on angina (Hallstrom et al., 1986; Sesso 
et al., 1998), suggesting possible reporting bias, as angina is the least amenable to 
objective verification. There are numerous cross-sectional studies establishing that 
depression is more common in CAD patients, but this does not establish the temporal 
relationships between depression and CAD development. This section examines 
longitudinal prospective follow up studies o f initially healthy populations. Evidence 
relating depression following ACS with morbidity and mortality is described in section 
1.3.3.
An important issue is that depression is often confounded with other determinants 
o f CAD. For example, depressed patients may smoke more. Smoking may be a 
confounder in studies of depression and CAD, but it could also be a mediator of the 
association between depression and CAD. This issue has yet to be resolved in CAD 
research.
Epidemiological evidence for the effects of depression on CAD comes from 
population based, unselected, healthy samples o f both men and women. One study by 
Anda et al. (1993) followed up 2,800 people for 12 years and found that depressed affect 
as reported by the General Health Questionnaire (GHQ), was associated with 50 - 60% 
excess risk o f fatal and non fatal ischaemic heart disease after adjusting for cardiac risk 
factors. Barefoot and Schroll, (1996) followed up 730 healthy men and women in 
Denmark from 1964 to 1991 and found that a 2-Standard Deviation (SD) difference in 
depression score was associated with a relative risk (RR) o f 1.71 (p =0.005) and 1.59 (p 
<0.001) for MI and death from all causes respectively, after adjustment for baseline 
variables. The author concluded that the graded relationships between depression scores
and risk, and the long lasting nature o f the effect seen, suggested that depression was 
seen as a continuous variable, representing a chronic psychological trait, rather than an 
episodic psychiatric condition. The ‘Precursors study’ by Ford et al. (1998), evaluated 
1190 male medical students and followed them up for 40 years. Those who reported 
clinical depression were at greater risk for subsequent CAD and MI than men without 
depression, with relative risk being 2.12 (95% C.I 1.24 -  3.63) and 2.12 (95% C.I 1.11 -  
4.6) respectively. O f note, the increased risk associated with depression was present 
even for those who had an MI occurring 10 years after the onset of the First depressive 
episode. Pratt et al. (1996) reported that a diagnosis o f major depression was related to a
4.5 fold increased risk o f MI, and depressive symptoms as measured by the CES-D, 
predicted 70% excess risk o f incident CAD in women and men (Ferketich et al., 2000). 
Ariyo et al. (2000) followed 4493 healthy patients at baseline for 6 years and found 
depression to be a statistically significant predictor o f CAD but with a small effect size, 
with a hazard ratio o f 1.15 for a 5 point increase in the 10 item depression scale (CES- 
D). Both meta-analyses by Rugulies (2002) and Wulsin et al. (2003) o f community 
samples reinforce the conclusions that higher depression amongst healthy populations at 
baseline, conferred an average relative risk o f 1.64 for cardiac death.
A more recent chapter by Steptoe (2006) reviewed 27 longitudinal observational 
studies published between 1964 and 2005, and pointed overall towards a positive 
association between depression and CAD although inconsistencies were present. 
Nicholson et al. (2006) carried out a meta-analysis o f cohort studies measuring 
depression with follow-up for fatal CAD/incident myocardial infarction (aetiological) or 
all-cause mortality/fatal CAD (prognostic). Results revealed that in 21 aetiological 
studies, the pooled relative risk o f future CAD associated with depression was 1.81 (95% 
Cl 1.53-2.15) with adjustment reducing the crude effect marginally from 2.08 (1.69- 
2.55) to 1.90 (1.49-2.42). In 34 prognostic studies, the pooled relative risk was 1.80
(1.50-2.15) but after adjustment for left ventricular function result (available in only 
eight studies), this attenuated the relative risk from 2.18 to 1.53 (1.11-2.10), a 48% 
reduction. Therefore, the authors concluded that depression has yet to be established as 
an independent risk factor for CAD because of the incomplete and biased availability of 
adjustment for conventional risk factors and severity of coronary disease.
One important point to emerge from these is that the intensity o f depression may 
be important. Studies that focused on the degree o f depression found that the risk of 
CAD was higher amongst people seriously depressed, than amongst those who were only 
moderately depressed, suggesting a dose response association (Pratt et al., 1996; Penninx 
et al., 2001). Studies involving a clinical diagnosis of depression by interview, as 
opposed to questionnaire measures o f depressed mood, have also found positive 
associations (Aromaa et al., 1994, Pratt et al., 1996).
There is a debate as to whether depression contributes to long term development 
o f atherosclerosis, or to the clinical manifestations o f the disease. Measurement o f non 
invasive indices o f atherosclerosis, such as the intimal medial layer o f arteries, or 
presence o f atherosclerotic plaque by either ultra sound scanning or electron beam 
scanning computer tomography (EBCT) o f the heart has allowed studies to answer this 
question. In the Work Site Blood Pressure Study (Haas et al., 2005), depressed mood at 
baseline predicted carotid plaque 10 years later after adjustment for traditional cardiac 
risk factors. Another larger study o f 4000 men and women in Rotterdam showed 
positive associations between depressive disorders and coronary artery and aortic 
calcification (Tiemeier et al., 2004). There also appears to be a relationship between 
subclinical atherosclerosis and other negative mood states like anxiety. W olff et al. 
(2005) studied 726 healthy French men and women both at baseline and at 2 years follow 
up, and despite no development of CAD found that those with higher anxiety scores at
both time points had greater progression in carotid intima media thickness (IMT) over a 
four year period than less anxious women.
One other distinct possibility is that depression may act as an acute trigger for an 
acute cardiac event in vulnerable individuals and this issue is explored in section 1.2 on 
acute triggering of Acute Coronary Syndrome.
Finally, longitudinal studies do not necessarily show causation between 
depression and the associations found with CAD. The fact that associations between 
depression and CAD remain, despite studies taking into account the various lifestyle 
factors that may be associated both with CAD and depression, suggests that health 
behaviours are only partly responsible for the positive associations found between 
depression and CAD. It gives greater credence to biological processes as being 
important in mediating the impact o f depression on CAD development. This is discussed 
further in chapter 2. Depression in relation to prognosis and adaptation to CAD is 
additionally explored further in section 1.3.
1.1.3.2 Anxiety
Anxiety has been defined as a state o f emotional distress ‘resulting from feelings 
o f being unable to predict, control, or obtain desired outcomes’ (Barlow, 2000). 
Researchers have used a variety o f assessment tools including diagnostic interviews, 
diagnostic criteria or self-reporting rating scales to measure trait anxiety (Spielberger et 
al., 1983).
In general, psychological distress has been shown to give an increased risk of 
CAD in men that is unexplained by work characteristics, lack o f social support or health 
behaviours. In a prospective occupational cohort study o f London based civil servants, 
baseline psychological distress, as measured by General Health Questionnaire (GHQ),
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was associated with an increased incidence o f self-reported CAD at 5 years follow up 
(odds ratio = 1.83, C.I: 1.5 -  2.3) and ECG abnormalities (odds ratio = 1.51, C.I: 1.1 -  
2.1) after adjustment for age, employment grade and follow up (Stansfeld et al., 2002). 
However, what has not been fully established is the question o f what aspects of 
psychological distress are particularly associated with CAD risk. The GHQ screens for 
both depressive illness and lesser levels o f anxiety and depression and the authors 
suggest that it may be the persistence of depressive or anxiety symptoms over long 
periods o f time that may be more important in the development of CAD than in short 
episodes o f a severe depressive illness.
Studies with community based samples suggest that anxiety disorders are 
associated with greater mortality (Kubzansky et al., 1997). Although several o f the 
epidemiological studies suggest that high levels o f anxiety increase CAD risk, most of 
the studies involve small samples, use a range o f measures of distress and are limited to 
men. The issue o f confounding is difficult when analysing the impact of anxiety and 
distress since risky health behaviours like smoking is often associated with such 
psychological states. Medalie et al. (1973, 1976) followed up an Israeli civil servant 
cohort and reported a strong or moderate association between anxiety and the incidence 
o f angina. Phobic anxiety predicted a 2.45 fold greater risk o f fatal CAD in 34,000 
initially healthy male professionals (Kawachi et al., 1994). In the Normative Aging 
Study, men with two anxiety symptoms were shown to have an increased risk o f cardiac 
death compared to those not anxious (Kawachi et al., 1994). In separate analyses of the 
same sample in a study by Kubzansky et al. (1997), men who reported high levels of 
worrying had more than a twofold increased risk o f nonfatal MI after 20 years o f follow 
up upon the same sample.
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There are a few studies, which have found no significant risk associated with 
CAD and anxiety (Allgulander et al., 1991; Hippisley-Cox et al., 1998), but these studies 
were suboptimal in that traditional cardiac risk factors were not controlled for. In 
addition, they were not true prospective designs as these studies compared the number of 
cardiac deaths in a psychiatric sample with age and sex specific CAD mortality rates in 
the same geographical area.
One final point to note in these studies is the follow up period. It was found that 
studies with a longer follow up were less likely to find a positive association than studies 
with less extended follow up. This was demonstrated in the Northwick Park Heart Study 
in which Haines et al. (1987) showed that men with high levels o f anxiety had nearly 
four times the risk of fatal CAD over 10 years after adjusting for traditional cardiac risk 
factors. This association between anxiety and fatal CAD disappeared when follow up 
was extended by another 10 years (Haines et al., 2001).
1.1.3.3 Type D personality
Personality is thought to have an impact on the cardiac disease process. Denollet 
et al. (1992) investigated coping styles in men with CAD and developed the type D or 
‘distressed’ personality construct. The distressed personality is characterised by the joint 
tendency to experience negative emotions and to inhibit these emotions whilst avoiding 
social contact with others. Type D personality is defined by high scores on negative 
affectivity (NA) and social inhibition (SI) dimensions. NA is defined as the ‘tendency to 
experience negative emotions’ including anger, hostile feelings, depressed affect, and 
anxiety, while SI is defined as the ‘avoidance o f potential dangers involved in the social 
interaction, such as disapproval or non reward by others’ (Denollet, 1998).
There is consistent evidence that type D personality is associated with
cardiovascular disease outcomes in patients with existing CAD. Denollet et al. (1995)
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showed in a prospective study o f 268 men and 35 women with documented CAD, that 
type D personality was associated with a six fold increase in the likelihood o f death from 
cardiac events two to five years post MI in men. In another longer prospective study by 
Denollet et al. (1996), it was shown that type D personality was associated with a four 
fold increase in mortality 6 - 1 0  years after a cardiac event, with a poorer outcome in 
post MI patients who had a decreased (<40%) left ventricular ejection fraction (LVEF) 
(Denollet et al., 1998). In all o f these studies by Denollet, type D personality was shown 
was shown to be significantly associated with worse disease outcomes, even after 
controlling for traditional cardiac risk factors. However, symptoms o f depression, anger, 
and anxiety did not add to the predictive power o f the type D construct. Denollet et al.
(1998), found that type D personality patients were likely to experience anxiety, 
depression and anger, therefore the inclusion o f negative affectivity in the definition of 
type D personality may explain this null finding. NA and SI were also not predictive of 
outcome individually. It was only the jo int presence of high scores on both dimensions 
that were linked to disease morbidity and mortality.
In a more recent study by the same group, (Denollet et al., 2006) they followed 
up 337 MI patients for 5 years, who filled out a general health questionnaire 
(psychological stress) and the type D personality scale, for adverse cardiac events (death, 
MI, revascularisation). Multivariate analysis revealed that left ventricular ejection 
fraction (LVEF) <40%, not having coronary artery by pass surgery (CABG) and type D 
personality were independent predictors o f major adverse events (odds ratio 2.90, C.I 
1.42-5.92; p = 0.003), whereas psychological stress was only marginally significant. 
This study concluded that type D reflected more than temporary changes in stress levels, 
as it predicted cardiac events after controlling for concurrent symptoms of stress.
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Whilst many o f the studies have suggested a potential link between type D and 
cardiac disease outcomes, there is yet, little established with regards to the specific 
biological pathways. Denollet et al. (1996) suggested that personality may be linked to 
CAD directly through pathophysiological mechanisms such as silent myocardial 
ischaemia, or platelet release and activation triggered by mental stress. A second way 
that type D personality may promote disease is through health related behaviours. The 
tendency of type D to inhibit behaviour in social interaction means they decrease the 
availability o f social support. A third possible mechanism is an unknown third variable 
that is a primary cause o f both personality trait and premature mortality. Type D 
personality could be a behavioural manifestation o f an underlying biological variable, 
which predisposes the individual to cardiac outcomes associated with underlying genetic 
causes. There is evidence that negative affectivity and social inhibition can be due in 
part to genetic factors (Bouchard, 1994).
1.1.3.4 Anger and Hostility
Early literature in the 1950’s and 1960’s focused on the roles o f anger, anger 
expression and hostility on CVD, and there was much research on type A coronary prone 
behaviours. Type A personality includes elements o f impatience, hard driving goal 
orientated behaviour, irritation and anger. Initial work suggested that type A men and 
women had higher cholesterol and greater evidence o f CAD compared to type B 
(Friedman & Rosenman, 1971), and a large prospective study o f 3,100 middle aged men, 
established type A as a risk factor for CAD. Type A men were twice as likely to develop 
CAD in the subsequent 8.5 years as those who were not classified as Type A (Rosenman 
et al., 1975). Since then, subsequent literature regarding Type A behaviour have found it 
to be a weak and inconsistent predictor of CAD incidence with negative findings 
(Ragland et al., 1988). In a study by Johnston et al. (1987), type A behaviour as
measured by the Bortner questionnaire was found not to predict major ischaemic heart 
disease in 5936 men aged 40-59 years after an average o f 6.2 years follow up.
Recently, more attention has been focused on anger and hostility as important 
components o f type A behaviour, which have been found to predict CAD incidence as 
separate dimensions in epidemiological research (Smith, 1992).
Hostility is defined as cynical attitudes to others and the wider environment 
(Barefoot et al., 1989), and is considered an enduring personality trait. A popular 
measure of hostility is the Cook- Medley Hostility Scale (Cook & Medley, 1954) which 
is described in more detail in chapter 4. Anger is associated with subjective arousal, and 
has both situational and trait aspects. It is often assessed by a self-report inventory such 
as the Spielberger Trait Anger Scale (Spielberger et al., 1983). It is an emotion and part 
o f a broader construct including hostility and aggressive behaviour (Smith, 1992). 
Hostility is one o f the better defined and understood expressions of anger. Hostility may 
also be a more sensitive predictor o f heart disease but it is unlikely that it is the only 
expression o f anger that increases cardiac risk. A prospective study by Gallacher et al.
(1999) assessed 2890 men using the Framingham scales comprising ‘anger symptoms’, 
‘anger in’, ‘anger discuss’ and a new construct ‘suppressed anger’. Results showed that 
both anger out and suppressed anger were predictive o f incident of ACS, independent of 
physiological, psychosocial and behavioural risk factors. Neither of these constructs was 
similar to hostility suggesting the presence of mechanisms other than hostility by which 
anger predicts cardiac risk.
There have been many studies on selected and mixed samples investigating 
hostility and anger. These emotions have been measured with a variety o f assessment 
tools in relation to CV morbidity and mortality, with both positive and negative findings 
(Hearn et al., 1989; Helmers et al., 1993; Barefoot et al., 1995). A large meta-analytic
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review of 45 studies concluded that hostility is an independent risk factor for CAD and 
all cause mortality (Miller et al., 1996). After controlling for other risk factors for CAD, 
the widely used Cook-Medley Hostility Scale and other cognitive-experiential measures 
were most predictive of all-cause mortality (weighted mean r = .16) and, to a lesser 
extent, CAD (weighted mean r = .08). More recently, a case control study from the 
Multiple Risk Factor Intervention Trial showed that men at high risk o f CAD who scored 
high on hostility, were more likely to die from CAD in the intervening 16 years, after 
adjustment for traditional coronary risk factors (Matthews et al., 2004). In the 
Normative Aging Study, each 1 point increase in hostility predicted a 6% increased risk 
of incident CAD over 3 years (Niaura & Goldstein, 2002). Kawachi et al. (1996) 
showed that men with high levels o f anger had 2.5 times more coronary events after 7 
years follow up. In the KIHD (Kuopio Ischaemic Heart Disease) study, hostility 
predicted a more than two fold increased risk o f MI and CV mortality over nine years, 
largely explained by behavioural risk factors (Everson et al., 1997). In addition, some 
studies have shown hostility and anger to be associated with subclinical cardiovascular 
disease such as carotid atherosclerosis in both healthy post menopausal women 
(Matthews et al., 1998) and amongst middle aged men (Julkunen et al., 1994). Angerer 
et al. (2000) have also linked hostility to progression o f atherosclerosis in serial coronary 
angiography, and higher levels of hostility were associated with greater coronary artery 
calcification 10 years later, in a subset o f participants taking part in the CARDIA study 
(Iribarren et al., 2000).
However, Matthews et al. (1998), who assessed the thickness of arterial lesions of 
patients with known documented CAD, found no relation with anger whereas Kawachi et 
al (1996) found mixed results.
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Overall though, evidence is strong, especially from methodologically sound 
population-based studies, that anger and hostility increase CAD risk in healthy 
populations. However, evidence is weaker in patients with documented CAD that anger 
and hostility are robust predictors o f recurrent events and cardiovascular mortality 
(Hemingway & Marmot, 1999). Regarding hostility in CAD patients, only one study 
reported a significantly raised risk of CAD events associated with higher hostility 
(Chaput, 2002) with many other studies reporting null effects (Irvine et al., 1999, 
Kaufmann et al., 1999). Two studies measured trait anger in people with existing CAD, 
with fatal or non fatal MI as the outcome. Denollet et al. (1998), found higher trait anger 
significantly predicted occurrence o f another MI whilst a second study found marginally 
significant positive associations (Mendes de Leon et al., 1996). Null effects were seen in 
other studies with regards to anger and its association with CAD in documented CAD 
patients (Welin et al., 2000; Ahern et al., 1990; Frasure-Smith et al., 1995, 1999, 2003). 
In common with the literature on anxiety, the research is limited to mainly men and 
especially Caucasian populations.
1.1.3.5 Overall conclusions concerning negative emotion and CAD
Consistent with previous reviews by Rozanski et al. (1999, 2005), there is a large 
body o f evidence relating negative affect to CAD, with particular supportive evidence for 
depression and anxiety based on prospective studies in initially healthy samples. The 
effects seen are stronger for depression than anxiety. The evidence is far more mixed 
with respect to hostility and anger. However stronger evidence is emerging for hostility 
and anger expression rather than trait anger (Krantz & McCeney, 2002). The weaker 
findings may be due to difficulties o f distinguishing reactive affective states after 
hospitalisation from trait anger, anxiety or personality effects. Overall, the evidence
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supports the concept that depression and anxiety are likely risk factors for cardiac disease 
development.
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1.1.4 Positive affect and cardiovascular health
Although the literature on negative emotion and its influence on health has been 
more extensively studied, there has been much more recent attention on the potential 
benefits of positive affect (PA) (Seligman & Csikszentmihalyi, 2000), defined as the 
feelings that reflect a level o f pleasurable engagement with the environment (Clark et al., 
1989) such as happiness, joy, excitement, enthusiasm and contentment. These can either 
be brief, known as state PA, which refers to short term bouts of PA in everyday life, or it 
can be more stable, enduring trait like feelings, referred to as trait PA. The latter is more 
likely to influence disease outcomes where underlying processes take time to develop i.e. 
the onset o f chronic diseases like CAD. State PA is thought to influence the progression 
o f ongoing disease events in a person with an underlying chronic illness.
There are two types o f well being described: eudaimonic and hedonic. 
Eudaimonic well being is the realisation o f one’s true potential (Ryff, 1989) whilst 
hedonic well being describes the experiences o f happiness and satisfaction. Optimal 
well-being is defined as being high on both eudaimonic and hedonic well being (Ryff et 
al., 2004). Mixed evidence exists for whether PA and negative affect (NA) are bipolar 
extremes o f the same scale or orthogonal factors (Diener et al., 1984; Watson et al.,
1988) i.e. are PA and NA bipolar ends o f the same construct with benefits of PA 
reflecting an absence of NA or are the two affects mutually independent with PA 
providing benefits independent of NA? Ryff et al. (2004) explored whether the different 
types o f well being have different biological correlates, and suggested that it is 
eudaimonic well being that may prompt reduced biological activation o f the organism in 
terms o f lower levels of daily salivary cortisol, pro inflammatory cytokines, 
cardiovascular risk profiles than states o f happiness or contentment (hedonic well being).
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These findings have implications for PA influencing CAD development and adaptation 
to CAD in the long term.
Regarding morbidity, both cross-sectional and prospective studies o f PA support 
an association between higher PA and general good health of participants (Ostir et al., 
2001; Cohen et al., 2003) after controlling for NA. For example, Ostir et al. (2001) 
assessed whether positive or negative affect, or both, predicted the risk of stroke in a 6- 
year prospective cohort study o f an initially healthy population-based sample of 2478 
older whites and blacks in North Carolina. Measures o f depressive symptoms include 
questions about the presence of negative affect, such as sadness, as well as the absence of 
positive affect, such as happiness and optimism. Thereafter, interviews were conducted 
annually for 6 years. Results found that increasing scores on the modified version o f the 
Centre for Epidemiological Studies Depression Scale (CES-D) were significantly 
associated with stroke incidence for the overall sample, (relative risk (R.R) =- 1.04 for 
each one-point increase, 95% confidence interval (C.l) = 1.01-1.09), over the 6-year 
follow-up period, after adjusting for socio-demographic characteristics, blood pressure, 
body mass index, smoking status, and selected chronic diseases. The positive affect 
score showed a strong inverse association with the future incidence o f stroke (R.R = 
0.74, 95% C.l = 0.62-0.88) after controlling for NA affect scores and other known 
vascular risk factors for a stroke.
There have also been studies showing evidence of PA being associated with the 
development o f CAD in initially healthy populations. Prospective studies have shown 
that positive beliefs (e.g. optimism) are associated with reduced risk o f adverse cardiac 
outcomes in initially healthy populations (Kubzansky et al., 2001; Matthews et al., 
2004). Kubzansky et al. (2007) carried out a prospective population based cohort study 
on 6025 men and women examining emotional vitality (characterised by a sense of
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energy, positive well being and emotional self regulation) and incident CAD (non fatal 
and fatal events) from hospital records in a 15 year follow up. The results found that 
after controlling for age, gender, and race/ethnicity, those with the highest levels of 
emotional vitality had a risk ratio o f 0.68 for CAD (95% C.l 0.58-0.78). After 
additionally controlling for standard cardiac risk factors and history o f psychological 
problems, a significant effect o f emotional vitality on CAD incidence was found, 
suggesting a 2-3% decrease in the risk of CAD for each unit increase on emotional 
vitality measure scale. The consistency of the association found between PA and CAD, 
after controlling for NA, suggests important and separate relationships between positive 
emotional factors and CAD.
Positive affect is also related to disease severity and physical functioning. The 
reporting o f physical symptoms partly reflects underlying disease state but it is also 
influenced by psychological states and traits o f patients (Cohen et al., 1991). Higher trait 
levels o f PA and subjective well being (SWB) have been associated with fewer 
symptoms and better self-reported health amongst patients with coronary artery disease 
(Sullivan et al., 2001). Positive affect has been found to both mediate and moderate the 
effects o f depression on physical health. Sullivan et al. (2001) carried out a prospective 
cohort study on 111 CAD patients examining both physical factors and psychological 
state or traits, which modify the relation between depression and physical health 5 years 
later. To examine the moderating effect on depression, the sample was divided into two 
groups on the basis o f Hamilton depression scores. In the low depression group, there 
was no difference in physical health but in the higher depression group, patients reported 
much better physical health if they had higher levels of PA. PA had more marked effects 
on physical health in the presence of depression. Other prospective morbidity studies 
have found that PA trait benefits re-hospitalisation rates for coronary problems 
(Middleton & Byrd, 1996).
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PA may influence CAD development in daily life by two possible mechanisms as 
proposed by Pressman and Cohen (2005). The first is the main effect model o f PA in 
which trait PA influences health outcomes by mediating behaviours or physiological 
responses that create the long term risk and the second model is that PA may directly 
influence health by change in health practice: medication adherence, changing to healthy 
lifestyles etc.
Recurrent or prolonged activation o f the arousal system (fight or flight response 
due to stress with attendant changes in blood pressure and heart rate) due to emotion can 
result in CAD (Krantz et al., 1981). Changes in state PA and associated acute changes in 
cardiovascular response in daily life could have implications for those with chronic 
cardiac disease where short term emotions may trigger an event such as a MI. The 
second mechanism proposed is the stress buffering model of PA in which individuals 
with high PA, experience less stress in the environment and when potential stressors are 
encountered, facilitates recovery from stress related activation by changes in 
cardiovascular or neuroendocrine response.
There are several within-person studies investigating whether periods o f high PA 
are accompanied by changes in cardiovascular reactivity. Studies have shown that state 
daily PA o f the individual to be associated with increased BP and not HR (Gellman et 
al., 1990; Jacob et al., 1999; Schwarz et al., 1994; Shapiro et al., 1997). Frederickson, 
(1998) experimentally demonstrated that positive emotions could shorten the recovery 
period o f physiological indices after exposing subjects to a stimulus designed to elicit 
negative emotions. However, it appears that PA has possibly less o f an influence on 
cardiovascular reactivity though, than NA. James et al. (1986) showed in a study that 
self-reported emotional arousal was associated with BP increases but in all cases, the
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negative emotions of anger and anxiety were associated by larger increases in 
cardiovascular response than the positive emotions of happiness.
There have also been experimental studies in which state PA is manipulated in 
the laboratory using some kind o f active PA manipulation such as using personally 
relevant stimuli like recall o f past events (Sinha et al., 1992; Waldstein et al., 2000; 
Schwartz et al., 1981; Yogo et al., 1995) and all showed an increase in cardiovascular 
response measured. This pattern may have been due to the behavioural activation 
associated with task performance.
There are also studies examining between-person differences in PA and 
physiology. Happiness as a measure is an important positive emotion for health with 
direct influence on health related biology (Steptoe et al., 2005). Biological correlates of 
cardiovascular markers such as BP and HR, and neurohumoral markers such as cortisol 
output and the awakening cortisol response, are altered in response to stress or emotion. 
In the observational study by Steptoe et al. (2005), 228 healthy volunteers underwent 
measuring heart rate (HR) measurement, salivary cortisol measurement, a psychological 
distress measure questionnaire (GHQ) and assessment of PA by aggregating momentary 
experiences o f happiness over a working day and leisure day. Findings showed that PA 
was inversely related to cortisol output over the day independently o f age, gender, socio­
economic position body mass and smoking. PA was also inversely related to heart rate 
in men only, which remained significant after additionally controlling for GHQ. PA was 
also seen to be related to the recorded ambulatory systolic BP assessed 3 years later 
(Steptoe et al., 2005).
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1.2 Acute triggering of ischaemia and ACS
1.2.1 Introduction
In addition to chronic psychosocial factors and emotional traits playing a role in 
cardiac disease over a period, there are varieties o f factors that may act more acutely in 
the triggering o f ACS in susceptible patients. This section summarises key points of 
some of the literature related to the study o f triggering o f ACS, the methodology used 
and the current limitations we have in interpreting the findings from studies carried out 
so far. In particular, I shall highlight the role o f timing o f psychosocial factors related to 
CAD development, the causal sequence o f emotional experiences, and discuss the role of 
acute emotional triggers o f ACS.
The problem of why acute cardiac events such as myocardial infarction (MI) or
sudden cardiac death occur when they do have been much researched. The key
biological events underlying an acute coronary syndrome (ACS) are the disruption of
coronary plaques by rupture or erosion, and the development of thrombus (Davies et al.,
1996). The most angiographically severe lesions are not necessarily at the highest risk of
rupture, and histological studies indicate that plaque rupture is a frequent event that only
occasionally results in an ACS (Casscells et al., 2003). It is thought that some acute
M i’s are stimulated by triggers; these are external stimuli, activities or mental states that
produce acute physiological changes, which promote pathophysiological responses
(Servoss et al., 2002). A trigger can be defined as a stimulus or an activity that produces
acute physiological or pathophysiological changes leading directly to onset o f acute
cardiovascular disease. (Strike et al., 2005; Tofler & Muller, 2006). There is no general
agreement about how long before symptom onset the stimulus must occur to be regarded
as an acute trigger, rather than a more general aetiological factor. Most research has
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focused on a I to 2 hour period before the onset o f symptoms, but there are possible 
triggers such as infection that have a longer time course. Triggering typically takes place 
against a background o f long term coronary artery disease (CAD).
Systematic reviews o f this literature indicate that emotional stressors may act as 
triggers (Strike et al., 2005). However, most of this work was carried out with acute MI, 
and not with the broader modern spectrum of ACS, that includes ST-elevation 
myocardial infarction (STEMI), non-ST-elevation MI (NSTEMI), and unstable angina 
(UA). Additionally, although there is quite extensive research on stress-induced 
myocardial ischaemia (Strike &Steptoe, 2003), research on triggering has not been 
directly linked with biological investigations o f the same patients.
Emotional stimuli are part o f a larger group of acute triggers that includes 
vigorous physical exertion, respiratory infection, drugs such as cocaine and marijuana, 
and heavy meals. (Smeeth et al., 2004; Willich et al., 1993; Mittleman et al., 1999; 
Lipovetzky et al., 2004). Triggering is also related to factors such as time o f day, day of 
the week and season of the year.
Circadian variation in vulnerability to acute coronary syndromes (Muller et al.,
1989) including transient ischaemia (Rocco et al., 1985; Mulcahy et al., 1988; Krantz et 
al., 1996) has been described, with a three-fold increase in risk o f angina in the first 
hours after waking (Willich et al., 1987). This period o f increased risk coincides with 
peak levels o f the stress hormone cortisol, which then recedes over the course of the day, 
and with plasma catecholamines, heart rate, and blood pressure. These factors may 
contribute to a reduction in the ischaemic threshold early in the day. During such a 
period, subjective states o f anger or anxiety, mental stress or intense physical exercise 
increase myocardial oxygen demand further. In the presence o f coronary disease, these
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changes may increase the risk o f a transient ischaemic attack, with the potential for 
developing unstable angina or myocardial infarction.
The demands o f everyday life and routines may superimpose their own circadian 
risk factor for ischaemia on CAD patients. Periods associated with commuting, or 
certain types o f social interactions may place greater demands on the cardiovascular 
system if they are associated with negative subjective states. Interestingly, Willich and 
colleagues identified a smaller secondary peak in ischaemic incidence in the late 
afternoon (Willich et al., 1999). Therefore, it will be useful to assess the relative impact 
o f emotional triggers against a background of biologically-mediated circadian changes in 
vulnerability to ischaemia.
1.2.2 Methodological issues in study triggering in the individual
The scientific study o f acute emotional triggers in daily life presents particular 
methodological challenges. Since triggers are unpredictable, they are difficult to study 
prospectively in relation to emotion and involve identifying patients at high risk and 
monitoring their activities and feelings over an indefinite period in the expectation that a 
cardiac event might occur at some point. Acute psychological triggers o f ischaemia such 
as anger, hostility, depression and anxiety occur against a backdrop o f ongoing life 
events, situations and pressures, and personality traits (type D), coping methods (social 
support, positive affect) and long term affective states and are likely to be associated 
with them. Many o f these experiences are internal and not open to objective verification.
Two broad strategies to investigate triggering are used. The first is to investigate
the impact on ACS admissions o f stressful events that affect large numbers o f people,
such as natural disasters, terrorist attacks, or sporting events. The advantage of this
approach is that the stimulus is identified and timed objectively. A population-based
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sampling frame can be used, and fatal as well as nonfatal cardiac events can be 
evaluated. Very often, however, the circumstances surrounding natural disasters or 
conflict are not well suited to systematic data collection.
Most o f the events o f ACS take place in individuals who are not exposed to large 
scale traumatic events. The second method is to collect data from patients after they 
have suffered an ACS or with suspected CAD, asking them about their experiences in the 
period before symptom onset. Data collection is retrospective. Information of this type 
is susceptible to memory loss or decay and retrospective biases concerning the social 
acceptability o f the activities preceding onset (such as anger), and to the influence of 
patients’ private beliefs about the causes o f heart disease. Studies o f the triggering of 
fatal cardiac events are difficult, unless the circumstances are witnessed by others, and 
the triggers of fatal events may be different from those for non-fatal ACS. Special 
methods o f data collection and analysis have therefore been developed to minimize these 
limitations o f interview-based studies.
1.2.3. Population-based studies
1.2.3.1 Earthquakes
Rates o f  cardiac events following earthquakes have been studied in the USA, 
Japan, Australia and Europe. Living through an earthquake is a devastating experience, 
but it is important to distinguish between the effects o f stress and responses to sudden 
physical exertion (e.g. running away from buildings), direct injury or trauma. The 
impact o f earthquakes on ACS onset has not been completely consistent. The most 
systematic analyses have been those o f the Northridge Earthquake that took place in the 
Los Angeles area in January 1994 (Leor et al., 1996; Kloner et al., 1997). A postal
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survey o f more than 100 hospitals showed that admissions for acute Ml increased from 
149 in the week before to 201 in the week after the earthquake (Leor et al., 1996). 
Examination o f the coroners’ records for Los Angeles County found that sudden deaths 
from cardiac causes increased from an average of 4.6 per day in the preceding week to 
24 on the day o f the earthquake (Leor et al., 1996). Only three o f these cases were 
associated with unusual physical exertion. A further analysis of all deaths in the county 
confirmed the increase CAD mortality, with no increase in deaths from other 
cardiovascular diseases or from non cardiovascular causes (Kloner et al., 1997).
Studies o f the Hanshin-Awaji earthquake in 1995 in the Kobe region o f Japan 
showed similar effects, with a large increase in the number of patients admitted with 
acute MI on the day o f the event (Suzuki et al., 1995). Somewhat smaller increases in 
rates were recorded following earthquakes in Greece and Australia (Trichopoulos et al., 
1983; Dobson et al., 1991). An exception to this pattern is the 1989 Loma Prieta 
earthquake in the San Francisco Bay area, which was not associated with increased ACS 
admissions (Brown et al., 1999). A possible explanation may lie in the timing o f these 
events. The Northridge earthquake struck at 4:31 am on a Monday morning in winter, 
and the Hanshin-Awaji earthquake early on a Tuesday morning in winter. By contrast, 
the Loma Prieta earthquake occurred at 17:04 pm on a Tuesday in October. There is a 
greater susceptibility to acute MI in winter months, and from other information about 
timing o f infarctions, a Monday morning in the winter is among the most lethal times for 
an event to take place (Barnett et al., 2005).
Given the unexpected nature o f such disasters, there have not surprisingly been 
few studies o f acute changes in the pathophysiological mechanisms underlying 
triggering. A major earthquake in Taiwan in 1999 happened by chance to take place as 
15 patients with suspected CAD were undergoing holter monitoring (Lin et al., 2001).
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Spectral analysis o f R-R intervals showed a marked increase in the low to high frequency 
ratio for about 40 minutes after the earthquake, indicative of vagal withdrawal. ST- 
segment depression was measured in several patients, and was correlated with the 
increase in low frequency power. Parati et al. (2001) described a single patient who was 
undergoing ambulatory blood pressure monitoring during an earthquake in central Italy. 
There was a large increase in pressure and in heart rate, which persisted for an hour, and 
the next 6 hours were characterized by high blood pressure variability. Other acute 
effects that have been documented include increased blood viscosity, fibrinogen and D- 
dimer levels (Matsuo et al., 1998), an increase in deep negative T waves without Q 
waves, and abnormal cardiac sympathetic function as revealed with metaiodobenzyl 
guanidine imaging (Yamabe et al., 1996).
1.2.3.2 War and terrorist acts
Studies of the impact of war and terrorist acts have generated mixed results. 
Meisel et al. (1991) reported that the incidence o f acute MI and sudden death increased 
in an area near Tel Aviv during the initial phase o f the Gulf War in 1991. This finding 
was corroborated by a national survey in Israel, in which there was a 58% increase in 
total mortality on the day of the first missile strikes, largely attributable to acute MI and 
SCD (Kark et al., 1995). Studies in other war zones have produced mixed results, but the 
quality o f data collected under such difficult circumstances is very variable (Mihatov et 
al., 1995; Dumitrascu etal., 1993).
It might be expected that traumatic events such as major terrorist incidents would 
have similar effects. A study o f 200 patients with implantable cardioverter defibrillators 
(ICD’s) in New York City showed an increase in serious arrhythmias following the 
attacks on September 11, 2001; the proportion of patients who experienced 
tachyarrhythmia more than doubled over the 30 days following the attacks in comparison
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with other months (Steinberg et al., 2004). Another study involving ICD patients in 
Florida also showed a near threefold increase in ventricular tachyarrhythmia triggering 
defibrillator shocks in the 30 days following the attacks (Shedd et al., 2004). But studies 
of cardiac death and admissions to acute coronary care in New York City in the period 
surrounding September 11th have shown no excess rates (Chi et al., 2003). Similarly, the 
major riots and civil unrest in the Los Angeles area in 1992 led to a marked increase in 
traumatic deaths, but no change in cardiovascular mortality (Birnbaum et al., 1997).
1.2.3.3 Industrial disasters
A recent study investigated the impact on ACS of a major explosion in a 
chemical plant in Toulouse, France (Ruidavets et al., 2006). This induced an earthquake 
measuring 3.4 on the Richter scale, and destroyed 27,000 homes. A threefold increase in 
fatal and nonfatal ACS was recorded over the 3 - 5 days following the explosion in 
comparison with several reference periods. Impact was confined to a small district 
immediately surrounding the plant.
1.2.3.4 Festivals and public holidays
A controversial literature has emerged relating anniversaries and culturally
significant dates with heightened cardiac mortality. Phillips and colleagues have argued
that mortality is raised around Christmas and New Year, (Phillips et al., 2004) in the
week following Passover among Jewish Americans, (Phillips et al., 1988) and on the 4th
of the month (a superstitious date) among Chinese and Japanese Americans (Phillips et
al., 2001). In the same vein, another study showed increases in cardiovascular mortality
at the turn o f the millennium (Poole et al., 2005). The reliability o f these effects has
been doubted, and it has been suggested that they may depend on the comparison periods
used (Smith, 2002). It is also questionable whether these effects are driven by emotional
responses, since other factors such as overeating, binge drinking, exposure to particulate
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matter from domestic fireplaces, difficulties in obtaining medical assistance, and hospital 
staffing issues during holiday periods may contribute (Kloner et al,, 2006).
1.2.3.5 Sporting events
Major sporting events can be very stressful for enthusiasts and supporters. An 
important match in the 1996 European soccer championship between France and the 
Netherlands resulted in a draw, and so proceeded to a penalty shoot out (sudden death) 
which the French won. Cardiovascular mortality during this exciting and much watched 
event was analysed in the complete Dutch population aged 45 or more (Witte et al.,
2000). There was a relative risk of death from acute Ml or stroke o f 1.51 (95% C.l 1.08 - 
2.09) on the day o f the match for men compared with the five days on either side, with 
no effect on women. No such effect was observed among French men (Toubiana et al.,
2001). A pattern of increased hospital admissions for acute MI in England on the day of 
the country’s 1998 World Cup match against Argentina has also been described; this 
match again involved a penalty shoot out, and England lost (Carroll et al., 2002). 
Another study from the Netherlands failed to observe any increase in ACS on the days of 
other international matches (Brunekreef et al., 2002), while a more recent study of 
football matches played by teams from the North-East of England over a 5 year period 
demonstrated a small increase in deaths from acute MI and stroke in men on the days on 
which these teams lost (Kirkup et al., 2003). Two reports from French-speaking 
provinces o f Switzerland showed higher rates of cardiac arrest and sudden cardiac death 
(SCD) during the 1998 World Cup compared with the periods immediately before and 
afterwards (Katz et al., 2005; Katz et al., 2006). The circumstances surrounding these 
deaths are not known, and it is possible that physical exertion, emotional stress, and 
alcohol consumption all contributed to triggering.
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1.2.3.6 Problem s o f  interpretation
The evidence from population studies of emotional triggering is mixed, but this is 
perhaps not surprising, since data are generally derived from opportunistic retrospective 
investigations o f difficult circumstances in which the health services had more 
immediate priorities such as treating injuries. Definitions of ACS, the time frames of 
studies, and the selection of comparison conditions have also varied widely. Very few 
negative or null associations between stressful events and ACS have been published, 
suggesting that there may be bias towards publication o f positive effects. More 
fundamentally, it is difficult in many cases to rule out alternative explanations of 
associations between disasters or traumatic incidents and ACS onset. These include 
concomitant behaviours such as vigorous physical exertion (escaping from disaster 
zones) or heavy eating and drinking (sporting events and festivals), exposure to toxins 
and pollutants (industrial disasters, war settings), and disruption of primary care and 
emergency services which might otherwise have prevented acute cardiac events. 
Nonetheless, the evidence is generally supporting of a positive relationship between 
exposure to population-level traumatic events and heightened rates o f ACS and SCD.
1.2.4. Individual emotional experiences
Early research involved collating reports from patients soon after hospital
admission. The incidence of emotional triggers varies widely between studies. For
example, the M ulticenter Investigation o f Limitation of Infarct Size (MILIS) study
involved 849 acute MI patients interviewed within 18 hours o f symptom onset, of whom
18% reported emotional upset (Tofler et al., 1990). The pilot stage o f the Triggers and
Mechanisms o f Myocardial Infarction (TRIMM) study included 224 acute MI patients,
35% of whom reported either emotional upset or stress within the preceding 24 hours
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(Willich et al., 1991). By contrast, just 2% o f the 1,114 patients in the Secondary 
Prevention Reinfarction Israeli Nifedipine (SPRINT) study reported mental stress as a 
possible trigger o f MI (Behar et al., 1993). Combining results from a number of studies, 
Culic et al. (2005) concluded that 6.8% of patients report emotional stress preceding the 
onset of MI.
There are two major difficulties with studies that simply enquire about the 
occurrence of triggers. First, patients’ reports may be influenced by their attempts to 
make sense of their predicament. Patients and their families develop causal models of 
heart disease, with stress featuring prominently (French et al., 2001). These views will 
affect responses to enquiries about the triggering period. Second, control groups or 
control time periods are not tested. Emotional stress may occur frequently in patients’ 
lives, and its association with ACS onset may be coincidental. Case-control methods can 
be used, but there are problems in identifying appropriate control groups (Maclure et al.,
2000). General population comparisons have the limitation that healthy individuals are 
most likely to participate, leading to a healthy volunteer bias, and that controls are less 
likely to agree to be assessed on a stressful day. Data from individuals hospitalised for 
other health problems can be used, but will be affected by whatever caused their medical 
condition
The investigators in the Determinants o f Myocardial Infarction Onset Study 
(Onset) have developed the case-crossover design, in which the critical time periods are 
compared with control times on a within-subject basis (Maclure et al., 2000; Maclure et 
al., 1991). This method involves questioning patients about possible triggers during the 
hazard period, and then in control periods. For example, an ACS patient might be 
questioned about emotional stress in the one hour preceding symptom onset, and also 
about the corresponding one hour that occurred 24 hours earlier (pair-matched interval
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approach), or another time period such as the last week or the previous 12 months (usual 
frequency method). If a patient is habitually emotionally stressed, then he or she will 
report stress for both times. By comparing hazard and control periods, the relative risk 
that an episode of emotional stress is followed by an ACS can be computed. Most of the 
results described in later sections have used this method.
1.2.4.1. Anger
Studies o f triggers based on interviews allow patients’ emotional experiences to 
be defined in some detail. These analyses have identified anger as a possible trigger of 
ACS. The Onset study interviewed 1623 patients, 39 of whom reported being very angry 
or furious in the 2 hours prior to acute MI (an incidence o f 2.4%) (Mittleman et al., 
1995). The odds o f ACS onset following acute anger relative to no anger in the pair- 
matched analysis were 4.0 (C.l. 1.9 - 9.4). This effect was independent of age, sex, 
cardiovascular risk factors, and the use o f beta-blockers, although aspirin had a 
protective effect. Interestingly, the risk o f anger triggering was inversely related to 
socio-economic status, so was more common in patients with little formal education. 
Anger was also assessed as a potential trigger in the Stockholm Heart Epidemiology 
Program (SHEEP). The absolute incidence o f intense anger in the hour preceding onset 
was 1.2% (Moller et al., 1999), with a relative risk (compared with usual levels of anger) 
o f 9.0 (C.l. 4.4 - 18.2).
Strike et al. (2006) tested the role of anger as a trigger not only o f acute MI but o f
other forms o f ACS in a cohort o f 295 patients selected for their ability to recall the onset
o f symptoms, and excluding individuals with co-morbid conditions that might have
affected mood and emotion. Episodes of anger, including arguments with neighbours,
anger during commuting, and family conflict, were reported by 17.4%. The odds ratio
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for onset of ACS after anger compared with no anger in the pair-matched analysis was 
2.06 (C.l. 1.12 - 3.92). Anger triggering was again more common in socio-economically 
deprived patients, similar to the findings from the Onset study. Anger triggering was not 
related to cardiovascular risk factors, having a previous MI, or to the presence of 
premonitory symptoms, but was more common in patients admitted with ST elevation 
MI compared with non-ST elevation MI or unstable angina. A case-crossover study of 
patients who had suffered an ischaemic stroke also showed an association with anger in 
the two hours preceding symptoms (odds ratio 14.0, C.l. 2.8 - 253.6) (Moller et al., 
2005).
1.2.4.2. Acute stress
The role o f work stressors as acute triggers has been studied in a Swedish patient 
cohort (Moller et al., 2005). Using case cross over methods, it was found that work 
stressors such as having high pressure deadlines in the previous 24 hours were associated 
with substantial increases in risk (odds ratio 6.0, C.l. 1.8 - 20.4), in comparison with the 
period 24-48 hours before the MI. This finding is significant in view o f the evidence that 
high job demands, either alone or in conjunction with low control, predict future CAD 
(Moller et al., 2005).
Other researchers have assessed general emotional distress. For instance, 
emotional upset was reported by 4.4% of patients in the 24 hours prior to onset in the 
TRIMM study, with a relative risk in a case-control analysis of 2.7 (C.l. 1.1 - 6.6) 
(Willich et al., 1993). Commuting stress resulting from exposure to heavy traffic has 
been evaluated in Augsburg, Germany (Peters et al., 2004). The odds of MI following 
exposure to traffic in the hour before onset of symptoms were 2.92 (C.l. 2.22 - 3.83).
1.2.4.3. Acute depression
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Depression has not been widely studied as an acute triggering o f ACS, although it 
is relevant both to the long term development o f CAD and to prognosis following cardiac 
events (Nicholson et al., 2006). In a study by Steptoe et al. (2006), the occurrence of 
episodes o f acute depressed mood prior to ACS symptom onset was examined. Discrete 
episodes of depression or sadness were reported by 18.2% of patients in the two hours 
before symptom onset. The odds o f ACS following depressed mood were 2.50 (C.l. 1.05 
- 6.56) in the case-crossover analysis. When analyses were limited to severely depressed 
mood, the odds were greater (5.08, C.l. 1.07 - 47.0). As with anger triggering, depressed 
mood in the hazard period was more common in lower socio-economic patients. It was 
unrelated to the clinical severity of the ACS, extent of coronary artery stenosis, or to a 
history of depression.
1.2.5. Methodological issues
The use of case-control and case-crossover designs has facilitated more valid 
conclusions to be drawn about emotional triggers, since these methods overcome many 
o f the biases present in studying acute causes. Nevertheless, a cautious attitude to 
interpretation is still necessary.
The case crossover method involves questioning patients about possible triggers
during the hazard period, and then in control periods. For example, an ACS patient
might be questioned about emotional stress in the one hour preceding symptom onset,
and about the corresponding one hour before the hour surrounding symptom onset and
the hour after (pair-matched interval approach). An alternative approach can also be
used in which another time is used such as the last week or the previous 12 months
(usual frequency method). If a patient is habitually emotionally stressed, then he or she
will report stress for both times. By comparing hazard and control periods, the relative
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risk that an episode o f emotional stress is followed by an ischaemic episode 
(characterised by ST depression on ECG or associated arrhythmia or change in heart rate 
or heart rate variability) can be computed. This method has several advantages in the 
analysis of transient events, since self-matching eliminates selection and individual 
reporting biases. Any differences in chronic cardiovascular risk profile between cases 
and controls are also eliminated, reducing the risk of residual confounding.
However, neither the case-crossover nor case-control designs involving 
hospitalised patients can completely eliminate reporting biases. Even though the same 
individuals provide information for hazard and control periods in the case-crossover 
design, ACS patients may emphasize emotional triggers in the presymptomatic period, as 
they develop their cognitive representation of the cardiac event (French et al., 2001). 
One method of addressing this issue is to seek verification of the patient’s behaviour or 
emotional state from bystanders or relatives who witnessed the scene. To date, data have 
been derived almost completely from patients themselves.
In the case-crossover design, the control period is more distant in time than the 
hazard period, and may lack the salience o f the hours preceding symptom onset. 
Memory for these control periods, even for a pair-matched period 24 hours earlier, may 
not therefore be as accurate as for the hazard period. This can result in an overestimation 
o f relative risk. However, an analysis o f patients with M eniere's disease involving 
repeated measures o f stress showed that memory decay did not influence classification of 
exposure to triggers (Moller et al., 2004).
Another important issue is whether emotional triggers precede acute symptoms, 
or whether the patient experienced premonitory signs. The presence o f premonitory 
symptoms may influence the hypothesised causal chain. For example, there are rapid 
increases in inflammatory markers such as IL-6 and C-reactive protein at the early stages
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of ACS (Libby et al., 2002). Inflammation can induce acute negative emotional states, 
even when the inflammatory stimulus is relatively mild (Strike et al., 2004). Hence, it is 
conceivable some emotional “triggers” are actually secondary to the early stages of 
plaque disruption.
In summary, it remains unknown whether the initial experience of cardiac pain 
then triggers the ECG changes and subsequent emotional response or whether it is 
emotion itself that causes the cardiac symptoms and then the ECG changes. Closer 
examination o f the mood and cardiac physiological changes surrounding the ischaemic 
episodes may elucidate this process.
1.2.6. Summary
To conclude, a range of studies suggests that behavioural and psychological 
stimuli may act as triggers o f acute MI. There is less known about the physiological 
effects o f emotional stresses and strains o f everyday life that may affect moment to 
moment mood in susceptible individuals, which could contribute to the development of 
CAD, both acutely, and in the long term. The SIS study addresses this particular issue 
and the method o f the study is described in chapter 4 with the results presented in 
chapters 5, 6 7 and 8.
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1.3 Long term psychosocial adaptation and quality of life after ACS
1.3.1 Introduction
This chapter so far has described the various psychosocial factors that are thought 
to influence cardiovascular disease development, and some of the literature concerning 
psychosocial factors in the triggering o f acute cardiac events. An additional issue is long 
term adaptation in survivors o f acute cardiac events. This is important both for the 
patient and family. A crucial finding is that adaptation and later quality o f life are not 
solely determined by clinical disease severity and treatment, but are also influenced by 
psychosocial factors.
The mortality rate for Ml patients is relatively high during the first month, after 
which it levels off. This is related to a number of clinical factors such as myocardial 
contractility (Peterson et al., 1997), and presence o f angina or arrhythmia (Bigger et al.,
1994). The 1 year cardiac mortality rate is 18% for persons over the age o f 75 years and 
increases with age (Aronow et al., 1998). Long term prognosis is also dependent on pre 
infarct cardiac risk factors such as diabetes (Sprafka et al., 1991). However, in addition 
to clinical factors, several psychosocial factors have been implicated in prognosis to 
CAD (Hemingway & Marmot, 1999).
Over the last decade, there have been significant advances in early recognition of 
MI and in medical treatment, and these have reduced early death, cardiac complications 
and recurrent episodes o f disease. Reducing patient cardiac mortality has meant there is 
a growing recognition o f the importance of outcomes following a myocardial infarction, 
such as physical symptoms, emotional distress and functional status (i.e. return to work).
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The needs o f people recovering after an acute cardiac event vary, with some 
having psychological problems and others needing risk factor management or lifestyle 
changes. In particular, a high degree of emotional distress may be seen whilst in the 
hospital coronary care unit (Cay et al., 1972), during early convalescence (under 3 
months post MI) (Wiklund et al., 1984) and at follow up 1 year post Ml (Mayou et al„ 
1978; Wiklund et al., 1984). Anxiety and depression post MI are still very common, 
have been associated with reinfarction and death, after adjustment for other cardiac risk 
factors (Laerum et al., 1988; Barefoot et al., 1999; Frasure-Smith et al., 1993, 1995), and 
are predictors of return to normal activity (Maeland et al., 1989). There is also more 
limited evidence that initial emotional distress at the time can predict outcomes for other 
aspects of quality o f life (Petrie et al., 1996), lifestyle changes (Billing et al., 1997) and 
medication adherence (Maeland et al., 1989). Many patients post MI avoid physical 
activity (Wiklund et al., 1984) and a substantial number retire early or become 
unemployed (Mayou, 1979), with reduced social activities as a consequence as well.
There are a number of psychosocial influences (especially depression and anxiety 
that often co exists) on adaptation and prognosis in CAD, in various longitudinal, 
community based, prospective studies on cardiac patients, in terms o f quality of life and 
well being, as well as the harder end points of cardiac mortality and morbidity. In my 
thesis, I am exploring both the psychosocial factors that may influence early 
development o f CAD, and which physical or psychological factors at the time of an acute 
event may predict later adaptation to established CAD.
1.3.2 Health related quality of life and psychosocial factors in cardiac patients
Health related quality o f life (HRQL) is broadly defined by the impact of the 
disease and medical treatment on the patients overall functioning and well being (Gill et 
al., 1994). Health related quality of life measures are derived from questionnaires that
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elicit from patients, the impact of their condition on their functioning, symptoms and 
quality o f life. The World Health Organisation (Soc Sci Med. 1995) describes quality of 
life as ‘an individual perception of their position in life, in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, standards, 
and concerns’. It is a multidimensional global construct with three main domains: 
physical, physiological and well being. Several general and disease specific instruments, 
for example the SF36 questionnaire, have been developed to assess different aspects of 
health related quality o f life in coronary patients with physical and mental health being 
their main components (Brown et al., 1989).
Differences in quality o f life have been observed in presence of cardiovascular 
risk factors or clinical manifestations o f disease (Rawles et al., 1992). Specifically, 
studies have shown that presence o f angina, shortness o f breath, congestive heart failure 
and consequent dysrythmias, co-morbidities, having a previous MI, surgery and 
revascularisation appear to be highlighted as predictors of poorer quality o f life in follow 
up periods ranging from 3 months to 5 years (Failde et al., 2006; Nash et al., 1999; 
Wiklund et al., 1989; Heller et al., 1997; Brown et al., 1999). Many o f the studies 
analysing predictors of poorer quality o f life post MI have found physical functioning to 
be greatest affected in patients who have had an MI compared to those who have not 
(Van Jaarsveld et al., 2001; Mendes de Leon et al., 1996; Failde et al., 2006).
In the clinical management of post MI patients, the focus on adaptation is often 
on the optimal physical functioning of the patient, but in the long term adaptation to 
CAD, optimising general health, vitality, social functioning and emotional functioning is 
just as important (Brown et al., 1999). Increasingly, health related quality of life 
outcomes are now used as end points in randomised clinical trials of MI patients to 
evaluate the efficacy o f medical or surgical treatments or post MI care (Strauss et al.,
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1995). Finally, identification at the time of hospital admission o f predictors of impaired 
quality of life would allow appropriate risk stratification on discharge for the clinician.
There have been several studies on the impact o f MI on quality o f life outcomes. 
These studies differed from each other by measuring particular dimensions o f quality of 
life, focusing only on a single aspect o f quality o f life, i.e. physical function, social 
function, mental health scores (Wiklund et al., 1984, King et al., 1993), although recent 
studies have used composite measures of quality o f life (Lim et al., 1993). Previous 
studies have had limitations in that they were cross-sectional in design (Medical 
Outcomes Study, Wiklund et al., 1989) or limited to selected patients enrolled in trials 
focussing on treatment or cardiac rehabilitation effects (Mayou et al., 1991; Beck et al.,
2001) rather than on longitudinal community based samples. Additionally, very few 
studies have been carried out that evaluated baseline characteristics o f the patients, or 
reported adequate clinical and non clinical data on relevant patients’ characteristics 
(Heller et al., 1997) that could be associated with impairment or improvement of quality 
o f life post MI.
Much o f the literature has tried to identify the key clinical, demographic, and 
psychological characteristics of patients associated with changes in health-related quality 
o f life following discharge after MI. Brown et al. (1999) carried out a cohort study on 
post MI patients over 4 years and compared them to community controls, to determine 
what factors were associated with a poor quality of life. The eight SF36 quality of life 
domain and overall scores were the main outcome measures. Results found that 
compared to age and sex matched controls, patients aged under 65 years showed 
impairment in all eight domains, the largest differences being in physical functioning 
(mean difference 20 points) and general health (mean difference 19 points). Multiple 
regression analysis revealed that impaired quality o f life was closely associated with
inability to return to work through ill health, a need for coronary revascularisation, the 
use of anxiolytic medication, and a variety of clinical symptoms. The greatest impact on 
quality of life is seen in patients of working age. Impaired quality o f life was reported by 
patients unfit for work, those with angina and dyspnoea, patients with coexistent lung 
disease, and those with anxiety and sleep disturbances. Similarly, Brink et al. (2005) 
found lower scores of quality o f life for both physical and mental scores 5 months after 
MI. In contrast, Beck et al. (2001) analysed predictors o f quality of life at 6 months and 
1 year after an acute MI, in a prospective cohort study o f 587 patients, and concluded 
that whilst age and psychosocial characteristics were associated with predictors of 
quality of life after MI, other clinical treatments or clinical characteristics had no effect. 
Although mean scores were slightly lower at 6 months than at the baseline, they did not 
actually change over the time course of follow up.
The follow up period over which the changes in quality o f life are measured is
also relevant, as are the distinct dimensions being measured. In the population based
prospective study conducted by Mendes de Leon et al. (1998), which investigated
changes in health-related quality o f life outcomes following a MI from a population-
based perspective. 2812 patients older than 65 years were followed up between 1982
and 1988. It was found that changes in quality of life were more significant in those who
had a recent MI (under a year) compared to those whose MI had occurred more than a
year before. In bivariate analysis, physical functioning declined more in MI patients than
in the non MI group (26.4% vs. 11.9%, p = 0.001) as did social functioning (31.4% vs.
20.8%, p = 0.06). The effect of MI on both physical and social functioning was shown to
be much stronger among the patients who had a recent MI (<1 year ago), than those
whose MI had occurred more than a year before post MI assessment. Similarly, the
study o f 539 post MI patients by Wiklund et al. (1989) showed that quality of life scores
were more favourable in participants at 5 years than at 1 year. At 5 years, there were
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smaller impairments in the domains of energy, sleep, and mobility when compared with 
normative data. However, the patients in the study were originally selected for a beta 
blocker trial and therefore represented a selected population.
The effect of socio-demographic variables on quality of life in cardiac patients 
has been described by several authors, who have shown that women and patients of 
lower socio-economic status have poorer quality o f life (Hemingway et al., 1997, Van 
Jaarsveld et al., 2002). Women showed a significantly lower quality of life compared to 
men, in a study by Emery et al. (2004), in which 536 cardiac patients (36% women) were 
followed up at 12 months. Heller et al. (1997) followed up 424 patients discharged from 
hospital after an Ml or angina episodes for 6 months, and again found that poorer quality 
o f life scores were predicted by sex and age. Age is another important predictor of 
quality of life (Beck et al., 2001; Nash et al., 1999). A more recent study by Failde et al. 
(2006) found that for each year of age increase, the physical function score (PCS) 
decreases by 0.2 points. This may be due to younger patients being treated more 
aggressively in hospital or having greater dissatisfaction with perceived disabilities. In 
the study by Brown et al. (1999), those aged under 65 years experienced a worse quality 
o f life at 4 years follow up, than those of similar age who had no infarct. However, this 
difference was not seen in the over 65 year age group, perhaps due to lower expectations 
or due to existing co morbidities with advancing age. The importance o f social support 
in predicting poorer prognosis post MI is supported in many studies (Ruberman et al., 
1984; Case et al., 1992; Jenkinson et al., 1993; Welin et al., 2000; Emery et al., 2004). 
Employment and marital status as well as lifestyle factors such as smoking have also 
been shown to predictor poorer quality of life measures (Heller et al., 1997; Brown et al., 
1998; Dias et al., 2005).
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Considering the effect of psychological factors on quality o f life, it has been 
shown that depression has an adverse effect on angina and quality of life. Studies of 
these relationships are more firmly established than the studies of effects that depression 
has on CAD mortality. Depression is associated with increased re-hospitalisation, more 
re-infarction, more angina, emotional instability, social impairment, delayed return to 
work and impaired quality of life (Cay et al., 1973; Wiklund et al., 1984; Maeland et al., 
1987). In addition, even minor elevations in depressive symptoms significantly impair 
quality of life and may increase the risk of CAD in healthy people, let alone those with 
advanced cardiac disease (Davidson et al., 2004). Depression also predicts physical 
inactivity in post MI patients. Allan et al. (2007) conducted a study on 502 patients post 
MI assessing their level o f depression, perceived behavioural control and exercise 
activity just prior to hospital discharge and followed up these patients at 12 months 
assessing the same factors. Results showed that depression and perceived behavioural 
control independently predicted fitness (p <0.005) and regular exercise activity (p 
<0.005) at 12 months, independent of age, gender, socio-economic status, illness severity 
and reported activity prior to hospitalisation.
Depression overlaps with other constructs. Patients who have undergone an MI
exhibit both an increase in anxiety and/or depression scores, both initially after the MI
and at a later date. These emotions have been shown to be related to much poorer
quality o f life measurements at follow up time points after the initial MI. Van Jaarsveld
et al. (2001) studied 89 post MI patients and 119 heart failure patients who were selected
from primary health care registers. An increase in anxiety was seen immediately after
the diagnosis o f MI, but at 6 months, an increase was also shown in depressive
symptoms. Feelings o f both anxiety and depression were higher at one year in the post
MI and heart failure patients than pre morbid levels. Supporting this relation between
anxiety seen after an acute cardiac event and later poorer quality o f life is a study by
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Wiklund et al. (1988). Wiklund et al. (1988) followed up 549 post MI patients after 
hospital discharge. Multivariate analysis showed that anxiety was closely associated 
with poorer quality o f life with persistent anxiety inhibiting satisfactory resumption of 
daily functioning.
To conclude quality of life is an important measure of a patients’ well being post 
MI, as advances in medical care mean that more patients are surviving the initial event to 
a greater age. Psychological disability is sometimes as great a barrier as physical 
impairment in the recovery from a physical illness.
1.3.3 Depression and prognosis in cardiac patients
Depression is disproportionately prevalent amongst cardiac patients, with much 
evidence to suggest that major depression occurs in about 15% of patients following an 
acute Ml and minor depression in a further 20 % (Lett et al., 2004; Barefoot et al., 1997; 
Carney et al., 1997; Rozanski et al., 1999). This section outlines the evidence that 
depression and often co-existing anxiety states are related to CAD prognosis in terms 
mortality and morbidity.
Longitudinal prospective studies have been carried out in several populations, 
such as patients recovering from an MI, those with stable CAD and those awaiting 
surgery. A variety o f measurements of depression have been used including the Beck 
Depression Inventory (BDI), the Zung self-report scale and the Centre for 
Epidemiological Studies Depression (CES-D) questionnaire. Some studies used clinical 
interview for assessment o f depression. Additionally a variety of follow up time periods 
were used.
The majority o f studies report that the presence of depression conferred 2.5 times 
the risk for mortality or non fatal cardiac events. In some studies, depression post MI
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was associated with a three to four fold increase in risk o f cardiac mortality, and this risk 
was not limited to major depression (Frasure-Smith et al., 1993, 1995; Ahern et al.,
1990). These studies have also shown that the prognostic impact of depression is 
independent o f other major prognostic factors, for example, severity of coronary 
atherosclerosis. In addition to the mortality risk associated with post MI depression, 
increased health care costs associated with readmission amongst depressed patients were 
also observed (Frasure-Smith et al., 2000). In the study by Frasure-Smith et al. (1999), 
896 patients post MI were followed up, and at one year it was shown that elevated 
depressive symptoms, (as measured by the BDI), predicted cardiac mortality after 
controlling for other predictors of mortality. The impact o f major depression appears to 
be as important as left ventricular dysfunction or a history of previous CAD (Frasure- 
Smith et al., 1993), and is a significant predictor o f 1 year mortality in women as well as 
men, independent of other post MI risks (Frasure-Smith et al., 1999).
Similar results for the effect of depression on mortality were shown by Carney et 
al. (2003), when 358 depressed patients post MI from the ENRICHD clinical trial study 
were compared to 408 non-depressed controls in terms of prognosis. Six months post 
MI, it was found was that the depressed patients had more than twice the risk for all 
cause mortality. In a longer term study, Barefoot et al. (1996) followed up 1250 patients 
who had underwent diagnostic coronary angiography for 19.4 years, and showed that 
those with moderate to severe depression were at 69% greater risk for cardiac death and 
78% greater risk for all cause death.
The findings o f these studies contrasts with the study by Lane et al. (2000, 2001,
2002) which followed up 288 post MI patients and found that depression was unrelated 
to cardiac or all cause mortality at 4 months, 1 year and 3 year follow up. However, the 
discrepancy may be due to the small sample size or inadequate assessment o f depression
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in this study. Jenkinson et al. (1993) followed 1376 patients post MI for 3 years and 
reported no association between depression at the time of hospitalisation and all cause 
mortality. Although here the sample size was larger, one limitation is that depression 
was assessed using a non validated scale with only three items for depression. A higher 
prevalence o f arrhythmia during ambulatory monitoring has been found amongst 
depressed CAD patients than in non-depressed CAD patients, which may partly explain 
the increased risk for cardiac mortality in depressed CAD patients (Carney et al., 1993).
There have also been studies assessing the association between depression and 
recurrent or new cardiac events, and not just all cause or cardiac mortality as a clinical 
outcome. Studies o f patients with stable CAD have reported significant associations 
between depression and clinical outcomes. Carney et al. (1988) followed 52 patients 
post catheterisation over one year and found that those with major depression had more 
than twice the risk of having a cardiac event, after controlling for other risk factors.
There have been a number of studies comparing symptoms of both anxiety and 
depression as predictors of cardiac events and increased health care consumption post 
MI. In the study reported by Strik et al. (2003), both depression and anxiety predicted 
subsequent cardiac events but in multivariate analysis that tested both anxiety and 
depression and hostility, only anxiety was shown to be an independent predictor of 
cardiac events. In the literature, studies of anxiety and depression that predict clinical 
prognosis post MI have controlled for disease severity (Denollet et al., 1998). Other 
prognostic studies have shown that the clinical disease severity at follow up correlates 
with the level o f depression or anxiety of the individual after controlling for confounders 
(Frasure-Smith 1995, 1999). Lesperance et al. (2002) showed that patients post MI had 
increased mortality rates as a function of the degree o f depressive symptoms at one and 
five years after the MI. In the study by Denollet et al. (1998) a positive association was
shown between symptoms of anxiety and increased mortality post MI, whilst two other 
studies did not show this effect (Lane et al., 2001, 2002 and Mayou et al., 2000). 
Frasure-Smith et al. (1995) showed in a multivariate analysis o f 222 patients with a 
previous MI, that depressive symptoms, anxiety and a major history of depression had an 
impact on outcome independent of each other. Specifically, an association between 
anxiety and recurrent cardiac events was seen but not between anxiety and mortality. 
Frasure-Smith and Lesperance et al. (2003) compared the effect of depression, anxiety, 
anger, stress, social support and self-reported health in prediction o f mortality post MI, 
and only negative affect came out as uniquely predicting poorer outcomes.
Overall, findings from various studies are mixed. In populations with known 
CAD, there are several studies showing significant relations between depression and 
cardiac morbidity and mortality (Mendes de Leon, 1998, Welin et al., 2000; Lesperance 
et al., 2002; Sirois & Burg, 2003). However, there are also several studies showing no 
relation whatsoever between depression and CAD (Vogt et al., 1994; Wiklund et al., 
1988; Legault et al., 1992; Irvine et al., 1999; Lane et al., 2000, 2001; Mayou et al., 
2000). It may be that these prognostic studies which have negative findings do so 
because they have small sample sizes, low participation rates and/or short follow up 
intervals, which reduce the possibility o f detecting effects, as noted by Carney and 
Freedland (2003).
However, the positive results found in prognostic studies may well have been 
because adjustments for confounding risk factors (e.g., disease severity) may not have 
been comprehensive, or the diagnosis of depression may have been confounded by the 
patients actual medical condition (Carney & Freedland, 2003). Another limitation in the 
literature is that majority o f studies have not included racial or ethnic minorities.
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Intervention trials examining the effects treating depression in cardiac patients 
with cognitive-behavioural therapy or pharmacotherapy, have not shown marked effects 
on coronary morbidity to date (Glassman et al., 2002; Mendes de Leon et al., 2006). But 
the strength of evidence relating depression to morbidity and quality o f life, warrants 
continued research on understanding mediating mechanisms.
The evidence suggests that one has to keep an open mind on the causal link 
between anxiety and depression and subsequent cardiac morbidity and mortality post MI 
and although hard clinical end points are considered in assessing this link, new outcome 
measures such as quality o f life have an increasingly importantly significant role in 
today’s increasingly elderly population.
1.4 Studies described in this thesis
The broad aim o f this thesis is to investigate the role o f psychological factors in 
the development of CAD both acutely in everyday life in patients with suspected 
coronary artery disease as well as in the long term adaptation following ACS. My thesis 
presents three studies concerned with psychosocial factors in patients with suspected and 
advanced heart disease, focusing particularly on the role o f negative emotions in 
vulnerability to myocardial ischaemia in daily life, the influence of acute emotional 
triggers o f ACS on long term quality of life, and the effect of depression following ACS.
The largest study described in this thesis, called the Silent Ischaemia Study (SIS), 
evaluated the influence o f emotional factors on cardiac health in daily life. Chapter 2 
will review the literature on the physiological mechanisms proposed to account for the 
associations between psychosocial factors described in this chapter and CAD 
development and prognosis, in terms of transient myocardial ischaemia, autonomic and
59
neuroendocrine function. It is based on the propositions that transient ischaemic 
episodes, altered heart rate variability or an altered diurnal cortisol profile during 
everyday life can be induced by emotional stress, and that they are damaging because of 
their association with prothrombotic and inflammatory processes. Chapter 3 will 
discusses a number of methodological issues relevant to the SIS study, and the 
measurement o f emotional experience and physiological function in everyday life of 
patients with CAD. In the light of the importance o f depression in CAD development 
(summarised in Chapter 1.1.3), and its possible influences on the autonomic nervous 
system and neuroendocrine function, I have also analysed heart rate variability (HRV) 
and cortisol profile in relation to depressed mood
The method of the Silent Ischaemia Study is described in Chapter 4. The 
relationships between depression, mood in everyday life, and autonomic and 
neuroendocrine function, are described in chapter 5 and 6, while the psychophysiological 
correlates of acute ischaemic episodes are detailed in chapter 7. Chapter 8 describes the 
results of a 6 month follow up of this clinical sample, to assess progression in disease 
and functional recovery and to discover whether emotional and psychophysiological 
factors predict clinical outcomes and changes in health-related quality of life over this 
period.
The SIS study examined emotional and clinical factors at an early stage of CAD 
in which the patients were having cardiac symptoms and positive cardiac tests but had 
not actually had an ACS event yet. The second and third studies presented in my thesis 
explore the role o f psychological experience in long term adaptation following ACS. 
Data were derived from the ACCENT (Acute Coronary Syndrome, Emotion and 
Triggers) study, an investigation carried out by the Psychobiology Group at UCL 
between 2002 and 2005. I was involved in collecting data, 12 and 36 months after the
patients in this study were initially hospitalised with an ACS. The focus o f the analyses 
in chapters 9 and 10, is on the early emotional predictors of long term functional 
recovery, and quality o f life following a cardiac event. Two issues are addressed: 
emotional predictors o f return to work at one year after ACS, and the relationship 
between the acute emotional and physical triggers implicated in the ACS event and long 
term psychological and physical adaptation. The thesis concludes with chapter 11 which 
discusses the findings from all three studies in how mood may relate to CAD 
development and adaptation long term via psychobiological processes and what these 
new findings add to the existing literature. In addition, limitations of the current research 
and proposals of potential further work are discussed to add to the body of research.
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Chapter 2: Mechanisms underlying the association between
psychological states and CAD
2.1 Introduction
The literature presented in Chapter 1.3 strongly supports a relationship between 
mental stressors (such as negative affect) and CAD (both the development o f CAD and 
the prognosis after CAD). This raises the question of what are the biological 
mechanisms through which negative emotions such as depression, anxiety, and 
anger/hostility exert their influence on CAD outcomes such as transient myocardial 
ischaemia (TMI), arrhythmias, angina, myocardial infarction (MI) or death from 
cardiovascular disease.
TMI is thought to be the one of the final pathophysiological effects of a variety of 
physiological responses. These include the activation o f the autonomic nervous system 
(ANS), the hypothalamic -  pituitary - axis (HPA), and a variety o f other inter-related 
biological mediators that are activated by acute or more chronic emotional and physical 
stressors in daily life. TMI itself may act as a precursor for fatal cardiac arrhythmias, 
myocardial infarction and death. Figure 2.1 is adapted from Brotman et al. (2007), and 
illustrates the stress response as it relates to CAD. It highlights the psychobiological 
processes underlying the link between emotion and CAD that will be explored in this 
thesis.
The purpose o f this chapter is to review the evidence for transient ischaemia in
everyday life and in the laboratory, its clinical significance, and the influence of
psychological states in daily life activity on TMI and the various biological mechanisms
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that may be relevant. In particular, I will discuss the relationship between heart rate 
variability and cortisol profile and negative emotions in daily life.
2.2 The physiological response to stress and its effects on the cardiovascular 
system
Homeostasis is the feedback mechanism that maintains constant internal 
conditions in the face of environmental changes. There are three main stages of the 
stress response: first, there is an alarm reaction where the body responds to stress; 
second, there is resistance when the body attempts to restore itself to a steady level; and 
third, if the stress continues, exhaustion occurs, with the risk of a stress related disorder 
(Stansfeld et al., 2002). Allostasis refers to the process by which the body responds to, 
and maintains homeostasis during daily life challenges (Sterling et al., 1988). If a 
normal stress response occurs frequently, is not limited or the individual does not adapt 
to a repeated stressor, adverse metabolic consequences ensue including the development 
o f  CAD. ‘Allostatic load’ refers to the repetitive or continuous build up of stressors or 
stress response.
Although glucocorticoids and catecholamines are the two main hormones of the 
‘flight or fight’ response activated by the HPA system, there are many other mediators 
including the autonomic nervous system and pro and anti-inflammatory cytokines 
(McEwen et al., 2008; Brotman et al., 2007).
The main system that brings about activation of the stress response resides in the 
hypothalamus and brainstem (Tsigos et al., 2002). Afferents to the hypothalamus and 
pituitary gland that modulate the stress response come from many sources, including the
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locus coeruleus and other noradrenaline-releasing brainstem nuclei, cortical input from 
sensory and daily life emotional (either positive or negative) triggers and inflammatory 
cytokines. The HPA is activated by corticotrophin-releasing hormone (CRH) from the 
hypothalamus, which prompts the release of corticotrophin from the pituitary, 
stimulating the production of glucocorticoids (cortisol) from the adrenal cortex and to a 
lesser extent, mineralocorticoids and adrenal androgens. Cortisol inhibits the release of 
gonadotrophins, growth hormone, and thyroid stimulating hormone, but importantly, in 
terms of cardiovascular effects, causes inhibition of inflammatory and immune 
responses, central redistribution of adiposity, reduced insulin sensitivity, and pressor 
effects (Girod & Brotman, 2004). The peripheral sympathetic nervous system, the other 
effector of the stress response, innervates tissues throughout the body, especially the 
heart, blood vessels, and adrenal medulla. It is the means by which the brain (and thus 
emotion) affects the heart and other body organs in response to acute stress (Tsigos et al.,
2002). The adrenal medulla responds with systemic catecholamine release (adrenaline), 
whereas the sympathetic nerve terminals in the blood vessels predominantly release 
noradrenaline into the circulation. The sympathetic nervous system has not only direct 
cardiostimulatory effects (increases the rate and force of contraction of the heart via beta- 
1-adrenergic receptors) and pressor (blood pressure) effects (via alpha-1-adrenergic 
receptors), but also has metabolic effects (insulin resistance and lipolysis) and varied 
immunological effects (Goebel et al., 2000).
Thus, there are varied effects of both the HPA and the SNS on both the
vasculature and metabolism. Both systems can increase blood pressure (BP), decrease
insulin sensitivity, activate homeostasis and precipitate endothelial dysfunction - an early
manifestation o f  atherosclerosis (Girod & Brotman, 2004; Curtis et al., 2002; Von Kanel
& Dimsdale, 2000; Brotman et al., 2005). The physiological effects of mental stress on
the heart are rapid (Bacon et al., 2006; Ghiadoni et al., 2000) and so the association of
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daytime stresses and strains in daily life with transient myocardial ischaemia is likely to 
be seen in patients with stable coronary lesions (Gullette et al., 1997). The 
atherosclerotic process is influenced by the cross interactions between the hypothalamic- 
pituitary-adrenal axis, the sympathetic nervous system, and inflammatory mediators. 
This is further described in section 2.2.
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Figure 2.1 Cardiovascular effects of stress and its measurement
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2.3 Summary of the pathophysiological processes underlying acute triggering of 
ischaemia
In chapter 1, I described the literature relating to acute triggering of ACS both in 
population studies and studies of individuals. In this section, I will summarise the 
underlying interconnected mechanisms, which can potentially lead to the acute triggering 
of ACS, culminating in TMI, angina, a MI or cardiac death.
The key pathological events underlying ACS are the disruption of coronary 
plaque and the subsequent development of a thrombus ('roller & Muller, 2006). Plaque 
rupture is the commonest type of disruption, accounting for some 70% of fatal acute MI 
and sudden cardiac deaths. Rupture occurs when the fibrous cap of the plaque is 
mechanically disturbed, or degraded by the action of matrix metalloproteinases released 
by macrophages. In other cases, injury is due to plaque erosion, as thrombus is 
superimposed on a plaque, which is intact except for the loss of the endothelial cell layer. 
Episodes of high haemodynamic shear stress may stimulate plaque disruption, so acute 
increases in heart rate, blood pressure, myocardial oxygen demand, and coronary 
vasoconstriction are all potentially important and may occur secondary to acute or 
chronic physical or emotional stressors.
Atherosclerotic plaques are dynamic structures in which the constituents of the 
lipid-rich core and the fibrous cap regularly change. The most angiographically severe 
lesions are not necessarily at highest risk of rupture. It is evident from histological and 
intravascular ultrasound imaging studies that episodic rupture is a frequent event that 
only occasionally results in an ACS (Naghavi et al., 2003). Two other factors therefore 
need to be taken into account. The first is the presence of a procoagulatory milieu. After 
plaque disruption, the local balance between circulating prothrombotic and thrombolytic 
factors will determine whether vessel occlusion takes place. The second is the presence
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of a myocardium that is susceptible to ischaemia. Autonomic processes (as indexed by 
heart rate and heart rate variability) strongly influence outcome after plaque disruption, 
with sympathetic hyperactivity provoking potentially life-threatening ventricular 
tachyarrhythmias, while vagal activity is protective.
Physical exertion and emotional stress stimulate sympathetic nervous system 
activation, vagal withdrawal, pressor responses, catecholamine release, increases in 
circulating interleukin (IL)-6 and other inflammatory markers, together with platelet 
activation and prothrombotic responses (Steptoe et al., 2007). Emotional stress also 
induces coronary artery vasoconstriction in patients with CAD, particularly in regions of 
stenosis. Acute mental stress administered under controlled laboratory conditions 
induces transient myocardial ischaemia as defined by decreased ejection fraction, wall 
motion abnormalities or ST segment changes in around one third to one half of patients 
with CAD (Strike & Steptoe, 2003). Stress-induced haemodynamic responses, 
particularly increases in systemic vascular resistance, coronary artery vasoconstriction, 
and microvascular changes, may all contribute to transient myocardial ischaemia. These 
studies are discussed in detail in section 2.3.
Unfortunately, there is little direct evidence as yet, documenting the activation of
pathways involved in mediating specifically emotional triggering of acute cardiac events
in ACS. The emotions identified in the triggering literature certainly stimulate relevant
biological responses in patients with CAD. For instance, anger recall elicits greater
increases in vascular resistance in CAD patients compared with controls, (Jain et al.,
1998) and vasoconstriction in stenosed vessels (Boltwood et al., 1993). Depressed mood
is associated with reduced heart rate variability in patients following MI, (Carney et al.,
2001) though relationships with inflammatory markers have been inconsistent (Schins et
al., 2005; Lesperance et al.,2004). The only study to date that has assessed physiological
responses to emotional stimuli in patients who have sustained an emotionally-triggered
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cardiac event was our investigation of 34 male ACS survivors (Strike et al., 2006). 14 
men had reported negative emotions (anger, stress or depression) in the two hours before 
symptom onset and 20 men had not. Haemodynamic variables and platelet activation 
were monitored in response to standardised mental stress tests. Both groups showed an 
increase in blood pressure in response to tasks, but the rate of post-stress recovery was 
slower in the trigger group. Systolic pressure remained higher at 30 minutes post-stress 
in the trigger than non trigger group. Additionally, the emotion trigger group showed 
significantly greater increases in platelet activation as indexed by monocyte-platelet 
aggregates; the acute response was larger, and activation persisted 30 minutes after stress 
in emotion trigger group. No differences were recorded in subjective distress between 
the groups. Patients who had experienced an emotional trigger therefore appeared to 
have heightened biological responsivity to emotional stimuli. If such responses 
coincided with plaque disruption, the result might be the development of an ACS.
2.4 Transient myocardial ischaemia
In this section, I assess the evidence for an influence of psychological factors on TMI in
everyday life. The following issues were addressed:
1. How common is psychological stimulation of TMI in everyday life? What
psychological states are the most common triggers? Are episodes likely to be 
silent or symptomatic?
2. Is psychological stimulation of TMI in everyday life more common among CAD
patients with particular psychological or social characteristics such as depression 
or low socio-economic status?
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3. What mechanisms are responsible for psychological stimulation of transient
myocardial ischaemia? Are they the same mechanisms as physical exertion?
Studies that are discussed are those that examined the link between standardised 
mental stress tests in the laboratory and myocardial ischaemic responses and also those 
that additionally looked at ischaemic responses during the elicitation of emotion. Studies 
that examined the link between emotion in everyday life and ambulatory myocardial 
ischaemia (both silent and painful) are also considered.
Studies have been categorised as follows:
1. Experimental studies performed in a laboratory setting, relating 
psychophysiological responses to mental stress tasks with myocardial ischaemia 
monitored in everyday life.
2. Observational studies performed in a naturalistic setting evaluating myocardial 
ischaemia in everyday life.
Patients in some but not all the studies were off beta blocker medication for an 
average of 48 hours, calcium blockers for 24 hours and long acting nitrates for at least 6 
hours. During a mental or exercise task an ischaemic response was defined on the ECG 
as horizontal or downsloping ST depression > 1mm or 1.5 mm upsloping below 
isoelectric baseline, measured at 0.08 seconds after J point and persisting for at least 60 
seconds. Using radionuclide ventriculography, ischaemia was defined as new or 
worsening wall motion abnormality (WMA) during stress or Ejection Fraction (EF) not 
increasing by more than 50% (physical task) or >80 % ( mental task).
2.4.1 Clinical significance of transient myocardial ischaemia (TMI)
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The significance of silent and transient episodes of ischaemia has been under 
debate from the 1970's, in conjunction with increasing popularity of the use of 
ambulatory monitoring devices for clinical and research purposes. 30-35% medically 
treated patients with stable episodes (with evidence of fixed atherosclerotic coronary 
artery disease and exercise-induced ischaemia) will have such silent episodes during 
normal everyday life (Campbell et al., 1986). Silent ischaemia occurs more frequently 
than actual chest pain symptoms in patients with stable angina.
Early studies (Rocco et al., 1985; Deedwania &Carbajal, 1990), showed an 
increased risk of coronary events in patients with ambulatory silent ischaemia. 
Deedwania et al. (1990) in his study, showed that the presence of ambulatory silent 
ischaemia identifies a subgroup at increased risk of death with higher peak exercise heart 
rates (>120 beats/min) and concluded that silent ischaemia was an independent predictor 
of mortality. In fact, this is more recently supported in a study by Biagini et al. (2005), 
which looked at the long term outcome in patients with silent versus symptomatic 
ischaemia during dobutamine stress echo (DSE). They found that the hard event rate 
(cardiac death/MI) was significantly greater in patients with silent ischaemia when 
compared to those symptomatic on DSE, and that silent ischaemia was an important 
predictor of these hard events at mean follow up of 5.5 years (SD 3.3).
This contrasts with earlier studies. Mulcahy et al. (1988) assessed the
significance of silent episodes of ischaemia in the absence of infarction, and the
relationship with left ventricular function (LVF), as well as assessing short (1 year) and
long term follow up (5 year) changes of LVF in patients with stable CAD on routine
therapy with or without ECG evidence of transient ischaemia in daily life. This study
concluded that in patients who do not suffer any intervening cardiac events, recurrent
transient myocardial ischaemia does not result in gradual deterioration in LVF over 1-5
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year period. In a larger, longer term prognostic study (Dargie et al., 1996), comparing 
stable CAD patients with TMI (silent or symptomatic) versus no TMI during daily life at 
baseline, there was no evidence of an association between the presence, frequency or 
total duration of ischaemic events on holter monitoring, either on or off treatment, and 
the hard end points of Ml/death.
However, stress-induced myocardial ischaemia has been shown to predict adverse 
health outcomes in CAD patients (Strike & Steptoe, 2003). Sheps et al. (2002) assessed 
mortality over an average of 62 months following the psychophysiological testing of 196 
CAD patients. All cause mortality was 16.2% in patients who had shown stress-induced 
transient ischaemia, compared with 6.6% in those who had not, independent of age, history 
of MI, baseline ejection fraction, and other clinical risk factors. However, it is not known 
whether these deaths were prompted by emotion-induced cardiac events or not.
2.4.2 Laboratory stress response and TMI
There is much evidence to directly show an association between mental stress- 
induced ischaemic changes and other haemodynamic variables in a laboratory setting, 
and the occurrence of ischaemic responses during daily living activities.
In a laboratory study by Krittayaphong et al. (1995), 42 men and women 
underwent 48 hour holter monitoring and a speech mental stressor task in the laboratory, 
with assessment of blood pressure (BP) and heart rate (HR) responses prior and during 
the test. Radionuclide ventriculography was also performed to assess ischaemic changes 
in the laboratory. This is one of the few studies reviewed in which 32 % patients were 
off medication, and the remainder continued their usual anti-anginal medication. 94% of 
episodes of ambulatory ischaemia were silent and there was a positive correlation
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between ambulatory ischaemia and peak HR and change in HR during mental stress, but 
no correlation with blood pressure stress reactivity. This study concluded that HR 
responses during laboratory induced mental stress, together with average 24 hour heart 
rate, can predict the occurrence of ambulatory ischaemia.
A larger study by Blumenthal et al. (Blumenthal et al., 1995), showed that those 
patients who displayed mental stress induced ischaemia in the laboratory were more 
likely to exhibit ischaemia during daily life (p <0.021), concluding that mental stress 
induced ischaemia (defined by new wall motion abnormalities on ventriculography) 
predicts daily life ischaemia, independently of exercise-induced ischaemia.
To determine further the relationship between mental stress induced myocardial 
ischaemia (MSIMI) in the laboratory and TMI during daily life and exercise, a database 
study (PIM1 study) was carried by Stone et al. (1999). Results showed that 49.4 % of 
patients who displayed myocardial ischaemia in response to speech tasks in the 
laboratory also displayed ambulatory ischaemia during holter monitoring, compared with 
34.9% of the remainder of patients who displayed no ischaemia in the laboratory. 
Additionally, the group of patients who developed ischaemia in response to mental stress 
showed higher cardiac ejection fraction (TF), cardiac output (CO) and lower systemic 
vascular resistance (SVR) during mental stress and were especially likely to exhibit daily 
life ischaemia. The study concluded that patients with daily life ischaemia have a 
heightened generalised response to mental stress, with a chronic state of sympathetic 
nervous system arousal, and a significant increase in systemic vascular resistance 
suggesting a propensity to coronary vasoconstriction. This notion of vasoconstriction is 
further supported by other studies. Legault et al. (1995) evaluated the relation of MSIMI 
to silent ischaemia on ambulatory monitoring. 46 patients underwent standardised 
standard mental stress tests, and exercise tests during which left ventricular EF was
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determined using nuclear imaging. Life stress, type A behaviour and hostility were 
determined using standard interviews, and 48 hour ambulatory monitoring was 
performed. The proportion of those displaying ambulatory ischaemia was 68.4% in 
MSIMI positive group and 37% for MSIMI negative group, with FF response to mental 
stress being a significant predictor of ischaemia independent of LVFF to exercise (p = 
0.03). Patients with MSIMI had longer duration and more frequent episodes of TMI. 
This study experimentally demonstrated an association between vulnerability to MSIMI 
and greater frequency of ambulatory ischaemia. It supports the theory that MSIMI may 
be due in part to vasoconstriction. However, life stress, type A behaviour and hostility 
were not associated with prevalence or severity of ambulatory myocardial ischaemia.
Gottdiener et al. (1994) showed that patients who exhibited MSIMI in the 
laboratory were susceptible to non-exertional ischaemia in sedentary daily activity 
independently of heart rate, and had a possible greater functional severity of CAD. 
Coronary vasoconstriction or abnormal vasomotor activity could possibly explain 
episodes of ischaemia, unrelated to increases in heart rate.
Several studies have shown that triggers of ambulatory ischaemia are 
heterogeneous (Barry et al., 1988), while other studies show heterogeneity among 
cardiac ischaemic and anginal responses to exercise, mental stress and daily life (Sheps 
et al., 1998). Given the diverse causes of ambulatory ischaemia, it is possible that 
different laboratory triggers (mental or physical) may be independently associated with 
the occurrence of ambulatory myocardial ischaemia. The results of these studies are 
summarised in Table 2.1.
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Table 2.1 Studies of TMI and laboratory stress response
Authors Design Medication Results
K rit ta y ap h o n g  
et al. 1995 
(n -  45)
48 h o u r  ho lte r  m o n i to r
S p e e ch  m en ta l  s tre ssor
BP/I IR /rad io n u c l id e  
v en tr icu lo g ra p h y
3 2 %  O f f  
6 8 %  O n
HR re sp o n se  d u r in g  labora tory  
in duced  I'M I an d  average  24 hour 
11R re la ted  to m ag n i tu d e  o f  
am b u la to ry  i sch aem ia  from holte r  
m o n i to r
Tegau lt  et al, 
1995
(n 46)
M en ta l  s tress  task
T xerc ise  test w ith  rad ionuc lide  
v e n tr i c u lo g ra p h ) .  S tandard  
in te rv iew  and  48 hr holter
O f f 23 pa tien ts  (5 0 % )  had an i schaem ic  
re sp o n se  to m enta l  stress,  w h ich  was 
a s so c ia ted  w ith  am b u la to ry  
isc h ae m ia  (13 o f  19 with  a m bula to ry  
i s c h ae m ia  had m enia l  s tre ss - in d u ced  
i s c h ae m ia  vs 10 o f  27 w ithout  
a m b u la to ry  ischaem ia ,  p - 0.04).  
M S IM I  pa tien ts  had longer  total 
d u ra t io n  (3 1.4 +/- 57 .0  vs 8.3 +/- 18 
m in u te s ,  p = 0 .06 )  and m ore  frequent 
e p is o d e s  o f  isc h ae m ia  (3.1 +/- 4 .6  vs 
0 .9  +/-  1.9 e p iso d es ,  p = 0.03).
S tone  et al. 
1999
(n = 196)
48 hr ho l te r  m o n i to r O f f 5 8 %  M S IM I .  Those w h o  d eveloped  
i sc h a e m ia  to m enta l  stress had  h igher  
HP, and  lo w e r  1IR and  w ere  m ore  
l ikely ex h ib i t  daily  life ischaem ia
G o t td ie n e r  et 
al. 1994
(n = 45)
48 hr ho l te r  m onito r .  S truc tured  
diary.
2 D ech o  (R eg iona l  M otion  Wall 
A b n o rm a l i ty )  a fte r  m ental stressors  
and  b icyc le  exerc ise
O f f P a t ien ts  with  M S IM I a lso  have  
in c reased  isch aem ia  during  sedentary  
act iv i t ies  in daily life.
B lu m e n th a l  et 
al. 1995
( n =  132)
48 hr ho l te r  m o n ito r  and 
r ad io n u c l id e  ven tr icu lo g rap h )  
d u r in g  exerc ise  and  m enta l  stress 
tes ting .
O f f Pa t ien ts  with  M S IM I in lab m ore  
likely exh ib i t  da ily  life i schaem ia  (p 
<0.21) .  A lso  d isp layed  larger 
dias to l ic  BP (p < .006)  and H R  
re sp o n se  (p <0 .018) .  M S IM I  pred ic ts  
daily  i sch aem ia  in d ep en d en t  o f  
exerc ise  induced  ischaemia .
Since none of these studies have assessed psychological state in everyday life, they
have not conclusively demonstrated whether emotional factors in everyday life stimulate 
ambulatory ischaemia. It is possible that those individuals displaying laboratory-induced 
MSIMI are more physically active, which is why they go onto display ambulatory 
ischaemia, or that they have more severe cardiac disease, or simply are more reactive
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individuals in general with heightened haemodynamic responsivity (Blumenthal et al., 
1995).
2.4.3 Relationship of TMI with psychological state
The most common method of evaluating the relationship between TMI and daily 
life psychological and physical stress has involved the use of diaries. In these studies, 
patients undergo ambulatory ECG monitoring, and also complete diaries of mood and 
activities periodically, so that associations can be investigated. Table 2.2 summarises the 
main diary studies.
The first such study was reported by Barry et al. (1988). This examined the
relationship of physical activity and perceived mental state to myocardial ischaemia
during 48 hour holter monitoring in daily life. A diary was introduced to the patient in
which the 24 hours were divided into 5 minute intervals. Patients were asked to make an
entry in the diary in blocks of time in the day, specifying the nature of activity and a note
of mental activities. The time of ischaemic episodes, the duration of HR at the onset, and
the number of episodes was recorded by the holter monitor. Results revealed that most
ischaemic events occurred during usual physical and mental activities (36%). 26% of
ischaemic events occurred during increased physical activity but with usual mental
activity. 22% of ischaemic events occurred at high levels of mental stress and low
physical activity. 10% occurred during sleep. Increasing mental or physical activity was
associated with increasing duration of ischaemia per unit time (p <0.05). This study
concluded that the intensity of both physical and perceived psychological status,
influenced ischaemic activity in daily life. These patients showed more frequent
episodes (92%) of asymptomatic transient myocardial ischaemia in daily life and
increasing intensity of physical or psychological state was proportional to the duration of
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ischaemia. This supports the notion that external forces do influence transient ischaemia 
in patients with CAD. However, this study involved a tremendous respondent burden, 
with participants in effect having to account for their activities and mood every minute of 
the day in real time. It is not known whether patients completed the diaries at the time, 
or filled them in retrospectively at longer intervals.
In a larger study, Gabbay et al. (1996) assessed the potency of both physical and 
mental activities as well as emotions (anger and anxiety) as proximate triggers of 
ischaemia. This study again involved a continuous diary over the monitoring period. 
Patients were asked to make a new entry into the diary whenever their activity changed, 
and provided ratings of physical effort and mood. Patients made an average of two diary 
entries per hour.
Ischaemia was found to occur most frequently during moderately intense physical 
and mental activities. Participants spent the largest proportion of time engaged in low 
and moderate intensity physical and mental activity. But when the data were corrected 
for the time patients spent at each level of activation, the likelihood of ischaemia was 
greatest in intense physical (p <0.0001) and stressful mental activity (p <0.03). The 
percentage of ischaemic time was elevated and equivalent for high intensity physical and 
high intensity mental activities (5%) compared with that of low intensity (0.2%). 
Strenuous physical activity (e.g. effortful walking) and experience of intense anger were 
potent ischaemic triggers. Heart rates at the onset of ischaemia increased with the 
intensity of activity (either physical or mental) and with anger. This study concluded 
that mental activities appear to be as potent as physical activity in triggering daily life 
ischaemia. However, it was difficult to differentiate the effects of the two types of 
activity, namely physical and mental. There was a low frequency of reported intense 
emotion, possibly because the respondent burden of the study was so high. Simultaneous
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occurrences of multiple activities during daily life make it difficult to specify 
independent behavioural triggers of ischaemia.
The reporting of chest pain does not neeessarily imply that ischaemia is occurring 
and may depend on the type of trigger of the ischaemic episode or particular trait 
characteristics of the individual. Evidence of an uncoupling of angina and ischaemia 
was shown in the study by Krantz et al. (1994), evaluating daily life physical and mental 
triggers of painful and painless myocardial ischaemia in the same group of CAD patients 
recruited for the study by Gabbay et al. (1996). Results showed that 85% of ischaemic 
episodes occurred without chest pain, and 66% of angina pain reports were made in 
absence of ST depression. Painful ischaemia was triggered at significantly higher levels 
of physical activity (p <0.005) (walking in 67% ischaemic episodes) and significantly 
higher levels of self-rated negative emotion (p <0.05) compared to silent episodes.
Another study focused particularly on symptomatic ischaemic episodes in 
everyday life. Kinne et al. (1999) studied 64 patients with CAD, 45 of whom showed 
symptomatic ischaemia during exercise testing. They completed electronic diaries 
during holter monitoring, assessing pain and associated activities. Personality tests were 
conducted, suggesting that symptomatic patients were more neurotic and reported lower 
active coping than asymptomatic cases. There were no differences in the ECG 
characteristics of symptomatic and asymptomatic episodes, but interestingly, there was a 
significantly greater increase in heart rate in the 2 minutes before symptomatic episodes. 
This was associated with physical exertion and greater ratings of tension. However, it is 
possible that the greater subjective tension experienced during symptomatic episodes 
was a consequence of the pain and worry about having a bout of ischaemia, rather than 
being relevant to the triggering of the episode.
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Silent episodes of ischaemia have been attributed to mental stress in the Barry et 
al. (1988) and Gabbay et al. (1996) studies, but the methods used do not allow for precise 
correlations between the onset of ischaemia and what the patients are doing or thinking 
at the time. The reason is that ischaemia may start during the intervals between diary 
ratings, so may not coincide with the reports of mental state. Freedman and Wong, 
(1998) carried out an investigation to determine the usual triggers of silent and 
symptomatic myocardial ischaemia in daily life, using a method that partly overcame this 
problem. 38 patients with stable coronary artery disease wore an ambulatory recorder 
for 48 hours. The device emitted a tone on detection of ischaemia and patients noted 
activities, feelings, and symptoms at the time. The analysis involved matching ischaemic 
episodes with perceived triggers. The results showed that 53% of episodes were silent 
(pain free). Triggers were defined as the activities occurring at the time of the ischaemic 
episode. Physical exertion was present for 56% of episodes, mental stress for 5%, and 
combined physical exertion and mental stress during 8%. Most of the episodes 
associated with mental stress were silent (69%), while most of those associated with 
physical exertion led to angina (65%). Ischaemic episodes in everyday life took place at 
lower heart rates than those elicited during exercise testing. This study concluded that 
daily life ischaemia is usually triggered by physical activity, and that mental stress alone 
is an uncommon trigger of silent or symptomatic ischaemia. However, the sample was 
very small, and the presentation of results made it difficult to deduce how many patients 
actually experienced ischaemic episodes.
The largest and most sophisticated study in this field was that published by
Gullette et al. (1997). This examined the effect of mental stress on daily life ischaemia
and tried to determine the relative risk of ischaemia triggered by specific emotions. 132
patients were recruited in a case crossover method in which the frequency of the
presumed trigger during non-ischaemic or control hours is compared to the trigger’s
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frequency in the ischaemic or case hours. This approach eliminates confounding due to 
inter-individual differences, and there was no potential for recall bias. Data were 
collected prospectively. Patients wore holter monitors for 48 hours during which they 
also wore a signal device that prompted them to complete entries in a structured activity 
and mood diary an average 3.2 times an hour from 6 am to midnight. In the diary, 
patients were asked to record activities when prompted by programmed auditory signal, 
and were asked to wear a watch that synchronized with the monitors’ internal clock so 
the time in diary corresponded to the time on ECG. The patients were also instructed to 
fill out self initiated diaries if they had any pain or intense emotion, recording time, 
posture, location, mental, physical activity, mood, symptoms and medication use. When 
prompted they recorded 2 positive emotions -  happiness and feeling in control and 3 
negative emotions - sadness, tension, frustration on a 5 point intensity scale. Occurrence 
of ischaemia was analysed without knowledge of the diary data.
Results showed a relative risk of myocardial ischaemia in the hour following
negative emotion of 3.0 for tension, 2.9 for sadness, and 2.6 for frustration. The
percentage of ischaemic hours was greatest during high levels of negative emotion
(tension, frustration). The percentage of ischaemic hours was lower during high levels of
positive emotions. The highest risk of myocardial ischaemia was associated with heavy
activity and with specific emotions. Heart rate was found to be higher in ischaemic
hours but was not significantly associated with negative emotion. This study concluded
that mental stress during daily life including reported feelings of tension, frustration, and
sadness, can more than double the risk of myocardial ischaemia in the subsequent hour
(relative risk 2.2, 95% confidence intervals 1.1 to 5.4). Mental stress was a common
trigger of ischaemia in daily life and in contrast, positive emotions such as feeling happy
and in control were associated with a lower risk of ischaemia (relative risk feeling happy
0.6, 95% confidence intervals 0.3 to 1.1; relative risk of feeling in control 0.7 confidence
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intervals 0.3 to 1.8). However, it can be seen that the size of the effect is smaller than 
that for negative emotions and the confidence interval is wider for positive emotions.
This study involved a method in which diary ratings were prompted around 3 
times per hour. This made it difficult to determine the precise temporal sequence in 
relation to ischaemia, since ischaemic episodes could have occurred during the intervals 
between ratings. In addition, small numbers of women and ethnic minorities were used.
The studies of TMI in relation to psychological factors are summarised in Table 
2.2. Limitations to the methodology of these studies will be discussed in chapter 3.
Table 2.2 Studies of TMI and psychological response
Authors Design Medication Results
B arry  et al. 
1988
(,n= 28)
48 h our  holter.  Pa t ien ts  kept  24 
h our  d iary  w h ich  w as  d iv id ed  into 
5 m in u te  in tervals  and  pa tien ts  
w e re  asked  to m ak e  an en try  in 
b locks  o f  t im e in the  day and  w hen  
ev e r  physical  act iv ity  ch an g ed  and 
m ak e  no te  m enta l  act iv it ies
O f f 22 %  i s c h ae m ic  even ts  at high level 
m en ta l  s tress
G a b b ay  et al.
1996
(n= 63)
48 h o u r  holter
S truc tu red  s e l f  init iated d iary 
(en try  i f  m o o d  or activity )
O f f I s c h ae m ia  g rea tes t  in intense  physical 
act iv ity  (p < 0 .0 0 0 1 )  and stressful 
m enta l  actix ity (p  < 0.03)
Level m enta l  activ ity  re la ted to total 
m in u te s  o f  i schaem ia
K ran tz  et al. 
1994 
(n^  63)
48 h o u r  holter ,  exerc ise  test, 
r ad io n u c l id e  im a g in g  at peak  
exerc ise
24 h our  d ia ry  se l f - repor t
O f f Painful i sch aem ia  t r iggered  with  h igher  
levels s e l f  rated n egat ive  e m otion .  85%  
ischaem ic  e p iso d es  w ith o u t  chest  pain. 
Painful isch aem ia  tr iggered  at h igher  
levels physical  activity (p  < 0 .0 0 5 )  and 
h igher  negat ive  em o t io n  (p  < 0 .05)
G ulle t te  et al.
1997
( n -  132)
48 h o u r  ho l te r
S ignal  d ev ice  from  m o n ito r  
em it ted  to  p ro m p t  d iary  en try  at 
ran d o m  poin ts  in the  day  in b locks 
o f  t im e
O f f 9 8 %  isch aem ic  e p iso d es  w ithou t  
sy m p to m s .  L m o t io n s  ( in c lu d ed  
tension ,  frustration , sa d n ess)  can m ore  
than d o u b le  risk o f  m y o ca rd ia l  
i sch aem ia  in su b s eq u e n t  hour.  RR 2.2 
Cl 1.1 to 5.4
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Authors Design Medication Results
F re e d m a n  and 
W o n g
1998
(n= 38)
48 h o u r  ho lte r
Signal  d ev ice  from m o n ito r  
em it ted  tone  on  de tec t ion  o f  
i sch aem ia  a n d  pa tien t  p ro m p te d  to 
note  act iv it ies ,  feel ings  and  
sy m p to m s  in d ia ry  at t im e  o f  tone 
o r in the  p re ce d in g  5 m inu tes
On T rig g e rs  o f  ischaem ia :  physica l  stress, 
5 6 %  e p isodes ;  m enta l  stress, 5 %  
ep isodes ;  c o m b in e d  p h y s ica l /m en ta l  
stress,  8 %  ep isodes ;  no tr igger ,  31 %  
ep isodes .  E p iso d es  a sso c ia ted  with  
m en ta l  s t re ss /no  stress w e re  m ore  often  
si lent  ( 6 9 %  and  7 5 %  re spec t ive ly )  than  
th o se  a sso c ia ted  w ith  physical  stress 
(4 5 % ,  p < 0 .01).  C o m b in e d  
m en ta l /p h y s ica l  s tress w ere  usually  
sy m p to m a t ic
2.4.4 Relationship of TMI with psychosocial factors
Results relating TMI with specific psychological characteristics are inconclusive 
at present. In a study by Carels et al. (2000), patients repeatedly monitored their levels 
of subjective tension in everyday life using diaries, and were categorised into high and 
low emotional responders. High responders were those who exhibit relatively large 
variations of self-reported tension levels. Those with a high emotional response had 
greater myocardial wall motion abnormalities on mental stress testing compared to the 
low responder group, and also had greater trait anxiety and depressive symptoms. There 
was no association of emotional responsiveness with hostility. In the study by Legault et 
al. (1995) described earlier, it was found that ambulatory myocardial ischaemia was not 
associated with life stress, type A behaviour, or hostility.
Depression is relatively common in patients with CAD and is associated with an 
increased risk of mortality and morbidity (Nicholson et al., 2006). A study by Jiang et 
al. (2003) evaluated the relationship between depression measured with the CES-D and 
myocardial ischaemia, both during mental stress tests and in daily life. A curvilinear 
association was seen, with more ischaemia as depression scores rose in the mild to
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moderate range (< 19), but less ischaemia as scores increased >19. There was no very 
compelling explanation of this pattern.
Taken together, these studies do not show a consistent pattern of associations 
between TMI and trait psychological factors, but the issue has not been very extensively 
studied.
2.5 Mechanisms underlying emotion-induced TMI in everyday life
2.5.1 Introduction
There are a number of important and potentially inter-related physiological 
mechanisms which underlie the association of negative emotions and other psychosocial 
factors on coronary artery disease development and progression. Depression related 
dysregulation of the ANS and HPA axis has been linked to hypercortisolaemia, elevated 
plasma and urinary catecholamines, impairment in platelet functioning, elevated heart 
rate and reduced heart rate variability (HRV) all of which have a negative impact on 
CAD prognosis (Carney et al., 1988, 2000; Rozanski et al.,1999).
Altered autonomic control appears to be positively associated with negative
mood states such as depression (Carney et al., 2001). Negative mood states also promote
arrhythmogenesis and findings relating to this will be discussed. In addition,
psychosocial factors may influence cardiovascular function through dysregulation of the
HPA axis, giving rise to a number of wide ranging effects, both in the short and long
term. 1 will also discuss the possible haemodynamic mechanisms with regards to
alteration in blood pressure and heart rate involved in transient ischaemia and mood. In
addition, 1 will discuss the other relevant biological relevant mechanisms involving
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haemostatic pathways in which platelet function, serotonergic function, fibrinogen and 
secretion of proinflammatory markers all play a significant role in the development of 
CAD.
In addition to direct physiological pathways, environmental, social and 
behavioural pathways (smoking, alcohol consumption, exercise) may also play an 
important role in the relationship of negative emotions increasing CAD risk. However, 
the main focus here will be on the physiological mechanisms through which 
psychosocial factors potentially affect TMI and CAD.
2.5.2 Autonomic Nervous System
One of the important mechanisms underlying the effects of emotion on morbidity 
and mortality in cardiac patients is neurohormonal dysregulation. Decreased 
parasympathetic and increased sympathetic nervous system activity predispose cardiac 
patients to myocardial ischaemia, ventricular tachycardia, ventricular fibrillation and 
sudden death (Carney et al., 1995; Glassman et al., 1998). These autonomic disturbances 
can be indexed by reduced HRV. Abnormalities of the ANS, associated with negative 
mood, could accelerate CAD progression and initiate cardiac events by altering cardiac 
autonomic tone, promoting the procoagulant and inflammatory processes and lowering 
the threshold of mental stress induced ischaemia. Studies have shown that low HR 
variability or excessive sympathetic activation analysed from ambulatory 
electrocardiogram (ECG) predict increased risk for developing coronary heart disease in 
healthy populations and increased mortality in cardiac populations (Stein et al., 1999). 
HR variability provides information on progression of focal coronary atherosclerosis 
beyond that obtained by traditional risk markers of atherosclerosis (Huikuri et al., 1999).
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This section will review the literature concerning the definition of HRV and 
impaired cardiac vagal control in both healthy populations and patients with CAD. A 
central aim of my thesis is to examine whether there is a similar association between 
reduced HRV in stable cardiac patients who are depressed either as a trait measure or as 
measured on a moment to moment basis in the day.
The ANS has two major branches - the sympathetic system associated with 
energy mobilisation, and parasympathetic system, associated with vegetative and 
restorative functions. There is a circadian rhythm with increased sympathetic activity in 
the day and increased parasympathetic activity at night. The two branches are rapidly 
modulated in response to changing environmental demands and it is this organised 
variability that regulates energy; optimal functioning being associated with variability 
(Lipsitz et al., 1992). Autonomic imbalance is when one branch dominates over the 
other, typically when the sympathetic system is hyperactive and the parasympathetic 
system is hypoactive, and it is associated with various pathological conditions (Malliani 
et al., 1994). The heart is under tonic inhibitory control by the parasympathetic nervous 
system. Resting cardiac autonomic balance favours energy conservation by way of 
parasympathetic dominance over sympathetic influences. The parasympathetic system 
exerts a dominant inhibitory influence on resting HR (Katona, 1982). Resting HR can be 
seen as an index o f  autonomic imbalance (Levy et al., 1990) and a large positive dose 
response relationship between resting HR and all cause mortality has been seen (Habib, 
1997). Additionally, an elevated HR has been shown to predict future CAD, 
independent of risk factors (Kannel et al., 1987).
Bork et al. (2000) have also shown that autonomic imbalance in the sympathetic 
direction is associated with metabolic, haemodynamic and trophic abnormalities, that 
contribute to elevated cardiac morbidity and mortality. Reduced HRV has been
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associated with diabetes (Ziegler et al., 2001; Singh et al., 2000), hypertension (Liao et 
al., 1996; Singh et al., 1998), total cholesterol and LDL cholesterol (Christensen et al., 
1999; Wannamethee et al., 1994), immune dysfunction and inflammation (Kiecolt Glaser 
& Glaser, 2002), as well as psychosocial stressors such as sedentary lifestyle (Rennie et 
al., 2003), substance abuse (Ingjaldsson et al., 2003) and smoking (Hayano et al., 1990). 
Increasing age has also been associated with reduced HRV (Antelmi et al., 2004).
Thus autonomic imbalance, especially decreased parasympathetic activity, may 
be a mediator between psychosocial stressors and increased cardiac morbidity and 
mortality.
There are multiple measures that can be used to index vagal activity. As 
described earlier, resting heart rate is under inhibitory control of the vagus, so can be 
regarded as a simple non-invasive measure of vagal function. The decrease in HR after 
termination of exercise is termed heart rate recovery. Faster HR recovery is associated 
with better health and decreased risk of mortality (Lauer et al., 2002). Abnormal 
recovery responses have been shown to be associated with an increased risk of all cause 
mortality in the long term (Cole et al., 1999, 2000) both in healthy people and cardiac 
patients (Shetler et al., 2001).
Heart rate variability (HRV) is defined as a measure of the cyclic variation in 
heart rate, and is a composite of numerous influences including blood pressure regulation 
and respiratory processes. Short term fluctuations of heart rate are mediated by cardiac 
autonomic activity. This can be assessed using frequency domain measures with power 
spectral analysis, or time domain measures. The heart is innervated by both sympathetic 
and parasympathetic vagal fibres which give rise to differing frequencies. By identifying 
these different frequencies and their association with branches of the autonomic nervous 
system, HRV can be used as a non-invasive tool for the assessment of cardiac autonomic
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control. The spectrum of HRV frequency can be decomposed into a series of frequency 
bands, each of which have a particular physiological significance and reflect in part, 
different branches of pathways of the autonomic nervous system controlling the heart.
There are three distinct rhythms identified within the beat-to-beat modulation of 
the heart; a high, low, and a very low frequency component (Task force, 1996). The 
high frequency (HF) component consists of oscillations in frequency range of 0.15 -  0.4 
Hz, which is mediated by vagal (parasympathetic) tone. The low frequency component 
(LF) has frequency oscillations between 0.04 and 0.15 Hz and is mediated by both 
sympathetic and parasympathetic influences. The ratio between HF and LF can be 
measured, and the higher the ratio, the greater the vagal tone. In 24 hour ambulatory 
ECG recordings, a very low frequency (VLF) component can be found with a frequency 
band of < 0.04 Hz which is possibly related to the renin-angiotensin system and other 
humoral factors. The exact underlying physiological mechanism underlying this 
component remains controversial.
It is commonly reported that LF and HF are highly and significantly correlated 
(Wang et al., 2005; Liao et al., 2002). Thus LF power reflects substantial 
parasympathetic influence. In addition, measures of baroreflex sensitivity (BRS), an 
index of responsiveness of the cardiovascular system to changes in blood pressure, are 
also useful indicators of vagal function.
HRV can also be assessed from calculation of the mean R-R interval and its 
standard deviation measured on short term (e.g. 5 minute) electrocardiograms. The 
smaller the standard deviation in normal to normal beat-to-beat (or R-R) intervals the 
lower is the HRV. There are many different types of arithmetic manipulations of R-R 
intervals, and time domain measures include standard deviation of normal mean R-R 
interval obtained over 24 hour holter recordings (called SDNN index) and the root-mean
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square of the difference of successive R-R intervals (the RMSSD index). The various 
methods of expressing HRV are probably equivalent, with no evidence that one method 
is superior to another, providing measurement windows are 5 minutes or longer (Bigger 
et al., 1992). The measurement of HRV has been standardised (Task Force, 1996).
2.5.2.1 Studies of the relationship between HRV and mood and TMI in healthy
and non-healthy populations
Three aspects of autonomic activity have been investigated in studies, namely the 
sympathoadrenal function (causing peripheral vasoconstriction and altered 
haemodynamic state), heart rate levels and control processes governing the balance 
between sympathetic and parasympathetic systems and baroreceptor reflex activity or 
control (BRC). There is evidence that resting heart rate in depressed individuals is 
higher than in non-depressed individuals without CAD (Moser et al., 1998). The 
relationship between depression and sympathetic nervous system activity can be 
measured by assessing urinary or plasma catecholamines in clinical cohort studies (Lake 
et al., 1982). Positive correlations have been found between urinary catecholamines and 
depression and anxiety after controlling for age, race and BMI (Hughes et al., 2004) in a 
healthy sample. Sympathetic activation can reduce the threshold for cardiac ventricular 
fibrillation but this occurs only in those with advanced CAD (Meredith et al., 1991).
The evidence relating sympathovagal balance, depression and CAD is quite 
mixed with a variety of different HRV indices measured and confounded often with the 
use of beta blocker medication for cardiac disease, which is used by those suspected of 
CAD and those who have well established disease. The findings are presented below in 
Table 2.3 which summarizes key studies highlighting issues such as beta blocker 
medication.
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Table 2.3 Studies analysing the relationship between depression and HRV in 
non-CAD patients and CAD patients
Study
Author
Year
Study design Beta
blocker
Yes/No
Time
domain
Frequency
domain
Results
Psychiatric
patients
Y eragani  
1991 
(n = 49)
19 M a jo r  dep ress ion .  
30 pan ic  d isorder ,  20 
con tro ls
N o P N N 50 ,
S D N N
LF, M F, H F N o  a ssoc ia t ion  with  
m a jo r  dep ress io n
Y eragan i  
1993 
(n = 2 1 )
21 Phob ic  anx ie ty ,  21 
no rm al  con tro ls ,  
e x a m in in g  dep ress io n  
and  anx ie ty
N o S D N N LF. M F, H F N o  re la t ionsh ip  with  
d ep re ss io n  or anx ie ty
R echlin  
1994 
(n -  80)
16 m a jo r  dep ress ion ,  
16 pan ic  d isorder ,  16 
reac tive  d ep ress ion ,  
16 am itr ip ty l in e  with  
16 no rm al  con tro ls ,  
an a ly s in g  dep ress ion  
and  pan ic  d iso rd e red
N o R M S S D LF, M F, H F M a jo r  dep ress ion  had 
lo w er  HF (0 .6 )  vs 1.2 
c on tro ls  and  R M S S D
T h ay e r  
1996 
(n = 34)
34  w ith  anx ie ty  
d isorde r ,  34 norm al 
con tro l ,  a na lys ing  
anx ie ty
N o LF, H F A n x ie ty  assoc ia ted  
w ith  lo w er  H F than  in 
contro ls
W atk in s  et al.,
1999
(n = 56)
C ross -sec t iona l  s tudy 
o f  56 m a jo r  
d ep ress io n  pa tients
N o B R C , R SA A nxie ty ,  but not 
d ep ress ion  assoc ia ted  
with  decreased  
baroref lex  contro l
M o s e r  et al., 
1998 
(n = 52)
C a se -co n t ro l  c ross-  
sec tiona l  s tudy  o f  26  
non  m ed ic a ted  
d ep re ssed  fem ales  and 
26  age  and  sex 
m a tc h ed  contro ls .
N o N N R SA , H F H R  g rea te r  in 
d ep re ssed  p a t ien ts  (p 
< 0 .0 3 )  than  contro l  
g ro u p  in the  a b sen ce  o f  
vagal  tone  ch an g e s
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Study
Author
Year
Study design Beta
blocker
Yes/No
Time
domain
Frequency
domain
Results
Healthy
population
Kim et al., 
2005
(n = 3 3 7 2 )
P o s tm e n o p au sa l  
w o m e n  ag ed  50  to 83 
y ears  w e re  en ro lled  
for 2 4 -h o u r  ho lte r  
m on ito r ing .  C E S -D  
Scale  and  the 
D iag n o s t ic  In terv iew  
S ch ed u le  w ere  
adm in is te red .
N o N N ,
S D N N ,
A S D N N ,
S D A N N
All the  t im e  d o m a in  
indexes  o f  H R V  w ere  
s ign if ican tly  low er  in 
p a r t ic ipan ts  with  
d ep re ss iv e  sy m p to m s  
c o m p a re d  w ith  those  
w i th o u t  d ep ress ive  
sy m p to m s
CAD Patients
C a rn ey  et al., 
1988 
(n -  77)
C A D  pa tien ts  in da ily  
act iv it ies ,  24  hr 
m o n i to r in g
E x a m in in g  d epress ion
Y es S D N N N o  re la t ionsh ip  to 
d ep ress io n
C arn ey  et al., 
1995 
( n =  19)
19 pa tien ts  with  C A D  
and  d ep ress io n  with 
19 age,  sex, sm o k in g  
m a tc h ed  con tro ls .  24 
h m on ito r ing ,  
e x a m in in g  depress ion
S D N N
R M S S D
p N N 5 0
S D N N  low er  in 
d e p re ssed  than  contro ls  
74 vs  94
K r i t ta y ap h o n g  
et al., 1997
(n = 42)
C A D  patien ts  with 
da ily  activit ies,  24 h 
m o n ito r ing ,  
e x am in in g  depress ion
S D N N L o w e r  S D N N  a m o n g s t  
highly d epressed  and  
h igher  H R
W atk in s  e t  al. , 
1999
(n = 66)
C A D  cross-sec t iona l  
s tudy ,  e x am in in g  
d ep ress io n
Y es B R C , R S A D epress ion  a ssoc ia ted  
w ith  decreased  
ba rore f lex  control.
C a rn ey  et al., 
2001
(n = 904)
C A D  case  con tro l  
c ross -sec t iona l  s tudy, 
e x a m in in g  d epress ion .  
38 0  d e p ressed  MI and  
4 2 4  n o n -d e p re ssed  M l 
p a t ie n tsu n d e rw e n t  
ho l te r  m on ito r ing .
Y es LnU LE.
E nV L F.
LnLF ,
E nH F
L n U L F ,  L n V L F .  L nL F  
w as  all s ign if ican tly  
red u ced  in post MI 
p a tien ts  with  
dep ress io n  than in n o n ­
d e p ressed  MI pa tients  .
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Study
Author
Year
Study design Beta
blocker
Yes/No
Time
domain
Frequency
domain
Results
C a rn ey  et al., 
2005 
(n = 678)
C A D  case  con tro l  
c ross -sec t iona l  study, 
e x a m in in g  311 
d e p re ssed  Ml and  367 
n o n -d ep re ssed  Ml 
patients
Yes V L F V L F  w as  lo w er  in 
d e p ressed  Ml patients .
(p  < 0 .0 0 1 )
G ehi et al., 
2005  
(n = 873)
C A D  cross-sec t iona l  
s tudy o f  s tab le  C A D  
patien ts
Yes S D N N ,
S D A N N
L n V L F ,  Ln 
LF, Ln HF,
N o  assoc ia t ion  
b e tw ee n  dep ress io n  
and  any  o f  H R V  
indices.
Stein  et al., 
20 0 0  
(n = 72)
C ase  con tro l  cross-  
sec tional  s tudy  o f  
stable  C A D  patients  
and n o n -d ep re ssed  
con tro ls
N o A verage
HR
SD N N
S D A N N
S D N N ID X
R M S S D
P N N 5 0
HF, LF, 
L F /H F  ratio, 
VLF, U L F  
R SA , Ln 
Total 
Pow er,
H R  w ere  h ig h er  and all 
H R V  ind ices excep t  
R M S S D ,  In HF and 
L F /H F  ratio wh ich  
w e re  s ign if ican tly  
re d u ce d  in m odera te ly  
to seve re ly  vs the non- 
d e p re ssed  group.
Table 2.3 abbreviations for HRV indices
Time Domain:
A V G H R ,  av e ra g e  hear t  ra te  in bea ts /m inu te ;  S D N N ,  s tan d ard  d ev ia t io n  o f  n o rm al- to -  norm al in te rbea t  
intervals;  S D A N N ,  s tan d ard  d ev ia t ion  o f  5 m in u te  m e a n  v a lu es  o f  n o rm al- to -n o rm a l  in te rbea t  intervals;  
A S D N N ,  a v era g e  o f  all 5 m in u te  s tan d ard  d e v ia t io n s  o f  no rm al  -  no rm al  in te rbea t  intervals;  S D N N ID X ,  
the  av e ra g e  o f  s tandard  d ev ia t io n s  o f  n o rm a l- to -n o rm a l  in terbea t  in tervals  for each  5 m in u te  period;  N ID X ,  
n o rm a l- to -n o rm a l  in te rbea t  in te rva ls  for e ach  5 m inu te  period, R M S S D ,  the root  m ean  square  su ccess ive  
d if fe ren ce  o f  n o rm a l - to -n o rm a l  in te rbea t  intervals;  pN N 5 0 ,  the p roport ion  o f  su ccess iv e  n o rm al- to -n o rm a l  
d if fe ren ces  in in te rbea t  in te rvals  > 5 0 m s  (percent);  R SA ,re sp ira to ry  s inus  a r rh y th m ia  (m s).  B R C , 
b a ro re c ep to r  reflex  con tro l  o f  hear t  rate
Frequency Domain
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TP, total p o w e r  (1 .1 5 x 1 0 s -  0 .4  H z)  for total 24 hour  cycle ;  ULF ultra  low freq u en cy  pow er,  ( 1 .1 5 x 1 0 s); 
VLF, very  low freq u en cy  p o w er ,  (0 .0 0 3 3 -0 .0 4  Hz),  low f requency  p o w e r  (0 .0 4 -0 .1 5  Hz),  M F, m ed iu m  
frequency  p o w e r  (0 .08  -  0 .15  Hz),  HF, high f requency  p o w e r  (0 .15 -0 .4  Hz); L F /H F  ratio, the ra tio  o f  low 
to high f req u en cy  p o w e r  L n U L F .  log o f  u ltra  low frequency  pow er,  L n V L F ,  log o f  very  low frequency  
pow er.  L nLF , log o f  low  f requency  pow er ,  L n H F ,  log o f  high  frequency  p ow er ,  Ln Total Pow er,  log o f  
total p o w e r
HRV is a significant independent predictor of mortality in high risk groups 
(Makikallio et al., 2001). In a study by Tsuji et al. (1994), the HRV data of an elderly 
subsample of participants of the Framingham Heart Study were analysed. All five 
frequency domain measures were significantly associated with all cause mortality, with 
log transformed LF power being the most significant index in multivariate models. The 
same has been shown in populations post MI, (Kleiger et al., 1987), the ATRAMI study 
(La Rovere et al., 1998), and in a study by Camm et al. (2004), which showed HRV to 
independently predict mortality after controlling for age, gender, LVEF, diabetes and 
beta blocker use. Reduced HRV has also been associated with development of 
atherosclerosis (Huikuri et al., 1999) and plaque rupture (Kennedy et al., 1997).
There are some contradictory findings with regards to emotional factors, like 
depression or negative affect and HRV. Rottenberg et al. (2007), in their meta-analysis, 
have described how some studies have shown that depressed patients have lower heart 
rate variability than non-depressed controls, whilst other studies reported no differences. 
It is important to take into account the confounding effects of medication, physical co­
morbidities and sedentary lifestyles as well as a variety of psychiatric conditions like 
anxiety or panic disorders. These confounders may in part, explain the varied findings 
relating to HRV and emotion, in particular depression. This meta-analysis of 13 cross­
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sectional studies revealed a small-to-medium effect size for depression in relation to 
HRV.
A study that characterised various other emotional states in CAD patients was 
carried out by Bacon et al. (2004) in which 135 patients were assessed to investigate the 
associations between mood and autonomic cardiac control in patients with CAD. Diary 
measures were taken every 20 minutes for 48 hours of holter monitoring, and within- 
person associations between mood and HRV were computed. Analyses showed that 
higher levels of negative emotions (e.g. anger, stress, sadness) were associated with 
decreases in high and low frequency power, whereas higher levels of positive emotions 
were related to an increase in low frequency power, independent of age, posture and 
medications. This finding was unexpected, since low frequency power is generally 
interpreted as indexing increased sympathetic over parasympathetic control, so an 
inverse association with positive emotions might have been anticipated. But the study 
does suggest that during daily life, negative emotion is associated with a reduction in 
vagal control and possibly an alteration in sympathetic control, transient alterations of 
which may contribute to acute triggering of cardiovascular events by emotional stress.
Vagal withdrawal can produce myocardial ischaemia and may be involved in 
ambulatory ischaemic events. A study by Kop et al. (2001) determined the time course 
o f autonomic nervous system activity preceding ambulatory ischaemic events and 
showed how physical and mental challenges provoke transient decreases in high 
frequency component (vagal tone). The study analysed trajectories of HRV before, and 
after ischaemic events and examined the role of exercise and mental stress in pre- 
ischaemic autonomic changes. 19 patients with stable CAD and a positive exercise test 
and evidence of ischaemia on previous ambulatory ECG were studied. They all 
underwent 48 hour monitoring. Frequency domain HRV measures were assessed for 60
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minutes before and after each of 68 ischaemic events and during non-ischaemic heart 
rate matched control periods. A validated diary system was used to evaluate patients’ 
physical and mental activities throughout the day. Patients were instructed to complete a 
standardised page each time activities changed markedly. Mental and physical activity 
levels coinciding with onset of ischaemia were graded on a scale from 1-6. Cut-off 
points for activity levels were used to compare trajectories HRV occurring at low 
(scores<5) versus high (scores>5) activity levels. Patients also recorded episodes of 
chest pain and the use of glycerol trinitrate spray (an anti-anginal medication to relieve 
symptoms of chest pain). Activity levels were cross tabulated with concurrent ischaemic 
events as well as with non-ischaemic control periods.
Results showed that high frequency HRV decreased from -60, -20 to -10 minutes 
before ischaemic events (p=0.04) and further from -4, -2 minutes, until ischaemia. Low 
frequency HRV decreases started at -4 min (p <0.05). Ischaemic events occurring at 
high mental activities were preceded by depressed high frequency HRV levels compared 
with events at low mental activity (p=0.038 at -4 minutes) whereas effects of mental 
activities were not observed during non ischaemic control periods. Heart rate variability 
measures remained significantly depressed for 20 minutes after recovery of ST segment 
depression, when events were triggered by high activity levels.
The study showed that decreases in HRV preceded myocardial ischaemia, as 
early as 10 minutes before the event and most pronounced in the 4 minutes before ST 
segment depression. Ischaemic events occurring at high mental activities were preceded 
by significantly decreased high frequency HRV levels, suggesting that vagal withdrawal 
can act as a precipitating factor for daily life ischaemia particularly in episodes triggered 
by mental activities, which is triggered by low heart rates.
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Although majority of patients (12 out of 19) were monitored without 
discontinuation of beta blocker (which are known to affect HRV parameters), results 
suggested a similar pattern of vagal withdrawal in those off medication. Measures of 
vagal withdrawal were found to persist until 20 minutes after ischaemia. It is possible 
that TMI has sustained residual effects on cardiac vagal tone, independent of activity 
levels or that ambulatory ischaemia persisted longer than detectable ST segment 
depression. Vagal withdrawal associated with mental activities appears to be specific to 
ischaemic events because high mental activity levels were associated with HRV 
decreases in ischaemia but not in non-ischaemic control periods. O f note, the events 
were asymptomatic, hence not susceptible to confounders like perceived pain on the 
autonomic nervous system.
2.5.2.2 HRV and unstable CAD patients
Regarding the relationship between specific emotional states like depression 
and the relationship with HRV, the literature is varied and differs between those with 
unstable CAD and stable CAD. It has been shown by Carney et al. (2001) that 
depression is associated with reduced HRV in patients with a recent myocardial 
infarction. In this study, 380 acute MI patients with depression and 424 acute MI 
patients without depression were recruited, who participated in the Enhancing Recovery 
in Coronary Heart Disease (ENRICHD) clinical trial undergoing 24 hour ambulatory 
ECG monitoring after hospital discharge. (The clinical trial consisted of post MI patients 
who were depressed being randomly assigned to usual care or to cognitive behavioural 
interventions to determine the effects of treating depression and social isolation on 
reinfarction and mortality). In univariate analyses, 4 indices of HRV (log transformed 
domain indices HRV: Ultra Low Frequency, Very Low Frequency, Low Frequency and
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High Frequency) were significantly lower in patients with depression than in patients 
without depression. Variables associated with HRV (age, sex, diabetes, present 
smoking) were then compared between patients with and without depression and 
potential confounds were identified. In the final multivariate model (in which variables 
were entered followed by depression status), all but one HRV index (high frequency 
power) remained significantly lower in patients with depression than those without. The 
conclusion was that greater autonomic dysfunction, as reflected by decreased HRV, is a 
plausible mechanism linking depression to increased cardiac mortality in post MI 
patients.
In another study on the same sample of patients (Carney et al., 2005), HRV 
indices were analysed from 311 depressed patients and 367 non-depressed patients 
enrolled in the ENRICHD trial. Results found that the log o f very low-frequency 
(LnVLF) power, was lower in the depressed than in the non-depressed patients (p 
<0.001). There were 47 deaths (6.1%) during a 30-month follow-up. After adjusting for 
potential confounders, the depressed patients remained at higher risk for all-cause 
mortality compared with the non-depressed patients (hazard ratio, 2.8; 95% confidence 
interval (C.I), 1.4-5.4; p <0.003). When LnVLF power was entered into the model, the 
hazard ratio for depression was 2.1 (95% Cl, 1.1-4.2; p = 0.03). The proportion of the 
risk for depression attributable to LnVLF power was 0.27 (95% Cl, 0.23-0.31; p <0.001). 
The authors concluded that low HRV partially mediated the effects of depression on 
survival post MI. HRV may therefore contribute to the understanding of possible 
biological mechanisms underlying depression’s role, as a risk factor for mortality in 
cardiac patients.
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2.5.2.3 HRV and stable CAD patients
Other researchers have found that depression is not consistently related to HRV in 
patients with stable CAD (Gehi et al., 2005; Stein et al., 2000). In a study by Gehi et al. 
(2005), a cross-sectional examination was made of the association between major 
depression (occurring in 22% participants) and 24 hour HRV in 873 out patients with 
stable CAD. Results showed no association between depression and HRV, as measured by 
time domain or frequency domain variables. Mean HRV was similar in participants with 
and without depression (all p values > 0.10), and participants with depression were no 
more likely than those without depression to have a reduced HRV (all p values > 0.10). 
The authors suggested that there may be a different pathophysiological basis to stable and 
unstable CAD, and that low HRV may be a mediator in depression and adverse outcomes 
in only unstable CAD.
Analysing the associations found between depression and reduced HRV further, De 
Jonge et al. (2007) carried out a study on the same dataset but divided patients according to 
cognitive and somatic symptoms of depression, to determine if depression that is 
associated with low HRV in post MI patients but not in stable CAD patients may be due to 
differential associations of somatic and cognitive depressive symptoms with HRV. They 
conducted a cross-sectional study o f 863 stable CAD outpatients, with the severity of 
somatic and cognitive depressive symptoms determined using factor analysis of items of 
the Patient Health Questionnaire (PHQ-9). Time-domain (SDNN, SDANN) and 
frequency-domain (VLF, LF, HF) indices of HRV were derived from holter monitoring. 
Results found that in the unadjusted analyses, somatic symptom scores were significantly 
associated with HRV (r = -.09 for SDNN; r = -.08 for SDANN; r = -.08 for LnVLF; r = - 
.08 for LnLF; r = -.10 for LnHF). However, after adjustment for demographic variables, 
co-morbidities, and lifestyle factors, somatic symptom scores were no longer associated
with lower HRV. Cognitive depressive symptom scores were not associated with HRV in 
either unadjusted or adjusted analyses. These results suggest that individual symptoms of 
depression may have differential associations with HRV and highlights the heterogeneity 
of depression in CAD patients and the possible differential associations with prognosis.
These findings conflict with those found in patients with stable CAD undergoing 
elective angiography (Carney et al., 1988; Stein et al., 2000). Stein et al. (2000) found a 
lower HRV in 40 patients with depression compared with 32 patients without depression 
with documented CAD by angiography. Results revealed heart rates were higher and 
nearly all indices o f heart rate variability were significantly reduced in the moderately-to 
severely depressed group versus the non-depressed group.
A possible explanation for the difference in results is the influence of medication. 
Medication used for treating angina, heart failure or hypertension improve cardiac vagal 
activity. Beta blockers like atenolol, are effective in increasing resting HRV measures of 
cardiac vagal activity and attenuate a stress induced reduction o f vagal tone (Vaile et al., 
1999). ACE inhibitors increase vagal inhibitory actions both peripherally and centrally 
(Potter et al., 1982). However, Gehi et al. (2005) found no evidence of an interaction 
between depression and beta blockers in analysis and no association of depression with 
HRV in the subset of participants not taking beta blockers. The majority of patients were 
also not taking antidepressants.
Possible confounding variables in the studies of HRV and depression are that 
studies have differed in relative proportions of male and female subjects in the samples, 
and there may also be differences in physical activity of the participants which may affect 
HRV results. Highly active individuals have been shown to have higher levels of HRV 
(Melanson, 2000). Other confounding variables may also be different diagnostic criteria
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for depression used in the studies, the presence or absence of medication or a failure in 
matching appropriate control groups.
2.5.2.4 Conclusions about HRV
To date, it is well established in the literature that depression is associated with 
both long term aetiology of CAD (Nicholson et al., 2006), as well as acute triggering of 
cardiac events (Steptoe et al., 2006) and to prognosis and adaptation to CAD (Carney et 
al., 2003, 2005). It has also been shown that depressed patients post-AMI have a 
reduced HRV (Carney et al., 2001) and that it is the reduction in HRV that partly 
mediates the effects of depression seen on post-AMI mortality (Carney et al., 2005).
However, results are mixed and differ when examining cohorts of patients at 
different stages of CAD development. Depression has been shown to be inconsistently 
related to HRV in patients with stable CAD (Stein et al., 2000; Gehi et al., 2005). 
Depression has also been shown to be inconsistently related to HRV in people without 
CAD (Moser et al., 1998; Kim et al., 2005). Depression in patients with advanced CAD 
has been shown to be associated with impaired autonomic cardiac control, i.e. reduced 
heart rate variability (HRV).
What is still unclear, from the existing literature is exactly when this relationship 
between depression and HRV evolves in the cardiovascular disease process, or whether 
reduced HRV is related to concurrent mood states or only to trait measures of depressed 
affect. Study of the association between negative affect and reduced HRV may provide a 
potential biological mechanism linking both acute stress in daily life, and chronic long 
term stress to disease outcomes. A central aim of my thesis is to examine whether there 
is a similar association between reduced HRV in stable cardiac patients who are
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depressed either as a trait measure as with the BD1 measurement or as measured on a 
moment to moment basis in the day by the Day Reconstruction Method (DRM) which is 
described in Chapter 3.
2.6 Arrhythmia/Implantable cardioverter defibrillator discharge
Acute emotional stressors provoke a variety of serious cardiac arrhythmias which 
may induce TMI or more prolonged ischaemia, or sudden death. The effects of acute 
mental stress (anger recall and mental arithmetic) and physical stress (bicycle testing), on 
T wave altemans (TWA), a marker of cardiac electrical instability, were evaluated in a 
study by Kop et al (2004). This study consisted of 23 patients with CAD and implantable 
cardioverter defibrillators and 17 controls. The study concluded that mental stress testing 
can induce cardiac instability amongst patients with arrhythmic vulnerability, and at a 
lower HR than with exercise, but no significant association was found between TWA and 
the severity o f ischaemia.
In contrast to the controlled laboratory task setting, the arrhythmogenic effects of 
extreme mental stress occurring in a terrorist attack setting was carried out by Shedd et 
al. (2004). They conducted an observational study to determine whether the World 
Trade Centre attacks in 2001 had an effect on the occurrence o f ventricular arrhythmias 
amongst 132 patients in Florida with implantable cardioverter defibrillators (ICD’s) who 
were far removed from the site of the attack. In the 30 days following the attack, a total 
of 14 patients (11%) had such arrhythmias, compared to 5 (3.8%) in the preceding 30 
days, concluding a 68% increase in the frequency of life threatening ventricular 
arrhythmias requiring ICD treatment. This supports previous descriptive and 
epidemiological studies, which have shown a link between sudden cardiac death and
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emotionally stressful stimuli such as those occurring in population catastrophies (Leor et 
al., 1996) as described in chapter 1.2.
Different types of emotion have a significant effect on arrhythmia. Whang et al.
(2005) prospectively analysed data on 645 1CD patients with symptoms of depression 
and the associated risk of ventricular arrhythmias that resulted in ICD discharge in the 
Triggers of Ventricular Arrhythmia (TOVA) study. Results showed that of the 645 
patients, those with moderate/severe depression (3.9%) had a more rapid ‘time to first 
shock’ for ventricular tachycardia (VT)/ventricular fibrillation (VF) compared with non­
depressed patients (hazard ratio HR 3.2, 95% Cl 1.1 to 9.9). Moderate/severe depression 
was also associated with the likelihood of any shock for VT/VF including recurrent 
episodes (HR 3.2; Cl 1.2 to 8.6). This risk was associated with depression severity in the 
total population as a whole (p for trend=0.02) and more specifically, among patients with 
CAD (p < 0.01), even after controlling for multiple confounders. This study is consistent 
with findings o f a previous study by Carney et al. (1993), in which depression (assessed 
by standardised psychiatric interview) was associated with VT episodes, detected by 24 
hour ECG monitoring among 103 CAD patients, even after adjustments were made for 
beta blocker use.
Anger may be another mood state associated with fatal arrhythmia. Lampert et 
al. (2002) systematically evaluated whether emotional or physical stressors can trigger 
spontaneous ventricular arrhythmias in patients at risk, and if so, how frequently. 277 
ICD patients were recruited and given diaries to record levels of mood states and 
physical activity during 2 periods preceding spontaneously occurring ICD shocks and 
during control periods 1 week later. Results were analysed in a case crossover approach. 
In the 15 minutes preceding shock, an anger level > 3 preceded 15% of the events 
compared with 3 % o f the control periods (p < 0.04; O.R 1.83; 95% Cl 1.04 to 3.16).
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Anxiety also appears to have a role in abnormal cardiac autonomic control which 
increases the risk of potentially fatal arrhythmias and can also trigger rupture of plaques 
by triggering coronary vasospasm (Kubzansky et al., 1998). Some researchers have 
suggested that anxiety is associated with especially high rates of sudden death and the 
cardiovascular effects of anxiety result from chronic or intermittent sympathetic activity 
with arrhythmogenic potential (Rozanski et al., 1999; Albert et al., 2005).
Lane et al (2005) assessed emotional triggers in patients with apparently healthy 
hearts who had suffered a cardiac arrest (idiopathic ventricular fibrillation) in 
comparison with Ml patients. Patients were interviewed systematically about the 
circumstances surrounding the cardiac events, and these accounts were rated 
independently by two experts for stress levels. The results indicated that in the 24 hours 
preceding a cardiac arrest or an MI, 36% of patients with ventricular fibrillation (VF) had 
experienced severe or moderate stress compared to 8% of Ml patients. It is possible that 
the emotional stress needs to be particularly severe in intensity to actually elicit clinical 
events in patients who do not have underlying CAD. Limitations in this study were that 
although patients were instructed to focus on the period preceding shock, there is a 
possibility of recall bias, with patients attributing post shock feelings o f anger to the pre 
shock periods as well. There is also the possibility that patients may have altered their 
behaviour during the control period 1 week after the shock.
Whether more benign ECG changes (minor ST depression) or heart rate 
variability changes are triggered by emotion remains unknown. Analysis of ST segment 
changes for ischaemic events is also relatively insensitive as a measurement tool. 
Radionuclide ventriculography and echocardiography are more sensitive, but impossible 
to use in everyday life studies. In the SIS study, the likelihood of arrhythmia occurrence 
was low, as our patients did not have advanced cardiac disease. However, in view of the
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above literature, ECG recordings were analysed for ventricular tachycardia and 
autonomic changes as well as ST depression for transient ischaemic changes in relation 
to mood in the SIS study.
2.7 Neuroendocrine processes
Psychosocial factors such as mood can be related to CAD by stimulating 
biological systems through central activation of neuroendocrine response as well as 
autonomic responses.
2.7.1 Cortisol physiology and relationship to cardiovascular risk
Cortisol is a glucocorticoid hormone produced in the adrenal cortex both 
spontaneously and in response to acute stressors, and is evident in blood, urine and 
saliva. Steroid hormones have important effects on the brain altering excitability of 
nerve cells and in the aftermath of stressful experiences for example in the day, by 
modifying neurochemical and structural features of the brain (Lupien & McEwen, 1997). 
Figure 2.2 shows a diagram of the influence that cortisol release has on various 
cardiological, metabolic, haemostatic and immune parameters in the body, alteration of 
which may lead to CAD development and affect adaptation to CAD in the long term.
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Figure 2.2 Glucocorticoid effects on various cardiovascular risk factors
(Girod & Brotman Cardiovasc Res, 2004)
As can be seen, cortisol is involved in a variety of pathophysiological processes
insulin resistance, prothrombotic responses and vascular inflammation (Girod & 
Brotman, 2004).
The measurement of salivary cortisol has become an important tool with which to 
investigate HPA axis function (Kirschbaum & Hellhammer, 1989). The HPA axis 
sustains life in stressful situations by increasing vascular tone, mobilising fuel, 
modulating inflammation and tissue repair processes, but chronic activation of this axis 
may override the short term physiological benefits of the stress response. Chronic tissue 
exposure to cortisol by chronic activation of HPA axis by mood states like depression
contributing to atherogenesis including disturbed metabolism, abdominal adiposity and
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(Plotsky et al., 1998) lead to metabolic and vascular changes, which may in turn 
accelerate atherosclerosis (Colao et al., 1999).
Cortisol shows a natural diurnal pattern in healthy adults, which peaks at 
approximately 20 -  45 minutes after waking and then decreases through the day, 
reaching a nadir at night and in the early hours of the morning, before increasing once 
again. (Kirschbaum & Hellhammer, 1989). The HPA axis is highly sensitive to 
psychological stimuli (Mason, 1968). Due to the large diurnal variation in cortisol 
concentrations (morning peaks and evening troughs), single measures are generally 
unreliable. 24 hour urine collections of cortisol allow an integrated estimate of the 
average free (unbound) cortisol concentration that circulate over the course of the day, 
but finer temporal resolution is not possible and average concentrations do not 
necessarily represent the overall tone of the axis (Brotman et al., 2007).
There are studies showing consistent associations between cortisol patterns and 
mood in healthy patients. Some studies having found that some patients who are 
depressed show an abnormal circadian rhythm with blunting o f the normal reduction in 
cortisol over the evening and hypercortisolaemia in the evening (Kirschbaum & 
Hellhammer, 1989). There are many studies reporting negative mood in medical 
conditions like Cushing’s syndrome that are characterised by hypercortisolaemia (Kelly 
et al., 1983; Loosen et al., 1992). Some studies suggest an association between 
depression and elevated cortisol levels in the morning (Yehuda et al., 1996). Other 
studies suggest that evening levels of cortisol show the highest association with 
depression (Gold et al., 1988).
The increase in cortisol in the first 20-30 minutes after awakening is known as 
the cortisol awakening response (CAR). Evidence suggests that it is unrelated to the 
mean underlying level of cortisol activity throughout the rest of the day (Edwards et al.,
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2001) with evidence for a genetic basis for the CAR, but not for the cortisol profile 
throughout the day (Wust et al., 2000), and thus implies that the CAR is under a distinct 
regulatory influence independent of the rest of the cycle (Clow et al., 2004). The CAR 
demonstrates a higher intra-individual stability than single measurements at pre-defined 
times. (Pruessner et al., 1997). The CAR has been associated with a wide range of 
psychosocial variables, stress and health but studies are inconsistent and it is unclear still 
whether health is associated with a larger or smaller CAR. Exaggerated increases in 
cortisol after waking have been associated with chronic stress (Steptoe et al., 2000). In 
addition, a larger CAR has been associated with depressive symptoms and a reduced 
positive affect (Pruessner et al., 2003; Steptoe et al., 2007) but also, a smaller CAR has 
been associated with patients suffering from chronic fatigue (Roberts et al., 2004).
Another aspect of the cortisol profile is the slope of decline over the day. This 
gradient is calculated as the difference between awakening and evening bed time values. 
A flatter slope has been found to be associated with depression (Weber et al., 2000) or 
stressful social experiences (Adam & Gunnar, 2001).
Salivary cortisol has proved to be an accurate reflection of plasma cortisol, and 
salivary sampling allows convenient assessment of diurnal patterns in a naturalistic 
ambulatory setting (Kirschbaum et al., 1989). It also allows assessment of the 
relationship between an individuals’ affective state and neuroendocrine changes over 
time, in response to potentially stressful naturally occurring activities and situations in 
daily life subject to daily hassles and strains.
Earlier studies had measured a single daily cortisol measurement to represent the 
cumulative effects of stress in a day, as carried out in studies by Brantley et al. (1988); 
Lundberg et al. (1989), which showed in general, elevated cortisol levels to be associated 
with stress. Results measuring cortisol this way was inconsistent. No relationship were
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seen between numbers of undesirable events in the day and between evening urinary or 
salivary cortisol levels in the study by Cummins and Gevirts, (1993).
Previous research has examined the impact of different daily stressors on mood 
and HPA activation using an ecological momentary assessment (EMA) design. EMA 
measuring stress and cortisol several times a day has distinct advantages over the end-of- 
the-day approach (Stone & Schiffman, 1994).
A variety of studies using momentary assessment, have shown that minor 
stressful daily events are associated with changes of mood in which positive affect (PA) 
decreases and negative affect (NA) increases to stress (Marco et al., 1993; Peeters et al., 
2003; Van Eck et al., 1998). Also studies have examined the association between minor 
stresses (by subjective mood appraisal at time points) and demonstrated that daily 
stressors give rise to negative emotional responses which activate the HPA axis and 
increase cortisol levels or produce altered cortisol patterns (Van Eck et al., 1996; Peeters 
et al., 2003; Smyth et al., 1998;). Momentary mood states also predict within person 
variability in cortisol in daily life and the association between NA and higher cortisol is 
consistently evident (Harris et al., 2000; Peeters et al., 2003).
Van Eck et al. (1996) examined the daily impact of stressful daily events in 87 
white collar workers over a period of 5 days. Stressful events were associated with an 
increase in cortisol secretion and stressful events that were ongoing at the time of 
assessment had a larger effect than those terminated early in the day. Smyth et al. (1998) 
extended this study to show that an increase in cortisol secretion was not only seen in 
response to a current acute stressor but also in anticipation of a stressor. Results 
suggested that affect may mediate the association seen between stress and cortisol, either 
by affect influencing the perception of daily events or being related to a heightened 
physiological effect o f stress.
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In the study by Peeters et al. (2003), patients with a major depressive disorder, 
assessed with the Beck Depression Inventory (BDI), were investigated by EMA in which 
self-reports of mood and events were assessed together with saliva sample. In contrast to 
healthy participants, the depressed group shows a blunted response to daily negative 
events.
A flattened slope has been found in association with work/home load stress in a 
sample of 156 healthy female adults (Adam et al., 2001). Another study by Adam et al.
(2006) showed that feelings of tension and anger were concurrently associated with a 
flatter diurnal cortisol rhythm, mainly due to an increase in evening cortisol level.
Results for PA are less consistent and some studies show no association between 
PA and cortisol levels (Peeters et al., 2003) However, others have shown that positive 
affect, as assessed by EMA, to be inversely associated with cortisol levels over the day 
(Steptoe et al., 2005; Polk et al., 2005). To date, there is currently little in the literature 
which has related cortisol profile to mood, as assessed by the day reconstruction method 
(DRM; Kahneman et al., 2004), which may provide a more precise picture of daily life 
experience.
Marked gender differences have been found in relation to cortisol profile and 
mood. In the study by Polk et al. (2005), a sample of healthy 334 adults showed that trait 
NA was associated with a higher overall total cortisol concentration and a greater 
morning rise in men even after controlling for waking levels of cortisol. Women high in 
trait PA had low morning cortisol levels, resulting in a low flat rhythm, in contrast to the 
men where those low in trait PA had cortisol levels that did not decrease in the afternoon, 
resulting in a high flatter rhythm.
The choice of salivary cortisol as a physiological index is practical as it can be
measured repeatedly in a non-invasive real life setting, and has shown intra individual
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stability over time. Responses are however affected by gender, smoking, use of oral 
contraceptive and other factors (Schulz et al., 1998). It is also true that the study of 
cortisol dynamics in daily life means that much of the control possible in a laboratory is 
sacrificed in order to gain ecological validity. The statistical method of analyses of the 
cortisol profile in the SIS study is outlined in chapter 4.
2.7.2 Cortisol and relation to depression in CAD patients
Disturbed cortisol regulation is one of the mechanisms that may link depression 
with CAD. Heightened cortisol output is partly responsible for vascular endothelial 
dysfunction in depressed individuals (Broadley et al., 2005). There have also been 
studies linking elevated levels of cortisol with CAD. Troxler et al. (1977) found 
significant correlations between elevated morning cortisol of 71 male outpatients and 
moderate to severe coronary atherosclerosis as evidenced on angiography. Coronary 
artery calcification is associated with flattened cortisol profiles over the day in middle- 
aged adults (Matthews et al., 2006). A prospective association between cortisol and 
future CAD has been documented in middle aged men (Davey Smith et al., 2005), while 
acute cortisol elevation following ACS predicts adverse cardiac outcomes (Bain et al., 
1989; Tenerz et al., 2003). Bain et al. (1989) studied cortisol levels in 20 post MI 
patients and 20 angina patients and found cortisol levels to be significantly elevated in 
patients within five hours of the onset of symptoms of an MI and concluded that early 
elevation of cortisol is sensitive (70%) and specific (85%) for MI, predicting MI in those 
with ischaemic chest pain. Raised cortisol concentrations also predict mortality in 
patients with chronic heart failure (Guder et al., 2007).
Evidence linking depression with cortisol directly in coronary artery disease
(CAD) is more limited. A recent study showed morning cortisol levels in women to be
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positively associated with the degree of stenosis found on angiogram (Koertge et al.,
2002). Otte et al. (2004) found that elevated 24 hour urinary cortisol was associated with 
clinical depression in patients with established CAD, but studies of patients following 
ACS have been inconsistent (von Kanel et al., 2007; Whitehead et al., 2007). Von Kanel 
et al. (2007) measured morning serum cortisol and haemostatic factors: activated clotting 
factor VII, fibrinogen, von Willebrand factor antigen, and plasminogen activator 
inhibitor-1 activity in 285 women (56 +/- 7 years) between 3 and 6 months after an ACS. 
Results showed that a higher serum cortisol levels predicted higher fibrinogen (beta = 
.17, p = 0.001) and higher von Willebrand factor (beta = .16, p = 0.008), all 
independently of covariates. Cortisol showed crude correlations with vital exhaustion (r 
= .14, p = 0.022) and with depression (r = .13, p = 0.043) but did not mediate the 
relationship between any of the psychosocial variables and haemostatic factors. These 
results suggested that morning cortisol levels showed some independent association with 
prothrombotic activity in women with CAD, and that these increased cortisol levels 
might contribute to atherosclerosis via eliciting a hypercoagulable state. However, no 
significant relationship was seen with regards to mood.
In the study by Whitehead et al. (2007) salivary cortisol was assessed eight times 
over a 24 hour period in 72 patients within 5 days of admission for ACS and depression 
was measured with the Beck Depression Inventory (BDI), and type-D personality was 
measured with the Type-D Scale-16. Results showed a typical diurnal pattern for 
cortisol, with low levels in the evening, high levels early in the day, and the cortisol 
awakening response (CAR), which was measured as the difference in cortisol between 
waking and peak responses 15-30 minutes later, was found to average 7.58+/-10.0 
nmol/1. In these results cortisol was not related to ACS severity or underlying CAD or to 
BDI scores, but the CAR was found to be positively associated with type-D personality 
independently of age, gender, and body mass (p=.007).
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CAD patients have shown an altered cortisol profile in response to stress. 
Nijm et al. (2007) assessed 30 post ACS patients for urinary cortisol, saliva sampling and 
inflammatory markers (IL-6 and CRP), finding that CAD patients had higher 24 hour 
urinary cortisol secretion and a flatter slope. The study also found that these patients had 
a significantly blunted cortisol response to acute mental stress compared with controls.
In summary, there is much evidence of an association between various aspects of 
the cortisol profile (cortisol mean values, CAR, cortisol slope) with mood as assessed 
both by the BDI and by momentary assessment in healthy participants but findings have 
been inconsistent. There is more limited evidence directly linking depression with 
cortisol in cardiac patients. Depression is prevalent in CAD and altered cortisol profiles 
have been associated with various aspects of cardiac disease. Dysfunction of the HPA 
axis is a plausible biological mechanism underlying the association between 
psychological states and CAD.
2.8 Haemodynamic changes
A study by Deedwania and Carbajal, (1992) measured the heart rate (HR) and 
blood pressure (BP) changes preceding the silent ischaemic events during the daily life 
of 25 men with CAD. 92% of transient ischaemic episodes were silent, and 61% of these 
were preceded by an increase in the heart rate of 5 beats /minute or more. The silent 
ischaemic events showed a circadian pattern with 34% of the total events occurring 
between 6.00 am and noon. The increase in HR and BP paralleled the increase in silent 
ischaemic events during these hours. In the PIMI study, described in the previous 
section 2.3 (Stone et al., 1999), patients with daily life ischaemia had a heightened
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generalised response to mental stress with a chronic state of sympathetic nervous system 
arousal and an exaggerated haemodynamic response to mental stress. In the ACIP study 
by Pepine et al. (1996), HR change was seen as the best independent predictor of TMI. 
The rise in heart rate increases cardiac oxygen demands and reduces supply due to a 
shorter period o f time available for coronary blood flow. This probably reflects 
neurohormonal changes as a result of stressors in the patients’ environment in everyday 
life. However, both vagal withdrawal or blood glucose changes and ischaemia itself 
could also contribute to increase in HR. Hostile emotions have also been associated with 
arterial constriction, increased BP and HR (Boltwood et al., 1993) and alteration in 
ventricular function as well as alterations in levels of catecholamines, cortisol and 
increased platelet aggregation (Rozanski et al., 1999).
2.9 Other mechanisms by which emotion may influence CAD development: 
platelet activation; serotonergic function; fibrinogen and pro-inflamammatory 
cytokines
Mechanisms that control coagulatory pathways that can result in the development 
of thrombi are of particular significance with relation to plaque rupture and a detailed 
review o f the research is outside the scope of this thesis. However, as these mechanisms 
interact with other pathways relevant to the thesis, for the sake of completeness, they will 
be briefly described here.
Markovitz and Matthews, (1991) suggested that enhanced platelet reactivity to 
stress is a key mechanism by which stress can trigger ischaemic episodes in everyday life 
and contribute to CAD. Platelets are central in homeostasis, thrombosis and
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development of atherosclerosis and ACS (Lefkovits et al., 1995). Depression is 
associated with increased platelet reactivity (Musselman et al., 1996, 2000). It has also 
been shown that CAD patients with depression have greater plasma concentration of 
platelet specific proteins, beta thromboglobulin and platelet factor 4, compared to non­
depressed CAD patients (Laghrissi-Thode et al., 1997). In addition, serotonin is 
involved in mood and emotion regulation and studies have shown that depression is 
associated with serotonergic function in both the central nervous system (Meltzer et al., 
1989) and in the peripheral circulating platelets (Owens et al., 1994). Most circulating 
serotonin is actually contained within the platelets, and secreted by them on activation at 
a site of endothelial injury. This contributes to platelet activation, smooth muscle 
proliferation, vasospasm and thrombus formation (De Clerck, 1991). Fibrinogen is 
important in the role of thrombus formation following activation o f the clotting cascade, 
following endothelial injury or plaque disruption. Fibrinogen is a large plasma protein 
produced by the liver, and a structural component of thrombus once it has been 
enzymatically converted to fibrin, after activation of the clotting cascade. A raised 
fibrinogen level has been associated with increased risk of CAD (Kannel et al., 1987; 
Meade et al., 1993).
Finally, CAD is increasingly seen as a chronic inflammatory response to vascular
endothelial injury (Ross et al., 1999). Depression may also contribute in triggering
endothelial injury (Miller et al., 1999), triggering dysregulation of the neurohormonal
system (Plotsky et al., 1998) or increasing susceptibility to infection by pathogens
colonising the vessel wall (Sawayama et al., 2005; Smeeth et al., 2004). Interaction
between platelets, leucocytes and endothelial cells stimulate pro-inflammatory, pro-
thrombotic processes which contribute to plaque rupture and thrombosis in ACS
(Freedman & Loscalzo, 2002). Negative mood or emotions can also adversely affect the
inflammatory processes via the action of pro-inflammatory cytokines. This is a two way
113
process i.e. negative mood can affect cytokines and cytokines can influence mood. 
Penninx et al. (2003) showed in a study of 3000 adults, that depressed mood was 
associated with elevated C-Reactive Protein (CRP), inter-leukin 6 (IL-6) and tumour 
necrosis factor (TNF), after adjustment for confounders. Acute psychological stress has 
been shown to increase IL-6 by increasing inter-leukin 1 (IL-1) beta gene expression in 
peripheral blood cells (Brydon et al., 2005). The pro-inflammatory cytokines IL-1 and 
IL-6 stimulate the HPA axis, initiating a classic stress response resulting in elevated 
circulating glucocorticoids (Sapolsky et al., 1987). Cytokines induce behavioural and 
psychological expressions o f stress, such as negative emotions, feelings of anhedonia and 
other recognised symptoms o f depression. Depression and acute stressors may maintain 
the inflammatory response once initiated, by possibly diminishing the immune system 
sensitivity to glucocorticoid hormones that are responsible for terminating the 
inflammatory response (Carney et al., 2002).
2.10 Conclusion
To summarise the key points of this chapter which addresses the original 
questions proposed in the introduction, TMI is a common occurrence in everyday life 
(Deanfield et al., 1984) and associations have been shown with a variety of emotions 
(Gullette et al., 1997) and more so with negative emotions. Silent ischaemia is also 
common (Freedman and Wong, 1998; Deedwania et al., 1992), although of uncertain 
significance. Pathological ischaemic changes do not always occur with chest pain 
symptoms (Kinne et al., 1999), and there appears to be an inconsistent relationship 
between angina and ischaemia (Krantz et al., 1996).
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TMI in daily life is more common in CAD patients with particular psychosocial 
characteristics. A significant association is found especially in patients with depression 
(Jiang & Blumenthal, 2003).
The principle biological mechanisms suggested so far to account for these 
associations are haemodynamic changes, heart rate variability (i.e. vagal withdrawal 
provoking ischaemia), arrhythmias and neuroendocrine changes.
Chapter 3 discusses the methodological limitations to some of the studies that 
have assessed TMI in daily life, together with important medication-related issues. It 
also describes the aims and hypotheses o f this thesis, and its contribution to 
understanding the biological mechanisms underlying the association between mood and 
myocardial ischaemia.
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Chapter 3: Methodological issues in the study of psychosocial factors 
and transient myocardial ischaemia in everyday life
3.1 Introduction
This chapter will describe the objective of the thesis in relation to the three new
studies which I have carried out. In particular, I will discuss the methodological issues
relevant to the SIS study. This will include highlighting some of the current limitations 
in interpreting the findings from the ambulatory studies relating to transient daily life 
ischaemia and physiological mediators previously described in chapter 2. I shall also 
address the medication issues that influence cardiac parameters and the reason why HRV 
and cortisol, in addition to ischaemic episodes, were examined in relation to mood in the 
SIS study.
3.2 Problems in previous ambulatory studies
3.2.1 Diary methods to assess mental and physical activities in daily life
Previous studies have established a methodology for assessing the effect of
everyday physical and mental stresses on ischaemia in CAD patients, most often using
patient-completed diaries collected during a period of ambulatory ECG monitoring
(Gullette et al., 1997; Gabbay et al., 1996; Krantz et al., 1999). These methods enable
the relationship between episodes of ST segment depression and diary information on
stress and physical activity to be examined. However, such designs have raised a
number o f methodological issues. Firstly, paper and pencil diary ratings of subjective
states raise the problems of non-compliance and of participants filling in diaries
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retrospectively later. A recent study revealed that participants faked entries on over 87% 
of diary cards in a study of chronic pain, and that use of an electronic diary raised actual 
compliance to 94% (Stone et al., 2003). Electronic diary methods which effectively 
‘time-stamp’ patient responses seem to greatly enhance the validity of ambulatory 
studies (Bolger et al., 2003), but are quite cumbersome and intrusive, and may not be 
well understood by older patients.
A second problem with the diary methods that have been used to date, is that they 
may increase self-consciousness on the part of patients. If the person is required to 
indicate how they are feeling and what they are doing throughout the monitoring period, 
they may censor their activities, and endeavour to present a positive image to the 
investigators.
Assessment of mood has been traditionally based on retrospective self-report in 
the natural environment or laboratory-based studies but this cannot adequately assess the 
rather more complex and temporally dynamic psychological, behavioural, and biological 
processes in the natural environment of everyday life settings. Ecological Momentary 
Assessment (EMA) has been used as a methodology to overcome this problem (Stone et 
al., 1994, 2003). EMA involves repeated sampling of current mood and activities, and 
does not involve the more laborious assessments that have been used in most TIA 
studies. The EMA approach has allowed investigation of a number of research questions 
that include: (1) the comparison of retrospective data to momentary data; (2) evaluation 
o f the psychophysiological processes in everyday life; (3) the relation of mood, 
symptoms and other disease processes to characteristics of the natural environment; and 
(4) examination of dynamic changes in psychosocial variables that may mediate 
improvement following treatment. With EMA employed to characterise daily life, 
assessments are collected at regular time points rather than continuously. It may not be
possible to determine the temporal sequence of events preceding an ischaemic episode 
over a relatively short monitoring period. Events may be missed and participant burden 
may lead to lack of compliance with the study. This also leaves the question as to what 
duration of negative emotions is required to increase the risk of an ischaemic episode, 
and whether specific mood states increase the risk of ischaemia independently of each 
other.
Measurements of positive emotions have varied as well. In a review of the 
literature by Pressman and Cohen (2005), the majority of the studies used simple self - 
report ratings or questionnaires to assess positive affect (PA). For example, the Positive 
and Negative Affect Schedule (PANAS; Watson et al., 1988) has separate 10-item scales 
for PA and negative affect (NA), rather than the two being bipolar ends of the same 
scale. Most of the studies in the review had a time frame examining general trait feelings 
rather than the current or moment -  by moment mood state. Another measure is the 
positive affect scale derived from the CES-D (CES-D; Radloff, 1977), as utilized by 
Ostir et al (2001).
Steptoe et al. (2007) carried out an observational cohort study in which a sample 
of 716 men and women were assessed by measurement of both PA and NA by 
momentary sampling throughout the day, examining health-related psychosocial factors. 
It was found that PA was associated with greater social connectedness, emotional and 
practical support, optimism and lower levels of depression, independent of socio­
demographic factors and NA. In a further study by Steptoe et al. (2007), 72 healthy men 
were assessed by testing the relationship between cardiovascular markers and 
neuroendocrine markers and affect measured by EMA and the PANAS questionnaire. 
The findings were that PA was inversely related to biological responses in the laboratory
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and cortisol awakening responses, and those effects were stronger when PA was assessed 
by aggregating EMA samples rather than using the PANAS questionnaire.
The assessment of trait affect is often based on a single point of assessment, 
which can be influenced by momentary peak moods or recent moods (Frederickson & 
Kahneman, 1993). A better estimate of emotional experience is sampling mood at 
several time points across a period (Cohen et al., 2003), or sampling across multiple time 
points to distinguish frequency, peak periods, and intensity o f emotions and activities 
(Stone & Schiffman, 1994).
In summary, there is evidence from the ambulatory studies in Chapter 2 that 
emotional states and the stresses of everyday life can stimulate transient myocardial 
ischaemia in patients with CAD. Only a few studies (Gullette et al., 1997; Kinne et al., 
1999) have shown different types of emotional state to be differentially associated with 
ischaemia. These studies (Gabbay et al., 1996; Barry et al., 1988; Krantz et al., 1994) 
have highlighted how difficult it is to work out what proportion of patients show 
ischaemia specifically related to an emotional state, especially as levels of emotional 
arousal are typically quite low and subject to recall bias.
In addition, it is unclear whether people who fail to show emotion-related 
ischaemia do so because they are not actually susceptible (Strike et al., 2006) or because 
they do not experience sufficient arousal during the monitoring period. Accurate 
representation of the varying emotions during the day is a particular methodological 
issue in studies.
One last important point is that in order to assess the relative impact of mental
stress and affective states on cardiac function, the effect of physical activity needs to be
statistically controlled, as everyday physical activity has been associated with ischaemic
episodes (Gullette et al., 1997; Gabbay et al., 1996; Krantz et al., 1994; Barry et al.,
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1988). Actigraphy provides the means to partial out physical activity as an independent 
risk for ischaemic episodes. Some previous studies used diary records of physical 
activity, later rated by the experimenters for intensity (Gullette et al., 1997; Gabbay et 
al., 1996). Although experimenter ratings were validated against activity as rated by 
accelerometer (Patterson et al., 1993), the current availability of lightweight wrist-worn 
accelerometers which are well-validated against gold-standard measures of metabolic 
energy expenditure (Starling et al., 1999) really removes the need for detailed diary 
reports of activity in such studies. It also avoids the risk of patients interrupting normal 
daily activities by the need to regularly record physical activity. In the SIS study, 
participants wore an actiwatch to assess physical activity. The objective physical activity 
results have yet to be analysed and so are not presented in this thesis.
3.2.2 Medication issues
Patients with either suspected cardiac disease or established CAD are often on a 
range of cardiac drugs to limit the symptoms of angina, minimise risk factors like 
hypertension and confer prognostic benefit post MI. However, such medications will 
influence cardiac physiology and hence act as potential confounders in studies relating 
TMI with emotion. This section describes some o f the literature regarding medication in 
studies on cardiac patients.
There are several inconsistencies in the literature regarding which medication or 
combination of medications is optimal in the prevention of myocardial ischaemia. There 
are also inconsistencies regarding the prognostic benefit of treatment of symptomatic 
versus asymptomatic angina. The studies are heterogeneous with a variety of 
confounders (age, sex, co-morbidities) to account for and the jury is out as to the optimal 
treatment of cardiac symptoms.
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The question arises as to whether it is necessary to relieve all ischaemic activity 
or only that occurring with chest pain. Does the present use of anti-anginal medication 
neglect the early morning increases in TMI and are different dosages required to treat 
ischaemia adequately? Some studies have addressed the question of whether treatment 
responses can be improved by combination treatments versus monotherapy, taking into 
account the circadian pattern of myocardial ischaemia and irregular dosing by non- 
compliant patients. Effective treatment is important in the early hours of the day in view 
of circadian patterns of ischaemia. It has been argued that amlodipine, with its 
intrinsically long half life, either alone or together with a beta blocker, is likely to 
produce superior ischaemia reduction in clinical practice when patients frequently forget 
to take medication or dose irregularly (Deanfield et al., 1994, 2002). A brief summary of 
the major clinical trials regarding TMI in relation to medical therapy is outlined below.
A study by Davies et al. (1995) looked at the effects of the beta blocker agent 
atenolol, and the calcium blocker agent amlodipine, separately and together, on 
ischaemia both during treadmill testing and ambulatory ischaemia in the Canadian 
Amlodipine/Atenolol in Silent Ischaemia study (CASIS). The frequency of ischaemic 
episodes decreased by 28% with amlodipine (p = 0.083 , not significant), by 57% with 
atenolol (p <0.001), and by 72% with a combination of the two (p <0.05 vs. both single 
drugs; p <0.001 vs. placebo). This study concluded that there was evidence to suggest 
that ischaemia during treadmill testing was more effectively suppressed by the calcium 
blocker, amlodipine. This is supported by another study by Deedwania et al. (1999).
However, other studies argue that beta blocking agents alone are more useful. 
From the study by Davies et al. (1995), ischaemia during ambulatory monitoring was 
more effectively suppressed by atenolol than calcium blockers. This was supported by 
studies by Von Arnim et al. (1996) in The Ischaemic Burden Bisoprolol Study (TIBBS),
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and Pepine et al. (1994) in the Atenolol Silent Ischaemia Study (ASIST). Another study 
carried out by Stone et al. (1990) compared the beta blocker, propranolol and alpha-1 
receptor blocker, diltiazem as well as a calcium blocker, nifedipine, in the treatment of 
ambulatory ischaemia in 50 patients with stable angina. All of these medications were 
compared with a placebo each for 2 weeks in a randomised double blind crossover trial. 
Compared to the placebo, only propranolol was associated with a marked reduction in all 
manifestations of asymptomatic ischaemia. In contrast to the marked effects of active 
agents on ambulatory asymptomatic ischaemia, effects on exercise testing or angina were 
slight.
The findings of combination therapy are not conclusive. A large study by Fox et 
al. (1996) has shown no significant benefit in terms of exercise testing or in reduction of 
the total ischaemic burden from the combination of the two agents (atenolol versus 
nifedipine, a calcium channel blocker) when compared with each agent alone. 
Therefore, this suggests that no significant further benefit is gained from adding a second 
agent with a differing mechanism of action in patients with chronic stable angina. The 
question persists as to whether patients who show evidence o f TMI should receive a beta 
blocker or calcium blocker, or indeed both, and to what exact prognostic benefit this may 
confer in patients with stable angina.
In the SIS study, patients who had cardiac symptoms and positive treadmill tests 
or myocardial perfusion scans, were put on a standard set of medication as per NICE 
(National Institute of Clinical Excellence) guidelines unless contraindications were 
present. These consisted of an antiplatelet agent aspirin, a statin for 
hypercholesterolaemia, an ACE inhibitor, and a beta blocker or calcium blocker agent as 
an anti anginal or antihypertensive agent, as well as a long acting nitrate depending on 
frequency or severity of angina symptoms experienced prior to the angiogram. The beta
blocking agent dampens down sympathetic activation, reducing the heart rate, providing 
symptom control and reduces the likelihood of ischaemia. Episodes of ambulatory 
ischaemia can occur when patients are sedentary and can be provoked by mental stress. 
Situations triggering emotional distress cause increases in heart rate (HR), blood pressure 
(BP) and possibly coronary vasoconstriction. Beta blockers, through their action on 
central nervous system, may be effective in inhibiting this response. However, this agent 
is also used to treat psychiatric disorders like panic attacks (Heiser & Defrancisco, 1976) 
and so may affect mood as well as cardiac ischaemia. When researching the effects of 
TMI, it would be ideal to include patients off such medication but this is often not 
feasible to do so. In view of the reduced likelihood of ischaemic episodes during the 
ambulatory monitoring of medicated patients in the SIS study, other physiological 
mediators linking emotion with daily stress were studied. These were the measurement 
of HRV and salivary cortisol, which are both easy to measure and have been used 
extensively in previous literature in studying emotional state and its influence on CAD.
3.3 Alternative techniques - The Day Reconstruction Method (DRM)
To overcome laborious diary methods and a possibly higher drop out rate of older
less motivated and/or depressed subjects, I have adapted a new retrospective diary
method for characterising daily life experience called the Day Reconstruction Method
(DRM) as developed by Kahneman et al. (2004). This method assesses how people
spend their time and how they experience various activities and settings of their lives by
combining features of time-budget measurement and experience sampling. Participants
systematically reconstruct their activities and experiences of the previous day by
constructing a diary consisting of a sequence of episodes. Then they describe each
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episode by answering questions about the situation and feelings experienced to provide 
an accurate picture of experience associated with activities. Evoking the context of the 
previous day is intended to elicit specific and recent memories, and in doing so, to reduce 
the error and recall bias that occur when general recollections are studied. Thus, instead 
of asking patients how they felt at different times of day, they are asked to recall the 
emotions associated with specific episodes of behaviour. This new method has the 
advantages of being more efficient, generating less respondent burden, without 
disruption of normal activities. It also provides an assessment of contiguous episodes 
over a full day rather than a sampling of moments.
We therefore investigated mood over the ECG monitoring period by having 
patients complete the Day Reconstruction Method (DRM) interview for the same period. 
The DRM also provided an opportunity to assess positive as well as negative affective 
states. Since negative and positive states have been associated with increased and 
reduced risk of CAD respectively (Burg et al., 2003; Kubzansky et al., 2007), I 
speculated that patients mood state over the study period would relate to TMI or altered 
patterns of HRV seen on the ECG or altered patterns of the cortisol profile.
3.4 Aims and hypotheses of the SIS study and ACCENT study
3.4.1 Aims
The three studies described in this thesis were carried out to: -
a) Evaluate the influence of emotional triggers on cardiac health acutely on a moment to 
moment basis in daily life.
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b) Evaluate the influence of emotional acute triggers on the long term adaptation after an
established coronary event or procedure, in terms of psychological adaptation and
functional recovery.
c) Understand the psychophysiological basis for such effects.
3.4.2 Hypotheses
SIS  Study
1. Episodes of silent myocardial ischaemia or arrhythmia triggered during
ambulatory monitoring will be positively associated with negative mood states.
2. Trait measures of depressed affect as measured by validated scales and moment
to moment negative mood states over the day will be associated with reduced
heart rate variability. This hypothesis is tested using the DRM.
3. Episodes of silent myocardial ischaemia or arrhythmia triggered during
ambulatory monitoring will be positively associated with lower cortisol 
awakening response.
4. Trait measures of depressed affect as measured by validated scales will be
associated with flatter cortisol slopes over the day, and with an exaggerated 
cortisol waking response in patients with coronary artery disease.
ACCENT Study
5. Acute emotional state during hospitalisation for ACS will predict resumption of
work 13 months later independent of both socio-demographic and cardiological 
variables.
6. Acute emotional triggers of ACS are predictive of poor longer term adaptation to
ACS. Psychological and physical triggers, in the hours immediately before the 
symptom onset of ACS, will differentially predict mental and physical health 
adaptation 12 and 36 months later.
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3.5 Diagrammatic representation of bio psychosocial model of how emotion may 
influence cardiac health both at the early and late stages of cardiac disease 
development. Figure 3.1
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Chapter 4: Method SIS study
4.1 Participants
The participants in this study were 88 patients with angina and positive exercise 
tests or positive myocardial perfusion scans with symptoms of chest pain, who, having 
been seen by a cardiologist, were then placed onto a cardiac catheter waiting list 
prioritised as ‘soon’ or ‘urgent’. These patients were recruited from a Rapid Access 
Chest Pain Clinic over a 2 year period from one teaching tertiary hospital. Additional 
patients were recruited from the angiogram waiting list from two other tertiary teaching 
hospitals. After screening potentially suitable participants from patient records, they 
were contacted and invited to take part in the study.
A separate control group was not recruited, since we deliberately tested 
participants before their angiograms. I was confident that a proportion of patients 
(probably around one third) would turn out not to have CAD, so that I could make a 
comparison between patients with and without CAD using the single sampling 
procedure. Participants were deliberately tested before their angiograms were carried out 
so that I would be blind as to whether or not they had definite CAD.
CAD was subsequently documented by a positive angiogram and / or a history of 
myocardial infarction, coronary artery bypass surgery, or percutaneous coronary 
intervention (PCI).
We excluded patients with valvular disease, cardiomyopathy, congestive heart 
failure, Wolff-Parkinson-White syndrome, and uncontrolled hypertension as well as
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those with severe renal, neurological, or pulmonary disease. Also excluded were patients 
with chronic disease, which would interfere with general mobility, or psychiatric 
disorders as well as those not fluent in English, which invalidates the interview 
procedure. The study was approved by the medical research ethics committees of Royal 
Free Hospital, St. Mary’s Hospital, and University College Hospital, and all patients 
gave written consent.
4.2 Study design
Patients were contacted individually and recruited if they fulfilled the study 
criteria. Patients attended the study office on two consecutive mornings. On the first 
morning, physical measurements were taken, the ethical consent form was signed, and 
the patient was trained in collecting saliva samples. The holter monitor was also 
attached. On the second morning, the holter monitor was returned and saliva samples 
and diary collected, and the patient completed the DRM in an interview, which 1 
conducted. This is described in a later section in this chapter in more detail. All patients 
remained on their regular medication.
4.3 Psychosocial measures
Socio-demographic data, clinical data, and psychological data were collected at 
the interview. All participants recruited to the study were also asked to fill out a 
background questionnaire in their own time and bring to the first session of the study.
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4.3.1 Socio-demographic data
Socio-economic position was assessed at baseline using a number of measures 
contained in the interview (see appendix 3). Patients were asked for details of their level 
of educational attainment. This is an indicator of socio-economic position that is easily 
measured, applicable to people not in the active labour force as well as those in stable 
employment over time. The level of reported educational attainment was categorised 
into 7 groups; no educational qualifications, up to school certificate, CSE’s, GCSE’s, A 
level , Degree and Other but, for the purpose o f statistical analysis, this was combined 
into ‘Primary’ and ‘Secondary or above’. The participants’ level of yearly income was 
classified into five categories; ranging from less than £10,000, to over £40,000. 
However, for the purposes of statistical analysis, groups were categorised into ‘income 
above or below £20,000’. A deprivation index was also computed based on four criteria: 
living in a crowded household (defined as one or more person per room), not having 
access to a car or van, renting as opposed to owning their home, and being in receipt of 
state benefits. Participants were classified as low deprivation (negative on all items), 
medium deprivation (1 positive score) and high deprivation (2-4 positive items). The 
deprivation index gives a broader measure of social deprivation and access to resources 
and is based on the scale developed by Townsend (Townsend, 1990).
4.3.2 Clinical data
Clinical information was taken from the patients with respect to symptoms of 
chest pain, frequency, and cardiac investigations, such as an exercise tolerance test or a 
myocardial perfusion scan (otherwise known as a thallium scan), as well as established 
cardiac risk factors and current medications.
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4.3.3 Psychological trait assessment
The study questionnaire was a compilation of standard psychometric instruments 
designed to assess different aspects of emotional experience and well-being together with 
measures of health behaviours. The use of these measures is well established and all 
have been previously employed in assessing cardiac patients. Psychological and 
psychosocial factors including depression, anxiety, social support, socio-economic 
status, financial strain, work-related stress and marital stress will be analysed in my 
thesis. Questionnaires were used at baseline and at 6 months follow up.
The measures used in the baseline questionnaire (see appendix 4) were:
4.3.3 i) Illness A ttributions Questionnaire
Patients’ beliefs concerning the causes o f their heart problem and heart disease 
symptoms were measured using this questionnaire based on the major categories of 
causal attribution described by French et al. (2001) and Gudmundsdottir et al. (2001), 
and on the causal belief items from the Illness Perception Questionnaire (Weinman et al.,
1996). It consisted of 16 items such as ‘My illness is hereditary -  it runs in my family’, 
‘A germ or virus caused my illness’, etc. Answers were scored as yes (2), maybe (1) and 
no (0). Scores could range from 0 -  32.
4.3.3 ii) Hospital Anxiety Scale (HADS anxiety)
The anxiety component is one of two 7 item self-report screening sub-scales
taken from the Hospital Anxiety and Depression Scale (HADS), a well established
measure of psychological distress in medical patients. The complete measure was
originally developed to detect the presence of anxiety and depression in a clinical
population o f medical outpatients suffering from a wide variety of illnesses (Zigmond &
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Snaith, 1983). HADS has been widely used in studies with patients following AMI as an 
index of outcome, and to assess quality of life and psychological well-being 
(Trzcieniecka-Green & Steptoe, 1996; Whitmarsh et al., 2003). In this study, only the 
anxiety sub-scale was used (HADS anxiety scale). This 7-item scale is scored from 1 
(not at all anxious) to 3 (very often anxious), but with 5 items reverse scored. Total 
scores could range from 0 to 21. Higher scores reflect greater anxiety and patients were 
classified as being at least moderately anxious if their scores exceeded the recognised 
threshold of > 8 (Zigmond & Snaith, 1983). HADS was developed for patients with 
physical illness and was found to be a reliable instrument for detecting severity of 
emotional distress in a review of validation data by Herrmann (1997).
4.3.3 iii) Medical Outcome Short Form 36 (SF36)
Health status and quality of life were measured using the SF36 health status 
measure, adapted for use in the UK (Ware & Sherbourne, 1992). The SF36 assesses 8 
domains of health-related quality of life. There are 36 individual items, which are 
grouped into 8 multi-item subscales representing the 8 domains. These include physical 
function (limitations in physical activity due to physical health), role limitations due to 
physical problems (problems with work and daily activities due to physical health), 
bodily pain (severity), general health perception (evaluation of physical health and 
likelihood o f improvement), vitality (energy level), social functioning (interference with 
social activities due to physical and emotional health problems), role limitations due to 
emotional problems (problems with work and daily activities due to emotional 
problems), and mental health (anxiety and depression). Each subscale is scored so that 0 
represents the lowest (worst health) and 100 the highest possible (best health) level of 
function. Scores for the 8 subscales at baseline were calculated, and changes in the 
quality of life was measured by following the procedure advocated by Ware et al. (1994),
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to calculate the physical and mental health status. This measure also contains 2 summary 
component scores; summary physical health status was calculated by averaging scores 
for the physical health domain subscales (physical function, role limitations due to 
physical problems, bodily pain and general health perception) while summary mental 
health status was calculated by averaging scores for the mental health domain subscales 
(vitality, limitations due to emotional problems, social functioning, and general mental 
health). The SF36 has been used in a number of studies investigating quality of life 
among cardiac patients (Brown et al., 1999; Fogel et al., 2004; Rumsfeld et al., 1999). In 
previous published studies, internal reliability statistics have exceeded the minimum 
standard of 0.70 recommended for measures used in group comparisons (Ware & 
Gandek, 1998).
4.3.3 iv) Life Orientation Test (LOT)
This questionnaire is a measure of positive outlook on life (Scheier & Carver, 
1992). Optimism is measured by using the LOT, an eight item self-report measure (plus 
two filter items) assessing generalised expectancies for positive and negative outcomes. 
Participants were asked to indicate their degree of agreement with statements such as ‘In 
uncertain times, I usually expect the best’ using a 5 point scale ranging from 0 (strongly 
disagree) to 5 (strongly agree). O f the 8 scored items, 4 are worded in a positive 
direction and 4 are worded in a negative direction. Total optimism scores equalled 32 
with higher scores indicating greater optimism. Cronbach's alpha was 0.82 (Scheier et 
al., 1994). The benefits of optimism have been associated with rapid recovery after 
cardiac procedures surgery and improved quality of life in cardiac patients (Scheier et al., 
1989).
4.3.3. v) Beck Depression Inventory (BDI)
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Depression was measured using the second edition of Beck Depression Inventory 
(BDI), a standard measure of depressive symptoms (Beck, et al., 1988). This is a 21 item 
self-report instrument that assesses severity of depression symptoms over the past week, 
by asking participants to rate the severity of symptoms ranging from no symptoms (0) to 
severe (3). BDI scores can range from 0 to 63; BDI scores of 10 or greater indicate 
symptoms of mild to moderate depression (Ziegelstein et al, 2000). The BDI has been 
used in a number of studies of patients with cardiac disease and is considered a valid 
measure of depression (Buchanan et al., 1993; Crowe et al., 1996; Frasure-Smith et al.,
1997). A meta-analysis of studies (including cardiac patients) focusing on the 
psychometric properties and internal reliability of the BDI yielded a mean coefficient 
alpha of 0.81 for non-psychiatric participants (Beck et al., 1988).
In addition to the set o f psychosocial measures outlined here that comprised the 
baseline questionnaire, there were four other additional measurements used in the follow 
up questionnaire at 6 months.
The additional measures used in the follow up 6 month questionnaire (see 
appendix 6) were:
4.3.3. vi) Social Network
These were measured using the Social Network Index developed by Cohen et al. 
(1997) as an index of the diversity of social interactions. Participants were asked about 
the frequency of their interactions within a typical fortnightly period with 12 sets of 
contacts (e.g. children, friends, work colleagues). Greater values represented more 
diverse social networks, and scores could range from 0 to 12 (higher scores indicating
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larger social networks). For the purposes of analysis, participants were categorised into 
three groups; small social network (0 to 3 social contacts), medium social network (4 to 
5 social contacts) and large social networks (6 or more).
4.3.3 vii) Social Support
Social support was assessed using a scale previously shown to predict survival in 
elderly patients following myocardial infarction (Berkman et al., 1992). Participants 
were asked how many people they could count on for emotional support and responses 
were allocated to four categories: no support, 1 person, 2-3 people, 4 or more people.
4.3.3 viii) Cook and Medley Hostility Scale
The Cook and Medley Hostility (Ho) scale (1954) is a measure of hostility 
derived from the Minnesota Multiphasic Personality Inventory and found to be related to 
both the severity of coronary artery disease and the development of coronary artery 
disease (Williams et al., 1980; Barefoot et al., 1983). Barefoot et al. (1989) described 
three of the derived subscales as predictive of mortality: cynicism, hostile affect, and 
aggressive responding. The reliability o f the scale is satisfactory with an internal 
consistency being reported by the original authors as 0.86 and this has been further 
confirmed in other studies (Smith et al., 1985). I used 14 items in the hostility scale with 
10 being related to cynicism and 4 related to aggressive responding. It has been 
suggested that high scores on cynical hostility is associated with a particularly unhealthy 
psychosocial risk profile for CAD (Smith et al., 1985).
4.3.3 ix) Health Locus o f Control
This scale was developed from the original Health Locus of control developed by 
Wallston et al. (1976) as a unidimensional measure of peoples’ beliefs that their health is 
or is not determined by their behaviour. The scale has subsequently been developed to
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form a multidimensional health locus of control scale (Wallston et al., 1978) to include 
three 6 item Likert scales. This reflects three dimensions of health locus of control 
beliefs: internality (IHLC) i.e. a person believes his behaviour influences his health 
status; powerful others (PHLC) i.e. a person believes his health is influenced by the 
actions of other people e.g. doctors; and chance (CHLC) externality i.e. the person 
believes his health status is influenced by the actions of other people or due to fate, luck 
or chance. These health related behaviours determine a persons health status in part. 
The scales are internally consistent and valid. Each subscale is correlated approximately 
0.6 with its counterpart (Wallston et al., 1978).
4.4 Ambulatory ECG monitoring
4.4.1 Background
I will first explain the basic principles on which the ECG is based on, followed 
by an explanation of the ECG electrode placement and ECG changes that occur with 
cardiac ischaemia.
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Figure 4.1 Schematic representation of the heart.
Left
atrium
Left bundle branch
Right bundle branch'
Briefly, deoxygenated blood from the body is received by the top chamber- the 
right atrium. There is a pacemaker here called the SAN (Sino-Atrial Node). This fires 
across the atria to the Atrio-Ventricular Node (AVN), through the bundles of electrical 
fibres and then across the right and left ventricles. This wave of electrical excitation 
across the ventricles or the bottom chambers of the heart causes them to contract 
simultaneously to pump out oxygenated blood through the aorta to the body once more. 
The electrical signals correspond to the firing of the atria and the contraction and 
relaxation of the ventricles i.e. the bottom chambers of the heart. These anatomical, 
functional and corresponding electrical changes that occur can be represented on the 
ECG, which is essentially an electrical recording from the heart. The changes 
corresponding to transient myocardial ischaemia in everyday life setting are illustrated in 
Figure 4.3.
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4.4.2 Electrode placement
Participants underwent 3 channel, 6 patient cable lead, 24 hour holter monitoring. 
An amplitude modulated 3 channel holter recorder (Delmar Reynolds Life Card CF) was 
used. After skin preparation of the electrode sites to be placed on the chest, three sets of 
bipolar leads were placed on the patient. Electrode placement for channels CM2, CM5 
and modified II were placed as detailed in previous ambulatory ECG studies (Jiang et al., 
1995) to optimise the efficacy in detecting TMI changes and are shown in Figure 4.2.
Figure 4.2 Electrode placement (Jiang et al., 1995)
Monitoring was initiated between 9.00 am and 11.00 am. Postural testing in 5 
positions (supine, left lateral, right lateral, sitting and standing) each for 2 minutes was 
performed after an 8-minute calibration period in order to exclude artefactual ST- 
segment change.
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4.4.3 ECG analysis
All ECG analyses were carried out by experienced technicians at Hertford 
Cardiology Services. Calibrated 24 hour tapes were initially analysed visually by an 
experienced cardiac technician. An ischaemic response is defined as horizontal or 
downsloping ST depression >lm m  or < 1.5mm, upsloping, below the isoelectric 
baseline, measured at 0.08 seconds after the J point and persisting for at least 40 seconds. 
Measures of ischaemia were made by two technicians and also verified by a cardiologist 
blind to patient characteristics, and will be analysed in the SIS study. For each episode, 
the time of onset, duration and magnitude of ST segment depression, accompanying 
heart rates at the onset o f ST depression and peak heart rate during the episode was 
recorded. Figure 4.3 illustrates the sequence of ST changes that occur with cardiac 
ischaemia on an ECG. ST segment analysis is described in chapter 7 in relation to heart 
rate variability and mood as assessed by the DRM.
Arrythmias on the 24 hour recording were also recorded such as any episodes of 
a regular, abnormally fast heart beat (tachycardia). A tachycardia refers to a heart rate of 
greater than 100 beats per minute, caused by rapid firing of electrical impulses. If this is 
from a focus above the atrio-ventricular node (AVN) in the heart then this is called a 
supraventricular tachycardia (SVT) because the tachycardia originates above the 
ventricles of the heart. Episodes of ventricular tachycardia (VT) were also noted, in 
which there is a tachycardia of three or more beats in a row originating from the ventricle 
at a rate of more than 100 beats per minute.
As well as this, the number of couplets (two consecutive ventricular beats, 
preceded and followed by a normal beat), triplets (three consecutive ventricular beats, 
preceded and followed by a normal beat), and ventricular ectopics were recorded which
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is an extra heartbeat originating in the lower chamber of the heart due to abnormal 
electrical activity.
Figure 4.3 ST changes with ischaemia on an electrocardiograph.
A normal wave form:
The first wave is the P wave -  corresponding to the atria firing; followed by the 
next spike that is the QRS complex-corresponding to the ventricles contracting. The 
following wave after this is the T wave corresponding to the ventricles relaxing.
B flattening o f ST segment making T wave more obvious
C horizontal ST segment depression
The part we are interested in is the ST segment that becomes altered when the 
heart does not receive an adequate supply of oxygenated blood, due to narrowed 
coronary arteries.
D downsloping ST segment depression
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4.5 Heart Rate Variability analysis
In this study, heart rate variability (HRV) analysis was assessed both in the 
frequency and time domains.
4.5.1 Method of analysis
HRV analysis was carried out using the HRV tools package designed for Del Mar
Reynolds holter monitors. The 24 hour RR sequences were entered into the analysis
program and were screened for data quality. The following exclusions were applied, as 
recommended by the manufacturers:
•  Any aberrant beats (ventricular and atrial ectopics).
•  Any RR intervals < 300ms or > 3000ms.
•  Any RR intervals < 80% or > 120% of the previous RR.
•  Any intervals > three times the standard deviation of the preceding period.
Frequency and time domain measures were computed for every 30 minutes of the 24 
hour period, and also for day and night period. The timing of day and night was set on 
an individual case basis, depending on the hours specified in the DRM diary.
4.5.2 HRV indices
The HRV frequency analysis computed values for the following variables:
• Total power in ms2.
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• Very low frequency (VLF) power between the limits 0.003 Hz and 0.04 Hz in ms2.
• Low frequency (LF) power in the range 0.04 Hz to 0.15 Hz in ms2.
• High frequency (HF) power in the range 0.15 Hz to 0.4 Hz ms2.
In addition, the normalised LF and HF power were calculated using the following
formulae:
Low frequency normalised (LFn) = (LF* 100)/(total -  VLF -  Ultra low frequency)
High frequency normalised (HFn) = (HF* 100)/(total -  VLF -  Ultra low frequency)
Normalisation minimises the effect of changes in total power on the values of LF and 
HF.
The time domain analysis generated the following values:
• RR interval in ms.
• The square root of the mean square difference between successive RR intervals 
(RMSSD) in ms.
• The number of differences between successive RR intervals > 50ms, expressed as 
a proportion (pNN50).
The indices used for analysis were interbeat interval (IBI or RR interval in ms), 
normalised high frequency power (HFn) and normalised low frequency power (LFn) in 
Chapter 5, which presents the overall pattern of HRV results and in relation to time, age, 
CAD medication and mood. The same indices are used for analysis in Chapter 7, which 
presents results of HRV patterns in patients with an abnormal ECG and in relation to the 
ischaemic periods identified on abnormal ECG’s. In addition, a further index was
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analysed; normalised very low frequency power (VLFn), as this yielded interesting 
results. The sample rate was 4.0 Hz and detrending was carried out using linear 
subtraction (which removes the best bit straight line). Interpolation of missing values 
was carried out using the cubic spine approach (Task Force, 1996).
Each analysis was checked by hand to ensure that the data was satisfactory using 
the waterfall plot view of the spectrum. This is illustrated in Figure 4.4, which shows the 
frequency spectrum for one individual from 12:00 h on day one until 12:00 h on day two. 
The height of the bar at each frequency indicates the power o f the spectrum in that wave 
band. A high frequency peak between 0.2 and 0.3 Hz can be seen during the very early 
hours of the morning, indicating greater HF power during sleep. I also checked the 
overlaid spectra for day and night time. An example is shown in Figure 4.5, where the 
greater power in the high frequency band during the night is apparent.
Heart rate and HRV data were available for 85 patients. Two participants had 
monitors in which the battery ran low and one individual had the electrodes pulled off 
and which they then replaced themselves wrongly, invalidating the ECG recordings 
obtained, and so was not included in the analysis. One other patient was excluded from 
the analyses since data recorded was unsatisfactory in the quality of the recording, 
leaving 84 patients in the analysis. Because of the varying start and finish times of the 
assessments, the analysis of hour means would have resulted in a substantial amount of 
missing data. Therefore, HRV was divided into four 4 longer phases, as with the DRM: 
day 1 morning (start of monitoring -  13:00h), day 1 afternoon (13:00 -  18:00h), day 1 
evening (18:00 -  23:00h), and day 2 morning (7:30 -  end of monitoring). Day and night 
averages were also analysed.
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Figure 4.4 Waterfall spectrum plot
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Figure 4.5 Overlay spectra: average of night segments over average of day 
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4.6 Data analysis for transient ischaemia
The method of data analysis will be further described in detail at the beginning of 
each of the results chapters (chapters 5-8) but a broad overview in general is given in this 
section.
The analysis of the ambulatory monitoring period involved identifying episodes 
of symptomatic and asymptomatic ischaemia, and assessing concomitant mood and 
cortisol profile. Associations with negative moods was based on the case-crossover 
method, comparing time segments prior to the episode of ischaemia starting with the 
“control” periods of a) the comparable time segments the hour before and b) the time 
segments the hour after the ischaemic episode. A similar approach will be used to 
analyse heart rate and heart rate variability indices, both in the time and frequency 
domains.
The overall ambulatory records were analysed using analysis of variance and co 
variance, stratifying by individual in order to control for within-person confounding, and 
random effects regression models as appropriate.
The patients showing ischaemic changes on ECG were compared with the 
remainder using x2 tests for categorical variables and t-tests for continuous socio­
demographic, clinical and psychosocial variables. The groups were also compared on 
the heart rate, DRM mood variables and cortisol measures using analysis of variance and 
covariance.
Investigation o f the mood and cardiovascular responses surrounding each 
ischaemic episode was carried out by identifying the minute of onset and offset of each 
episode. Five minute segments of DRM mood and heart rate variability measures were
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then computed for the onset segment, the three 5 minute segments preceding onset, the 
end segment, and the two 5 minute segments following the end of the episode (seven 
segments in total). An example of this is given in the results chapter 7. The data over 
the episode period was compared with control periods.
For DRM mood, we used the corresponding time points for the hour before and 
the hour after the ischaemic episode. These two control periods were then averaged to 
generate an aggregate control mood profile to compare with the ischaemic period. In the 
analyses of heart rate and heart rate variability, only the control period 1 was assessed. 
The reason is that many ischaemic episodes took place towards the end of the 24 hour 
monitoring period, so there were too many cases with data missing from control period 2 
for it to be included in the analysis.
The analyses of acute mood changes and heart rate variability responses were 
also carried out as follows. First, a repeated measures analysis of variance was carried 
out for the 7 segments of the ischaemic / arrhythmic period. This showed whether there 
were systematic changes in mood or HRV in the minutes before and after each ischaemic 
episode of ST depression / VT. Second, repeated measures analysis was performed with 
period (ischaemia or control) and segment (the 7 within-period segments) as within- 
subject factors. Finally, analysis of covariance was carried out to compare specific 
segments, with gender and use of beta blockers as covariates.
Data relating to the question as to whether mood state before the onset of the 
ischaemic episode predicted the magnitude of autonomic response during the episode 
was also analysed. Since mood was relatively stable in the 15 minutes before episode 
onset, the three 5 minute segments were averaged to generate a single value for each 
mood. These mood ratings were then correlated with the changes in HRV indices 
between 15 minute pre-episode, and the 5 minute segment in which the episode started.
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4.7 Physical activity monitoring
Energy expenditure was measured using a wrist-worn actiwatch accelerometer, 
which assessed activity in one dimension (Actiwatch, Cambridge Neurotechnology, 
Cambridge, UK). This device (distributed in the USA by Mini Mitter) is a piezoelectric 
motion sensor. Data were analysed using proprietary software to define the following 
parameters: wake time in the morning, sleep latency (interval between going to bed and 
falling asleep), and sleep efficiency (proportion of the time in bed spent sleeping). The 
Actiwatch has been validated against polysomnography in both healthy populations and 
insomnia samples (Lichstein et al., 2006) and is used extensively in population and 
clinical studies (Lauderdale et al., 2006).
Subjects were asked to input unprompted ratings of pain whenever they 
experienced angina and recorded stress levels after any perceived stressful events during 
the day into the Actiwatch. This was scored on a scale of range 0-10 with 1 being mildly 
stressed and 10 being much stressed. Figure 4.6 below illustrates a typical actogram 
report from one of the participants (anonymised for data protection). Here it can be seen 
from the length and density of black lines corresponding to physical movement sensed 
by the Actiwatch put on that the participant had the watch placed on approximately at
11.30 am and went to sleep approximately midnight and awoke at about 7.00 am the 
following day. The actogram produced not only verifies patients’ reported awakening 
times relevant to measuring awakening cortisol responses and compliance regarding 
salivettes collection but also gives data about the sleep quality which is also thought to 
affect the HPA axis.
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Figure 4.6 Actogram
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Data relating the actogram findings with cortisol profile over the 24 hours and 
further work analysing actogram data with sleep quality and CAD, medication status and 
ECG changes is being planned in the near future and have thus not been presented in the 
thesis.
4.8 Physical and mental activity assessment in daily life: DRM
On day 1, before the monitoring period, participants completed a short half hour 
interview answering socio-demographic, clinical and psychosocial questions. The 
interview was completed face to face, and answers were recorded directly onto computer 
SPSS software. After the 24 hour ECG monitoring period, on day 2, a longer semi­
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structured interview was carried out to complete the Day Reconstruction Method 
(DRM). This typically took around one hour.
Patients were asked to systematically reconstruct activities and experiences of the 
previous day by first constructing a diary (initially, a rough version on paper for 
themselves as an aide memoir), consisting of a sequence of episodes, as if in a film. The 
patients were asked to write down the approximate times the episodes began and ended. 
Indications of the end of an episode might be going to a different location, ending one 
activity or starting another, or a change in the people they were interacting with. We 
then asked them to describe each episode by answering structured questions about the 
situation, when it occurred, what were they doing (check list o f activities), who they may 
have been with and how they felt. After completing a structured diaiy, we asked the 
participants to rate the feelings experienced (happy, tired, frustrated etc.) during each 
episode, on an affect scale ranging from 0 to 4. A rating of 0 meant one did not 
experience that feeling at all. A rating of 4 meant that this feeling was a very important 
part of the experience. Participants were asked to choose the number between 0 and 4 
that best described how they felt for each o f the episodes listed in the 24 hours of 
monitoring.
The DRM is a relatively recent method involving a retrospective report on an 
emotional state with a procedure designed to facilitate accurate recall. To date, the 
method appears to be successful reproducing a complex pattern of diurnal variation in 
tiredness which has previously been obtained in an ESM study (Kahneman et al., 2003) 
but there is little in the literature on validity as few studies have used the DRM since it 
was first described (Kahneman et al., 2004). There are no within-subject comparisons 
performed with respect to using this new method compared to momentary assessment. 
From the personal experience of carrying out the SIS study, the majority of participants
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found it to be an acceptable, easy-to-follow method but a minority did find it time 
consuming, laborious, with difficulty recalling episodes accurately unless prompted by 
the accompanying spouse or required guidance from the interviewer.
4.9 Day Reconstruction Method analysis
4.9.1 Scoring the DRM
The DRM provides a continuous sequence of activities with associated affect 
ratings. So, for every minute of the waking day, information is available about what 
activity every patient was engaged in and what affects were being experienced. 
However, the episodes vary widely in number, timing and duration. This is illustrated in 
Table 4.1, which details episodes between 12:00h and 15:00h for three patients. It can 
be seen that two patients reported four episodes during this period, and one patient 
reported five. However, the length o f episodes varies between individuals, as do the 
activities and affect ratings associated with these activities.
In order to relate affect derived from the DRM to biological measures, it is 
necessary to derive measures for each period of the day, rather than each activity. The 
following scoring system was therefore used. The recording was divided into 5 minute 
segments, timed chronologically from midnight on the first monitoring day (e.g. segment 
128 = 10:40 -  10:45h). For each segment, the corresponding DRM episode was 
identified for every individual. Taking the example in Table 4.1, between 14:15 and 
14:20h, patient 1 was in episode 3 of the afternoon (socialising), patient 2 was in episode 
3 (travel), and patient 3 was in episode 4 (working). The ratings for each affect were 
then attached to every time segment, irrespective of ongoing activity. Almost all the
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DRM episodes were timed to the nearest 5 minutes (e.g. beginning at 12:20h or 12:25h, 
but not at 12:23h). The result is a rating on each affect dimension for every 5 minute of 
the recording period.
Table 4.1 Illustrative DRM results
Activities of three patients between 12:00h and 15:00h
12:00 13:00 14:00 15:00
PI Eating Travelling Socialising Housework
P2 Working Socialising Travel Working
P3 Preparing
food
Watching TV Dressing Working Socialising
Five minute segments were selected to allow affect surrounding individual 
biological measures to be analysed precisely. For example, if transient myocardial 
ischaemia occurred at 14:43, the emotions during the 5 minute segment 14:40-14:45 
could be analysed and compared with the segments preceding (14:30-14:35; 14:35-
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14:40) and following (14:45-14:50, 14:50-14:55) the episode. However, the 5 minute 
segments were also averaged into hour means of all the waking time of the 24 hour 
monitoring period.
4.9.2 Derivation of morning, afternoon and evening affect measures
The DRM was begun at the beginning of day 1. However, patients woke up at 
different times on both days, went to bed at different times, and continued the DRM until 
their second interviews at different times of day 2. Table 4.2 summarises the number of 
patients contributing to hourly affect means for days 1 and 2. DRM data were 
unfortunately lost altogether from one individual because of a computer failure. O f the 
remaining 87, one individual did not continue the DRM beyond 16:00h because of an 
accidental fall in the evening meant that the participant was transferred to hospital.
As can be seen from Table 4.2, 84 patients provided DRM results for most of the 
hours of day 1, but with some variations. For example, two patients provided no data 
between 14:00 and 15:00h on day 1, since they were taking afternoon naps throughout 
that time. On day 2, there was no hour block during which all participants provided 
DRM data.
In order to maximise the number o f patients in the main analysis, the recording 
period was therefore divided into 4 longer phases: day 1 morning (wake up -  13:00h), 
day 1 afternoon (13:00 -  18:00h), day 1 evening (18:00 -  bedtime), and day 2 morning 
(wake up 13:00h). 84 patients provided data for all phases. The mean for each affect 
was also calculated for the entire study period.
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Table 4.2 Availability of hourly DRM data
Hours -  day 1 N Hours -  day 2 N
4 :0 0 -7 :0 0 44 4 :0 0 -7 :0 0 52
7 :0 0 -8 :0 0 77 7 :0 0 -8 :0 0 82
8 :0 0 -9 :0 0 85 8 :0 0 -9 :0 0 85
9 :0 0 -1 0 :0 0 85 9 :0 0 -1 0 :0 0 85
1.1:00- 12:00 84 11:00-12:00 42
12:00-13:00 84 12:00-13 :00 24
13:00-14:00 87
14:00-15:00 87
15:00-16:00 85
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Hours -  day 1 N Hours -  day 2 N
17:00-18:00 87
18:00- 19:00 84
19:00-20:00 84
20 :00 -21 :00 84
21 :00-22 :00 84
22 :00-23 :00 81
23 :00 -24 :00 40
The DRM provides ratings of 8 affective states: happiness, warmth, anger, 
depression, worry/anxiety, frustration/annoyance, impatience, and tiredness. Several of 
these negative affective states are inter-correlated. In order to reduce the amount of data 
presentation and avoid the problem of duplication, for this analysis I have focused on 4 
states: happiness, depression, tiredness, and combined negative affect (average of anger, 
depression, frustration and worry). Additionally, when looking at more detail in mood
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changes surrounding acute ischaemic episodes in chapter 7 , 1 have focused on additional 
mood states e.g. combined affect (a composite score of the difference between overall 
negative affect and positive affect) that may surround the ischaemic episodes.
4.10 Salivary cortisol measurement
Cortisol was assessed from saliva collected with the salivette sampling device 
(Sarstedt, Rommelsdorf, Germany). This non-invasive technique can be used at home 
and interferes only minimally with normal daily routines. Cortisol in saliva reliably 
reflects free (unbound) fraction of cortisol in plasma (Kirschbaum & Hellhammer, 1989).
Awakening was either spontaneous or by alarm clock. Subjects were asked to 
refrain from drinking caffeinated beverages and smoking before saliva sampling. 
Furthermore, they were instructed not to brush their teeth before the end of sampling 
time in the morning, not to eat and drink in the 10 minutes before sampling, and to rinse 
their mouth with water before sampling.
Nine saliva samples were collected over the 24 hour monitoring period. On the 
first day that participants arrived, the first sample was taken at 09:00 on arrival. 
Subsequent samples were then taken at 11:00, 14:00, and 19:00 and before bedtime. On 
the following day, samples were taken on waking, 15 minutes after wakening and 30 
minutes after wakening and then the final ninth sample was taken on arrival for interview 
at 09:00 (about 2 hours after waking). Some patients were scheduled to start the study at 
around 11:00 instead of 09:00. The first sample for these individuals was taken at 11:30, 
the second sample taken at 14:00, then 19:00 and before bed time. On the following day, 
samples were taken on waking, 15 minutes after wakening, 30 minutes after wakening
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and another sample at home at 09:00. The final ninth sample was taken on arrival for 
interview about 11:00. Samples were collected using cotton dental rolls held in the 
mouth until saturated, and then stored in salivettes that were collected from participants 
at the end of the ECG monitoring period. Tubes were returned personalty to the 
investigator on day 2. These were then stored in a freezer at -20°C until analysis, 
centrifuged at 2400rpm for 5 minutes, and analysed using a high sensitivity 
chemiluminscence assay at the Technical University, Dresden (Germany).
Separate analyses were carried out of cortisol over the day (measured on day 1) 
and the cortisol awakening response (CAR) measured on day 2. Cortisol over the day 
was analysed using repeated measures analysis of variance with clinical group 
(CAD/non-CAD) and depression group (BDI > 10 / < 10) as between-subject factors, 
and the 5 samples over the day and evening as within-subject factors. Further details of 
the analysis of the cortisol secretory profile is described in chapter 6.
4.11 Datastorage
All data collected was treated as confidential. Interview data, consent forms, 
questionnaires and follow up data were kept in a locked filing cabinet with restricted 
access. Data was anonymised and entered onto a computerised database which was 
password protected.
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4.12 Other statistical analyses
Data was collected using a sample of 88 participants. The data were analysed 
using the Statistical Package for Social Sciences (SPSS). Different approaches to 
analysis were considered and these are described further in the result chapters 5-8.
4.13 Clinical follow up
Clinical follow up was carried out on all participants at 6 months after the initial 
study was carried out. Psychosocial measures were repeated using telephone interview 
(see appendix 5) and postal questionnaires (see appendix 6), which measured in addition 
to the previous psychosocial measurement at baseline, social network and support 
measures, hostility and health locus of control measures as described earlier in section 
4.2.
4.13.1 Telephone interview follow up measures
The telephone interview was based on a similar interview format used in an 
earlier study (Ziegelstein et al., 2000) that assessed 10 adherence behaviours relevant for 
cardiac patients who had suffered an ACS. Participants were assessed for progression of 
CAD in terms of recurrence of cardiac symptoms or new cardiac events requiring 
hospital admission.
Patients were also asked about any other new illnesses diagnosed as well as 
whether or not they had attended a cardiac rehabilitation programme (if appropriate) and
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how many sessions of the total number they had attended. They were also asked whether 
or not they had implemented advice given to them by medical staff including increasing 
their level of exercise, maintaining a healthy weight, managing their stress levels 
appropriately, maintaining their alcohol intake within recommended limits, following a 
healthy diet and giving up smoking (if applicable). Patients were also asked what 
medication they were prescribed and whether they were compliant.
An adherence index was developed, similar to the one use by Ziegelstein et al. 
(2000), to assess 5 adherence behaviours relevant to patients who have had an ACS: (1) 
taking medications as prescribed, (2) eating a healthy diet, (3) maintaining a healthy 
weight, (4) exercising regularly, (5) managing / reducing stress levels. Scores ranged 
from 0 (partial or non-adherence) to 1 (adherent). Patients could therefore score a 
minimum of 0 to a maximum of 5.
Although this study is not powered to assess prospective associations of 
psychosocial risk factors and clinical outcomes, analysis of the follow up data will give 
some indication as to whether a larger scale study would be worthwhile.
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Chapter 5: SIS study Results -  The relationship between heart rate 
variability, depression and other moods in patients with suspected 
coronary artery disease
5.1 Introduction
The aim of these analyses is to describe the associations between heart rate 
variability and cortisol and depressed mood as assessed with the BDI, and a broader 
range of mood states monitored using the DRM. These analyses are relevant to the 
hypothesis outlined in chapter 3.
The results in this chapter will be divided into three broad sections. Firstly, I 
shall discuss the characteristics of the total sample according to demographic, clinical 
and psychosocial factors. 1 will then discuss the differences within the total sample 
according to gender and depression level. Those participants that scored >10 on the BDI 
on the pre interview questionnaire pack are classified as having moderate to high level of 
depressive symptoms.
In the second section, I shall describe the findings from the Day Reconstruction 
Method diary (DRM) detailing the affect of the participants over the 24 hour period of 
monitoring on a moment to moment basis, except of course over the night time period 
when participants were asleep. I shall discuss the overall patterns over the day and 
evening for all 88 participants for the four different affects - happiness, negative affect, 
depressed mood and tiredness -  in relation to gender and depression level.
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In the final section, 1 shall discuss the results of the HRV analyses. I shall 
describe the overall pattern of results for each of the HRV indices, and then discuss 
associations with time of day, medication, gender, and CAD status. Finally, I will 
discuss the associations of depression and positive affect with HRV.
5.2 Basic characteristics of participant sample
5.2.1 Total sample-demographic and medical characteristics
The total number of participants was 88 (See Table 5.1). Overall, age of 
participants ranged from 37 years to 82 years with a mean age of 61.6 ± 9.5 years. 
68.2% were male, 71.6 % of the sample was white and 60.2% were married. 
Approximately, 53.4% of the sample had secondary education or higher and 48.3% of 
the participants had a below average annual household income (< £20,000 per year). 
Approximately, one third of the sample lived alone (31.4%). Unsurprisingly, 85.8 % 
were either current or ex smokers.
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Table S.l Basic demographic and psychosocial characteristics of patient sample 
(N=88)
Frequency N Valid Percentage %
Gender: Male 60 68.2
Female 28 31.8
Marital Status: Married 53 60.2
Single/other 35 39.8
Ethnicity: Non White 25 28.4
White 63 71.6
Age completed education: >16 years 51 58.6
Educational Attainment (Secondary and above) 47 53.4
Employment (Full time only) 21 23.9
Household income (<£20,000) 42 48.3
Living alone 27 31.4
Smoker current 21 24.1
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Frequency N Valid Percentage %
Smoker past 50 61.7
Alcohol current 66 75.0
History affective disorder 25 29.1
Depression level high (BDI > 10) 37 43.0
Anxiety level high (HADS > 8) 34 38.6
Emotional Support (two or more) 58 66.7
Practical Support (two or more) 50 56.8
Physical activity (>7 days per week) 34 38.6
Sexually active current 43 48.9
Regarding psychological factors, approximately one third had a history of an 
affective disorder in the past (29.1%) and correspondingly almost half (43.0%) scored 
over 10 on the BDI questionnaire indicating a high level of depressive symptoms. 38.6% 
of the sample scored over 8 on the HADS scale indicating a high level of ‘anxiety with a 
mean score of 6.5 ± 3.7. The mean optimism score was 14.4 ± 3.9. The maximum score
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is 24 and generally, the greater the score the greater the optimism (Scheier & Carver, 
1985). In this particular sample, the score was just above average. The patients in this 
study are particularly impaired in vitality (52.4 ± 21.5), have limitations due to physical 
problems, (50.3 ± 41.3) and scored poorly on general health perceptions (59.9 ± 18.6). 
By contrast, social and physical functioning is relatively good with SF36 scores of 78.2 ± 
20.9 and 68.7 ± 23.1 respectively. With respect to quality of life in terms of the mean 
physical health, mental health and physical function, SF36 scores were high. Generally, 
participants were not impaired due to emotional problems or pain, scoring highly on 
limitations due to emotional problems (61.7 ± 41.1), and on limitations due to pain (73.1 
± 18.3). Thus, it appears that overall, the total sample is quite impaired in their overall 
quality of life in a variety of dimensions. These scores are summarised in Table 5.2.
Table 5.2 Overall results for SF36, anxiety and optimism for total sample (N=88)
Frequency N Mean (SD)
BDI depression score 86 10.2(7.1)
HAD anxiety score 88 6.5 (3.7)
Optimism score 87 14.4 (3.9)
Physical health status score 88 62.5 (20.8)
Mental health status score 87 65.0(20.8)
SF36 Physical function score 88 68.7(23.1)
SF36 Vitality 87 52.4(21.5)
SF36 Social functioning 83 78.2(20.9)
SF36 Limitations due to physical problems 87 50.3 (41.3)
SF36 Limitations due to emotional problems 87 61.7(41.1)
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Frequency N Mean (SD)
SF36 Pain scale 84
SF36 General health perception 87
SF36 Mental health perception 87
Clinical factors are summarised in Table 5.3, where it can be seen that a 
substantial proportion had hypertension and hypercholesterolemia and a family history of 
relatives diagnosed with CAD before the age of 65 years. Interestingly, only 16.5% of 
the sample was diabetic. It is known that diabetic patients commonly present with silent 
myocardial infarction (Stevens et al., 2001) and do not experience the typical symptoms 
of chest pain. As the patients recruited were on a waiting list for an angiogram following 
a positive treadmill or myocardial perfusion scan test, this may account for the lower 
than expected percentage seen for this established cardiac risk factor.
A substantial majority (61.5%) had an above normal body mass index (normal 
range 18-25). Despite this, 38.6% of the sample reported doing some form of physical 
exercise on every day of the week.
Clinical diagnoses were not carried out until after the study was complete, but 
63.6% were classified as being CAD positive (the participant had a positive angiogram 
result showing disease in coronary vessels or a positive myocardial perfusion scan along 
with cardiac symptoms and/or a history of cardiac disease). 36.4% were classified as 
being CAD negative i.e. either a normal angiogram result or inconclusive results of other 
cardiac investigations.
73.1 (18.3) 
59.9(18.6) 
68.0(18.7)
163
40.8% of the total sample went on to have some cardiac interventional procedure, 
either percutaneous coronary intervention (PCI) which involved either angioplasty or 
stent insertion or cardiac bypass surgery (CABG). The remaining patients were either 
reassured after a normal angiogram, or given medical therapy for their symptoms by a 
cardiologist. Data concerning management following angiography were only available 
for 80 patients, since the remainder declined the procedure because they became 
symptom free and no longer wished to have an angiogram. These patients were classed 
as CAD negative if they had no previous CAD history as well as being symptom free.
Table 5.3 Basic clinical characteristics o f patient sample (N=88)
Frequency N Valid Percentage %
Body Mass Index (BMI) kg/m2 >25 56 61.5
Frequency chest pain 25 29.5
(everyday /more than once a day)
Exercise ECG test positive 72 91.1
Myocardial perfusion scan positive 11 91.7
3 vessels diseased 13 28.3
angiographically
Cardiac Risk Factors
Diabetes 14 16.5
Hypertension 47 53.4
Hypercholesterolemia 66 76.7
Personal history o f cardiac events 16 18.2
Family history o f  cardiac events 57 67.1
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Frequency N Valid Percentage %
Medication
Aspirin 77 88.5
Beta blocker 59 67.0
Nitrate 37 43.0
ACE Inhibitor 28 35.0
Statin 72 81.8
Clinical Outcome
CAD Positive ( + angiogram) 56 63.6
CAD Negative 32 36.4
Conclusion o f  Angiogram:
-Reassure 12 15.8
-Medical Therapy 26 34.2
-Cardiac By Pass Surgery 10 13.2
-PCI y 32 42.1
PCI y Percu tan eo u s  co ro n ary  in te rven tion  at the  t im e  o f  a n g io g ram  or w as  re co m m e n d e d  for a future 
date.
5.2.2 Gender
Men and women were compared using t-tests for continuous variables and x2
tests for categorical variables. These results are presented in Table 5.4. The average age
of the men and women was comparable with no significant differences between them, as
was the proportion of white people, educational level and employment. A higher
proportion of women living alone (46.4%) compared with the men (24.1%) was found
(X2 = 4.4, p = 0.037). 46.4% of women were married compared with 66.7% of men,
although the difference was not significant (x2 = 3.3, p = 0.071). This may relate to the
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observation that 66.7% of women had a household income of less than £20,000 a year 
compared to men (40.0%), which was found to be statistically significantly different (x2 
= 5.3, p = 0.04).
Table 5.4 Demographic factors related to gender
Men W omen Differences
(n=60) (n=28) (P)
Age 61.52 ± 10.3 61.75 ± 7 .8 0.92
Marital Status 66.7 % 46.4 % 0.1
Ethnicity (white) 68.3 % 78.6 % 0.45
Age o f  finishing full 
time education (above 
16 years)
59.3 % 57.1 % 1.0
Educational attainment 
(Secondary and above)
55.0% 50.0 % 1.0
In employment 40.0 % 32.1 % 0.64
Household income 
(less than £20,000 p.a)
40.0 % 66.7 % * 0.04*
Living alone 24.1 % 46.4 % * 0.04*
Values are mean ± SD or %. * Significant gender difference, p < 0.05.
There were no statistically significant differences between the two groups 
according to chest pain symptomatology, i.e. presence or absence of chest pain, 
frequency of chest pain (number of times of chest pain per week) or positive cardiac 
investigations prior to the angiogram. This is shown in Table 5.5. The two genders were 
again comparable with regards to BMI, diabetes, hypertension, hypercholesterolemia and 
personal or family history. The only difference was that fewer women were ex smokers
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(41.7%) compared with men (70.2%). (x2 = 5.8, p = 0.024). This may be a reflection of 
the demographic trends of smoking in the past, when there were gender issues of social 
and cultural norms of a particular era.
Interestingly, fewer women had positive CAD (46.4%) than men (71.7%) after 
the actual angiogram was carried out. This is consistent with literature relating cardiac 
symptoms to actual clinical disease in men and women (Bugiardini et al., 2005).
Regarding medication, the only differences to emerge for cardiac drugs relating 
to gender were related to statin usage. Only 67.9% of the women were taking statins 
compared with 88.3% of the men (%2 = 5.4, p = 0.035). There was a gender difference in 
beta blocker usage that approached statistical significance. 53.6% women were taking 
beta blockers, compared with 73.3% of the men (%2 = 3.4, p = 0.066).
Table 5.5 Clinical factors related to gender
Men Women Differences (p)
(n=60) (n=28)
B ody M ass  Index (B M I)  (k g /m 2) 25.9  ± 4.8 27.5 ± 4.8 0.13
Frequency  ches t  pain 28.1 % 32.2 % 0.2
(everyday /m o re  than once  a day)
Exerc ise  E C G  test posi t ive 92.5 % 88.5 % 0.43
M yocard ia l  pe rfus ion  scan 
positive
85.7 % 1 0 0 .0 % 1.0
3 vesse ls  d iseased 3 1 .6 % 12.5% 0.5
angiograph ica l ly
Cardiac Risk Factors
Diabetes  (N I D D M /I D D M ) 16.7% 16.0% 1.0
H ypertens ion 50.0  % 60.7 % 0.37
Men
(n=60)
Women
(n=28)
Differences (p)
H y p erch o le s te ro laem ia  7 4 . 6 %  8 1 . 5 %  0.6
Personal h istory C A D  2 1 . 7 %  1 0 .7 %  0.25
Fam ily  h istory C A D  6 6 . 1 %  6 9 . 2 %  0.81
M edication
Aspir in  9 1 . 5 %  8 2 . 1 %  0.28
B eta  B locker  7 3 . 3 %  5 3 . 6 %  0.09!
Nitrate  46 .6  %  35.7 %  0 .36
A C E  Inhibitor  3 9 . 6 %  2 5 . 9 %  0.32
Statin 8 8 . 3 %  6 7 . 9 %  0.03*
Clinical Outcome 
C A D
Posit ive(+  a n g io g ram )  71 .7 %  4 6 .4 %  0.03*
♦Significant gender difference, p < 0.05. ! Approaching significance.
More differences between the sexes emerged in the analysis of psychological and 
behavioural factors that are presented in Table 5.6. The difference in emotional support 
approached significance (x2 = 4.7, p = 0.08) with a higher proportion of women (82.1%) 
reporting that they had two or more supports than men (59.3%). This difference was not 
seen in levels of practical support received.
A significantly greater number of women (41.1%) had a history of an affective 
disorder compared with 20.3% of men (x2 = 6.9, p = 0.01). Significant differences were
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also found in the HADS anxiety scale, with scores averaging 8.0 ± 3.7 in women 
compared with 5.9 ± 3.6 in men (t = -2.6, p = 0.01). When scores were categorised with 
a threshold of 8 and above, 64.3% women had high levels of anxiety compared with 
26.7% of the men (x2 = 11.4, p = 0.001). However, there were no statistically significant 
gender differences in severity of depressive symptoms with almost identical average BDI 
score, and 50.0% women and 39.7% men scoring above 10. In addition, there were no 
significant gender differences in relation to SF36 quality of life measures, optimism, and 
vital exhaustion.
Regarding lifestyle differences, the average units of alcohol consumed by women 
per week was lower, being 5.0 ± 8.8 compared to men whose average unit intake was 
13.7 ± 15.7 (F = 6.7, p = 0.012). Women were also more sedentary and did significantly 
less exercise than men averaging 3.48 ±  3.0 times per week compared with men at 5.0 ± 
2.5 times per week (F = 6.7, p = 0.01).
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Table 5.6 Psychological and behavioural factors related to gender
Men Women Differences
(n=60) (n=28) (p)
P sychological and QL Factors
E m otional  support  5 9 .3 %
(tw o or m ore)
Practical support  5 5 .0 %
(tw o or m ore)
History  o f  affec tive  d iso rde r  2 0 .3 %
D epress ion  level high  (BDI > 3 9 .7 %
10)
A nxie ty  level high  (H A D >  8) 26 .7  %
BDI D epress ion  score  1 0 .0 ±  7 .66
A nxie ty  (H A D S )  score  5.9 ± 3 . 6
O ptim ism  score  ( L O T  0-24) 14.5 ±  3.8
SF36  C o m b in e d  Physica l  64.1 ± 2 1 . 0
health  sta tus score
SF36  C o m b in e d  M ental  67 .4  ± 2 1 . 3
health  sta tus score
Physical func tion  score  71.7 ± 2 1 . 4
Vitali ty  54.8 ± 2 2 . 3
Social fu n c tion ing  80.4 ±  20 .9
L im ita t ions  due to physical 53 .0  ±  42.1
prob lem s
SF36 Pain scale 74 .8  ± 1 8 . 3
SF36  Genera l  health  59 .7  ± 18.5
perception
82 .1%
60 .7%
41 .1 %
50.0%
64.3 %
10.6 ± 6.0 
8.0 ± 3 . 7
14.1 ± 4 . 2
59.1 ± 2 0 . 3
60.1 ±  19.2
62.2  ± 2 5 . 6
47.3 ±  19.2 
73.1 ± 2 0 . 2  
44 .6  ± 39.9
69.5 ± 17.9
60.3 ± 19.3
0.01*
0.69
0 .0 1 *
0.5
0 .0 0 1 *
0.7
0 .0 1 *
0.6
0.3
0.1
0.07
0.13
0.14
0.4
0.2
0.9
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Men Women Differences
(n=60) (n=28) (P)
SF36 M ental  heal th  
perception
70 .2  ±  18.8 63.3 ± 17.9 0.13
Behavioural Factors
S m o k in g  cu rren t 25 .4  % 2 1 . 4 % 0.8
S m o k in g  past 70.2 % 4 1 . 7 % 0.02*
A lcohol  co n su m p tio n 80.0  % 64.3 % 1.0
A lcohol  units  p e r  w eek 13.7 ±  15.7 5.0 ± 8.83 0.01*
Physical exerc ise  f req u en cy  
(n u m b er  o f  t im es  pe r  w e e k )
5 .0 ±  2.5 3.48 ± 3.0 0.02*
Physical exerc ise  du ra tion  
(m inu tes)
51.75  ± 59.7 61 .96  ±  88.6 0.53
Values are mean ± SD or %. * Significant gender difference, p < 0.05. I/NIDDM = Insulin /Non 
Insulin Dependent Diabetes Mellitus
5.2.3 Differences related to BDI scores
Two individuals did not complete the BDI. The remaining 86 patients were 
divided into those with scores greater than or equal to 10 (n = 37) and less than 10 (n = 
49). There were no differences between those scoring high and low on the BDI with 
regards to age, sex, marital status, ethnicity, educational level, income or whether they 
lived alone or not. The only significant difference in the demographic variables seen was 
regards to employment. Unsurprisingly, a lower percentage of the sample that scored 
high on depression was in full time employment (24.3%) compared with those who 
scored under 10 (44.9%) (x2 = 3.87, p = 0.04). These differences are summarised in 
Table 5.7.
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Table 5.7 Demographic factors related to depression level
Depression level 
low
(BDI score <10)
Depression level 
high
(BDI score 10+)
Differences
(P)
Age 61.7 + 10.4 61.9 + 8.3 0.92
Gender Male 
Female
62.2% 57.1% 0.5
Marital Status 57.1 % 62.2 % 0.66
Ethnicity (white) 75.5 % 67.6 % 0.5
Age o f  finishing full time 
education (above 16 years)
60.4 % 56.8 % 1.0
Educational attainment 
(Secondary and above)
51.0% 55.8 % 0.67
In employment 44.9 % 24.3 % * 0.04*
Household income 
(less than £20,000 per year)
40.8 % 58.3 % 0.13
Living alone 31.3% 33.3 % 1.0
* Significant depression level difference, p < 0.05,
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There were few differences between the depressed and non-depressed groups in 
relation to clinical factors, as presented in Table 5.8. A similar number of people were 
CAD positive in both of the groups. The only statistical significance found between the 
two groups was aspirin medication. Those scoring high on the BDI were less likely to be 
taking aspirin (x2 =6.1, p = 0.018). This may be due to depressed patients being less 
likely to adhere to medication (Gehi et al., 2005).
Table 5.8 Clinical factors related to depression level
Depression level low 
(BDI score < 10)
Depression level 
high
(BDI score 10+)
Differences
(P)
Body M ass  Index (BM1) (k g /m 2) 26.3 i  5.4 26.3 ± 4.1 0.98
Frequency  ches t  pain 28 .6  % 29.4  % 0.9
(everyday  /m o re  than  once  a  day)
Exerc ise  E C G  test positive 9 1 .1 % 90 .9% 0.9
M yocard ia l  perfus ion  scan positive 100 .0% 100.0%
3 vesse ls  d iseased  ang iograph ica l ly 33.3 % 2 5 . 0 % 0.82
Cardiac Risk Factors
Diabetes  ( N ID D M /ID D M ) 14.9% 1 6 .7 % 1.0
H ypertens ion 5 3 .1 % 54.1 % 1.0
H yp e rch o le s te ro laem ia 77.1 % 77.8 % 1.0
Personal h is tory  C A D 20.4  % 1 6 .2 % 0.78
Fam ily  h is tory  C A D 70.2 % 63.9  % 0.8
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Depression level low Depression level Differences 
high
(BDI score < 10) (p)
(BDI score 10+)
M edication
A spirin 95.8  % 78.4  % 0.02*
B eta  B locker 69 .4  % 62.2 % 1.0
N itra te 50 .0  % 36.1 % 0.3
A C E  Inhibitor 31.8  % 38.2 % 1.0
Statin 8 1 . 6 % 81.1 % 1.0
Clinical Outcome
C A D  Posit ive  (+  an g iog ram ) 61 .2  % 64.9  % 0.8
Significant depression level difference, p < 0.05.
Finally, interestingly, there were no statistically significant differences between
the two groups with respect to smoking but there was a difference with respect to alcohol
consumption (%2 =4.0, p = 0.04). In contrast to what is expected from the literature in
that depressed patients adopt unhealthier lifestyles, a significantly higher proportion of
the non-depressed group reported to consume alcohol than the depressed group i.e.
83.7% patients in the non-depressed group versus 64.0% in the depressed group.
Unsurprisingly, 45.9% of those scoring high on the BDI also had a history of an affective
disorder which contrasts to 17.0% of those scoring under 10 (jf =8.23, p = 0.004).
However, similar levels of emotional support was reported by the two groups, (depressed
and non-depressed). This is summarised in Table 5.9. Consistent with what would be
expected, patients who had the higher level of depression scored significantly lower on
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all the SF36 quality of life measures, optimism scores, and vital exhaustion. However, 
those who were more depressed scored greater on the pain scale with differences 
approaching statistical significance (p = 0.06).
Table 5.9 Psychological and behavioural factors related to depression level
Depression level low 
(BDI score under 10)
Depression level 
high (BDI score 
10+)
Differences (p)
Psychological Factors
Em otional  support 66 .7  % 64.9  % 0.62
( tw o or m ore)
Practical support 63.3 % 48.6  % 0.32
(tw o or m ore)
History o f  affec tive  d isorder 1 7 .0 % 45 .9  % 0.004*
Anxie ty  level high  (H A D >  8) 2 2 .4 % 59 .5% 0.001*
B DI D epress ion  score 5.6 ± 2 . 5 16.2 ± 6 . 8 <0.01*
A nxie ty  { H A D S )  score 5.2 ±  3.1 8.4 ± 3 . 8 <0.01*
O ptim ism  sc o re (L O T  0-24) 15.3 ± 4 .0 13.4 ±  3.7 0.03*
SF36  C o m b in e d  Physical health  status 
score
70.6  ±  16.1 51.5 ± 21.8 <0.01*
S F 36  C o m b in e d  M ental  health  status 
score
74.3 ± 17.2 52.8 ± 19.4 <0.01*
SF36 Physical func tion  score 75.5 ±  16.5 60.1 ± 2 7 . 8 0.002*
SF36  Vitali ty 59.1 ± 1 9 .4 43.5 ± 2 0 . 8 0.001*
SF36 Social func tion ing 87.2 ± 1 4 .6 67.8 ± 2 2 . 8 <0.01*
SF36  L im ita t ions  due  to physical  
p rob lem s
64.1 ±  39.2 31.8 ±  38.0 <0.01*
SF36  L im ita t ions  due  to em otiona l  
prob lem s
77.1 ± 35.2 40.5 ± 40.2 0.01*
SF36 Pain scale 75.9  ± 16.6 68.3 ± 19.4 0.06
SF36 Genera l  health  pe rcep tio n 67.6  ± 14.7 49.3 ± 18.6 <0.01*
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Depression level low Depression level Differences (p)
high (BDI score 
(BDI score under 10) ]n+ \
SF36  Mental  heal th  pe rcep tion  7 4 .8 ±  15.6 59.2 ± 1 9 . 3  <0.01*
Behavioural Factors
Sm o k e r  current  2 2 . 9 %  2 7 . 0 %  1.0
S m o k er  past  3 4 . 8 %  4 5 . 5 %  1.0
Alcohol c o n su m p tio n  8 3 .7 %  6 4 .9 %  0.04*
Alcohol  units  pe r  w e ek  11.98 ± 1 3 . 3  9.9  ± 1 6 . 3 5  0.5
Physical exerc ise  frequency  (n u m b er  4 .9  ±  2 .6  4.2 ± 2 .89  0.24
o f  t im es  per w eek )
Physical exerc ise  dura tion  (m inu tes)  64 .7  ± 83.1 44 .7  ± 46.8  0.19
Values are mean ± SD or %. * Significant depression level difference, p < 0.05.
5.2.4 Differences related to CAD status
The patient sample was divided on the basis of subsequently diagnosed CAD. 
Those with and without definite CAD were compared using t-tests for continuous 
variables and %2 tests for the categorical variables. The purpose of the analysis was to 
address the question of whether patients with genuine CAD can be distinguished from 
others on the basis of socio-demographic, clinical, or psychological factors.
Socio-demographically, the CAD group were significantly older (F = 6.2, p = 
0.015) and were more likely to be men (76.8%) than women (23.2%) (x2 = 5.3, p = 0.02). 
The increased prevalence in CAD among men is consistent with previous findings 
(Carroll et al., 2003). There were no other differences between the definite CAD group 
and no significant CAD group with regards to marital status, ethnicity, educational level, 
income or whether they lived alone or not. This is summarised in Table 5.10.
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Table S. 10 Demographic factors related to CAD
No significant CAD 
(n=32)
Significant CAD Differences
(n= 56) (p)
Age (Y ears  ± SD) 53.3 ± 9 . 7 3 63.5 ± 9 . 0 0 .03 '
G en d er Male
Fem ale
67 (5 3 .1 % ) 
15 (4 6 .9 % )
43 (76 .8% ) 
13 (23 .2% )
0.02 '
Marita l Status: M arried
S ing le/o ther
22 (68 . 8%)  
10 (31 .3% )
31 (55 .4% ) 
25 (44 .6% )
0.26
Ethnicity: N o n  W hite  
W hite
8 (2 5 % )  
24  (7 5 % )
1 7 (3 0 .4 % )  
39 (69 .6% )
0.63
A ge co m p le ted  educa tion :  > 1 6  years 17 (5 4 .8 % ) 34 (6 0 .7 % ) 0.65
E ducationa l  A t ta in m en t  (Secondary  and abo v e)  16 (5 0 .0 % ) 3 1 ( 5 5 .4 % )  0.66
E m p lo y m en t  (Full  t im e  only) 13 (4 0 .6 % ) 20 (3 5 .7 % ) 0.7
H ouseh o ld  incom e (< £2 0 ,0 0 0 ) 15 (4 8 .4 % ) 27 (48 .2% )
Liv ing  a lone 8 (2 6 .7 % ) 1 9 ( 3 3 .9 % )  0.63
* Significant CAD difference, p <  0 .05 .
There were also few differences between the CAD and the non-CAD group when
examining clinical factors, other than the expected finding that the CAD group was more
likely to have had a history of CAD (x2 = 4.8, p = 0.02). In relation to medication, the
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only difference was that the CAD group were more likely to have been prescribed ACE 
inhibitors (%2 = 13.2, p = 0.0). However, there were no differences in presence or 
frequency of angina, positive cardiac investigations or cardiac risk factors. This is 
shown in Table 5.11.
Table 5.11 Clinical factors related to CAD
No significant CAD Significant CAD Differences
(n=32) (n= 56) (P)
B ody  M ass  Index (B M I)  
( k g /m 2)
27 .6  ± 4.4 25 .6  ± 5 . 0 0.06
Frequency  chest pain 
(everyday  /m o re  than  once  a 
day)
25 (7 8 .1 % ) 52 (92 .9% ) 0.09
E xerc ise  E C G  test  posi t ive 24 (8 5 .7 % ) 48 (94 .1% ) 0.09
M yocard ia l  pe rfus ion  scan  
posi t ive
6 ( 1 0 0 % ) 5 (83 .3% ) 1.0
3 vesse ls  d iseased  
ang iograph ica l ly
0 1 4 (2 8 .3 % ) 0.01*
Cardiac Risk Factors
D iabetes  ( N I D D M /I D D M ) 4 ( 1 3 .3 % ) 1 0 ( 1 8 .2 % ) 0.8
H ype r tens ion 1 7 ( 5 3 .1 % ) 30 (53 .6% ) 1.0
H y p e rch o le s te ro la em ia  ' 25 (7 8 .1 % ) 41 (75 .9% ) 1.0
Personal  h istory C A D 2 (6 .3 % ) 1 4 (2 5 .0 % ) 0.04
Fam ily  h is tory  C A D 21 (6 7 .7 % ) 36 (66 .7% ) 1.0
S m o k e r  current 7 ( 2 1 .9 % ) 1 4 (2 5 .5 % ) 0.8
S m o k e r  past 15 (5 1 .7 % ) 35 (67 .3% ) 0.23
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No significant CAD Significant CAD Differences
(n=32) (n= 56) (P)
M edication
Aspirin 27 (8 4 .4 % ) 50 (90 .9% ) 0.5
Beta  b locker 18 (5 6 .3 % ) 41 (73 .2% ) 0.2
Nitrate 1 0 ( 3 1 .3 % ) 27 (50 .0% ) 0.12
A C E  Inhibitor 3 ( 1 0 % ) 25 (50 .0% ) 0.01 *
Statin 25 (7 8 .1 % ) 47 (83 .9% ) 0.6
♦Significant CAD difference, p < 0.05.
As can be seen from Table 5.12 there were no significant differences in anxiety, 
depression or any of the quality of life measures. This is inconsistent with findings from 
previous literature on psychosocial factors relating to CAD as was discussed in chapter 
1.1. However, it should be pointed out that the sample in this study was small, so 
differences might not be expected.
T a b le  5 .12  P sy ch o lo g ica l and  b e h a v io u r a l fa c to rs  re la ted  to C A D
No significant CAD  
(n=32)
S ig n ifica n t C A D  
(n =  56)
D ifferen ces
(P)
Psychological Factors
E m otional  support 21 (6 7 .7 % ) 3 7 ( 6 6 .1 % ) 1.0
( tw o or m ore)
Practical support 1 6 ( 5 0 .0 % ) 3 4 ( 6 0 .7 % ) 0.4
( tw o or m ore)
History o f  affec tive  d iso rder 11 (3 4 .4 % ) 1 4 (2 5 .9 % ) 0.5
D epress ion  level high 13 (4 0 .6 % ) 24 (44 .4% ) 0.8
(BDI >  10)
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No significant CAD S ig n ifica n t C A D  D ifferen ces
(n=32> (n =  56) (p)
1 2 ( 3 7 .5 % )  22 (39 .3% ) 1.0
A nxie ty  level high (H A D >  8)
BDI D epress ion  score 10.3 ± 8.0 10.2 ± 6 . 6 0.96
A nxie ty  (H A D S )  score 7.0 ± 4 . 2 6.3 ± 3 . 5 0.39
Optim ism  score  ( L O T  0-24) 13.7 ±  3.6 14.8 ±  4.1 0.2
Physical health  sta tus score 65.5  ± 2 1 . 0 60.8  ± 2 0 . 7 0.3
M ental  health  sta tus score 67.1 ±  18.5 63 .8  ± 2 2 .1 0.5
Physical function score 72.3 ± 18.5 66.6  ± 2 3 . 5 0.3
Vitality 55.6 ± 20 .9 50.5 ± 2 1 . 8 0.3
Social func tion ing 83.0  ± 15.2 75.3 ± 2 3 . 3 0.1
L im ita t ions  due to physical 
p rob lem s
54.8 ± 4 1 . 0 47 .7  ± 4 1 . 6 0.45
L im ita t ions  due to em otional  
p rob lem s
60.2  ±  38.9 62.5 ± 4 2 . 7 0.8
SF36 Pain scale 76.5 ± 15.5 71 .0  ± 19.5 0.18
SF36 G enera l  health  
perception
60.0  ±  20.3 59 .9  ±  17.8 0.99
S F 36  M ental  heal th  percep tion 70.5 ± 15.5 66.5  ± 20.3 0.34
Behavioural Factors
S m o k e r  current 7 ( 2 1 .9 % ) 1 4 ( 2 5 .5 % ) 0.8
S m o k er  past 15 (5 1 .7 % ) 35 (67 .3% ) 0.2
Alcohol con su m p tio n 24 (7 5 % ) 42 (7 5 % ) 1.0
Alcohol  units  per w eek 8.9 ±  12.5 12.2 ±  15.5 0.3
Physical exerc ise  f requency  
(n u m b er  o f  t im es  pe r  w eek)
4.1 ± 3 . 0 4.7 ± 2 . 6 0.3
Physical exerc ise  dura tion  
(m inutes)
49 .5  ±  79.1 58.1 ± 64.4 0.6
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5.2.5 Differences related to beta blocker medication
When the same psychological and quality of life factors were assessed in relation 
to beta blocker medication, the only differences to arise were in the mean anxiety score. 
Those participants on beta blocker medication were significantly less anxious (t = -1.7, p 
= 0.099) with a mean anxiety score of 7.5 ± 3.7 compared to a mean score of 6.1 ± 3.7. 
In contrast, beta blocker medication made no difference to depression scores. Beta 
blocker medication blocks the sympathetic overdrive in stress provoking situations, 
reducing the heart rate and has an established use in medicine for treatment of panic 
attacks (Heiser & Defrancisco, 1976) and so it is unsurprising that it may alleviate the 
anxiety levels of participants taking the medication and hence make a significant 
difference to the anxiety scores o f the patient sample. O f note, the beta blocker 
medication did not affect the patients’ quality of life (see Table 5.13).
Table 5.13 Overall results for SF36, anxiety and optimism in relation to beta 
blocker medication for total sample (N=88)
Beta blocker 
medication
Frequency
N
Mean (SD) Differences (p)
BDI depression score Yes 57 9.9 (7.4) 0.6
No 29 10.8(6.6)
HAD anxiety score Yes 59 6.1 (3.7) 0.01*
No 29 7.5 (3.7)
Optimism score Yes 58 14.4 (4.3) 0.99
No 29 14.4(3.1)
Physical health status score Yes 59 65.2 (20.8) 0.08
No 29 57 .0(20 .1)
Mental health status score Yes 58 67.0 (20.5) 0.2
No 29 61.0(21.1)
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Beta blocker Frequency Mean (SD) Differences (p)
medication N
Physical function score Yes 59 70.5 (22.5) 0.3
No 29 65.0 (24.4)
Vitality Yes 58 53.1 (22.3) 0.7
No 29 51.0 (20.1)
Social functioning Yes 55 80.7 (20.5) 0.1
No 28 73.4 (21.1)
Limitations due to physical Yes 58 53.9(41.0) 0.25
problems
No 29 43.1 (41.7)
Limitations due to emotional Yes 58 65.5 (40.9) 0.2
problems
No 29 54.0 (41.2)
SF36 Pain scale Yes 56 75.8(18.2) 0.05!
No 28 67.5 (17.4)
SF36 General health perception Yes 58 62.6(18.8) 0.06
No 29 54.5 (17.4)
SF36 Mental health perception Yes 58 68.7(18.5) 0.63
No 29 66.6(19.3)
* Significant medication difference, p < 0.05. ! Approaching significance
O f note, there were no significant differences between those participants on beta 
blockers, and those who were not, in relation to age, gender, and any of the clinical 
variables, (see Table 5.14).
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Table 5.14 Characteristics of patients on beta blocker medication and patients
not on beta blocker medication.
B eta  b lo ck er  
m ed ica tio n
N o beta  b lo ck er  
m ed ication
Differences
(P)
&inIIs ( n -  29)
Age (years) 61.95 yrs ±9.1 SD 60.9 yrs±10.5 SD 0.62
Body mass index (BMI) 
kg/m2 > 25
26.3 ± 5.3 SD 26.6 ±3.95 SD 0.78
Frequency chest pain 51.1 % 11.5% 0.3
(everyday /more than 
once a day)
Exercise ECG test 
positive
94.2 % 85.2 % 0.4
Myocardial perfusion 
scan positive
80.0 % 100.00% 0.4
Risk Factors for CAD
Diabetes
(NIDDM/IDDM)
16.9% 15.4% 0.6
Hypertension 50.8 % 58.6 % 0.55
Hypercholesterolaemia 77.2 % 75.9 % 0.32
Personal history CAD 22.0 % 10.3 % 0.2
Family history CAD 33.3 % 32.1 % 0.56
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5.3  A ffec t o v er  th e  stu d y  p eriod  assessed  using  the D ay R eco n stru ctio n  M eth od
5.3.1 O v era ll P a ttern s
Figures 5.1 and 5.2 show the pattern of DRM ratings of the following mood 
variables : happiness, combined negative affect, depression and tiredness over the study 
period. These variables were chosen, as we wanted to analyse the emotions over the day 
that occur commonly and frequently in the period analysed and have relation to CAD 
development and triggering of ACS (Sirois & Burg, 2003; Tofler & Muller, 2006). In 
addition, the moods chosen were similar to those studied in mood adjective check lists 
such as the PANAS (Clark et al., 1989). One hour means are plotted to give an idea of 
the changes over time, although the formal statistical analysis involved four aggregated 
periods (see section 4.8.2). The figures begin at 7:00 - 8:00 am on day 1, continuing 
throughout that day, then restarting when patients woke up on day 2 and finishing at 
10:00 - 11:00 am on day 2.
Ratings of happiness from the total sample of participants showed an average of 
around 3 (on the 0-6 scale) in the morning on waking, rising about midday with a further 
rise to more than 4 in the evening before falling slightly when retiring to bed (see Figure 
5.1). Participants rated their lowest happiness on first waking the following day. There 
is a mid morning rise, a mid afternoon rise and a mid evening peak. Broadly speaking, 
participants are generally scoring greater in happiness affect than they are in negative 
affect.
In contrast, looking at negative affect, there are fewer changes over the day with 
an average rating of below 1 first thing in the morning and remaining fairly constant 
rating throughout the day with a very minimal increase in negative affect rating at
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approximately mid afternoon. The negative affect rating the following day was similar 
to that experienced on the morning of day 1.
Figure 5.1 Happiness and negative affect
Happiness and negative affect
Affect rating
4.5
4
3.5
3
Happiness2.5
2 Negative affect
1.5
1
0.5
0
Time
Figure 5.2 shows the general pattern of depressed mood and tiredness over the study 
period. We can see significant differences in tiredness over the course of the day with a 
rating of almost 2 on waking and then a steady increase as would be expected from 19.00 
till bedtime. The lowest tiredness rating was seen on waking the following day. In 
contrast, DRM ratings for depression were fairly constant, varying between 0.5 and 1.0 
with no particular peaks and troughs through the period of monitoring. (See Figure 5.2)
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Figure 5.2 Depression and tiredness
Depression and tiredness
Affect rating
3.5
3 - • Tiredness Depression
2.5
2
1.5
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Time
5.3.2 Ratings of affect over time of day with relation to gender
Table 5.15 summarises the ratings of affect over time according to gender, with 
the DRM ratings divided into four phases over the day. Repeated measures analysis of 
variance showed a main effect of time for happiness (F = 13.6, p < 0.001), with higher 
ratings in the afternoon and evening compared with the mornings, with no differences 
between men and women. There was a similar result for negative affect, with the 
significant time effect reflecting the mirror image of happiness (F = 3.52, p = 0.020), 
namely lower negative affect in the afternoon and evening compared with the morning. 
Tiredness also showed a difference over time (F = 6.06, p < 0.001) with tiredness 
reaching maximal levels in the evening period as expected. There was also a main effect 
of gender (F = 4.53, p = 0.036), since overall, women reported greater tiredness than
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men. The analysis of depression again showed significant differences over time, (F = 
3.89, p = 0.015). In this case, the effect was due to lower levels of depressed mood on 
the morning of day 2, since the other three values did not differ. However, there were no 
significant effects seen between the sexes.
T ab le  5 .15  M ean  a ffect ra tin g s o v er  tim e o f  d ay  w ith  re la tion  to g en d er
Morning (SD ) Afternoon  (SD ) Evening (SD ) Morning2 (SD )
Happiness
Male 3.08(1.3) 3.5(1.4) 3.7(1.5) 3.05(1.3)
Fem ale 2 .7 4 (1 .2 ) 3 .5 (1 .4) 3.8 (1.5) 3.1(1.3)
N egative Affect
Male 1.0(0.9) 0.95(1.0) 0.8 (0.85) 1.03 (0.94)
Fem ale 1.1(0.9) 0 .96  (0 .97) 0 .8 4 ( 1 .0 ) 1.1(0.75)
Tiredness
Male 1.3(1.8) 1.3(1.5) 2.0 (1.6) 1.1(1.7)
Fem ale 1.9(2.0) 2 .2(1 .9 ) 2.5 (1.6) 2 .0(1.8)
Depression
Male 0.6(1.1) 0.7(1.3) 0.5 (0.9) 0.5(1.2)
Fem ale 0.7(1 .2) 0 .85 (1 .6 ) 0 .8 ( 1 .3 ) 0 .5(0.9)
Mean Values. (SD) = Standard Deviation.
5 .3 .3  R atin gs o f  a ffect o v er  th e  d ay  in re la tio n  to  B D I d ep ressio n  level
I compared the affect ratings from the DRM in patients with high and low BDI 
scores using repeated measures analysis of variance with BDI group as the between- 
subject factor, and phase of the day as the within-subject factor. The results are 
summarised in Figures 5.3 to 5.6. Although it can be seen from Figure 5.3 that
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happiness ratings tended to be higher in participants with low BDI scores, this effect was 
not significant. But there were main effects for BDI depression in the analyses of 
negative affect (F = 8.64, p = 0.004), tiredness (F = 13.5, p < 0.001) and depressed mood 
(F = 9.89, p = 0.002). As might be expected, depressed individuals had greater negative 
affect, greater tiredness and more depressed mood over the study period. These effects 
did not interact with time of day. These data provide some corroboration for the affect 
ratings made with the DRM.
Figure 5.3
Happiness and BDI depression
Affect rating
Morning 1 Afternoon Evening Morning 2
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Figure 5.4
Negative affect and BDI depression
Affect rating
2 12 BDI high 
■  BDI low
I
Morning 1 Afternoon Evening Morning 2
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Figure 5.5
Tiredness and BDI depression
Affect rating
E2 BDI high
Morning 1 Afternoon Evening Morning 2
Figure 5.6
Depressed mood and BDI depression
Affect rating
2 i
1.5
0  BDI high 
■  BDI low
0.5 -
■
Morning 1 Afternoon Evening Morning 2
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5.4 Heart rate variability (HRV)
5.4.1 M eth od  o f  s ta tistica l a n a ly sis
Satisfactory heart rate variability data for all time periods were obtained from a 
total of 76 patients. One patient failed to complete the BDI, and affect data (DRM) was 
lost for another individual. Patients included and excluded from the analyses did not 
differ on socio-demographic, clinical or psychological characteristics. Several measures 
of heart rate and HRV were obtained, but in the interests of space I have limited the 
results to the interbeat interval, the root mean square standard deviation (RMSSD) and 
two frequency domain measures: normalised high frequency (HF n) and normalised low 
frequency power (LF n). Patterns of IBI, RMSSD, normalised HF and LF power over 
the day were analysed using repeated measures analysis of variance, with time period 
(morning 1, afternoon, evening, night, morning 2) as the within-subject factor. The 
Greenhouse-Geisser correction was applied when sphericity assumptions were violated. 
The associations between heart rate variability measures and age and BMI were analysed 
with product-moment correlations, while t tests were used to assess relationships with 
gender, ethnicity, smoking status, CAD status, and medication with beta blockers.
Participants were divided into depressed and non-depressed groups according to 
whether their BDI scores were < or > 10. Depression groups were compared on heart 
rate variability measures using repeated measures analysis of covariance, with time 
period as the within-subject factor, and age, gender, CAD status and medication with 
beta blockers as covariates. A similar method was used to investigate associations with 
positive and depressed affect over the day, dividing the sample by median split on these 
variables. Subsequently, analyses were repeated on the subset of patients with definite 
CAD. Data are presented as means ± (SD).
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5.4.2 Overall pattern of HRV indices
Figures 5.7 show the general pattern of HRV results over the 24 hours for all 
participants. As for the DRM, hour means are presented, although in the case of HRV, 
these continue throughout the night as well as the day. What can be seen is the lower 
interbeat interval and increase in HRV at night time in all indices except for the low 
frequency power index when participants are asleep during which the vagal tone is 
predominant. This reflects the inhibitory influence of the parasympathetic nervous 
system on the resting heart rate. The drop in power seen in the normalised low 
frequency index possibly represents less sympathetic activation of participants when 
asleep, as this index reflects more of the balance between the sympathetic and 
parasympathetic branches of the autonomic nervous system. This pattern is consistent 
with the normal physiological pattern we would expect the participants to show.
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F igu re 5.7 O vera ll p attern  o f  h eart rate v a r ia b ility  o v er  th e  stu d y  
p eriod
Interbeat interval Normalised HF power
1100
1050
1000
E 950
900
850
800
750
RMSSD Normalised LF power
^  </ </ •/
R -R 30 minute average R-R intervals.
R M S S D  = Root mean square of difference of successive R-R intervals.
H Fn
L Fn
= normalised High Frequency (0.15 to 0.40 Hz) in ms2 
= normalised Low frequency ratio (0.04 to 0.15 Hz) in ms2
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5.4.3 Effect of time on HRV indices
The primary analyses of interbeat interval and HRV were carried out with the 
four time periods specified in section chapter 4.5.2, namely the morning, afternoon, and 
evening of day 1, the night period, and the morning of day 2. Post hoc comparisons 
were carried out using Tukey’s LSD test. The mean values for each of the HRV indices 
across the five time periods are shown in Table 5.16.
T a b le  5 .16  E ffect o f  tim e on H R V
M orn  1 N oon E ve N igh t M orn  2
m ean m ean m ean m ean m ean
(SD) (SD) (SD) (SD) (SD)
IB I (R R ) 844.8 844.0 870.9 1 0 0 1 . 8 849.1
(128.0) (130.2) (140.7) (158.0) (146.0)
R M S S D 20.3 21.7 22.9 29.4 2 1 . 6
(10.3) (9.6) ( 1 0 . 8 ) (14.2) (9.95)
H F  n 23.6 23.4 25.5 32.3 24.2
(9.8) (9.2) ( 1 0 . 1 ) (14.1) (8.5)
L F  n 6 8 . 1 68.55 67.3 63.9 67.4
(13-3) ( 1 2 . 0 ) ( 1 2 . 8 ) (14.8) (11.5)
Mean values with standard deviation in parentheses
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There were significant time effects on IBI (F=81.6, p < 0.001). The IBI interval 
was significantly longer at night compared to all other four periods (p < 0.001). This is 
to be expected as the heart rate drops when asleep due to the predominance of the 
parasympathetic system. This was consistent with the pattern seen in Figure 5.7. The 
IBI in Morning 1 and in the afternoon period was also significantly different to the 
evening period (p = 0.01). The IBI in Morning 2 was additionally significantly different 
but less so, to the prior evening period (p = 0.05). There were significant time effects on 
RMSSD (F=21.4, p <0.001). The RMSSD interval was similarly significantly longer at 
night, compared to all other four periods (p < 0.001). This was consistent with the 
pattern seen in Figure 5.7. The only other significant effects seen were when comparing 
RMSSD in the morning period of the first day with the evening period (p = 0.05).
In the frequency domain, there are again significant time effects on HFn (F=24.4, 
p <0.01). Once more, there were significant differences at night compared to all other 
four periods (p < 0.001) i.e. there was greater HFn at night compared to all other times of 
the day of monitoring and the morning after. As well as this, there were significant 
differences when comparing the HFn in the first morning period with evening (p = 
0.021) and again when comparing the HFn in the afternoon with the evening (p = 0.003). 
The differences between periods are greater with HFn than with LFn or any of the time 
domain measures.
There are also time effects with LFn (F= 4.6; p = 0.08) but the changes seen 
when comparing different time periods of the 24 hours are less sensitive. In fact, 
significant effects are only seen at night with each of the other time periods: morning 1 
(p = 0.01); afternoon (p = 0.005); evening (p = 0.02); morning 2 (p = 0.02). The changes 
seen at night i.e. less LFn power reflecting less sympathetic activation at night, or
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conversely greater parasympathetic influence and is consistent with the pattern expected 
physiologically.
5.4.4 Effect of beta blocker medication, coronary artery disease status, gender 
and age on HRV indices
The association of heart rate and HRV with beta blocker use, CAD status 
(present/absent), gender and age were first analysed using point-biserial correlations for 
medication, CAD and gender, and product-moment correlations for age. Further detailed 
analyses of significant effects were carried out using repeated measures analysis of 
variance and the primary analyses of these are presented here.
Beta blockade had a pronounced effect. As can be seen in Table 5.17, patients 
medicated with beta blockers had longer IBIs during all periods except the night (/ = 2.17 
to 4.59, all p  < 0.05). Medicated patients also had reduced HF power in the night (t = - 
2.11, p  = 0.039) together with greater LF power (/ = 2.05, p = 0.044) compared with non 
medicated patients. The IBI result is plotted in Figure 5.8 (y axis shows IBI in ms; x axis 
shows the five time periods).
Beta blockers would normally be expected to reduce heart rate and increase heart 
rate variability, so we expected medicated patients to have longer IBIs, higher HFn and 
lower LFn. The results for IBI were as expected, while the HRV results were not. Other 
investigators have noted greater HRV in patients medicated with beta blockers (Carney 
et al., 1988). However, the data on the effect of beta blockers on HRV in cardiac 
patients is surprisingly limited (Sandrone et al., 1994). The differences observed here 
were very modest, despite being statistically significant. However, it is of note that beta
196
blockade prevents the rise in the LF component observed in the morning hours (Sandrone 
et al., 1994).
Figure 5.8
Interbeat interval and beta 
blockade
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Beta Blocker correlated with longer IBI and more HFn at night 
(r= 0 .025;p = 0 .023) and less LFn at night (r= -0 .25;p = 0 .023)
Table 5.17 Effect of beta blockade on IBI, HFn and LFn
Beta blocker Morn 1 Noon Eve Night Morn 2
Medication mean mean mean mean mean
(SD) (SD) (SD) (SD) (SD)
IBI YES 889.6 876.2 900.0 1018.4 882.6
(117.0) (131.3) (150.6) (161.0) (142.5)
NO 759.3 788.6 822.1 974.7 786.1
(108.3) (119.7) (114.1) (151.6) (134.4)
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Beta blocker Morn 1 Noon Eve Night Morn 2
Medication mean mean mean mean mean
(SD) (SD) (SD) (SD) (SD)
YES 25.7 24.8 26.8 30.8 25.2
(11.0) (10.2) (11.8) (13.9) (10.3)
NO 20.5 21.8 24.3 37.1 23.8
(8.4) (8.6) (8.5) (15.4) (8.1)
YES 67.2 67.3 66.2 65.5 66.9
(13.7) (13.4) (14.3) (14.6) (12.9)
NO 68.5 69.5 68.1 59.1 66.3
(14.5) (11.8) (12.0) (16.2) (12.6)
Interbeat interval and RMSSD did not differ in men and women. But there were 
significant gender by time interactions for HFn and LFn HRV indices (F = 6.55 and 3.82 
respectively, p < 0.01). As can be seen in Table 5.18, men and women did not differ 
substantially over the day. But in the night, women had greater HFn and less LFn than 
men did. This indicates that women had greater parasympathetic activity and 
sympathetic withdrawal in the night.
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Table 5.18 Effect of gender on IBI, HFn and LFn
Gender Morn 1 Noon Eve Night Morn 2
mean mean mean mean mean
(SD) (SD) (SD) (SD) (SD)
H F n MALE 23.7 23.9 25.5 29.7 23.7
(9.84) (10.0) (1L2) (13.6) (9.5)
FEMALE 24.6 23.7 27.1 39.6 26.9
(11.9) (9.3) (10.5) (14.7) (9.8)
L F n MALE 67.2 67.3 66.2 65.5 66.9
(13.7) (13.4) (14.3) (14.6) (12.9)
FEMALE 68.5 69.5 68.1 59.1 66.3
(14.5) (11.8) (12.0) (16.2) (12.6)
This finding is consistent with the previous literature (Liao et al., 1995; Yamasaki 
et al., 1996).
Age was positively associated with IBI in the afternoon and evening (r = 0.27 and 
0.33, p  < 0.01), and with a longer IBI, greater HF power and reduced LF power during 
all time periods except the night (r = 0.41 to 0.60, all p  < 0.001). This is consistent with 
previous studies (Tsuji et al., 1996) in which age is a major determinant of HRV and in 
which the impact of a 10 year increment in age was that of a 10 beat/min increment in
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heart rate (Tsuji et al., 1996). In addition, with increasing age, the parasympathetic and 
sympathetic spectral power components decrease (Liao et al., 1995). Negative 
correlation between LF power and age has also been shown in studies by Tsuji et al. 
(1996).
There was no association between heart rate variability measures and ethnicity, 
smoking status, BMI, or the presence of significant CAD.
5.4.5 Association between BDI depression and HRV indices
As noted in Chapter 3.4.2, I hypothesised that patients who were more depressed 
would show reduced HRV, specifically lower RMSSD, lower HFn and possibly greater 
LFn. The primary analysis involved repeated measures analysis of variance with BDI 
>10 or <10 (i.e. comparing depressed and non-depressed groups) as the between-subject 
factor and revealed no significant associations between depression and HRV for any of 
the parameters tested. In each case, the main effect for BDI depression status was not 
significant nor did depression interact with time of day. In the absence of group effects, 
we examined the associations further using regression analysis with BDI score rather 
than depression group as an independent variable, along with age, gender, CAD status 
and beta blockade. None of the associations in any time period with any variable was 
significant. There were no significant relationships between HRV and depression level as 
categorised using the BDI score. These results are summarised in Table 5.19. It is 
possible that effects will only be present among patients with definite CAD. The 
analyses were therefore repeated comparing the 20 high BDI and 26 low BDI patients 
with CAD. Again, none of the differences was significant. A third approach was to use 
the full scale of the BDI, and correlate BDI scores with IBI and HRV measures for each 
period of the day and night. Once again, none of these associations was significant.
200
Table 5.19 Effect of depression level (BDI) on HRV time and frequency domain 
indices
Morn 1
mean
(SD)
Afternoon
mean
(SD)
Eve
mean
(SD)
Night
mean
(SD)
Morn 2
mean
(SD)
RR
BDI low 862.6 854.8 884.4 1010.2 862.8
(133.6) (134.6) (147.7) (157.9) (142.8)
BDI high 822.2 834.6 856.0 992.5 833.3
(120.5) (133.6) (137.7) (162.2) (153.4)
RMSSD
BDI low 23.2 22.2 23.3 30.2 22.3
(16.6) (13.1) (12.96) (16.2) (15.0)
BDI high
18.8 22.9 23.6 30.6 22.8
(7.4) (10.9) (12.1) (16.7) (10.5)
H F n
BDI low 24.6 24.7 26.8 33.7 25.2
(10.6) (9.9) (11.8) (14.5) (10.1)
BDI high 23.1 22.63 24.5 31.4 23.9
(10.5) (9.7) (9.5) (15.0) (9.2)
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Morn 1
mean
(SD)
Afternoon
mean
(SD)
Eve
mean
(SD)
Night
mean
(SD)
Morn 2
mean
(SD)
L F n
BDI low 65.9 65.8 65.2 62.9 65.2
(14.7) (14.1) (15.1) (15.5) (14.3)
BDI high 70.0 71.0 69.3 64.3 68.8
(12.7) (10.7) (64.3) (15.5) (10.3)
BDI low/high = Beck Depression Inventory score low (< 10) high (>10)
5.4.6 HRV and DRM-derived affect measures
The absence of associations between BDI scores and HRV does not mean that
cardiac autonomic control is unrelated to psychological state. It is possible that HRV
will be associated with the more refined measures of mood derived from the DRM
interview. For this analysis, I took the aggregate levels of DRM happiness, depression,
and negative affect, and divided the sample on each variable by median split. I then
compared HRV indices in high and low groups on happiness, depressed mood and
negative affect. Repeated measures of analysis of covariance was carried out with mood
group (high/low) as the between-subject variable, and time of day as the within-subject
variable, with age, gender, CAD status and beta blocker use as covariates. These
variables have been chosen, as there is extensive literature on HRV and the influence of
both positive and negative emotions. Bacon et al. (2004) showed that in 135 cardiac
patients, negative emotions such as stress and sadness were associated with both high
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and low frequency power whereas positive emotions were associated with an increase in 
low frequency power independent of age, posture and medication.
5.4.6.1 HRV and positive affect
Happiness was related to the two frequency domain HRV measures. The results for LFn 
power are summarised in Figure 5.9, adjusted for covariates. The repeated measures 
analysis of covariance showed a main effect of happiness (F= 12.21; p <0.001), together 
with a happiness group by time interaction effects (F= 8.42; p < 0.001). Happier people 
showed lower LF power throughout the study period, with particularly large differences 
in the mornings. If LF power indexes sympathetic/parasympathetic balance, this result 
suggests that happier individuals have less cardiac sympathetic activation.
The reverse effects were observed for HFn power, where again the main affect 
for happiness group (F=8.06; p <0.001) and the group by time interaction were 
significant (F=4.6; p = 0.035). These results indicate that happier people showed 
significantly increased HF power (i.e increased heart rate variability) at all times of the 
day after taking into account other factors such as age, gender, CAD and beta blocker 
use. When BDI scores were included as additional covariates, the effect for positive 
affect remained significant for HF and LF power (F = 8.27 and 16.95 respectively, p < 
0.005). These results are shown in Figure 5.9, where it is evident that the greater HF and 
reduced LF power in patients experiencing more positive affect was sustained throughout 
the study period.
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Figure 5.9
Mean normalised HF and LF heart rate variability across day-time and night periods in 
lower positive affect (solid bars) and higher positive affect (hatched bars) groups (n = 
75). Values are adjusted for age, gender, CAD status, medication with beta blockers, 
BMI, smoking status and habitual physical activity. Error bars are s.e.m.
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5.4.6.2 HRV and negative affect
There were no significant associations between DRM depressed mood and HRV.
No significant effects involving negative affect were observed in these analyses either.
The pattern of results for LFn and HFn is illustrated in Figure 5.10. Depressed affect
was not related to heart rate or HRV in the sample as a whole. But when analyses were
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limited to the 46 patients with documented CAD, differences did emerge. Specifically, 
patients reporting greater DRM depressed affect had significantly less HF power (F = 
5.07, p = 0.030), and greater LF power (F= 4.93, p = 0.032) over the study period, after 
controlling for age, gender and medication with beta blockers.
Figure 5.10
Mean normalised HF and LF heart rate variability across day-time and night periods in 
patients with documented CAD (n = 46) who experience higher depressed affect 
(stippled) and lower depressed affect (hatched bars) assessed with the DRM. Values are 
adjusted for age, gender, medication with beta blockers, BMI, smoking status and 
habitual physical activity. Error bars are s.e.m.
Heart rate variability and depressed affect
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Figure 5.11
Mean interbeat interval across five periods of the day in higher depressed affect (stippled 
bars) and lower depressed affect (hatched bars) groups of patients with documented 
CAD (n = 45). Values are adjusted for age, gender, and medication with beta blockers. 
Error bars are s.e.m.
M orning 1 E v e n in gA fternoon M orning 2
Additionally, the depressed affect group by time interaction was significant in the 
analysis of IBI (F = 3.48, p = 0.009), after adjustment for covariates. The results, shown 
in Figure 5.11, indicate that IBIs tended to be shorter in the higher depressed affect 
group, with the difference being most prominent in the night, i.e. a higher heart rate is 
seen in the depressed group especially so at night. Thus it emerged that HRV was 
related to positive affect in the complete sample, but to depressed affect only in the 
patients with documented CAD.
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5.5. Discussion
5.5.1 Summary of DRM results
Summarising the overall patterns found, positive affect was shown to be lowest in 
the morning on first awakening and a mid morning rise, mid afternoon arise was 
observed with a peak rating in mid evenings. Overall happiness had the higher levels of 
endorsement and negative affect (NA) had lower levels. The fact that overall people are 
generally happier than they are sad is consistent with a study by Stone et al. (2006), 
which used the DRM approach to study diurnal rhythms of emotion on a working day in 
909 women. Our study also agrees with Stone et al. (2006), with the findings of PA 
being greater in the evening rather than the morning and having a diurnal rhythm. This 
contrasts to previous studies that have shown PA to be highest in the morning (Wood & 
Magnelio, 1992), not in the evening. However, in the study by Wood and Magnello 
(1992), the authors used only 6 time points in contrast to the more detailed timings used 
in the DRM.
NA and depression were both shown to be rather constant through out the day 
and this lack of diurnal rhythms supports the study by Wood et al. (1992) but not some 
other previous studies (Stone et al., 2006; Monk et al., 1985). Tiredness was shown to 
increase progressively during the day and at an accelerated rate in the evening, as would 
be expected, and supports other studies that used the DRM (Stone et al., 2006). 
Tiredness was also significantly greater in women compared to men. This supports 
findings of gender differences in tiredness in cardiac patients. In a study by Wiklund et 
al. (1993) comparing the subjective symptoms and well-being in women and men 12 
months post MI, after controlling for differences in age and co-morbidity, women
207
reported significantly higher frequencies of psychological and psychosomatic 
complaints, including sleep disturbances.
Comparing the different affects in relation to depression the findings from the 
DRM correlated well with what would be expected when mood was assessed by the 
questionnaire (BDI). The negative emotions and not the positive emotion of happiness 
were significantly greater in the depressed group as assessed by the BDI. This, to some 
extent, provides support for the methodology of the DRM.
5.5.2 Strengths and limitations of the DRM
The strengths of the DRM are centred round the fact that multiple assessments of 
affect are used to assess patterns and allow a more fine tuned analysis of fluctuating 
emotions in the day than can be achieved with standard retrospective questionnaires or 
with ecological momentary assessment (EMA) techniques. EMA methods provide the 
most immediate and direct measures of affect in everyday life, but have a high 
respondent burden. There is also the problem that EMA measures cannot be very 
frequent (e.g. every 15 minutes), or else they will interrupt ongoing behaviour. This 
means that significant experiences over the day might be missed if they did not coincide 
with the timing of EMA. The DRM overcomes this problem by conceiving of the day as 
a continuous sequence. Because episodes are defined concretely, the recall of incidents 
and their associated affect should be more precise than is the case with standard 
retrospective methods The DRM interview takes approximately an hour to complete 
and feasibly could be done efficiently by large numbers of participants in a communal 
setting by self-report questionnaires or on the internet. The new method is acceptable to 
the patients, not time consuming and relatively easy to follow. The patterns of affect
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seem sensible and the association between daily activities and emotions provide further 
support for validity of the assessment method.
The limitations in the DRM method as applied in this study include the fact that 
although affect was analysed in relation to time of day, gender and BDI, we did not 
analyse affect in relation to age. Age has been shown to affect emotional experience in 
daily life, with positive emotions increasing with age after 60 years (Carstensen et al.,
2000). Younger people have less PA in the mornings than older patients (Kahneman et 
al., 2004; Stone et al., 2006). The study sample I tested was too small and biased 
towards older ages to allow such comparisons to be made. The DRM was only 
completed over a single day. The study could have been repeated to divide the 
participants according to whether they were being tested in a working day or a non­
working day. Diurnal rhythms may well be associated with activities associated with or 
caused by working. In order to determine whether stable individual differences in 
diurnal mood patterns exist, the assessment of multiple days is required.
Overall, the DRM appears to provide a valuable picture of emotional experience 
in daily life with minimal recall bias and provides a user friendly efficient assessment. 
But studies that use EMA and DRM methods simultaneously are required definitively to 
confirm that the pattern and intensity o f affects recalled using the DRM provide an 
accurate representation of moods as they were actually experienced. Unfortunately, it 
was not possible to include EMA measures in this study. The relationship between 
various affects and the triggering of ECG changes in patients with suspected CAD is 
discussed in chapter 7.
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5.5.3 Summary of heart rate variability results
The results suggest that reduced HRV may not be related to aggregate measures 
of depressive symptomatology in patients with suspected CAD, but that the relationship 
may depend on prevailing levels of affect during the study period. By contrast, positive 
affect is associated with a favourable profile of HRV both in patients with and without 
confirmed CAD. These associations may be relevant both to the processes through 
which depression increases risk in cardiac patients, and the pathways relating positive 
mental states with CAD prevention.
When characterising the emotions of patients suspected of coronary artery 
disease, it appears that the BDI, a validated depression questionnaire, did not show a 
consistent relationship with autonomic function. I found no association between 
depressive symptoms assessed with the BDI and indices of HRV in this study. The 
relationship was tested in the complete sample and in the subset of patients with definite 
CAD, and was investigated both with a categorical division between high and low BDI 
groups, and using the BDI as a continuous variable. This result may reflect a genuine 
lack of association between depressive symptoms and HRV in patients with suspected 
CAD. Although a relationship between reduced HRV and depression has repeatedly 
been observed in patients following acute coronary syndromes, the literature on stable 
CAD is mixed and this has been described in the earlier chapter 2.5.2.3 on heart rate 
variability.
Similar samples of patients with cardiac symptoms and positive non-invasive 
tests awaiting angiography have been involved in previous studies of HRV (Carney et 
al., 1988, 1995), although analyses have often been limited to patients with definite 
coronary stenosis. A number of studies have shown that depressed cardiac patients have 
reduced HRV (Carney et al., 1995, 2000, 2001).
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The proportion of patients with significant stenosis and definite CAD was similar 
to that of other studies (Dumville et al., 2007). Patients without significant CAD may 
not be at elevated risk for cardiac problems but nevertheless use increased medical 
resources (Potts et al., 1993). BDI levels did not differ between CAD and non-CAD 
patients.
Most studies relating depression with HRV have either measured the ECG’s over 
a short time period (Guinjoan et al., 2004), oc else have averaged 24 hour recordings into 
a single value (Gehi et al„ 2005; Krittayaphong et al., 1997, Carney et al., 1988). I 
decided that it would be interesting to discover whether the diurnal pattern of HRV 
varied with depression and positive affect. The diurnal HRV was as expected, with 
increased HF power and reduced LF power in the night compared with the day. The 
same profile has been observed both in healthy populations and cardiac patients 
(Yamasaki et al., 1996), and reflects the normal profile of increased parasympathetic and 
reduced sympathetic activation at night. We found that women had greater HF and 
lower LF than men, as is typical in the literature (Liao et al., 1995). Negative 
correlations between LF power and age have also been described before (Yamasaki et 
al., 1996).
The null result may have been due to other factors. For example, our patients 
continued with their cardiac medication including beta blockers, and this could have 
obscured the relationship between HRV and depression. However, the dominant effect 
of this medication was on heart rate rather than HRV.
The sample size of 75 is relatively small, though comparable with many previous 
studies of depression and HRV (Krittayaphong et al., 1997, Stein et al., 2000). Around 
42% of patients had BDI scores > 10, but it is possible that some of the patients who 
refused to take part were more depressed.
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However, a stronger possibility is that the dissociation arose because some 
patients with elevated BDI scores were not particularly depressed over the HRV 
monitoring period. We used the DRM to measure affect over the study period to 
characterise participants’ emotional experience of daily life, a different picture emerged 
relating depressed mood with HRV (section 5.4.6.2). This study throws some light on 
the explanation for these inconsistencies, in showing that associations between HRV and 
with depressed mood over the day as measured by the DRM are present.
This new method has been advocated by Kahneman and co-workers (Kahneman 
et al., 2004) as a useful alternative to ecological momentary assessment. As discussed in 
Chapter 3.3, on methodological issues relating to the SIS study, the DRM has the 
advantages that it provides concurrent assessment of subjective experience, activities and 
social situations, so that experience-weighted analyses can be carried out. Because all 
waking hours are covered, there is a lower likelihood that emotionally salient events will 
be missed, in comparison with momentary sampling techniques involving ratings every 
one to two hours.
Depressed affect from the DRM was positively correlated with BDI rating (r =
0.65). However, the association between the two is not very tight, and there was only 
42% shared variance. Interestingly, depressed affect was associated more closely with 
HRV than was the BDI, with higher LF power and lower HF power in the more 
depressed individuals (Figure 5.10). Additionally, heart rates were faster in patients 
experiencing more depressed affect, particularly at night (Figure 5.11). It is notable that 
these effects were only observed in patients with definite CAD, and not in the complete 
study group. This suggests that moment to moment depression may be associated with 
impaired autonomic cardiac control in patients with coronary disease.
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By contrast, the associations between positive affect and HRV were evident in 
the complete study group. Individuals who were happier over the day had greater HF 
and reduced LF power throughout the study period (Figure 5.9). This effect was 
independent of age, gender, CAD status and medication with beta blockers. It was also 
independent of BDI scores, suggesting that positive affect has distinct biological 
correlates that are not simply the product of the absence of negative affective state 
(Steptoe et al., 2005). These results indicate that patients with suspected CAD who 
report high positive affect have greater parasympathetic activation and reduced 
sympathetic/parasympathetic balance compared with less happy individuals. There is 
growing evidence from laboratory studies on healthy participants that greater positive 
affect is directly related to health relevant biological processes in terms of reduced 
neuroendocrine, inflammatory and cardiovascular activity (Steptoe et al., 2005).
5.5.4 Strengths and limitations of study
A strength of this current study is that it suggests that not only in the laboratory 
but also in naturalistic real life settings, greater positive affect has a direct relationship 
with reduced sympathetic/ parasympathetic cardiac autonomic control. These results 
suggest that one biological mechanism that may be relevant is a favourable pattern of 
autonomic cardiac control. An additional strength of the study is that it had a 
prospective design, since neither the investigators nor the participants were aware of 
their diagnosis at the time of investigation.
This study has a number of limitations. The sample size was relatively small, and
we did not test a control group of participants with no cardiac complaints and no
medication. A substantial minority of eligible patients declined to take part; although
travel problems and business were the main reasons given for refusal, it is possible that
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more severely depressed individuals were excluded. The majority of participants were 
white men, and it would have been desirable to recruit a wider range of ethnic minority 
groups and a larger percentage of women. The DRM is dependent on accurate recall of 
emotional experiences during the episodes that made up the study period. It was 
completed during face to face interactions with the researcher, and this could have 
influenced reported affective responses to some activities. A longer period of ECG 
recording may have picked up more consistent associations with mood, though the DRM 
has not been used on periods greater than 24 hours in the past. The BDI may not be the 
most appropriate instrument for assessing depression in this population. We chose it 
because of its associations with prognosis in patients with acute coronary syndromes 
(Nicholson et al., 2006) and because it has been recommended for this population 
(Davidson et al., 2006), but studies of HRV have used interviews to define clinical 
depressive disorder (Gehi et al., 2005; Carney et al., 2001). A further limitation is the 
absence of ejection fraction data, since HRV is known to be reduced in those with poor 
left ventricular function (Nolan et al., 1998).
Irt summary, it may well be that it is the absence of positive affect rather than 
presence of negative affect that is more important, since there was a strong relationship 
with HRV that was independent of important covariates such as medication. This may 
have clinical implications for cardiac patients. However, HRV is not the only biological 
indicator investigated in this study, and different patterns might emerge for other 
measures such as cortisol profile over the day, cortisol awakening response (CAR) and 
transient myocardial ischaemia. These findings are presented in chapters 6 and 7.
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Chapter 6: The relationship between cortisol, depression and other 
moods in patients with suspected coronary artery disease
6.1 Introduction
It is described in chapter 1.1.3 and 1.3.3 that depression is prevalent in CAD 
patients and associated with increased risk of future CAD events and mortality (Burg & 
Sirois, 2003; Frasure-Smith et al., 1993; Lesperance et al., 2000, 2003). However, little 
is known about mechanisms linking depression or emotion and subsequent cardiac 
events. Elevated cortisol levels or an elevated cortisol awakening response (CAR) due to 
enhanced activity of the hypothalamic-pituitary-axis (HPA) is a possible mechanism 
with attendant changes in hypertension, hyperlipidaemia, endothelial changes and insulin 
resistance, which all serve to increase risk o f CAD development and prognosis (Girod & 
Brotman, 2004).
Several studies have been described in chapter 2.7.2, showing associations 
between cortisol and CAD (Koertge et al., 2002). Prospective associations between 
cortisol and future fatal, and non fatal cardiac events have also been described in post 
ACS patients (Bain et al., 1989).
The literature relating cortisol with depression is complex, but impaired
suppression of cortisol secretion by dexamethasone is characteristic of a subset of
clinically depressed individuals, and elevated basal levels may also be present (Gold et
al., 1988; Weber et al., 2000; Wong et al., 2000; Holsboer, 2001). Other studies have
suggested that elevated morning cortisol may be a pre-morbid factor for subsequent
depression (Goodyer et al., 2000; Harris et al., 2000) and has been associated with a
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history of depression (Bhagwagar et al., 2003). An association between cortisol levels 
over the day and depressed mood assessed with the Beck Depression Inventory (BDI) 
has also been described (Peeters et al., 2006).
Cortisol shows a diurnal pattern in healthy adults peaking at 20-45 minutes 
(Cortisol awakening response: CAR) after waking and then steadily decreasing to its 
lowest levels in the night and early morning. Patients with CAD exhibit a cortisol 
pattern that is markedly different (Nijm et al., 2007). Patients with depression also show 
a markedly different cortisol pattern and these have been described earlier in the review 
in chapter 2.7.1 (Harris et al 2000; Pruessner et al., 2003). As well as depression being 
associated with elevated levels of cortisol in healthy patients (Young et al., 1994) it has 
also been shown to be elevated in patients with CAD (Otte et al., 2004). Additionally, in 
patients with CAD, this potential association between depression and increased cortisol 
may be attenuated by co morbid medical conditions, e.g. hypertension (Litchfield et al., 
1998), medication use e.g. beta blockers (Deininger et al., 2001) and depression severity 
(Nelson etal., 1997).
Despite the evidence that depression is prevalent in CAD patients and cortisol 
output is related to depression in both healthy and CAD patients, there is limited 
evidence directly linking depression with cortisol in CAD patients (Otte et al., 2004). 
Limitations are that awareness of the disease itself may contribute to disturbed mood and 
cortisol profiles. A diagnosis of coronary disease is stressful, and patients may respond 
with neuroendocrine .activation and depressed mood, making it difficult to analyse the 
relationship between cortisol profiles in depressed CAD patients.
In the present study, I therefore investigated patients with chest pain who had 
been referred to hospital for specialist diagnosis before definitive coronary angiography 
had been carried out. The majority of patients were diagnosed with CAD, but some were
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found not to have occluded arteries. Neither investigators nor patients were aware of 
actual clinical disease state at the time of cortisol measurement. This allowed us to 
assess the relationship between depressed mood and cortisol in patients with and without 
definite CAD who had endured similar clinical experiences in terms of diagnostic 
testing. Evaluation of the possible role of sleep is potentially possible by analysis of 
actigraphy readings, since disturbed sleep in depression may influence diurnal cortisol 
profiles (Madjirova et al., 1995). The cortisol awakening response and cortisol rhythm 
over the remainder of the day and evening were analysed separately.
Two broad questions were addressed in these analyses.
1. Do patients with CAD who are more depressed have a flatter slope over the day, 
independent of age, gender, medication, and times of waking and sleeping?
2. Do patients with CAD have a greater cortisol measured on waking and 15 and 30 
minutes after waking independent of the relation to depression?
In summary, in this chapter, 1 shall discuss the results of the cortisol analyses. 
Firstly, Twill compare the overall pattern of results of the cortisol profile between CAD 
patients who are more depressed with those who are less depressed as measured by the 
BDI and DRM. Secondly, independent of depression, I shall discuss whether those 
patients with CAD have a greater cortisol awakening response and how this may 
contribute to elucidating the biological pathway by which depression can cause CAD.
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6.2 Method
Patients
The method of the SIS study including selection criteria of recruitment of patients 
is described in detail in chapter 4. Here is a brief summary of the method in relation, 
particularly, to the cortisol sampling method and analysis.
Participants were 88 patients referred to the rapid access chest pain clinic and 
were regarded as probable CAD cases on the basis of symptomatology plus positive 
exercise tests or positive myocardial perfusion scans. They participated in the study 
prior to coronary angiography. All the patients had experienced new onset chest pain, 
had been referred to the specialist clinic, and had positive risk-stratifying tests. Patients 
who were and were not subsequently diagnosed as having definite current CAD thus 
underwent identical clinical procedures, and were all likely to have anticipated a cardiac 
diagnosis at the time of the study. 144 patients were eligible to take part, of which 56 
refused/ The main reasons given were travel problems (patients had to come to the 
laboratory on two consecutive days), or because patients were too busy with work or 
other commitments. Patients who declined were significantly older (mean 64.9, SD 10.2 
years) than those who took part (mean 61.1, SD 9.8 years, t = 2.16, p = 0.032), but did 
not differ in gender distribution.
Procedure
Patients were recruited in the hospital outpatient clinics. Subsequently, they
attended the research laboratory at University College London individually on the
morning of day 1 of the study. Anthropometric measures were taken and participants
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were equipped with a 24 hour holter monitor (data described elsewhere) and a wrist 
actigraph. The cortisol sampling procedure was explained and practiced. Patients 
returned to the laboratory at the same time on the next day (day 2), at which time an 
interview about the study period was completed. A questionnaire including the BDI was 
also administered.
Measures
Depression was assessed with the BDI. Socio-demographic and clinical 
information was obtained by interview. Weight and height were measured, from which 
body mass index (BMI) was calculated. Prior history of CAD was obtained from clinical 
notes. After the patients had completed the study, we collected findings from their 
subsequent angiography, recording the presence or absence of definite CAD, and the 
number of significantly diseased coronary arteries.
Cortisol was collected from saliva samples using Salivettes (Sarstedt, Leicester, 
UK). Measures were taken soon after arriving in the laboratory (between 9:00 and 10:00 
am), and patients were instructed to take further samples at 11:00am, 4:00pm, 7:00pm 
and just before bed. On day 2, they were asked to take samples immediately on waking 
and at 15 and 30 minutes after waking. Samples were returned to the laboratory later in 
the morning, and salivas were stored in a freezer at -20°C until analysis which was 
carried out using a high sensitivity chemiluminscence assay at the Technical University, 
Dresden (Germany). Inter and intra-assay coefficients of variance (CVs) were <8 %.
Physical activity was measured with a wrist actigraph (Actiwatch, Cambridge
Neurotechnology, Cambridge, UK). This device (distributed in the USA by Mini Mitter)
is a piezoelectric motion sensor. Data were analysed using proprietary software to define
the following parameters: wake time in the morning, sleep latency (interval between
going to bed and falling asleep), and sleep efficiency (proportion of the time in bed spent
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sleeping). The Actiwatch has been validated against polysomnography in both healthy 
populations and insomnia samples (Lichstein et al., 2006) and is used extensively in 
population and clinical studies (e.g. Lauderdale et al., 2006). Patients were also asked 
whether they had slept well on the night before morning cortisol assessments.
Statistical analysis
Two patients failed to complete the BDI, and two patients had missing cortisol 
data over the day, so analyses were carried out on 84 individuals. 52 (61.9%) were 
diagnosed as having CAD on the basis of having one or more vessels with > 50% 
stenosis on angiography, while 32 (38.1%) did not have CAD. The CAD group had an 
average 1.95 ± 0.82 significantly stenosed vessels. The CAD and non-CAD groups were 
compared on socio-demographic, clinical and sleep characteristics using x2 f°r 
categorical and t-tests for continuous variables. Separate analyses were carried out of 
cortisol over the day (measured on day 1) and the cortisol awakening response (CAR) 
measured on day 2. Cortisol over the day was analysed using repeated measures analysis 
of variance with clinical group (CAD/non-CAD) and depression group (BDI > 10 / < 10) 
as between-subject factors, and the 5 samples over the day and evening as within-subject 
factors. The Greenhouse Geisser correction of degrees of freedom was computed when 
appropriate. Subsequently, analyses of covariance were performed with age, gender and 
medication with beta blockers as covariates. The slope of cortisol decline was calculated 
as the reduction in cortisol per hour between the laboratory (10:00 am) and bed time 
sample.
The CAR is the change in cortisol that occurs over the first over 20-30 minute
following waking, (Clow et al., 2004) and was assessed by repeated measures analysis of
the waking, 15 and 30 minute saliva samples. The CAR is critically dependent on the
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waking cortisol sample being obtained without substantial delay, since postponement can 
reduce the magnitude of the awakening response (Wright & Steptoe, 2005). Time of 
waking on day 1 was based on self-report, while time of waking on day 2 (when the 
CAR was assessed) was defined objectively on the basis of characteristic increases in 
physical activity assessed using the Actiwatch. Delaying the ‘waking’ sample by up to 
15 minutes following objectively defined waking does not substantially influence the 
CAR (Kupper et al., 2005; Dockray et al., 2008). Only individuals with delays >15 
minutes were therefore excluded from CAR analyses, leaving 72 patients in the analyses.
6.3 Cortisol results
Patients with CAD were significantly older and more likely to be male than those 
without CAD (Table 6.1). There were no differences in education, marital status, 
smoking or history of clinical depression. The majority of the participants were 
prescribed beta blockers, aspirin and statins, with no differences between groups. 
However, CAD patients were more likely to be prescribed ACE inhibitors. CAD 
patients were more likely to have a history of CAD (previous ACS, etc), though rates 
were low. 19% of the total sample had a previous history of coronary heart disease 
(CHD), and as would be expected, significantly more (26.9%) of the CAD positive group 
had a previous history of CHD compared to those who had none (6.3%) (p = 0.02). 
Scores on the BDI averaged 10.17, with 42.9% scoring > 10, while 14% had BDI scores 
> 18. There were no differences between CAD and non-CAD patients group in 
depression scores. The two groups did not differ in sleep characteristics.
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6.3.1 Depression and cortisol over the day
The reported times of cortisol samples over day 1 were 09:48h ± 30.7min, 11:34h 
± 43.0min, 16:14h ± 26.1min, 19:18h ± 37.4min and 23:24h ± 68.5min, indicating good 
adherence to the protocol. Cortisol averaged 6.25 ± 2.5 nmol/1 over the day, and the 
cortisol slope averaged 0.74 ± 0.48 nmol/l/h. Cortisol over the day was not associated 
with age, smoking status, BMI, medication with statins, aspirin or ACE inhibitors, or 
with time of waking in the morning. But women had lower cortisol over the day than 
men (means 5.04 ± 1.79 vs 6.79 ± 2.53 nmol/1, p = 0.002), and flatter cortisol slopes 
(means 0.46 ± 0.30 vs 0.87 ± 0.49 nmol/l/h, p < 0.001). Additionally, patients taking 
beta blockers had higher average cortisol over the day and evening (means 6.67 ± 2.55 vs 
5.39 ±2.06 nmol/1, p = 0.024).
There was a significant interaction between CAD status, depression and time in 
the repeated measures analysis of variance (p = 0.009). Depression was related to 
cortisol output in CAD patients (p < 0.001), but not in the non-CAD group (p = 0.68). 
The results for CAD patients are summarised in Figure 6.1. Cortisol early in the day was 
lower in the depressed than non-depressed CAD patients after adjustment for age, 
gender, beta blockade, and time of waking in the morning (p = 0.003). But the reverse 
pattern emerged later in the day, with cortisol being higher among depressed CAD 
patients at bed time (p = 0.038), with a near significant effect at 7 pm (p = 0.060). The 
cortisol slope over the day was therefore substantially lower in depressed than non­
depressed CAD patients (means 0.51 ± 0.49 vs 0.99 ± 0.46 nmol/l/h, adjusted for age, 
gender, beta blockade, and time of going to bed, p < 0.001). The same pattern of results 
emerged when the BDI was entered as a continuous variable into a regression on the 
cortisol slope over the day, and when a more stringent criterion for depression (BDI >
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15) was applied. Cortisol over the day and evening was unrelated to sleep latency, sleep 
efficiency, or subjective sleep quality.
6.3.2 Depression and cortisol awakening responses
Participants woke at 06:19h ± 65min on average. Cortisol increased markedly 
between waking and 30 minutes in the complete sample (p < 0.001). Sleep efficiency 
and sleep latency were unrelated to CAD status or to cortisol over the early morning 
period. More depressed patients woke earlier in the morning, and early waking was in 
turn associated with a lower cortisol on waking (r = 0.26, p = 0.029). However, the CAR 
was not related to depression, but cortisol levels were greater in CAD than non-CAD 
groups (p = 0.04). As shown in Figure 6.2, cortisol was higher in the CAD than non- 
CAD groups throughout the waking period after adjustment for gender, beta blockade 
and waking time. The increase in cortisol between waking and 30 minutes did not differ 
in CAD and non-CAD groups.
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Table 6.1 Characteristics of patients with and without coronary artery disease
Coronary artery 
disease
No coronary artery 
disease
P
(n =  52) (n = 32)
Gender: Men 41 (78.8%) 17(53.1% ) 0.017
Women 1 1 (21.2%) 15 (46.9%)
Age (years) 63.9 ± 8 .8 58.3 ± 9.7 0.008*
Ethnicity (white) 37(71.2% ) 24 (75.0%) 0.80
Educational attainment 
(High school and above)
30 (57.7%) 16(50.0% ) 0.51
Marital status (married) 29 (55.8%) 22 (68.8%) 0.26
Smoking status
Current smoker 13 (25.0%) 7(21.9% ) 0.45
Former smoker 23 (44.2%) 12(37.5% )
Never smoker 16(30.8% ) 13 (40.6%)
Body mass index (kg/m2) 26.0 ± 3 .5 27.7 ± 4.4 0.078
Medication
Beta-blockers 38 (73.1%) 18 (56.3%) 0.15
Statins 44 (84.6%) 25 (78.1%) 0.56
Aspirin 47 (92.2%) 27 (84.4%) 0.30
ACE inhibitors 24 (52.2%) 3 (10.0%) 0.001*
Previous CAD 14 (26.9%) 2 (6.3%) 0.022*
History o f depression 8(15.4% ) 9(28.1% ) 0.17
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Coronary artery 
disease
(n = 52)
No coronary artery 
disease
(n = 32)
P
BDI (mean) 10.12 ± 6.7 10.25 ± 8 .0 0.94
BDI > 10 23 (44.2%) 13(40.6% ) 0.82
Sleep latency (min) 12 ± 14 20 ± 2 6 0.073
Sleep efficiency (%) 78.9 ± 16.9 79.1 ± 17.0 0.96
Wake up time (hours: min) 6:14 ± 64 6:03 ± 6 3 0.43
Sleep quality (good) 31 (59.6%) 23 (74.2%) 0.24
N (% ) and Mean ± standard deviation *Significant CAD difference, p < 0.05.
Figure 6.1 Mean salivary cortisol across the five sample points of the day and
evening in CAD patients with BDI scores >10 (solid lines), and <10 (dashed lines), 
adjusted for age, gender, beta blockade and reported time of waking and going to bed. 
Error bars are standard errors of the mean (s.e.m.).
Figure 6.1 Cortisol in depressed and non-depressed CAD patients
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Figure 6.2 Mean salivary cortisol on waking (wake), 15 minutes (wake+15) and 30 
minutes (wake+30) after waking in CAD patients (solid line) and non-CAD patients 
(dashed lines), adjusted for age, gender, beta-blockade and objective time of waking. 
Error bars are s.e.m.
Figure 6.2 CAR in CAD and non-CAD patients
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6.4 Discussion
This study evaluated cortisol output over the day in patients with suspected CAD 
in relation to depressive symptoms measured with the BDI. The results indicate that the 
cortisol slope over the day was flatter in depressed patients with CAD, but was not 
related to depression in patients without CAD. This effect was due to the combination of 
lower cortisol early in the day and higher cortisol in the evening in the more depressed 
CAD patients, and was independent of age, gender, medication, and times of waking and 
sleeping. Additionally, cortisol early in the day, measured on waking and 15 and 30
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minutes after waking, was greater in CAD than non-CAD patients, but did not relate to 
depression.
Depression was assessed as a subclinical mood variable rather than a clinical 
category in this investigation. The reason is that subclinical depressive symptoms are 
associated with the development of CAD and with prognosis following acute cardiac 
events (Nicholson et al., 2006). Moderately elevated BDI scores (> 10, the same 
criterion as used in this study) have been shown to predict cardiac mortality and non- 
fatal recurrence in patients following ACS (Lesperance et al., 2002; Spijkerman et al., 
2006). The association with the flatter cortisol rhythm over the day in CAD patients is 
therefore potentially significant clinically.
Previous studies of cortisol and depression in patients with documented CAD 
have been mixed. Otte et al. (2004) showed a positive relationship between depression 
assessed both by diagnostic interview and questionnaire and 24-hour urinary cortisol in 
the Heart and Soul Study. This was independent of age, gender, BMI, smoking, co- 
morbid illness, medication and cardiac function. 24-hour measures do not allow the 
profile of cortisol output over the day to be analysed. Whitehead et al. (2007) measured 
salivary cortisol over the day and evening in patients hospitalised for ACS and found no 
association with depression. By contrast, a positive correlation between morning cortisol 
and depression was recorded in a study of 285 patients assessed 3-6 months after ACS 
(Von Kanel et al., 2007). The absence of an association in patients without CAD is 
consistent with Taylor et al’s (2006) findings in depressed individuals with elevated 
cardiovascular risk factors but without coronary disease.
Flatter cortisol rhythms over the day can only be defined using repeated 
sampling, and are difficult to assess using blood sample in an everyday life settings. 
Flatter cortisol slopes have previously been associated with greater tension and anger
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over the day (Adam et al., 2006), posttraumatic stress disorder (Aardal-Eriksson et al.,
2001), and poor marital relationships quality in both younger and older adults (Barnett et 
al., 2005). Matthews et al. (2006) recently demonstrated that flatter cortisol profiles 
were associated with coronary artery calcification (an indicator of sub-clinical CAD) in 
apparently healthy middle-aged adults. One feature of flatter rhythms is that cortisol 
levels are elevated in the evening, even though values are low compared with earlier in 
the day. This pattern was apparent in the present study, with higher cortisol among 
depressed than non-depressed CAD patients. An elevation of cortisol in the evening has 
been demonstrated in a number of studies of clinically depressed patients (Plotsky et al., 
1998).
Cortisol early in the day and the CAR were analysed separately from cortisol 
over the remainder of the day and evening. The CAR is a distinctive component of the 
diurnal cortisol profile and correlations between the CAR and other indicators of cortisol 
over the day are low (Schmidt-Reinwald et al., 1999).
In the present study, we found no differences in the magnitude of the CAR (the 
rise from waiting to 30 minutes) in relation to depression, or between CAD and non- 
CAD patients. However, the overall level of cortisol output was elevated in CAD 
patients (Figure 6.2). This indicates that raised cortisol levels in the early morning 
period are associated with definite coronary disease in patients with cardiac symptoms. 
This study was cross-sectional, so the causal significance of this pattern can not be 
determined. Nevertheless, the findings are consistent with the study of 238 women 
following ACS, in which early morning cortisol was elevated in only those with 
significant (> 50%) coronary stenosis (Koertge et al., 2002). Davey Smith et al (2005) 
showed that cortisol/testosterone ratios predicted the incidence of CAD over a 16.5 year 
follow-up of middle-aged men in Wales, but that effects were mediated by insulin
resistance. In a large case-control study, patients prescribed oral glucocorticoids were 
found to be at an increased risk of CAD and heart failure (Souverein et al., 2004).
6.5 Strengths and limitations
A particular strength of this study is that patients were investigated prior to a
definitive diagnosis of current CAD. Thus, the CAD and non-CAD groups were both in
the same clinical situation, and knowledge of illness could not influence either
depression ratings or cortisol. The study therefore included a comparison group of
patients without CAD, unlike most studies of depression and cortisol in relation to
cardiovascular disease (Otte et al., 2004, Whitehead et al., 2007). The delineation
between the two groups was based on whether they had current CAD of a sufficient
severity to cause chest pain. Some patients may have had a previous history of CHD but
a normal coronary angiogram, and would not then be placed in the CAD positive group.
It should also be noted that the non-CAD group not only had chest pain, but also positive
exercise and/or myocardial perfusion scans. These participants were therefore distinct
from the group of patients who present with chest pain of non-cardiac origin but no other
positive objective test results, among whom psychiatric problems are relatively common
(Bass & Mayou, 2002). We do not know whether mild atheroma or other factors such as
gastro-oesophageal disease or chest wall syndromes accounted for the positive objective
test results (Fruergaard et al., 1996), since it was not feasible to follow the non-CAD
group further to establish a definitive diagnosis of the causes of their chest pain. It is
probable, however, that these factors would serve to reduce the differences between
CAD and non-CAD groups, so the presence of distinctive cortisol patterns is even more
striking. It should also be noted that the levels of depressed mood were comparable with
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those found in other investigations of patients with CAD (Otte et al., 2004; Vaccarino et 
al., 2007).
The study also has a number of limitations. The sample size was relatively small, 
and patients could not be assessed in the absence of medication. Cortisol was recorded 
over a single day, and repeated measures are likely to generate findings that are more 
robust. Compliance with the sampling times was assessed by self-report and it was not 
possible to assess the reliability of these reports objectively.
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Chapter 7: Transient myocardial ischaemia and ventricular
tachycardia
7.1 Introduction
The ECG records were analysed by Hertford Medical for episodes of ST segment 
depression and ventricular tachycardia (VT). ST depression was defined as horizontal or 
downsloping ST depression > 1mm or 1.5 mm upsloping below the isoelectric baseline, 
measured at 0.08 seconds after J point and persisting for at least 60 seconds. VT was 
defined as three or more beats in a row on an ECG that originated from the ventricle at a 
rate of more than 100 beats per minute.
Nine patients experienced one or more episodes of ST depression and five 
experienced VT (one had both ST depression and VT). The characteristics of these 
episodes are summarised in Tables 7.1 and 7.2.
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Table 7.1 Details of ST segment depression episodes
ID Sex Age CAD? Episode onset D uration Patient self- O bservations
(mins) repo rt of
chest pain
008 M 68 Y es 20 :0 8 , day  1 17 Y es
9 :00  d ay .2
08 :24 , d ay  2 6
0 8 :5 7 , day  2 8
030  M 55 N o  5:00 , day  2 23 N o  N o  D R M  before
ep isode  onset (asleep )
034 M 56 N o  0 6 :03 , day  2 3 Y es A sleep  du ring  episode,
no D R M
17:00 day 1 
21 :0 0  day 1 
09 :0 0  day 2
035 F 72 Y es 13:27, d ay  2 1 Y es D R M  data  lost
11:30 day 1
0 8 :22 , day  2 2 15:45 day 1
19:30 day 1
0 8 :30 , day  2 3
049  M 80 ' Y es 20 :0 4 , d ay  1 1 N o
0 8 :5 4 . day  2 15
09 :33 , day  2 3
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ID Sex Age CAD? Episode onset D uration P atient self- O bservations
(mins) repo rt of
chest pain
066 F 61 N o  0 8 :49 , day  2 2 Y es
14:15 d a y )
0 9 :13, day  2 24 15:30 day 1
16:00 day 1 
19:30 day 1 
2 1 :3 0  day 1 
0 5 :3 0  day 2 
0 6 :3 0  day 2 
0 7 :0 0  day 2 
0 8 :0 0  day 2
072 F 70 Y es 15:16. day  1 7 Y es EC G  data  lost
10:36, day  2 17
13:15 day 2
080  IF 52 Y es 15:33, d ay  1 3 N o
19:52, day  1
07 :41 , day  2
084 F 63 N o  08 :4 6 , day  2 6 N o
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Table 7.2 Details of ven tricu lar tachycard ia episodes
ID Sex Age CAD? Episode onset D uration Patient self- O bservations
(secs) repo rt of
chest pain
027 M 74 N o  19.53, d ay  1 2 N o
20 :5 2 , day I 2
028 M 58 N o  16:55, day  1 2 N o
059 M 55 N o  0 8 :4 5 , d ay  2 11 Y es
13:15 day  1 
13:05 day 2
072 F 72 Y es 01 :10 . day  2 2 Y es A sleep  du ring  ep isode
(no  D R M )
13:15 day  2
081 M 64 Y es 0 6 :44 , day  2 2 N o  A sleep  du ring  ep isode
(no  D R M )
It can be seen that three patients had a single episode of ST depression, two 
patients had two episodes, and the remaining four patients had three episodes. These 
episodes lasted from 1-17 minutes, and occurred at a range of times of day and night, 
with a high proportion on the morning of day 2(13/19 episodes). The VT episodes were 
all short, with the exception of one that lasted 22 minutes. Interestingly, although 7 
patients reported one or more episode of chest pain over the study period, only one of 
these (patient 008, episode 3) coincided with ST depression or VT. This indicates that
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the episodes of cardiac abnormality in this study were predominantly silent, without 
chest pain.
Three broad questions were addressed in these analyses:
1. Do patients who experience ST depression and / or VT differ from the remainder
in terms of socio-demographic characteristics, clinical factors, psychosocial 
variables, DRM mood, heart rate variability or cortisol profiles? These issues 
were addressed by between-subject comparisons of ST depression / VT patients 
and the remainder.
2. Are there characteristic changes in heart rate, heart rate variability or DRM mood
around the ST depression / VT episodes in patients who experience these cardiac 
problems? This question was investigated by studying the profiles of cardiac and 
mood changes around the time of each episode, in comparison with control 
periods in the 13 ST depression / VT patients.
3. Are there associations between mood and cardiac responses at the time of ST
depression / VT episodes? These issues were studied by correlating mood, heart 
rate and heart rate variability responses around the time of each episode.
7.2 Methods
The 13 ST depression / VT patients were compared with the remainder using x2 
tests for categorical variables and t-tests for continuous socio-demographic, clinical and 
psychosocial variables. The groups were also compared on the heart rate, DRM mood 
variables and cortisol measures detailed earlier, using analysis of variance and 
covariance. Analyses comparing the combined ST depression / VT group were followed 
by analyses of the ST depression group only.
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Investigation of the mood and cardiovascular responses surrounding each ST 
depression / VT episode was carried out, by identifying the minute of onset and offset of 
each episode. Five minute segments of DRM mood and heart rate variability measures 
were then computed for the onset segment, the three 5 minute segments preceding onset, 
the end segment, and the two 5 minute segments following the end of the episode. An 
example is shown in Table 7.3 of the first ST depression episode for patient 008, which 
started at 20:08 on day 1, and continued until 20:25.
Table 7.3 Timing of acute ST depression / VT episodes
Pre 3 Pre 2 Pre 1 Start End Post 1 Post 2
-15 -10 -5 +5 + 10
19:53 - 19:58 - 20:03 - 20:08 - 20:25- 20:30 - 20:35 -
19:58 20:03 20:08 20:13 20:30 20:35 20:40
This procedure made it possible to identify acute changes leading up to and 
following each episode. When the episode was > 5 min, the ‘end’ segment followed 
directly on from the ‘start’ segment.
It is possible that mood and / or heart rate variability could be altered throughout 
this 40-45 min period. The data over the period o f the episode was therefore compared 
with control periods. For DRM mood, we used the corresponding time points for the 
hour before and the hour after the ST depression / VT episode. So for the episode 
starting at 20:08, the periods centred on 19:08 and 21:08 were analysed, as detailed in 
Table 7.4.
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Table 7.4 Timing of control periods for acute ST depression / VT episodes
Control period 1
Pre 3 
-15
Pre 2 
- 1 0
Pre 1 
-5
Start End Post 1 
+5
Post 2 
+ 1 0
18:53 -  
18:58
18:58 -  
19:03
19:03 -  
19:08
19:08 -  
19:13
19:25-
19:30
19:30 -  
19:35
19:35 -  
19:40
Control period 2
Pre 3 
-15
Pre 2 
- 1 0
Pre 1 
-5
Start End Post 1
+5
Post 2 
+ 10
20:53 -  
20:58
20:58 -  
21:03
21:03 -  
21:08
21:08 -  
21:13
21:25-
21:30
21:30 -  
21:35
21:35 -  
21:40
These two control periods were then averaged to generate an aggregate control 
mood profile to compare with the ST depression / VT period. In the analyses of heart 
rate and heart rate variability, only the control period 1 was assessed. The reason for this 
is because many ST depression / VT episodes took place towards the end of the 24 hour 
monitoring period, so there were too many cases from control period 2  which were 
missing data and therefore could not be analysed.
7.3 Comparison of ST depression / VT patients and the remaining participants 
in relation to general characteristics, mood, HRV measures and cortisol profile
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7.3.1 Comparison of ST depression / VT patients and the remaining participants 
with relation to socio-demographic, clinical, psychological and quality of life 
characteristics of participants with ECG changes and the remainder
Comparing the socio-demographic variables between the participants who had 
ECG abnormalities of ST depression and VT, and those who had no changes, revealed 
no significant differences between the two groups in relation to gender, age, ethnicity, 
education or marital status (see Table 7.5). Additionally, there were no significant 
differences between the two groups in terms of clinical risk factors of hypertension, 
diabetes or smoking status. When comparing the groups on medication, the main 
significant effect was the differences in beta blocker use (p = 0.03). A greater percentage 
of the participants (72.0%) who had normal ECG’s were on beta blocker medication than 
those who displayed an abnormal ECG response (38.5%). Given that beta blocker 
medication is anti-arrhythmic, increases parasympathetic drive, and reduces heart rate, 
this is an unsurprising result.
Another significant difference between the two groups (p = 0.02) was related to 
sleep quality. Of those who had an abnormal ECG, only 33.3% had good sleep quality, 
compared to 68.9% participants who had a normal ECG. On the physiological side, the 
differences in cortisol are quite striking and these have been described in section 7.3.4.
Results from the SF36 suggest that participants with ECG abnormalities have 
significantly greater impairment to certain aspects of their quality of life. Participants 
with ECG abnormalities had significantly lower SF36 scores in the following 
dimensions: limitations due to emotional problems, mental health and pain. Participants 
with ECG changes scored 65.3 ± 40.1 on limitations due to emotional problems versus
29.2 ± 37.5 in the remainder (p = 0.02). The group with ECG abnormalities also scored 
worse on the limitations due to mental health score (66.4 ± 20.7 versus 50.4 ± 19.3 in the
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normal ECG group, p = 0.03). Additionally, the group with ECG abnormalities scored 
significantly worse on the pain scale (60.6 ± 17.0 versus 74.4 ± 18.1 in the normal group; 
p = 0.03). Accordingly, in addition to poor mental health and quality of life, a trend was 
noted towards greater limitation in social functioning amongst the group with ECG 
changes approaching significance (79.0 ± 20.4 in the ECG changes group versus 64.8 ± 
24.5 in the remainder, p = 0.07). SF36 results are summarised in Table 7.6.
Table 7.5 Characteristics of patients with ST depression or VT on ECG
Normal ECG 
(n = 75)
ST depression and 
VT on ECG (n= 13)
Differences
(P)
G ender M en 52 (6 9 .3 % ) 8 (6 1 .5 % ) 0.75
W om en 23 (3 0 .7 % ) 5 (3 8 .5 % )
A ge (years) 61 .2  ± 9 .7 64.3 ± 9.4 0.36
Ethnicity W hite 55 (7 3 .3 % ) 8 (61 .5% ) 0.51
O ther 20  (2 6 .7 % ) 5 (38 .5% )
E ducationa l q u a lifica tions P rim ary 36 (4 8 .0 % ) 5 (38 .5% ) 0.56
S eco n d ary /ab o v e 39  (5 2 .0 % ) 8 (6 1 .5 % )
M arita l sta tus M arried 45 (6 0 .0 % ) 8 (6 1 .5 % ) 1 .0
N o t m arried 30 (4 0 .0 % ) 5 (38 .5% )
Sm oking  sta tus C urren t 20 (2 6 .7 % ) 1 (7 .7% ) 0.30
Ex / n o n -sm o k e r 55 (7 3 .3 % ) 1 2 (9 2 .3 % )
D iabetes Y es 11 (1 4 .9 % ) 3 (27 .3% ) 0.38
N o 63 (8 5 .1 % ) 8 (72 .7% )
H ypertension Y es 41 (54 .7% ) 6 (46 .2% ) 0.76
N o 34 (45 .3% ) 7 (5 3 .8 )
B eta B locker m edication Y es 54 (72 .0% ) 5 (38 .5% ) 0.03*
N o 21 (28 .0% ) 8 (6 1 .5 % )
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Normal ECG ST depression and Differences
3 II (St VT on ECG (n= 13)
(P)
Statin  m edication Y es 63 (84 .0% ) 9 (69 .2% ) 0.24
N o 12 (1 6 .0 % ) 4 (3 0 .8 % )
A spirin  m ed ication Yes 65 (8 7 .8 % ) 1 2 (9 2 .3 % ) 1 . 0
N o 9 (1 2 .2 % ) 1 (7 .7% )
B ase line  H A D  anxiety  score 6 .4 1 ± 3 .8 8 .0±3 .7 0.24
B aseline  B D I depression  
score
10.1 ± 7 .5 11.1 ±5 .6 0.73
M o derate /severe  depression  
(B D I score>  10)
Y es B D I > 1 0  
N o  B D I < 10
31 (4 2 .5 % ) 
42 (5 7 .5 % )
6 (4 6 .2 % ) 
5 (5 3 .8 % )
0.56
C A D P ositive 50 (6 6 .7 % ) 6 (4 6 .2 % ) 0 . 2 1
N eg a tiv e 25 (3 3 .3 % ) 7 (5 3 .8 % )
Sleep  quality G ood 51 (6 8 .9 % ) 4 (3 3 .3 % ) 0 .0 2 *
Poor 23 (3 1 .1 % ) 8 (6 6 .7 % )
* Significant difference, p <  0.05.
Table 7.6 Mental health and SF36 in patients with ST depression or VT on ECG
Normal ECG
(n =  75)
ST depression and 
on ECG (n= 13)
VT Differences 
(P)
BDI depression  score 10.2±7.5 11.115.65 0.73
H A D  anxiety  score 6 .4 ± 3 .8 8 .013 .7 0.24
Physical health  s ta tus score 63 .3121 .1 5 4 .6120 .5 0.24
M ental health  sta tus score 6 6 .4 1 2 0 .7 50 .4119 .3 0.03*
Physical function  score 6 8 .6 1 2 3 .6 61 .0 1 1 9 .4 0 .36
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Normal ECG
(n = 75)
S T  depression and V T  
on ECG (n= 13)
Differences
(P)
V itality 5 2 .2 ± 2 2 .1 48 .9 1 2 0 .3 0.67
Social function ing 7 9 .0 1 2 0 .4 6 4 .8 1 2 4 .5 0.07!
L im ita tions due to physical 
p rob lem s
5 2 .7 1 4 1 .0 3 4 .4 1 4 4 .2 0.24
L im ita tions due to  em otional 
p rob lem s
65 .3140 .1 2 9 .2 1 3 7 .5 0.02*
SF36 Pain scale 74 .4118 .1 6 0 .6 1 1 7 .0 0.03*
SF36 G eneral health  percep tion 6 0 .3 1 1 8 .9 57 .6121.1 0.7
SF36 M ental health  percep tion 6 8 .9 1 1 8 .6 5 7 .3 1 1 9 .4 0.08!
^Significant difference, p < 0.05. [Approaching significance.
7.3.2 Comparison of ST depression / VT patients and the remaining participants 
with relation to DRM mood
In addition to the DRM moods of happiness, negative affect, depression and 
tiredness that were included in chapter 5, I will also include, in this chapter, data on two 
additional moods; anger and worry. This is because I am particularly interested in 
discovering whether these specific moods can also be found in those participants who 
show ECG changes during the day. There is substantial literature relating hostility to 
atherosclerosis development (Barefoot et al., 1983). Anger has been shown to be a 
trigger of myocardial ischaemia (Steptoe et al., 2006; Culic et al., 2005). Worry, or 
anxiety, has also been shown to predict cardiac morbidity and mortality in susceptible 
patients (Kubzansky et al., 1998).
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In this chapter, I present mean values of affect ratings over the day, rather than 
over the broader categorisation of five time periods, as described in chapter 5. This is 
because in chapter 5 I looked at the general pattern of mood in relation to HRV, whereas 
in this chapter I use a more fine grained analysis of mood in relation to the ECG 
recording of the patient.
Table 7.7 compares mean values for the DRM affect measures in the two groups. 
In particular, it allows analysis of the mood at the specific time points surrounding the 
ischaemic periods. Although Table 7.7 suggests increased negative affect and depression 
scores in participants with ECG changes compared to the remainder, there were no 
statistically significant differences in affect ratings between the two groups.
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Table 7.7 Mean affect ratings across all episodes in day in relation to changes on ECG
Affect rating across all episodes N Mean SD p differences
Happiness
N o EC G  ch anges 75 3.25 1.0 0.67
ST  or V T 12 3.1 1.2
Negative affect
N o EC G  change 75 0 .87 0 .77 0.36
ST o r VT 12 1.1 0.77
Angry
N o  E C G  change 75 0 .36 0 .58 0.68
ST  or V T 12 0 .29 0 .57
Depression
N o  EC G  change 75 0.62 1.1 0.6
ST  o r V T 12 0.8 1.2
Worry
N o  EC G  ch ange 75 1.1 1.3 0.4
ST  o r V T 12 1.5 1.1
Tiredness
N o E C G  change 75 1.7 1.6 0.95
ST  o r V T 13 1.7 1.1
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7.3.3 Comparison of ST depression / VT patients and the remaining participants 
with relation to heart rate and other HRV indices
Table 7.8 summarises heart rate and HRV levels over five periods of the day 
(morning 1, afternoon, evening, night, and morning 2) in the two groups. There were no 
significant differences in any of the HRV indices between participants who experienced 
ST depression and/or VT, and the remainder, at any time of day.
The results in section 7.3 indicate that patients who experience ST depression 
and/or VT could not be distinguished from the remainder of participants in terms of 
mood or HRV over the study period. This suggests that if there are differences, they are 
more likely to be detected in finer grained analyses of the periods surrounding each 
episode of ischaemia or arrhythmia.
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Table 7.8 HRV time and frequency domain indices with relation to changes on ECG.
M o rn l N oon Eve N ight M orn2
m ean m ean m ean m ean m ean
(SD ) (SD ) (SD ) (SD ) (SD )
1BI (RR)
N o  E C G  ch anges 851.4 858 .2 878.1 1003.2 858.3
(128 .4) (1 3 2 .1 ) (142 .9 ) (158 .8) (142.5)
Both ST  or V T 825.2 804 .9 861.3 1005.6 826.4
(136 .1) (1 2 4 .5 ) (1 1 8 .1 ) (120 .6 ) (140 .0)
HF n
N o EC G  change 24.1 23 .9 26 .0 31.7 24.5
(10 .5) (9 .9 ) (11 .7 ) (14 .3 ) (9.8)
Both ST  or V T 23.56 25.5 28 .4 39.4 27.4
(10 .7 ) (9 .2 ) (9 .1 ) (16 .7) (9.0)
LFn
N o  E C G  change 67.8 6 7 .6 66.5 64.7 66.6
(14 .4) (1 3 .6 ) (14 .6 ) (15 .1) (14 .0)
B oth ST  or V T 66.7 64 .4 65.3 55.6 62.1
(1 E 4 ) (1 2 .7 ) (12 .9 ) (17 .1) (12 .6)
vLF n (log)
N o EC G  change 7.2 7.1 7.1 7.4 7.3
(0 .73 ) (0 .7 ) (0 .7) (0 .69) (0 .65)
B oth ST  or V T 7.3 7.1 7.0 7.4 7.2
(0 .82 ) (0 .69 ) (0 .8) (0 .69 ) (0 .65 )
NN = 5 m inu te  av erag e  N -N  in tervals. (R -R  in tervals)
H F  n = N o rm a lised  H igh  F req u en cy  (0 .15  to  0 .40  H z) in m s2
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LF = Normalised Low Frequency (0.04 to 0.15 Hz) in ms2
vLF.n.log = Log o f normalised very low frequency (0.03 to 0.15 Hz) in ms2
(SD) = Standard deviation o f mean value o f HRV indices.
7.3.4 Comparison of ST depression / VT patients and the remaining participants 
with relation to cortisol profile
Separate analyses were carried out on cortisol sampled over the day and the 
cortisol awakening response (CAR). As expected, cortisol levels were high early in the 
morning, and declined over the day. Patients experiencing ST depression / VT were 
compared with the remainder. In repeated measures of analysis of cortisol over the day 
and evening, there was a main effect of group (F = 5.74, p = 0.019). Cortisol levels were 
significantly lower in participants showing ST/VT changes than those with no such 
changes on the ECG (See Figure 7.1).
Figure 7.1 Mean salivary cortisol on waking (wake), 15 minutes (wake+15) and 30 
minutes (wake+30) after waking in patients showing ST/VT changes (red solid line) and 
patients showing no changes on ECG (solid blue line), unadjusted for age, gender, beta 
blockade and objective time of waking. Error bars are s.e.m.
Figure 7.1
Cortisol over the day
25
Wake W+15 W+30 10am 11:30am 4pm 7:30pm 11:30pm
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However, after adjustment for beta blocker medication, gender and bed time this 
difference was no longer quite significant (F = 3.7, p = 0.058). When analysing cortisol 
over the day with participants who had ST depression only, a similar pattern was found 
with a main effect of group (F = 7.02, p = 0.01). But once again, after adjustment for the 
same covariates, this difference was no longer significant (F = 3.75, p = 0.056).
With regard to cortisol slope, there were no significant associations found in 
relation to participants showing either ST/VT changes on ECG ( F = 0.12, p = 0.73) or 
ST depression only on ECG ( F = 1.61, p = 0.21), and those with no ECG changes after 
adjustment for the same covariates.
However, the most interesting result is the CAR effect, which is significant after 
controlling for covariates, both using CAR area under the curve increase and the increase 
between waking and 30 minutes.
The difference in CAR between the participants showing ST depression on ECG 
and those with no changes on ECG were analysed in two ways. One way is to analyse 
the difference between the 30 minute cortisol mean values after waking and the initial 
cortisol mean value on waking. The second way is to analyse the difference between the 
area under the curve increase between the two groups of participants, which is more 
accurate as it takes into account an increased number of cortisol values at specific time 
points.
There was no difference in mean waking values between those participants with 
ECG changes and those with no changes. However, when considering the CAR, there 
was a significant difference between the groups after adjustment for covariates, including 
beta blocker medication, gender, and wake time. Patients with ECG changes had 
significantly lower CAR’s, whether analysed using changes between waking and 30
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minutes (F = 4.09, p = 0.047), or analysed by area under curve increase (AUC) (F= 
3.996, p = 0.05).
7.4 The acute changes in mood and HRV within the participants showing ECG 
abnormalities
This section presents the data on the acute responses within the ECG abnormality 
group. The analyses of the acute mood change surrounding the ischaemic episode is first 
described, followed by the analyses of the acute heart rate and HRV changes surrounding 
ischaemic episodes.
The analyses of acute mood changes (section 7.4.1) and heart rate variability 
responses (section 7.4.2) were carried out as follows. First, a repeated measures analysis 
of variance was carried out for the 7 segments o f the ischaemic / arrhythmic period. This 
showed whether there were systematic changes in mood or HRV, in the minutes before 
and after each episode of ST depression / VT. Second, repeated measures analysis was 
performed with period (ischaemia or control) and segment (the 7 within-period 
segments) as within-subject factors. Finally, analysis of covariance was carried out to 
compare specific segments, with gender and use of beta blockers as covariates.
The DRM analyses were carried out with 9 of the 13 patients ( 6  ST depressions / 
3 VT). For three patients, episodes of cardiac abnormalities on the ECG occurred when 
the individual was asleep, and one DRM dataset was lost.
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7.4.1 Mood changes preceding and following ST depression / VT episodes
In the analyses of acute mood changes, significant results were found in relation 
to moods of happiness and worry, and ischaemic/arrhythmic episodes of the participants.
Happiness: There was near significant cubic effect in analysis of the ischaemic period, 
(F (1,8) = 4.57, p = 0.065), together with a significant cubic period by segment 
interaction, (F (1,8) = 6.24, p = 0.037) (see Figure.7.2).
Figure 7.2
Happiness ratings
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As can be seen in Figure 7.2, positive affect was relatively low in the 15 minutes 
before onset of the ischaemic or arrhythmic episode, and rose after the episode started. 
In post hoc tests, there were significant differences (after adjusting for gender and beta 
blocker use) between ischaemia and control periods for segment -15, segment -10, 
segment -5, and the episode start segment (all p < 0.05). However, there were no 
differences after the episode starts. These results suggest that happiness is lower in the
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15 minutes before onset of ST depression / VT episodes. This association between 
emotion and the cardiovascular response suggests a possible pathway linking emotion 
with triggering of cardiac events. It may be that the absence or a drop in positive affect 
(or conversely a greater negative affect) could be significant in triggering an acute 
ischaemic episode. However, it is feasible that the ischaemic episode itself may trigger a 
less positive affect or negative affect in the individual, particularly if accompanied by 
chest pain.
Worry: A main effect o f segment in the analysis of the ischaemic period (F (6,48) = 2.54, 
p = 0.032) was seen. In the analysis, including the ischaemic and control periods, the 
period by segment interaction was also significant (F (6,48) = 3.51, p = 0.006). As can 
be seen in Figure 7.3, results show a reverse of the pattern that was seen for happiness, 
with higher worry in the minutes before episode onset and less worry after the ischaemic 
period, similar in ratings to that of the control group. It may be the increase in negative 
emotion in the time period prior that may trigger the onset of an ischaemic episode. This 
suggests that negative emotions also plays a converse role of what was shown earlier 
with positive emotions, in that an increase in negative emotion is associated with the start 
of an ischaemic episode.
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Figure 7.3
Worry ratings
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Angry and depressed moods: Analysis revealed that there were no significant effects, 
although period by segment interaction approaching significance for depression (F (1,8) 
= 4.82, p = 0.059) was found, with greater depressed mood in the minutes before episode 
onset. The near significant association supports the limited literature, in that depressed 
mood can act as an acute trigger in ACS (Steptoe et al., 2006).
Tiredness: There were no significant changes or differences in ratings of tiredness in the 
period immediately surrounding episodes of ST depression / VT. There was neither a 
significant main effect of segment in the analysis of the ischaemic period, nor a 
significant period by segment interaction in the analysis, including the ischaemic and 
control periods.
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Combined mood: A combined mood measure was generated by adding together ratings 
of anger, depression, worry and tiredness and subtracting them from happiness. 
Measures that are more positive indicate more positive mood. With this combined 
measure, the period by segment interaction was significant (F (1,8) = 8.43, p = 0.020). 
In post hoc analyses, mood was more negative in the -10 and -5 segments preceding 
ischaemia than in the control segments (see Figure 7.4). Mood improved following the 
episode compared with the minutes before onset (significant difference between -5 and 
end and +5 min segments, p < 0.05).
Figure 7.4
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What is striking is the consistency seen in the magnitude of change in the various 
emotions prior to an ischaemic episode and after the ischaemic episode, compared to the 
control segments within each individual, and the converse patterns that has been seen for 
the positive emotion of happiness and negative emotion of worry.
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7.4.2 Heart rate and HRV changes preceding and following ST depression / VT 
episodes
Repeated measures analysis of variance was carried out for the 7 segments of the 
ischaemic/arrhythmic period, in order to discover whether there were systematic changes 
in the HRV indices (i.e. IB I, HFn, LFn, and VLF power) in the minutes before and after 
each episode of ST depression / VT. As for mood, repeated measures analysis was 
performed with period (ischaemia or control) and segment (the 7 within-period 
segments) as within-subject factors, followed by analysis of covariance which was 
carried out to compare specific segments, with gender and use of beta blockers as 
covariates.
Interbeat interval: The analysis of the ischaemia period shows a main significant effect 
of segment (F (6,72) = 5.41, p = 0.002). In post hoc comparisons, the IBI was reduced 
from 5 minute before the onset of the ischaemic episode, reaching its lowest value in the 
segment at the end of the episode (Figure 7.5). There is also a significant cubic period 
by segment interaction (F (6,72) = 3.58, p = 0.005) in the comparison of ischaemic and 
control periods. The differences between the ischaemic and control periods were 
significant for -10, -5, Start, End, + 5 and + 10 segments, after controlling for gender and 
beta blocker use.
In summary, Figure 7.5 demonstrates how the heart rate speeds up prior to the
ischaemic episode and then reduces in rate afterwards, promptly returning almost to
baseline levels. What is striking is that the increased heart rate does not occur over the
10-15 minutes before the episode (when mood was different), but much more acutely.
This makes it unlikely that the elevated heart rate is involved in triggering of the
episodes of ST depression / VT, unless this is a very short-term effect. Rather, it may be
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a compensatory mechanism of increased vagal tone produced after or with the ischaemic 
episode and hence a lowering of the heart rate, in order to limit the extent of the 
ischaemic episode occurring.
LFn power: The analysis of the ischaemia period shows a main significant effect of 
segment (F (6,72) = 3.25, p = 0.017) and a cubic period by segment interaction (F (1,12) 
= 10.39, p = 0.007) in the comparison of ischaemic and control periods. In post hoc 
analysis controlling for gender and beta blocker use, the only difference was in the start 
segment, where LFn abruptly decreases (Figure 7.6).
Figure 7.5
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Figure 7.6
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The sharp reduction of LFn power seen in Figure 7.6 here only at the start of the 
ischaemic period, indicates a reduced sympathetic drive or conversely an increased 
parasympathetic drive, which may be a compensatory response to limit the extent of 
ischaemia / arrhythmia. This sharp reduction in LFn at the onset of ischaemia and hence 
overall dominance of parasympathetic drive or vagal tone may be a pathway in adapting 
and limiting the extent of ischaemia occurring during everyday life in susceptible cardiac 
patients. However, when analysing the effect of other HRV indices no significant effects 
were found with either HFn power or VLF power.
So this study did demonstrate significant changes in HRV in the minutes before 
onset of ST depression / VT, despite the small number of patients contributing to these 
effects. Results were the same when analysis was limited to ST depression cases alone. 
These findings are not consistent with some other literature on HRV and the relationship
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with transient myocardial ischaemia as discussed in chapter 2.5. These results and their 
implications will be further discussed in section 7.6 and Chapter 11.
7.5 Associations between cardiac and mood responses preceding and following 
ST depression / VT episodes
I tested whether mood state before the onset of ST depression / VT predicted the 
magnitude of autonomic response during the episode. Since mood was relatively stable 
in the 15 minutes before episode onset, the three 5 minute segments were averaged to 
generate a single value for each mood. These mood ratings were then correlated with the 
change in IBI and change in LFn power between 15 minutes pre-episode, and the 5 
minute segment in which the episode started.
The results of these correlations are shown in Table 7.9. The data indicate strong 
associations between mood and cardiac responses to the onset of ST depression / VT. 
Individuals with more positive combined moods showed smaller IBI reductions and 
decreases in LFn power (i.e. less sympathetic drive) than those with less positive moods. 
These effects were due to a combination of greater happiness and less depression and 
worry in the more positive individuals. The negative relationship between combined 
mood and IBI response remained significant after adjusting for gender, use of beta 
blockers, and IBI 15 minutes before the episode (r = 0.89 p = 0.007). The associations 
with worry and depressed mood also remained significant (p < 0.05). This indicates that 
the association was not due to beta blocker users having moods that are more positive 
and smaller IBI responses, or patients in a more positive mood having slower heart rates 
and smaller responses.
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Table 7.9 Correlations between mood and cardiac responses during ST 
depression / VT episodes
IBI difference
-15 min to episode onset R
LF n power difference
-15 min to episode onset 
R
Total mood q 9 4 * ** 0.73*
Happiness 0.84** 0 .6 6 *
Worry -0.83** -0.33
Anger -0.72* -0.60
Depression -0.78* -0.76*
* P  <  0.05; ** P  < 0.01; *** P  <  0.001
The relationship between combined mood and IBI response is illustrated in
Figure 7.7. It can be seen that patients with more positive mood in the 15 minutes before 
ST depression /VT episodes had smaller reductions in IBI when the episode started. A 
similar pattern was present for happiness in the 15 minutes before episode onset, as 
illustrated in Figure 7.8. Patients who were happier during this period showed smaller 
IBI responses.
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Figure 7.7
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7.6 Discussion
7.6.1 General
There were no significant differences between the group with ECG changes 
compared to the remainder with respect to socio-demographic and clinical variables. 
The two exceptions were for those on beta blocker medication and those who had good 
sleep quality. The patients were significantly more likely to be on beta blocker 
medication in the group with no ST or VT ECG changes. This finding from the SIS 
study is to be expected, as beta blocker medication blocks sympathetic drive and thus 
reducing the heart rate and depresses the myocardium. As a result, physicians often 
prescribe this medication to CAD patients to reduce the frequency of ischaemic episodes 
by altering the myocardial demand for oxygenated blood (Chierchia et al., 1990).
The second finding was of better sleep quality in the group with no ischaemic or 
arrhythmic ECG changes. Poor sleep quality has been associated with adverse cardiac 
prognosis, and the association is not explained by depression or standard coronary risk 
factors (Leineweber et al., 2003). However, it remains to be further elucidated whether it 
is the ischaemic changes that causes poor sleep quality or that poor sleep promotes 
cardiac ischaemia.
Regarding quality of life, overall the patients in the ST / VT group were 
significantly impaired with regards to mental health status, emotional health, and pain. 
Poorer mental health and increased limitations due to emotional problems associated 
with the group with ECG changes of ST depression / VT, supports the body of evidence 
relating mental stress and negative emotions to cardiovascular parameters (Sirois & 
Burg, 2003; Rozanski et al., 1999, 2006).
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7.6.2 DRM
Analysis of affect by the DRM in relation to the group with ECG changes, 
revealed that there were no significant differences between the two groups with respect 
to the different affects of happiness, anger, worry, and tiredness. There was a trend seen 
with results approaching statistical significance, in that the group with ST and / or VT 
changes had an increase in negative affect (p = 0.36) and depressed mood (p = 0.4). 
Whilst the trend seen supports, to an extent, findings from previous ambulatory studies in 
which negative emotions have been associated with ischaemia, e.g. anger; (Gabbay et al., 
1996; Ironson et al., 1992); tension, sadness (Gullette et al., 1997) and stress (Barry et 
al., 1988; Krantz et al., 1996), I did not detect any significant differences between the 
two groups regarding different types of negative affect or positive affect. It could be that 
the sample size was too small or the number of actual ECG ischaemic changes detected 
were too few for analysis in conjunction with affect. A substantial majority were on 
cardiac medication, which may attenuate any ischaemic event. Previous ambulatory 
studies assessed mood by periodic diary ratings in the monitoring period, not by the more 
continuous assessment which the DRM provides.
Specific emotions like worry have been associated with an increased risk of CAD 
(Kubzansky et al., 1997; Kawachi et al., 1995). However, changes or lack of changes of 
negative emotions associated with the ischaemic episodes seen in this study are not 
supported by findings in other studies. For example, Lampert et al. (2002) 
systematically evaluated whether emotional or physical stressors can trigger spontaneous 
ventricular arrhythmias. In this work, patients with implantable cardioverter- 
defibrillators (ICDs) were given diaries to record levels of defined mood states and 
physical activity, during 2 periods preceding spontaneously occurring ICD shocks (0 to 
15 minutes and 15 minutes to 2 hours) and during control periods 1 week later. In
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contrast to findings from this study, anger was independently associated with the pre 
shock period whereas worry was not associated. A limitation in our study is that during 
the 24 hour period of monitoring, there may be insufficient frequency or level of arousal 
in the various affects like anger or depressed mood to show strong effects.
There were significant results for happiness, a positive emotion. The affect rating 
just before the onset of the ischaamic episode is low but becomes higher just after the 
ischaemic episode starts. This is consistent with findings from the derived index, 
combined mood, in which a lower positive mood is seen just before the onset of the 
ischaemic episode and a higher positive mood just after the ischaemic episode started. 
These acute changes in mood occur within minutes, correlating with the transient 
myocardial ischaemic episode, again suggesting that the DRM provides a better tool in 
the assessment of affect on a moment to moment basis, in relation to cardiovascular 
reactivity. There has been little in the literature to date relating the momentary effects of 
positive emotions to favourable biological states. It may be that the rise in positive mood 
correlating with the ischaemic episode just after it has started, may act as a protective 
factor in limiting the extent of ischaemia.
7.6.3 HRV
There were no significant differences between the group with ECG changes and
the remainder in any of the HRV indices. But analysis of the specific indices just prior
to the onset of ischaemic episode, and just after, revealed significant differences in
relation to the interbeat interval and LFn. An increased heart rate just prior to the
ischaemic episode is seen followed by a reduction in heart rate afterwards, returning to
the baseline in minutes. In addition, a sharp reduction in LFn power (reduction in
sympathetic drive) is seen prior to the ischaemic episode with a more gradual return to
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the baseline. The HR is an index of myocardial oxygen supply. LFn represent the 
sympathetic / parasympathetic balance of the autonomic nervous system. The SIS study 
analysis of the HRV in relation to the acute ECG changes, revealed a reduced 
parasympathetic and an increased sympathetic drive, just after the ischaemic episode has 
started. An initial increase in HR prior to the episode and then a prompt decrease in HR 
is observed, just after the start of the ischaemic episode. This autonomic dysregulation 
can lower the threshold for myocardial ischemia and VT in patients with CAD and 
supports findings from the previous literature (Carney et al., 2002, Podrid et al., 1990). 
Many studies have found a higher heart rate at rest is a risk factor for sudden cardiac 
death in the general population, increases the risk of progression to atherosclerosis 
(Palatini et al., 1999) ventricular arrhythmia (Podrid et al., 1990) and ischaemia (Palatini 
et al., 1997).
It is possible that both the HR increase at the start of the episode and the 
reduction in LFn serve as a compensatory reflex mechanism to increase vagal tone in 
order to act as a ‘brake’ on the cardiovascular system in prevention of the ischaemic 
episode extending further into a full blown myocardial infarct.
7.6.4 The associations between DRM mood and HRV
The associations of increased positive (combined mood) with a reduction in IBI
interval and a reduced LFn at the start of the episode followed by a rise, is consistent
with the notion that positive emotion was associated with an increased HRV and
supports other studies in the literature. McCraty et al. (1995) shows that positive
emotional state is associated with an increase in medium frequency power in healthy
participants. Bacon et al. (2004) showed that higher levels of positive emotions to be
associated with an increase in low frequency power independent of age, posture and
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medication in CAD patients. However, previous studies have shown that mental stress 
reduced vagal control of the heart as evidenced by reduced HF in CAD patients 
(Grossman et al., 1996; Kop et al., 2001) and higher levels of negative emotions like 
anger, stress and sadness have been associated with decreases in high and low frequency 
power (Bacon et al., 2004). Depression has been shown, in particular, to relate to 
reduced levels of HF power (Carney et al., 2001) and other studies have shown that those 
with anxiety and depression are associated with 24 hour reduction in HF power (Gorman 
et al., 2000). Thayer et al. (1996) found worry to be associated with shorter IBI’s and 
lower high frequency power. In summary, there is an extensive literature on the 
associations of negative emotions with reduced HRV but less so on positive emotions 
and HRV. This may be because of reduced frequency of such positive emotions in CAD 
patients or that previous studies are unable to detect momentary cardiac changes with 
momentary changes in affect.
The advantage of our study is that the HRV changes surrounding with the acute 
ischaemic episode can be analysed in conjunction with the moment to moment.affect, 
allowing a more accurate assessment of emotions relation to transient autonomic tone.
7.6.5 Cortisol
The results suggest that patients with ST depression and / or VT on the ECG 
showed significantly lower levels of mean cortisol values and a significantly lower CAR 
compared to the group with normal ECG’s. There were no significant associations with 
cortisol slope.
The cortisol awakening response (CAR) is a reliable biological marker for 
assessing adrenocortical activity (Pruessner et al., 1997). In healthy adults, salivary free
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cortisol concentrations increase by between 50 and 60% in the first 30 minutes 
immediately post-awakening (approximate average increase of 9 nmol/1, range 4-15 
nmol/1). However, there are no agreed norms for the absolute concentrations, of free 
cortisol in saliva, either immediately post-awakening (range of 4.7-18.5 nmol/1) or 30 
minutes post-awakening (range of 8.6-21.9 nmol/1). Reasons for these discrepancies 
include confounding factors such as gender, age, awakening time, light and participant 
adherence (Clow et al., 2004). The CAR is under a distinct regulatory influence, 
different from the rest of the diurnal cortisol secretory cycle and studies have 
demonstrated an association between the CAR and psychosocial variables. Some studies 
have shown a larger CAR in depressed people (Pruessner et al., 2003) and low positive 
affect (Steptoe et al., 2005). On the other hand, smaller CAR’s have been seen in those 
with chronic fatigue syndrome (Roberts et al., 2004) and it remains unclear whether good 
health is consistently associated with larger or smaller awakening responses.
The SIS study results found a reduced CAR in those patients who exhibited 
ischaemic ECG changes. The these ischaemic changes may be speculated as an ECG 
marker of chronic cardiac stress or a type of fatigue similar to the findings by Roberts et 
al. (2004). The reduced CAR associated with the ECG changes in cardiac patients 
supports a potential pathway as to how TMI may be induced in everyday life in response 
to mood. The findings from the SIS study of lower mean cortisol values throughout the 
24 hours contradict findings from studies that have shown positive associations between 
higher mean values of cortisol values and increased CAD risk (Bain et al., 1989; Troxler 
et al., 1977, Von Kanel et al., 2007). The fact that mean cortisol levels were lower in the 
group with ECG abnormalities may be related to other factors unmeasured such as IL-6 , 
a pro inflammatory circulating cytokine as in the study by Fantidis et al. (2002), as a 
mediator to cause CAD in the long term in the group with ischaemic or arrhythmic 
changes on ECG.
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From both this chapter and the previous chapter, the SIS study found HRV to be 
related to ischaemic episodes and mood, whilst the cortisol slope was flatter in the 
depressed CAD patients as well as showing an exaggerated CAR in the total CAD 
patients group, independent of depression. Also, a reduced CAR was seen in the group 
exhibiting ECG changes. This association between changes in both HRV and cortisol 
profile in relation to ischaemia and changes in affect is supported by previous stress 
findings indicating HRV and cortisol differences such as in the study by Taylor et al. 
(2006). However, Ansgar et al. (2007) investigated temporal variation in HRV, cortisol 
and mood across the day and focused on differences between depressed and non­
depressed individuals at risk o f CAD (increased number of cardiac risk factors). 
Participants recruited completed PANAS questionnaires at baseline and during 
laboratory stress tests as well as completing mood questionnaires at prompted times. 
They underwent ECG ambulatory monitoring, wearing an accelerometer to account for 
physical activity and provide cortisol samples. In contrast to the SIS study, the 
interesting finding in this study is firstly, the lack of HRV and cortisol differences 
between the depressed and the non-depressed at risk patients in daily life. Secondly, 
high levels of negative emotions are related to HRV in the non-depressed and not the 
depressed individuals, and there was no indication of hypercortisolaemia in the 
depressed sample as in previous studies (Maes et al., 1994; Keller et al., 2006; Stewart et 
al., 2005). The evidence is mixed with findings from the SIS study supporting some 
studies but not others.
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7.7 Summary
To answer the questions posed at the beginning of the chapter, patients who 
experience ST/VT do differ from those with normal ECG’s but only slightly. There are 
characteristic changes in the DRM affect, HR and HRV surrounding the ischaemic 
episodes and there are definite associations between mood and cardiac responses.
Overall, patients who experienced ST depression or VT on ECG slightly differed 
from those with normal ECG’s with respect to beta blocker medication and sleep quality 
only . Otherwise, the two groups did not differ with respect to socio-demographic 
factors or clinical factors. There were differences between the two groups on the quality 
of life, particularly relating to mental health and emotional issues. An altered cortisol 
profile was seen in the group with ECG changes in that they had a significantly lower 
CAR and lower mean cortisol values throughout the period of monitoring but this was 
not the case for the other biological markers assessed. In general, there were no 
significant differences between the two groups as a whole in relation to affect as assessed 
by the DRM or HRV.
However, when the actual ST or VT episodes were examined in more detail, 
particularly in the time period before the onset and after the episode started, there were 
characteristic changes seen in DRM affect, HR and HRV with significant differences 
emerging with respect to these particular biological markers and the ischaemic episode.
With regards to affect, as measured by the DRM, both happiness and worry were 
significantly associated with the ischaemic episodes and was a converse picture of each 
other. There were no significant differences seen with other negative emotions such as 
depression, anger and tiredness. This contradicts the extensive literature on negative
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emotions and its’ associations with CAD, particularly depression (Strike & Steptoe, 
2002).
Of the HRV indices, HR and LFn both changed significantly with the ischaemic 
episode, consistent with an increased parasympathetic drive, increased vagal tone and 
reduced sympathetic drive just after the ischaemic episodes starts.
Finally, positive associations between increased combined (more positive) mood 
and cardiac responses (reduced IBI and LFn) surrounding the episode were seen and 
could represent a compensatory mechanism to limit ischaemia and provide a possible 
explanatory link as to how mood and emotion may influence CAD development.
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Chapter 8: 6 month SIS data analyses
8.1 Introduction
The SIS study examined psychosocial factors influencing cardiac or 
neuroendocrine changes acutely in relation to mood in daily life. All patients recruited 
were those who had experienced symptoms, had undergone cardiac investigations, and 
were awaiting a definitive diagnosis to confirm CAD by angiography. At 6  months, the 
majority had undergone the hospital procedure and were either reassured, advised 
medical management, or underwent a surgical procedure; namely percutaneous coronary 
intervention (PCI) or coronary artery by pass graft (CABG).
There is an extensive literature to suggest that both emotional factors like 
depression and anxiety may influence prognosis with CAD in cardiac patients (Strik et 
al., 2003; Wiklund et al., 1989; Brown et al., 1999). Additionally, a variety of clinical 
factors including methods of management or severity of disease e.g. heart failure, angina 
are also related to CAD prognosis (Heller et al., 1997). In patients who have 
experienced an actual MI, it is noted that a high degree of emotional distress may occur 
in the hospital setting (Cay et al., 1972) and in the few months following diagnosis 
(Wiklund et al., 1984). This may have an impact on the patients’ quality of life (QOL) at 
a later stage in terms of mental and physical health adaptation. Indeed, quality of life in 
patients following an MI is predicted by a variety of emotional (anxiety, depression) and 
clinical factors at hospitalisation (congestive heart failure) with adverse outcomes 
(Frasure-Smith et al., 1991; Heller et al., 1997).
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In the SIS study follow up at 6  months, patients had not recently experienced an 
MI but had newly been given a diagnosis of CAD disease or not. The diagnosis of 
cardiac disease may affect the patients psychologically. Patient’s perceptions of cardiac 
disease and their beliefs are known to influence psychological and clinical outcomes 
(Petrie et al., 1996; 2002). However, to date, much of the literature on psychosocial 
factors and prognosis of CAD focuses on patients’ who have actually suffered an acute 
MI with accompanying aggressive management in hospital, not at an earlier stage of 
disease, as in the SIS follow up. Disease in the coronary arteries for some participants 
had probably been identified at an early enough stage that they were able to help avoid 
an acute MI. Armed with this knowledge at 6  months after the initial study, patients may 
have had the potential to reduce the risk of cardiac events by modifying known cardiac 
risk factors and take measures to reduce emotional stresses and strains and hence 
significantly improve quality of life. On the other hand, knowledge of heart disease may 
provoke anxiety, depression and worry which could influence emotional and physical 
adaptation in the long term. Psychosocial factors influencing the psychological and 
physical outcomes and QOL of such a group of patients at an early stage of CAD 
development has been little addressed so far.
The main issues that will be investigated in this chapter are the following:
1. Does psychological distress (anxiety/depression) and health-related 
quality of life improve over the 6  months following investigation and hospital 
management? Do these changes vary with diagnosis (definite CAD or not) and with 
method of management (PCI, reassurance only, or medical management)?
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2. What factors assessed at time 1 (including HRV, cortisol and mood 
measures) predict clinical outcomes (readmission, recurrence of symptoms), 
psychological distress, and QOL at 6  months?
8.2 Method
Clinical follow up was carried out on all participants at 6  months, after the initial 
study was carried out. 8 8  participants of the SIS study were all individually contacted by 
telephone and a brief 15 minute structured clinical interview was carried out between the 
investigator and participant. This enquired about general health, cardiac symptom 
recurrence, re-admission to hospital, changes in health behaviour (with respect to diet, 
exercise, weight, stress, smoking and alcohol consumption) and medication adherence. 
The interview was recorded on paper records and the anonymised data were then 
inputted into an SPSS file for further analysis.
In addition to the telephone interview, a questionnaire consisting of a compilation 
of standard psychometric instruments designed to assess different aspects of emotional 
experience and well-being, together with measures of health behaviours was sent to the 
participant to post back in a self-addressed envelope.
Similar to the baseline questionnaire used, the measures used in the 6  month 
questionnaire were:
i) Illness Attributions Questionnaire
ii) Hospital Anxiety Scale (HADS anxiety)
iii) Medical Outcome Short Form 36 (SF36)
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iv) Life orientation test (LOT), a measure of optimism
v) Beck Depression Inventory (BDI)
In addition to the psychosocial measures outlined here that were included in both the 
baseline and the six month questionnaire, the following four other additional 
measurements were used in the six month follow up questionnaire:
i) Social network
ii) Social support
iii) Cook and Medley Hostility scale
iv) Health locus of control
Details of the telephone interview, method of scoring and the postal questionnaire 
psychometric measurements used have already been described in Chapter 4 (Method of 
SIS study). At 6  months, all participants were sent the questionnaire along with an 
explanatory letter regardless if they had been contactable by telephone or not. After one 
week, all those who failed to complete and return the questionnaire were sent two further 
serial reminder letters each. Patients who were classified as non-responders were mostly 
those who were uncontactable due to having moved in the interim or having gone abroad 
for a significant part of the year. Three participants refused to take part in the follow up 
citing dissatisfaction with clinical treatment at the tertiary hospital caring for them. One 
participant passed away within the six month period following a cardiac procedure.
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8.3 Results
8.3.1 Description of the sample
70 of the 8 8  patients were interviewed at 6  months, and 6 6  completed the 
questionnaire measures. 77 (88.5%) patients completed either or both sets of 
questionnaire measures. The interval between the original study and the follow-up 
period averaged 29 weeks and 4 days (SD 45.1 days). A table of the characteristics of 
the participants obtained at the 6  month assessment is shown next (Table 8.1), according 
to demographic, clinical, health behaviours and emotional factors.
Table 8.1 Basic demographic and psychosocial characteristics of patient sample 
at 6 months
Characteristics at 6 months Frequency N Percentage %
Demographic factors
Gender: Male 51 66.2
Female 26 33.8
Marital Status: Married 31 40.3
Single/other 46 59.7
Ethnicity: Non White 20 26.0
White 57 74.0
Educational Attainment (Secondary and above) 40 51.9
Household income (<£20,000) 46 60.5
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Characteristics at 6 months Frequency IN Percentage %
Clinical Factors
CAD positive (definite CAD) 49 63.6
CAD negative (not significant CAD) 28 36.4
Personal history o f CAD (cardiac events, 14 18.2
treatment)
Previous MI 12 18.1
Diabetes 13 18.6
Angina symptoms present 35 45.5
Clinical management
Reassurance 10 14.7
Medical 30 44.1
PCI/Surgery 28 41.2
Health Behaviour
Smoker current 16 21.1
Emotional factors
History affective disorder 14 18.2
Depression level high (BDI score >10) 32 42.7
Anxiety level high (HADa score >8) 28 36.4
The average age of the sample at 6  months follow up was 62.3 years (ranging 
from 37 years, to 82 years; SD 9.1). The table highlights that the sample was 
predominantly male (66.2%) and white (74%), and over half the sample were not 
married (59.7%). This is interesting in light of the fact that social support plays an
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important role both in the development and prognosis of CAD. Better prognosis is found 
in those with greater social support, in terms of emotional or practical support, that may 
be provided by a spouse (Orth-Gomer & Udon, 1990) and the benefits seen are greater in 
men than in women (Orth-Gomer et al., 2000).
51.9% had achieved an educational level of secondary schooling and above, but 
almost two thirds of the sample (60.5%) had an annual household income of less than 
£20,000. This high percentage may reflect the large proportion that had retired, were on 
sick leave, or on benefits following unemployment due to chronic medical conditions, all 
of which occur more commonly in the older population sample. In the literature there 
are consistent relationships described between social class, socio-economic status, and 
CAD prognosis (Hemingway & Marmot, 1999).
Clinically, it is of note that of the sample with suspected CAD at the outset, 
almost half the sample (45.5%) experienced regular frequent angina symptoms at 6  
months after the initial study was carried out. Only under a fifth of the sample had 
established cardiac risk factors, such as diabetes or a previous history of CAD. After 
angiography was performed, 63.6% of the sample had definite CAD i.e. one or more 
coronary vessels demonstrating 50% or more stenosis, suggesting a small but significant 
proportion that has silent ischaemia in everyday life that may be undetected until 
angiography confirms vessel disease. Clinical management was divided almost equally 
between medication (44.1%) and an interventional procedure (41.2%). This may 
indicate that advances in sophistication of medical care allow the clinician to identify 
disease in the coronary arteries at an early enough stage to warrant conservative 
management and obviate the need for surgical intervention like PCI.
Despite only 18.2 % of the sample having a history of an affective disorder, 
42.7% of the participants scored highly (> 10) on the BDI scale at six months. In
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addition, 36.4% of the sample scored highly on the HADS scale at six months. The 
literature indicates that anxiety can independently predict CAD prognosis (Kubzansky et 
al., 1998; Lane et al., 2001).
8.3.2 Experience over the follow-up period
Readmission to hospital for cardiac problems and recurrence of symptoms was 
explored in this sample of patients at 6  months follow up. These data were collected 
during the telephone interview and so are available from 70 patients. Of these, 9 patients 
(12.9%) were readmitted, and 22 patients (31.4%) had recurrent symptoms. 28 patients 
(40%) had one or both.
Table 8.2 below compares patients with CAD and no CAD, and Table 8.3 
compares patients managed differently in the hospital following the result of the 
diagnostic coronary angiogram. These comparisons were made using repeated measures 
analysis of variance, with group as the between-person and time as the within-person 
variable.
The results of the analyses are interesting in that they highlight two main points. 
Firstly, there is no real change in psychological distress or quality of life over the 6  
months. On average, people report the same problems on follow-up. There were no 
significant effects of time or group by time interactions for any variable. Reassurance 
about their condition or surgical intervention appears to make little difference to 
emotional or physical adaptation over the next 6  months. Secondly, there is no 
difference in response depending on whether or not people had diagnosed CAD. One 
might have expected the non-CAD group to do better perhaps, after they had been 
reassured that they did not have heart disease. However, these participants do not show
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any greater improvement in distress, or any reduced risk of symptom recurrence. It may 
be that the numbers in the sample were too small to detect any significant differences in 
response. Alternatively, the follow up time may have been too short at six months. It 
would be beneficial to repeat the study at 12 months or at 5 years as in previous follow 
up studies on larger cohorts (Frasure-Smith et al., 1995; Lesperance et al., 2002).
Table 8.2 6 month changes in relation to CAD status
Group Baseline 6 months P group 
by time
effect
D epression C A D 9 .67  ± 6 .5 8.28  ±  8.0 0 .50
N o C A D 10.30 ±  8.6 9 .76  ± 9.1
A nxiety C A D 5.7 ± 3 .2 6 .0  ± 3 .5 0 .09
N o C A D 8.8 ± 4 .3 6 .9  ± 4 .3
P hysical h ealth  sta tus (SF 36) C A D 62 .4  ±  19.5 65.1 ± 2 1 .8 0.85
N o C A D 6 4 .4  ± 2 1 .6 6 8 .9  ± 2 1 .6
M ental health  sta tus (SF 36) C A D 6 6 .8  ± 2 0 .9 69.3 ± 2 1 .4 0.97
N o  C A D 6 8 .2  ±  19.2 70 .6  ±  18.3
R eadm ission C A D 6 (1 3 .6 % ) 0.80
N o  C A D 3 (1 1 .5 % )
Sym ptom  recu rrence C A D 15 (34 .1% ) 0.53
N o  C A D 7 (26 .9% )
R eadm ission  / recu rrence C A D 1 8 (4 0 .9 % ) 0.84
N o  C A D 1 0 (3 8 .5 % )
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As far as clinical management is concerned, it could be expected there would be 
some changes at 6  months follow up. It might be expected that there would be a 
difference in both the physical and emotional adaptation, between a patient who has 
undergone a prolonged hospital stay for a coronary artery by pass graft (CABG) 
operation versus a patient discharged on the same day with reassurance after a normal 
coronary angiogram. The differences relating to management are summed up in Table 
8.3.
Table 8.3 6 month changes in relation to clinical management
Group Baseline 6 months P group 
by time 
effect
D epression PCI 8.4 ±  5.6 6 .6  ± 3 .8 0.9
M edica tion 11.7 ±  8.3 10.4 ±  8.5
R eassu ran ce 12.4 ±  11.8 11.4 ±  13.8
A nxiety PCI 5.2  ±  3.1 5.5 ±  3.1 0.4
M edica tion 6 .4  ± 3 .0 6.3 ±  3.6
R eassu ran ce 10.0 ± 3 .4 8.8 ± 4 .7
Physical health  sta tus (SF 36) PCI 63.1 ± 2 0 .1 68.5 ± 2 9 .1 0.9
M edica tion 58.3 ± 16.0 62.5 ±  18.3
R eassu ran ce 66 .2  ± 3 0 .4 68 .8  ± 2 9 .1
M ental health  sta tus (SF 36) PC I 69 .8  ±  20 .7 7 3 .0  ± 2 0 .1 0.9
M ed ica tio n 61 .9  ±  19.0 65.3 ± 2 0 .1
R eassu ran ce 68.2  ± 19.1 68.8  ± 2 3 .4
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G roup Baseline 6 m onths P group 
by time 
effect
R eadm ission PCI 5 (1 8 .5 % ) 0.16
M ed ica tio n 3 (1 1 .1 % )
R eassu ran ce 0 (0% )
Sym ptom  recurrence PCI 11 (4 0 .7 % ) 0.13
M ed ica tio n 8 (2 9 .6 % )
R eassu ran ce 1 (1 2 .5 % )
R eadm ission  / recurrence PC I 13 (4 8 .1 % ) 0.10
M ed ica tio n 11 (4 0 .7 % )
R eassu ran ce 1 (1 2 .9 % )
The results were disappointing. The only difference in repeated measures
analysis of variance was in anxiety, where the main effect of group was significant (p =
0.008). This is not a trend over time, but a general difference between groups that was
present at both time points. It shows that the reassurance group had higher anxiety than
the others, and this persisted at 6  months. It may be that the more anxious or worried
people interpreted innocuous symptoms as life threatening chest pain and despite the
normal angiogram failed to be reassured due to fixed beliefs about their presumed ill
health (Cheng et al., 2003). The finding of the group with no significant CAD having
higher anxiety at both time points is not surprising. Several studies have found that
anxiety, depression and bodily concerns e.g. chest pain correlate with global frequency
or intensity ratings of angina (Young et al., 1980, Costa et al., 1985; Carney et al., 1992).
Studies have shown that patients with a tendency to anxiety, depression, and general
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neuroticism are more likely to complain of chest pains, convince the clinician to carry 
out angiography and this may explain why often, eventually no significant CAD is found 
(Carney et al., 1991).
Aside from this, there were no group or group by time interactions. It is, 
however, interesting that none of the patients that were managed by reassurance only 
were readmitted and only one patient in this group had any symptom recurrence. 
Unfortunately, the difference was not significant, due to small numbers. But 
presumably, this reflects the fact that clinicians were correct in their final diagnosis 
following angiography and appropriately gave this particular group of people 
reassurance in that they are at low risk for future problems.
8.3.3 Predictors of recurrence of symptoms and hospitalisation
The question investigated in this section here was whether factors measured at 
the time of the study predicted hospitalisation or the recurrence of symptoms over the 6  
month follow up period. The analysis involved 3 stages:
a) testing the bivariate association (e.g. the association between beta blocker use and 
symptom recurrence)
b) testing the significant associations after controlling for age and gender
c) putting all the significant effects from stage b) into a multivariate analysis, to see 
whether they are independent of each other. The possible predictors included 
demographic and clinical factors, baseline quality of life and HRV measures. The 
findings are shown in Table 8.4.
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Table 8.4 Predictors of symptom recurrence and readmission
Factor N (% ) or mean 
with recurrent 
sym ptom s
P Odds ratio (O.R) 
adjusted for age and 
gender (95% C.I.)
P
Symptom
recurrence
Marital status Married 9/42 (21.4%) 0.037* 1
Unmarried 13/28 (46.4%) 3.45 (1.05 -  11.3) 0.041 ♦
Physical health 
status (SF36)
No symptoms 
Symptoms
67.5 (18.9) 
52.3 (19.0)
0.003 ♦ 1
0.97 (0.94 -  0.99) 0.016*
History o f  
depression
No
Yes
15/58 (25.9%) 
7/12(58.3% )
0.04* 1
3.0 (0 .7 7 -  12.02) 0.11
Beta blocker use Yes 10/20 (50.0%) 0.05 1
No 12/50 (24.0%) 0.43 (0 .1 4 -  1.38) 0.16
Readmission
History o f CAD No
Yes
5/58 (8.6%) 
4/12(33.3% )
0.04* 1
1 2 .9 (1 .8 3 -9 1 .4 )
0.01*
Physical health 
status
No admission 
Readmission
6 4 .7 (19 .7 )
4 9 .0 (18 .2 )
0.027* 1
0.97 (0 .9 3 -1 .0 )
0.071
NN day mean No admission 
Readmission
890.8 (119.2) 
722.0 (88.6)
<0.001* 1
0.98 (0 .9 7 -0 .9 9 )
0.002*
NN night mean No admission 
Readmission
1030.6(142.7) 
825.2 (104.1)
<0.001* 1
10.99 (0 .9 8 -1 .0 )
0.003*
RMSSD day 
mean
No admission 
Readmission
23.6 (9.4) 
13.8 (4.4)
0.005* 1
0.78 (0 .6 4 -0 .9 4 )
0.011*
RMSSD night No admission 31.4 (15.2) 0.04* 1 0.022*
Mean Readmission 19.6 (6.3) 0.87 (0 .7 7 -0 .9 8 )
+ Additional adjustment for beta blockade ♦Significant difference, p < 0.05.
Sym ptom  recurrence: The results show  that sym ptom  recurrence at 6 m onths fo llow  up
was predicted by marital status and physical health status at baseline. Patients w ho were
married and had good physical health status at baseline w ere less likely to have a
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recurrence of symptoms after multivariate analysis. 40.9 % patients with recurrence of 
symptoms were married compared to 59.1% of those who were not married (%2 = 4.9, p = 
0.03). After regression analysis in which age and gender were included, marital status 
was found to be predictive of symptoms recurrence (Odds Ratio (O.R) 3.45; C.l 1.1 -
11.3; p = 0.04). This once more supports the findings of how social support in terms of 
having a spouse (Chandra et al., 1983; Coyne et al., 2001), or a close confidant (Dickens 
et al., 2004), is associated with a beneficial outcome post MI. In terms of physical 
health, those who experienced a recurrence of symptoms scored significantly lower on 
the SF36 combined physical health status at baseline, with a mean of 52.3 ± 19.0 SD in 
this group versus 67.5 ± 19.0 SD in the group who were symptom free at 6  months (p = 
0.003). Symptom recurrence was also more common in patients who were not taking 
beta blockers and had a history of depression, but these effects were not significant once 
age and gender were taken into account. In the multivariate analysis, the only factor that 
remained significant after adjustment for age and gender, marital status, history of 
depression and beta blocker medication, was the SF36 physical health status measure 
(O.R 0.96, C.l 0.93 -  0.995; p = 0.03).
Readmission: Readmission was associated with a prior history of CAD (previous cardiac 
events or treatment), with physical health status on the SF36 (though not after adjustment 
for age and gender), and most interestingly with significantly higher heart rates. The 
mean normal to normal (NN) interval was significantly shorter both in the day and at 
night in patients who were readmitted, and these effects remained significant after 
adjustment for age, gender and beta blockade. In addition patients who were readmitted 
at 6  months were more likely to show a significantly reduced HRV (RMSSD) both in the 
day and at night.
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The findings from the SIS study, in which reduced HRV and higher HR predicted 
readmission for further cardiac events (after adjustment for relevant covariates), supports 
earlier findings relating reduced HRV and long term cardiac mortality in cardiac patients 
(Carney et al., 1995; Stein et al., 1999). One potential reason for readmission may be 
that the higher HR and the reduction in HRV correlated with an increased sympathetic or 
decreased vagal input, which may predispose the patient to cardiac arrhythmias or 
ischaemia necessitating hospital readmission.
8.3.4 Predictors of quality of life and emotional state at 6 months
The measures used in these analyses are the physical health status measure from 
the SF36, BDI depression and HAD anxiety. For these measures, we have the baseline 
assessment as well, so the question is what other factors predict 6  month levels 
independently of baseline levels.
Physical health status (SF36): Changes in physical health were not predicted by any of 
the demographic variables. There was however, a significant interaction between time 
and the presence of non-cardiovascular health problems (p = 0.02). The results are 
shown in Table 8.5 and Figure 8.1. These illustrate that people with non-cardiac health 
problems did not show any improvement in physical health status over the follow-up 
period, while those with no other health problems did show an improvement. This effect 
remained significant in linear regression on 6  month physical health status scores, with 
age, gender and baseline score as covariates (p = 0.049). It would be expected that other 
co-morbidities such as obesity, osteoarthritis would affect the patient’s physical health 
status regardless of cardiac function.
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Table 8.5 Change of physical health status at 6 months
Other current health Mean SD p
problems
Physical health status Yes 65.2 21.9 0.02*
BASELINE
No 60.5 18.6
Physical health status 6 Yes 64.0 23.0
months
No 68.3 20.4
’"Significant difference, p < 0.05.
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Figure 8.1 Change in PHS score over 6 months in relation to other current 
health problems
PHS
70
68
66
64
62
60
58
56
PHS score with health
problems
PHS with no other
health problems
baseline 6months
6 months physical health status was also predicted by worry as assessed with the 
DRM (see Table 8.6). Patients who reported more worry during the sampling day had 
worse physical health status at 6 months, and this was independent of baseline physical 
health status, age, gender, CAD status, and readmission and recurrence in the 
multivariate analysis (t = -2.21; p = 0.032). This has not been shown before, and so the 
DRM appears to be providing unique data.
6 month physical health status was also predicted by the cortisol slope over the 
day. Participants with a steeper cortisol slope showed significantly greater 
improvements in physical health status (t = 2.75; p = 0.009) independently of baseline 
physical health status, age, gender, CAD status, BMI, smoking, symptom recurrence, and
284
readmission (Table 8.6). Variation in cortisol rhythms has been observed in some 
disease states and may be related to health outcomes.
Table 8.6 Determinants of physical health status at 6 months
Adjusted Odds Ratio 
(OR)
95%  C l P
Age 0.7 - 4 .1 -6 2 .6 0.5
Gender -.05 -1 2 .3 -8 .5 0.62
Worry -0.22 - 8 .8 -  -0.37 0.03*
Readmission at 6 
months
-0.11 -2 0 .3 -6 .3 0.3
Recurrence o f  
symptoms
-.03 - 1 1 .2 - 8 .7 0.8
Physical health status 
at baseline
0.55 0 .3 - 0 .8 4 <0.01*
Cortisol slope 0.3 © I o 4^ 0.09*
* Significant difference, p < 0.05.
Depression: Changes in depression were not predicted by any demographic variables. A 
history of depressive illness was predictive, but perhaps not in the way that might have 
been expected. People with a history of depression had higher BDI scores at baseline,
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coming down at 6 months. So history of depressive illness predicted improvement in 
BDI score rather than deterioration. A reason for the improved BDI score at 6 months 
may be because 85.3% of the sample of patients who had medication or a surgical 
intervention was reassured by the definite diagnosis and corrective treatment procedure. 
Alternatively, the remaining 14.7% of patients who had normal coronary angiograms 
were appropriately reassured of their disease free state in the follow up period which 
may account for the improved BDI level at 6 months. There was no relationship with the 
DRM after baseline depression was taken into account. Neither were there any 
significant relationships seen between changes in depression and the HRV indices, which 
is surprising given that much of the existing literature described a strong association 
between depression and altered autonomic control (Carney et al., 2000).
Anxiety'. Changes in anxiety were not predicted by any of the demographic variables and 
nor by any of the clinical or treatment variables. There were no significant relationships 
seen between changes in anxiety and the HRV indices. A reason for the lack of finding 
of an association between with anxiety and depression with any of the HRV indices may 
be due to the fact that these patients had not undergone a full blown cardiac event with 
subsequent damage to the myocardium and consequent electrical instability and altered 
HRV. A reason for the lack of finding of an association between with anxiety and 
depression with changes in physical health status, is again possibly due to the fact these 
patients had not had a full MI, or cardiac complications, with the attendant emotional 
aftermath of a significant cardiac event and reduced patient confidence in terms of 
physical capabilities. In addition, the sample size may have been too small to detect any 
differences in any of the variables tested. The BDI and HAD anxiety scales may not 
have been sensitive enough to detect mood changes in this population over a 6 month 
period.
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To summarise this section, the key findings were that physical health status at 6 
months was predicted by worry (p = 0.032), physical health status at baseline (p = <0.01) 
and cortisol slope over the day (p = 0.009), after adjustments for potential confounders.
8.4 Discussion of results
This section shall discuss the results relating mainly to the findings of the 
predictors of the clinical factors; namely symptom recurrence in patients and readmission 
in patients at 6 months, as well as discuss the findings pertinent to the predictors of 
quality of life and emotional state at 6 months.
The predictors of recurrence of symptoms and hospitalisation were physical 
health status measure and heart rate and HRV respectively after adjustments were made 
for confounders in multivariate analysis. With regards to symptom recurrence, in 
multivariate analysis physical health status measure was the only predictive factor after 
adjustment for age, gender, marital status, history o f depression and beta blockers. This 
could be due to the fact that those with poorer physical health status had more severe 
cardiac disease inadequately treated either with medication or interventional procedure 
and thus experienced more clinical symptoms at 6 months. This supports the finding that 
physical functioning has been shown to be affected the most in post MI patients at 3 
months (Failde et al., 2006) and 12 months (Van Jaarsveld et al,. 2001; Mendes de Leon 
et al., 1998).
With regards to readmission, reduced HRV and higher HR, but none of the socio­
demographic variables or psychological factors, predicted readmission. Other studies 
that have examined cardiac patients have shown altered HRV to be related to cardiac
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events. Reduction of HRV and higher heart rates have been shown to be a predictor of 
cardiac events in a wide spectrum of patients, ranging from post MI (Kleiger et al., 1987; 
Bigger et al., 1992) to unstable angina patients (Lanza et al., 2006) to those additionally 
with stable heart disease (Van Boven et al., 1998). In a large prospective multicentre 
trial study by Lanza et al. (2006), 543 patients with unstable angina and preserved left 
ventricular function (LVF), underwent 24 hour ECG holter monitoring within 24 hours 
of hospital admission. Amongst the tested variables were the time domain and frequency 
domain HRV variables. Primary end points were in hospital and six-month total and 
cardiac deaths. Results suggested that a low HRV, as detected on holter monitoring 
started within 24 hours after admission for unstable angina, are predictors of in-hospital 
and medium-term mortality in patients with unstable angina and preserved LV function. 
In our study, several of the HRV indices (NN, NNSD, LF, and LF/HF ratio) were 
significantly associated with readmission at six months. The association between a 
reduced HRV in several of the indices and higher heart rates in post MI patients have 
been further supported in a variety o f other studies. Kleiger et al. (1987), followed up 
808 post MI patients and found a relative risk of mortality being 5.3 times higher in the 
reduced HRV group even after adjusting for clinical, demographic factors and ejection 
fraction (EF). Bigger et al. (1992) followed up 715 patients post MI for four years and 
found that after adjustment for age, New York Heart Association functional class and EF 
the association between mortality and total power, ULF, and VLF remained significantly 
strong and LF and HF remained only moderately strongly associated with mortality.
Of the quality of life measures, physical health status at 6 months was predicted
by those who had other current health problems and worry as measured by the DRM.
People who are more worried or anxious over the DRM day may have a tendency to be
excessively fearful or cautious about resumption of physical activity or an increase of
physical activity following a new diagnosis of cardiac disease (Day et al., 2005; Petrie et
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al., 1998). This particular illness belief may partly explain the body of literature, which 
shows how anxiety has a unique contribution in predicting cardiac mortality and 
morbidity (Shen et al., 2008; Strik et al., 2003). Furze et al. (2005) carried out a 
prospective follow-up study over 1 year, of 133 people with angina, and found that 
patients with more misconceived or maladaptive beliefs were more anxious or worried 
and physically limited than were people with fewer such beliefs, with significant 
differences in physical functioning. It was a change in angina beliefs more so than actual 
change in angina frequency over 1 year that was the most significant predictor for 
physical functioning at follow-up, after controlling for the effects of demographic 
variables and the outcome variable at baseline. The DRM could be applied to such 
patients so that moods are easily and quickly identified using a relatively efficient 
method and could be potentially corrected by cognitive behavioural therapy within the 
context of a cardiac rehabilitation programme.
There were no significant associations with any of the HRV indices in the 
analysis of predictors of emotional adaptation and physical health at 6 months. This 
finding is a contradiction to a significant number of studies linking depression and other 
emotions to altered autonomic control (Carney et al., 2000, 2001; Kim et al., 2005, 
Kawachi et al., 1995, McCraty et al., 1995, Sloan et al., 1994; Rechlin et al., 1994). 
HRV would be expected to predict greater physical health status given that amounts of 
RR variability and slower fluctuations are significantly associated with physical activity 
(Bemardi et al., 1996). Exercise is known to benefit cardiac health by improving 
autonomic control. In the study by Rosenwinkel et al. (2001) exercise training has been 
shown to be associated with a relative enhancement of vagal tone, improved heart rate 
recovery after exercise, and reduced morbidity in patients with cardiovascular disease.
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A possible explanation for discrepancies between this study and established 
literature findings is that many of the studies in the existing literature focused on patients 
who already had a full blown coronary event and not simply just angina symptoms or 
accompanying positive cardiac investigations only.
Finally, 6 month physical health status was predicted by cortisol slope over the 
day. Studies have related cortisol slope to physical activity in healthy adults. Ice et al. 
(2005) carried out a study which examined factors associated with cortisol level and 
slope in healthy older adults. Forty-eight older adults (mean age 76.4 ± 5.8 SD years) 
were interviewed regarding health, stress, affect, and social networks. Participants 
collected saliva over a three day period while keeping a record of their emotions and 
activities. In multivariate models, affect was no longer significantly associated with 
cortisol as in univariate models, and amongst other factors, age (p < 0.001), physical 
activity (p = 0.017), and hours slept (p < 0.001) predicted cortisol slope. There is less 
established in the current literature relating cortisol slope as a predictor of physical health 
status in cardiac patients.
To conclude, to address the questions asked at the beginning of the chapter, it 
appears that psychological distress (anxiety and depression) changes little over the 6 
months following investigation and hospital management. There were no changes in 
emotional distress of the participants associated with the actual diagnosis (definite CAD 
or not). However, there were differences found relating to method of management (PCI, 
reassurance only, or medical management). As expected, none of the patients who were 
reassured were readmitted although, interestingly, it was this group that showed 
significantly higher anxiety scores than the others and this effect persisted at 6 months 
follow up.
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HR, HRV, cortisol slope and mood measures were amongst the factors assessed 
at time 1 (i.e. baseline) that predicted clinical outcomes (in terms of readmission and 
recurrence of symptoms), psychological distress, and quality of life, (physical health 
status) at 6 months.
Clinically, symptom recurrence at 6 months was more likely to be seen in those 
who were unmarried and in those with poorer physical health status on the SF36 
measurements, while readmission at 6 months was associated with a reduced HRV and a 
higher heart rate.
Of the quality of life measures, impaired physical health status at 6 months was 
predicted by physical health at baseline, worry as measured by the DRM, and patients 
who had a steeper cortisol slope. Interestingly there was a lack of association between 
the psychological measures of anxiety and depression over the 6 months and any of the 
HRV variables.
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Chapter 9: Long term adaptation to CAD
9.1 General overview
This chapter and chapter 10 describes two sets of findings from the ACCENT 
(Acute Coronary Syndrome, Emotion and Trigger) study which focuses on psychosocial 
factors influencing adaptation to established CAD. The ACCENT study involved 295 
ACS patients admitted to four London hospitals, recruited between 2001 -  2004 on the 
basis of standard symptomatic, electrocardiograph and biochemical (troponin T) criteria. 
Patients were excluded if they had co-morbid conditions that might influence mood, 
neuroendocrine function or cardiac enzymes. They underwent a structured interview on 
an average of 2.56 days after admission, in which exposure to possible triggers (physical 
exertion, smoking, sexual activity, cocaine, marijuana, anger, stress and depression) were 
assessed in the two hours prior to symptom onset, and in various control periods. The 
new statistical technique of case-crossover analysis developed for studying transient 
acute exposures was used.
Findings from the ACCENT study, concerning triggering of ACS, have been 
described in section Chapter 1.2. Briefly, some of the results from the data set in the 
study suggested that the relative risk of ACS onset is raised after physical exertion or 
anger in the hours before symptom onset compared with no physical activity or no anger 
respectively (Steptoe et al., 2006). The effects of triggering have been observed not only 
in acute MI but other types of ACS (Strike & Steptoe, 2005). Also observed was that 
episodes of acute depression are associated with increased risk (Steptoe et al., 2006). 
The relative risk of ACS after moderate or severe depression in the two hours before 
symptom onset compared with no depression was 4.94 (C.l. 3.03 to 7.57). This result is
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interesting in light of the evidence that depression is a risk factor for the long term 
development of CAD (Hemingway and Marmot, 1999), and that depression post MI is 
associated with increased morbidity and mortality (Van Melle, 2004).
The causal sequence linking acute depression with ACS onset is uncertain. 
Depression may increase risk of plaque disruption and subsequent thrombosis, but 
alternatively, negative mood may be because of inflammation.
Depression after an acute cardiac event may impair the rehabilitation processes 
post MI, and reduce the likelihood of returning to work (Soderman et al., 2003), which is 
a functional marker of adaptation. Depression also impairs physical and emotional 
adaptation to ACS in the long term leading to an overall reduced quality of life (Beck et 
al., 2001; W elinetal., 2000; Wiklund etal., 1989).
The SIS study (described in chapters 4-8) was carried out on patients with 
suspected cardiac disease who had not yet had a cardiac event like an MI or ACS. In 
contrast to the ACCENT study, psychosocial factors were examined that may influence 
or trigger cardiac ischaemia during everyday life hassles and strains, which may 
eventually over a period of time, lead to ACS in the long term via psychobiological 
processes. Other than the investigation of acute triggering just prior to an MI, the 
ACCENT study described in this chapter also allowed investigation of psychosocial 
factors affecting the long term adaptation to ACS. Patients were followed up both at one 
year and three years by both telephone interview and self-report questionnaire, to 
examine the influence of depression and other psychosocial factors on their long term 
clinical and psychological adaptation to the ACS event.
Whilst one set of findings from the ACCENT data set relate to aetiology of
possible triggers of ACS (which is not presented here), here I present analyses that relate
to prognosis after the ACS event, in particular, emotional and physical adaptation in the
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recovery phase after hospitalisation, and to see if any of these factors are associated with 
the initial trigger of the event. This may elucidate the casual direction of the linking 
pathway between depression and CAD, i e. does depression lead to physiological 
changes and behavioural changes to cause an increased risk of coronary events, or is the 
converse a possibility, i.e. does the acute coronary event itself lead to changes that cause 
depression and other emotional and physical symptomatology?
These analyses of the ACCENT study were carried out to answer two questions:
Firstly, what are the clinical and psychological factors that may determine return to work 
in these patients? It has been recently described in the literature that a proportion of 
ACS patients develop difficulties in long term adaptation in psychosocial functioning, 
with regards to return to work, specifically at 1 year post ACS. We evaluated the 
prevalence of return to work at one year in this set o f patients and investigated what the 
clinical and psychosocial predictors of return to work were, as an indicator of adaptation 
to ACS in the long term.
Secondly, can triggers of acute cardiac events predict the type of adaptation made 
by the patient in the long term? I have analysed how emotional and physical factors 
associated with the acute triggering of an ACS may relate to emotional and physical 
adaptation in the long term at one year and three year follow up, and specifically, 
whether the particular type of trigger (emotional or physical) could differentially predict 
the emotional and physical adaptation at three years.
Chapter 9 will begin with a description of the method of the ACCENT study 
followed by the results and conclusion from the one year follow up regarding return to 
work. Chapter 10 will describe the results and conclusion from both the one year and 
three year follow up regarding adaptation and quality of life after ACS.
294
9.2 Psychological and clinical predictors of return to work after acute coronary 
syndrome
9.2.1 Introduction
It has been estimated that some 90 million working days are lost annually within 
the European Union because of CAD morbidity (Leal et al., 2006). Returning to work 
after acute coronary events not only has economic benefits to the individual and 
community, but improves morale and the quality of life of patients and their families.
It is well established that returning to work is not a simple function of clinical 
status, but is influenced by demographic, social and psychological factors. Patients’ 
perceptions of their illness and disability appear to be important predictors (Petrie et al., 
1996; Mittag et al., 2001). Emotional responses such as depressed mood may also be 
significant, although results have been inconsistent (Petrie et al., 1996; Mittag et al., 
2001 ; Mayou, 1984). Much of the data relating psychological factors with return to 
work was collected in the 1970’s and 1980’s, when clinical management of acute 
coronary syndrome (ACS) was very different to the present day (Mayou, 1984; Cay et 
al., 1973; Maeland et al., 1987; Stem et al., 1977). Developments in the management of 
ACS including thrombolysis, revascularisation and early mobilisation have dramatically 
changed patients’ experience and expectations (Bertrand et al., 2002; Ryan et al., 1999), 
and it is not clear whether early emotional responses to ACS continue to be related to re­
employment in the modem era.
This analysis investigated predictors of failure to return to work, and specifically 
the role of the emotional responses such as depressed mood that are the focus of my 
thesis. The findings have recently been published (Bhattacharyya et al., 2007).
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9.2.2 Methods
Patients
The participants in this study were the 155 patients who were in paid employment 
at the time of ACS, out of a total of 295 patients admitted to four hospitals in the London 
area between 2001 and 2004, and recruited as part of an investigation of emotional and 
behavioural triggers of cardiac events (ACCENT study; Strike et al., 2006). They were 
selected on the following criteria: a diagnosis of ACS based on the presence of chest pain 
with verification by diagnostic electrocardiographic (ECG) changes (new ST elevation 
>0.2mV in 2 contiguous leads V1,V2,V3 and >0.1 mV in 2 contiguous other leads, ST 
depression >0.1 mV in 2 contiguous leads in the absence of QRS confounders, new left 
bundle branch block or dynamic T wave inversion in more than one lead) and / or 
cardiac enzyme changes (troponin T measurement >0.01 ug/1 or a creatine kinase 
measurement more than twice the upper range of normal for the measuring laboratory). 
Patients were aged from 18-90 years, were able to recall the time of onset of symptoms, 
and did not to have co-morbid conditions that might influence either symptom 
presentation, mood or troponin positivity (Ammann et al., 2004). Patients were excluded 
if they had severe psychiatric illness or cognitive decline impairing ability to complete 
measures, and if they could not speak English. The study was approved by the medical 
research ethics committees of University College Hospital, St George’s Hospital, 
Southend Hospital and Kingston Hospital, and all patients gave written consent.
Measures
Admission notes and ECG's were assessed by a cardiologist and scrutinized for
presentation as ST elevation myocardial infarction (STEMI), non-ST elevation
myocardial infarction (NSTEM1), or unstable angina (UA). The troponin T (8 6 % of
cases) and creatine kinase (79% of cases) levels measured during the admission and the
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presence of arrhythmia and heart failure were recorded. We computed composite risk 
scores based on the algorithm developed in the Global Registry of Acute Coronary 
Events (GRACE) study (Beck et al., 1988). This uses nine measures (age, history of 
congestive heart failure, history of MI, systolic blood pressure and heart rate on 
admission, ST segment depression on ECG, initial serum creatinine, elevated cardiac 
enzymes and no in-hospital percutaneous coronary intervention) to define risk of 6 - 
month post discharge death applicable to all types of ACS. Information was obtained 
from medical notes about cardiovascular disease history and medication pre-admission, 
and about the management of the ACS. Management strategies were classified as 
medical, percutaneous coronary intervention (PCI), or coronary artery bypass graft 
(CABG). Smoking, alcohol consumption, and physical activity were assessed using 
standard measures (Strike et al., 2006).
Patients were given a set of questionnaires while in hospital, and this was 
completed 7-10 days post-admission. Depressive symptoms were assessed using the 
Beck Depression Inventory, (Beck et al., 1988) a 21-item measure that has been widely 
used for the assessment of symptoms in cardiac patients. Each item is rated from 0-3, so 
total scores can range from 0-63, with higher values indicating greater depression. The 
internal consistency (Cronbach a) in this study was 0.88.
Socio-economic status (SES) was defined by two measures: educational 
attainment and a social deprivation index. The latter assessed access to resources based 
on four criteria: living in a crowded household (defined as one or more persons per 
room), renting as opposed to owning a home, not having use of a motor vehicle (car or 
van), and living on state benefits. Patients were classified as a low deprivation (negative 
on all items), medium deprivation (1 positive), and high deprivation ( 2 - 4  positive). 
Previous history of depression was measured as the use of antidepressant medication at
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the time of hospital admission, and by asking patients to estimate whether they had been 
moderately or severely depressed at any time over the past 6  months.
Information concerning return to work was obtained during a telephone interview 
with each patient, carried out 12-13 months post-discharge. Patients were asked if they 
had started work again, and whether they were working full-time or part-time. 
Information about attendance at rehabilitation was also obtained during these interviews, 
and the recurrence of cardiac disease (defined as a further ACS requiring hospital 
admission and treatment, or recurrence of chest pain leading to revascularisation) was 
recorded. I was not involved in the recruitment of the original sample. However, I 
carried out most of the 12 month follow-up assessments, and a proportion of the 36 
month assessments.
Statistical analysis
Twelve month data were obtained from 126 (81.2%) of patients. The patients 
included in this analysis did not differ from those who were lost to follow-up in age, 
gender, ethnicity, marital status, educational attainment, smoking, body mass index 
(BMI), alcohol consumption, physical activity, type of ACS, previous cardiovascular 
history, or BDI. However, patients lost to follow-up tended to be more socially deprived 
(p = 0.01) and had lower GRACE risk scores (p = 0.042) than those included in the 
study. Patients who did and did not return to work by 12 months were compared on 
socio-demographic, clinical and psychological factors using %2 statistics for categorical 
variables and analysis of variance for continuous measures. All tests were two sided. 
The factors that were significantly associated with return to work in univariate analysis 
were entered into a multiple logistic regression. Odds ratios (O.R) adjusted for all other 
factors are presented together with 95% confidence intervals (C.I.).
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9.2.3 Results
One hundred and one (80.2%) patients were working at 12 months following 
ACS, of whom 64 (63.4%) were working full-time, and 37 (36.6%) part-time. The 
interval between ACS and restarting work averaged 3.4 months, ranging from less than 
one month to 11 months. Patients who did and did not return to work did not differ in 
gender distribution, age, ethnicity, educational qualifications, social deprivation scores, 
or marital status (Table 9.1). There were also no associations with lifestyle factors such 
as smoking, BMI, and alcohol consumption, but patients who were physically inactive 
prior to ACS were less likely to return to work.
Table 9.1 Characteristics of patients working and not working at 12 months
W orking Not working P
oIIs (n = 25)
Gender Men 89 (88.1%) 2 2  (8 8 .0 %) 0.98
Women 12(11.9%) 3 (12.0%)
Age (years) 54.5 ±8.2 55.9 ±9.8 0.47
Ethnicity White 87 (86.9%) 2 0  (80.0%) 0.44
Other 14(13.1%) 5 (20.0%)
Educational None 37 (36.6%) 12 (48.0%) 0.49
qualifications
Primary 24 (23.8%) 6  (24.0%)
Secondary 40 (39.6%) 7 (28.0%)
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Working Not working P
(n = 101) (n = 25)
Social Low 57 (56.4%) 10(40.0%) 0.13
deprivation
Medium 26 (25.7%) 8  (32.0%)
High 18(17.5%) 7 (28.0%)
Marital status Married 75 (75.3%) 17(68.0%) 0.53
Not married 26 (25.7%) 8  (32.0%)
Smoking Current 47 (46.5%) 16 (64.0%) 0.18
status
Ex/non-smoker 54 (53.5%) 9 (36.0%)
Body mass (kg/m2) 27.5 ±4.3 27 .914 .5 0.65
index
Physical None 53 (53.0%) 18(72.0%) 0.055
activity
Low 29 (29.0%) 2  (8 .0 %)
> 2  times/week 18(18.0%) 5 (20.0%)
Alcohol 12.0 ± 15.9 11.21 14.3 0.83
(units/week)
The clinical features of patients who were working and not working after 12 
months are summarised in Table 9.2. Returning to work was unrelated to the type of 
ACS, number of vessels diseased, and previous myocardial infarction. Patients with low 
GRACE risk scores were more likely to return to work. Fewer patients who were 
working at 12 months had experienced arrhythmia (4 vs 24%) or heart failure (5 vs 16%)
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on admission than those who failed to resume work. There was no association with 
whether the ACS was managed medically, or with percutaneous coronary intervention 
(PCI), or coronary by pass graft intervention (CABG). Patients who experienced 
recurrence of cardiovascular problems leading to readmission or revascularisation, were 
less likely than others to be working at 12 months. There were no associations with risk 
factors or medication before admission, or with attendance at cardiac rehabilitation.
Self-reports of moderate to severe symptoms of depression over the 6  months 
before admission, were not related to the likelihood that patients would be working at 12  
months (Table 9.2). Eight patients were taking antidepressant medication at the time of 
admission; half of these patients were not working at 12  months, compared with 82.2% 
of those who were not taking antidepressants. Additionally, BDI scores measured 7-10 
days post-admission were 36% lower in patients who returned to work compared with 
those who were not working (p = 0.018). The timing of return to work, and whether 
patients resumed full, or lighter, part-time duties were not predicted by psychological 
state or clinical factors at the time of admission.
Table 9.2 Clinical features of patients w orking and not working at 12 months
W orking Not working P
(n = 101) (n = 25)
ACS type STEMI 66 (65.3%) 18(72.0% ) 0.53
NSTEMI
UA
/ 35 (34.7%) 7 (28.0%)
N vessels diseased 1.71 ± 0 .7 9 1.76 ± 0 .8 8 0.78
Previous ACS Yes 7 (6.9%) 0.85
No 94 (93.1%) 2 (8.0%)
23 (92.0%)
GRACE risk score 81.8 ± 20.1 90.0 ± 2 1 .0 0.072
W orking 
(n = 101)
Not working  
(n = 25)
P
Heart failure Yes 5 (5.0%) 4(16.0% ) 0.055
No 96 (95.0%) 21 (84.0%)
Arrhythmia on Yes 4 (4.0%) 6 (24.0%) 0.004*
admission
No 97 (96.0%) 19(76.0% )
Clinical management Medical 24 (24.7%) 6 (24.0%) 0.50
PCI 59 (60.8%) 13 (52.0%)
CABG 14(14.4% ) 6 (24.0%)
Recurrence Yes 34 (33.7%) 14(58.3% ) 0.026*
(readmission,
revascularisation) No 67 (66.3%) 10(41.7% )
Attendance at cardiac Yes 72 (71.3%) 20 (87.0%) 0.12
rehabilitation
No 29 (28.7%) 3 (13.0%)
Diabetes pre-admission Yes 9 (8.9%) 3 (12.0%) 0.64
No 92 (91.1%) 22 (88.0%)
Hypertension pre­ Yes 36 (35.6%) 11 (44.0%) 0.44
admission
No 65 (64.4%) 14(56.0% )
Statin use pre-admission Yes 9 (8.9%) 1 (4.0%) 0.42
No 92 (91.1%) 24 (96.0%)
Moderate/severe Yes 28 (27.7%) 10(40.0% ) 0.23
depression (6
months) No 73 (72.3%) 15 (60.0%)
Antidepressant use pre­ Yes 4 (4.0%) 4(16.0% ) 0.027*
admission
No 97 (96.0%) 21 (84.0%)
’•‘Significant difference, p <0.05.
The multiple regression analysis of predictors of return to work at 12 months is 
summarised in Table 9.3. The factors that emerged as independent predictors were 
arrhythmia during admission, recurrent cardiac events, and BDI score following
admission. Thus patients who experienced arrhythmia (p = 0.030) and recurrent cardiac 
events (p = 0.025) were substantially less likely than others to be working 12 months 
after ACS. The BD1 effect indicates that for every unit increase in BDI depression score 
following admission, there was a 1 0 % reduction in the likelihood of returning to work by 
12 months (p = 0.032).
Table 9.3 Determinants of return to work 12 months after an ACS
Adjusted 
odds ratio
95% C.I. P
Age 0.91 (0.31 to 2.66) 0.87
Gender (M/F) 1.77 (0.19 to 16.0) 0.63
GRACE score 0.98 (0.93 to 1.03) 0.38
Arrhythmia 0.09 (0.01 to 0.79) 0.030*
Heart failure 1.19 (0.12 to 11.4) 0 . 8 8
Recurrence 0.25 (0.01 to 0.84) 0.025*
Antidepressant use pre­
admission
0.62 (0.01 to 28.7) 0.81
BDI following admission 0.90 (0.82 to 0.99) 0.032*
* Significant difference, p < 0.05.
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9.3 Discussion
A total of 80% of patients in this study had resumed work 12 months after 
admission for an ACS. This is comparable with the rates of 78-83% recorded in other 
recent studies (Soejima et al., 1999; Soderman et al., 2003; Boudrez & de Backer, 2000). 
Return to work was predicted by clinical factors on admission, by cardiovascular 
complications during the intervening 12  months, and by depressive symptoms measured 
in the days following admission. Demographic factors, preadmission risk profile, 
attendance at rehabilitation were not predictive.
This study showed that clinical markers of ACS severity were predictors of 
subsequent return to work. The significance of clinical indicators has been limited in 
past studies, with few associations being observed (Petrie et al., 1996; Soejima et al., 
1999; Soderman et al., 2003). Neither ACS type, elevated cardiac enzymes, nor number 
of diseased vessels predicted resumption of work in the present study. However, in 
univariate analyses, patients who resumed work were less likely to have experienced 
cardiac arrhythmia in hospital, with near significant effect for heart failure and the 
GRACE index. The GRACE index has been found to predict mortality in the 6  months 
following ACS (Eagle et al., 2002), a result that has been independently replicated 
(Hamalainen et al., 2004). Interestingly, the method of management of ACS was also 
unrelated to work resumption, with similar rates among patients treated medically or 
with PCI and CABG. This endorses the view that when used appropriately, surgical and 
interventional procedures have favourable effects on long term adaptation and recovery.
We observed a robust association between depressed mood during hospitalisation
for ACS and return to work 12 months later. The effect was independent of
demographic and clinical markers, and of depression prior to ACS (Table 9.3). These
304
results add to the evidence for adverse effects of depressive responses to ACS. Other 
early phase psychological factors are also important predictors, including patients’ 
understanding of their illness (cognitive representation), (Petrie et al., 1996) and 
physicians’ and patients’ expectations of disability.
Work resumption was not predicted by age, gender or SES, in contrast with 
studies in the 1970’s and 1980’s (Mital et al., 2004). These differences may relate to 
changes in social expectations and in working practices. During periods of relatively 
high unemployment (as were present 2 0  years ago), competition for jobs is great, so 
lower SES patients with limited skills may be disadvantaged. The physical exertion 
required in lower SES occupations has also diminished markedly over recent decades 
because of mechanisation, so returning to work is not prevented by physical incapacity. 
In the past, it may also have been more acceptable for women, especially if married, to 
not return to paid employment (Mital et al., 2004). We found that patients with higher 
social deprivation scores were more likely to be lost to follow-up. It is conceivable that 
this biased the findings relating return to work with SES. However, patients who were 
lost to follow-up also had lower GRACE scores than those studied at 12 months. This 
suggests that lower SES patients with mild ACS were particularly at risk of withdrawing 
from the study. The reason is probably that these individuals had resumed work and 
were not available for interview. The 12 month telephone interviews were mostly 
carried out on weekdays during the working day and evening, and these individuals may 
not have been at home during these times. Their exclusion is likely to have reduced 
rather than increased the proportion of lower SES patients who had restarted work, so 
will not have biased results against finding an association between lower SES and failing 
to return to work.
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The absence of a relationship between return to work and attending cardiac 
rehabilitation is intriguing. The rehabilitation classes offered to patients varied by 
hospital, so no standard schedule was involved. Previous studies have found that 
attendance at rehabilitation does not predict return to work unless the programme is 
specifically focused on resumption of work and related activities (Soderman et al., 2003).
9.4 Strengths and limitations
The strengths of this study include its prospective design of a cohort of patients 
hospitalised for ACS, the inclusion of different types of ACS which is more appropriate 
to the current era of medicine as up-to-date categorisation have been used and 
characterisation of patients in terms of multivariate clinical risk. The BDI scale was used 
to assess depressive symptoms, which is a well established validated scale, used in 
previous studies on cardiac patients (Buchanan et al., 1993; Frasure-Smith et al., 1997).
This study also has a number of limitations. Data were not collected from a 
consecutive series of ACS admissions, since patients were excluded if they were not able 
to recall the time of onset of symptoms, and if they had co-morbid conditions that might 
influence symptom presentation or mood. The reason is that the analysis was carried out 
in the context of a larger study of emotional and behavioural triggers of ACS (Strike et 
al., 2006). Consequently, the study included a higher proportion of STEMI than 
NSTEMI/UA and a greater number of men than women compared with recent cohorts 
(Eagle et al., 2002; Hasdai et al., 2002). We did not assess clinical depression, since our 
concern was with depressed mood, and this was assessed by questionnaire. However, 
there is evidence that even moderate depressed mood in cardiac patients is associated
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with adverse outcomes (Jiang et al., 2003). The response rate was good (81.2%), but the 
loss of 18.8% might have influenced the pattern of results. The information we collected 
on type of occupation was not sufficiently detailed for analysis, but is known to relate to 
return to work (Gehring et al., 1988). The associations we observed with clinical and 
psychological factors all concerned return to work, rather than timing of return or 
whether patients resumed full or part-time work; larger samples may be required to 
investigate these aspects fully. Additionally, unmeasured factors may have acted as 
confounds of the association between depressed mood and failure to return to work. 
Finally, assessment of return to work was based on self-report. Although it is unlikely 
that patients would report they were in paid employment when they were not (and vice 
versa), their recollection of the timing of return to work may have not been completely 
accurate. This may be one reason why depression soon after hospitalisation did not 
predict the timing of resumption of work.
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Chapter 10: The long term effects of acute triggers of ACS on
adaptation and quality of life
10.1 Introduction
The purpose of this analysis was to discover whether the experience of acute 
physical and emotional triggers predicts long term adaptation independently of clinical 
and socio-demographic factors. The literature on acute triggers has been focused almost 
exclusively, on whether they stimulate the onset of ACS, and on the underlying 
biological mechanisms. The possibility that the experience of an acute emotional or 
physical trigger might have long term effects on adaptation has not been addressed. We 
therefore followed up the cohort of the ACS patients in the ACCENT study previously 
described in section 9.2.2, in which acute triggering by physical exertion and emotional 
factors had previously been assessed (Strike et al., 2006), and predicted that patients who 
had experienced triggers would show impaired quality of life 12 and 36 months later, 
compared with patients without triggers. Emotional responses such as anxiety and 
depression in the days following ACS are known to influence later quality of life, the 
likelihood of returning to work, and emotional well-being (Bhattacharyya & Steptoe, 
2007; Lane et al., 2001; Mayou et al., 2000). Anxiety in hospital was therefore taken 
into account in the analysis.
Additionally, we hypothesised that emotional and physical triggers might have 
different associations with long term outcomes. We reasoned that physical exertion 
during the hazard period could lead to nervousness about physical activity, leading to 
physical de-conditioning, impaired vitality and fatigue. Emotional triggers could elicit 
preoccupation with negative emotional experiences, and be associated with impaired
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long term mental well-being. We therefore tested for differential prediction of mental 
and physical quality of life from emotional and physical exertion triggers.
10.2 Methods
Patients
The patients were 295 men and women aged 18-90 years admitted with ACS to 
one of four hospitals in the London area. (ACCENT study; Strike et al., 2006). Patients 
were included in the study on the same criteria as the one year follow up study described 
in section 9.2.2. Symptom onset occurred while sleeping in 38 patients, so 257 patients 
provided information about triggering of ACS.
Measures
Information about cardiovascular history, psychiatric history, clinical factors 
during admission and management was obtained from medical notes as described in 
section 9.2.2.
Procedure and assessment o f triggers
Patients were invited to take part as soon as possible after admission to hospital. 
The study was explained verbally and a patient information sheet was provided, and 
written consent was obtained. A total of 375 patients were potentially eligible for the 
study; of these, 48 patients (12.8%) were discharged or transferred to other hospitals 
before the interview could take place, and further 32 patients (8.5%) refused. The 
interviews were carried out an average 2.56 ± 1.5 days after admission, with 95% being 
completed within 5 days of admission.
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The structured triggering interview was based on the procedures used in the 
Onset and SHEEP studies (Mittleman et al., 1995; Moller et al., 1999; Mittleman et al., 
1993). Patients were asked in detail, about the circumstances surrounding the onset of 
acute symptoms. Vigorous physical exertion was defined as activity of at least 6  
metabolic equivalents (METS), as used in earlier studies. In the light of this literature, 
we specifically focused on physical exertion within 1 hour of symptom onset (Mittleman 
et al., 1993; Willich et al., 1993; Hallqvist et al., 2000). The assessment of negative 
emotional states enquired about the occurrence of anger, stress and depression or sadness 
within 2 hours of symptom onset (Mittleman et al., 1995; Moller et al., 1999; Steptoe et 
al., 2006), and patients reporting moderate or intense emotional states were categorised 
into the emotional trigger group. Activity and emotion over additional periods were 
assessed for case-crossover analyses described elsewhere (Steptoe et al., 2006).
After the interview was completed, patients were given a questionnaire that they 
completed and returned 7-10 days post-admission. Socio-economic status (SES) and 
depression were assessed as in the previous study described in section 9.2.2. Anxiety 
was measured using the anxiety scale from the Hospital Anxiety and Depression 
(HADS) scale (Zigmond & Snaith, 1983), a widely used measure suitable for medical 
patients (Herrmann, 1997). Scores can range from 0 - 2 1 ,  and patients were classified as 
moderately or severe anxious if their ratings exceeded the recognised threshold (> 8 ).
12 and 36 month assessments
Patients were reassessed 12 and 36 months after discharge by telephone interview 
and questionnaire. Mental well-being was assessed using the HAD anxiety scale and the 
mental health scale from the Short Form 36 (SF36) health status measure (Ware et al., 
1992). This consists of 5 items related to anxiety and depression (see appendix 11). 
Physical health status was assessed using the SF36 physical health summary scale. This
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combines scores on four of the SF36 scales (physical function, role limitations due to 
physical problems, pain and general health perception). Additionally, we used the 
vitality scale from the SF36 as an additional measure of physical health status. Each of 
the SF36 measures was scaled from 0-100, with 100 indicating the best possible quality 
of life. Cronbach a scores for the SF36 scales ranged from 0.81-0.90. Patients also 
provided information about whether they had experienced any recurrence of cardiac 
symptoms over the follow-up period.
Statistical analysis
194 of the 257 (75.5%) patients were reassessed at 12 months, and 160 (62.2%) 
at 36 months. Non-respondents either could not be traced, refused to be reassessed, or 
were deceased. Patients who completed the 12 month assessment did not differ from 
those who failed to take part in gender, ACS type, medical history, the occurrence of 
emotional and physical triggers, or in anxiety in hospital. However, non responders were 
significantly younger (57.6 vs 61.2 years, p = 0.024), had higher social deprivation 
scores (p = 0.041) and lower scores on the Grace index of clinical risk (p = 0.040), 
indicating that younger, less affluent patients with less severe ACS were lost to follow- 
up.
These analyses use a combined emotional trigger variable, composed of patients 
who reported stress, anger or depressed mood during the hazard period. Physical 
exertion triggering was indexed by the one hour exertion measure described by Strike et 
al. (2006). Patients who experienced emotion prior to the ACS event were placed in an 
‘emotion trigger group’ and those that did not experience an emotional trigger were 
placed in a ‘non emotion trigger’ group. The two groups were compared using t-tests for 
continuous and x2 tests for categorical variables.
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The relationship between emotional and physical triggers and mental well-being 
and physical health status at 12 and 36 months, was assessed with multiple regression 
analyses, on the two dependent variables concerned with mental well-being: anxiety 
(HADS) and mental health (SF36) and the two dependent variables concerned with 
physical function: vitality, and physical health scores (SF36). Along with the measures 
of triggers, age, gender, SES, Grace risk score, anxiety in hospital, history of clinical 
depression and recurrence of symptoms were entered as covariates in all analyses, so 
these analyses were controlled for factors that potentially confound associations. 
Additional covariates were included in particular analyses, based on their associations 
with the specific outcome measures. Results are presented with regression coefficients 
(B) and 95% confidence intervals (C.I.).
10.3 Results
Seventy two (37.5%) patients experienced acute emotional distress during the 2 
hour trigger period preceding ACS onset, while 11 (5.9%) reported physical exertion. 
2.6% of patients reported both physical exertion and emotional stress. The negative 
emotional states included acute anger (16.3%), stress (27.9%), and depression and 
sadness (16.3%). The characteristics of patients with emotional triggers are detailed in 
Table 10.1. Emotional trigger patients were significantly younger than those with no 
emotional triggers, and tended to be more socially deprived (p = 0.083). There were no 
differences in other socio-demographic factors, clinical indicators, treatment plan, 
cardiovascular history, lifestyle or history of clinical depression. Anxiety levels in 
hospital were moderately elevated, but did not differ between groups. In the proportion
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of patients who reported symptom recurrence over the 12  month period there was no 
difference between the groups.
Table 10.1 Socio-dem ographic and clinical characteristics o f ACS patients
Em otional trigger 
group
(n = 72)
No emotional 
trigger group (n = 
120)
P
Gender Men 56 (77.8%) 93 (77.5%) 0.96
Women 16(22.2% ) 27 (22.5%)
Age (yrs) 59.0 ± 10.2 62.5 ± 11.6 0.034*
Ethnicity Non-white 6 (8.3%) 18(15.0% ) 0.18
Social deprivation Low 29 (40.3%) 60 (50.0%) 0.083
Medium 19 (26.4%) 34 (28.3%)
High 24 (33.3%) 26 (21.7%)
ACS type STEMI 53 (73.6%) 82 (68.3%) 0.52
GRACE score 92.3 ± 2 3 .5 98.7 ±28.1 0.11
N vessels diseased 1.76 ± 0 .8 2 1.81 ±0.81 0.70
Treatment Medical 17(23.9% ) 38 (31.7%) 0.23
PCI 45 (63.4%) 66 (55.0%)
CABG 9(12.7% ) 16(13.3% )
Previous ACS 6 (8.3%) 13 (10.9%) 0.63
Diabetic 10(13.9% ) 12(10.0% ) 0.48
Aspirin pre-admission 9(12.5% ) 24 (20.0%) 0.24
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Emotional trigger 
group
(n = 72)
No emotional p
trigger group (n =
120)
Beta blockers pre-admission 13(18.1% ) 20(16.8% ) 0.85
Current smokers 32 (44.4%) 52 (43.3%) 0.88
Body mass index 27.5 ± 4.5 26.8 ± 4.4 0.33
Physical activity Sedentary 43 (59.7%) 74(62.2% ) 0.12
Low activity 21(29.2% ) 22(18.5% )
High 8(11.1% ) 23(19.3% )
activity
History o f depression 13(18.1% ) 21(17.5% ) 0.92
Anxiety in hospital 6.11 ± 3.5 5.43 ± 4.2 0.30
Symptom recurrence 9(13.4% ) 27(23.9% ) 0.09
(12months)
*Significant difference, p < 0.05.
10.3.1 Triggers and mental well-being at 12 months
Anxiety on the HAD scale averaged a score of 6.24 ± 4.5 at 12 months, and 
32.5% of patients scored above the threshold for moderate or severe anxiety. Scores on 
the SF36 mental health scale averaged 71.6 ± 20.9. Both anxiety and mental health 
scores were significantly correlated with anxiety in hospital (r = 0.29 and -  0.28 
respectively, p < 0.001), and with a history of clinical depression (p < 0.01). Mental 
health was poorer in lower SES patients (p = 0.007). Anxiety levels at 12 months tended
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to be higher in patients who were admitted with an NSTEMI/UA compared with a 
STEMI (p = 0.057). Anxiety and mental health were worse at 12 months in patients who 
had been prescribed aspirin pre-admission, but were better in those prescribed beta 
blockers. Recurrence of symptoms over 12 months was strongly associated with both 
anxiety and poor mental health (p < 0 .0 0 0 1 ).
Emotional triggering was positively associated with anxiety at 12 months 
independently of age, gender, SES, Grace risk score, ACS type, aspirin and beta blocker 
medication pre-admission, anxiety in hospital, history of depression, and symptom 
recurrence (p < 0.001, Table 10.2). Additionally, anxiety in hospital, symptom 
recurrence and prescription of beta blockers pre-admission were independent predictors 
of 12 month anxiety. Anxiety at 12 months adjusted for covariates averaged 7.32 ± 4.2 
in the emotional trigger group, and 5.22 ± 4.2 in the non-trigger group (p < 0.001). The 
odds ratio for having an anxiety score above the clinical threshold was 6.24 (C.I. 2.4 to
15.7, p < 0.001), for patients reporting emotional triggers versus no triggers after 
adjustment for covariates.
Similar patterns were recorded for the SF36 mental health scale, with positive 
associations between emotional triggering and poor mental health independently of age, 
gender, social deprivation, grace risk score, ACS type, pre-admission medication, 
anxiety in hospital, depression history and symptom recurrence (B = - 7.18, C.I. -13.4 to 
- 0.97, p < 0.001). Mean adjusted scores were 67.8 ± 21.9 in the emotional trigger and
74.9 ± 27.2 in the no trigger patients. Physical exertion during trigger period was not 
associated with the 1 2  month mental health score.
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Table 10.2 Predictors of 12 month anxiety
Regression coefficient (B) 
(95% C.I.)
P
Age 0.028 (-0.08 to 0.14) 0.61
Gender 0.119 (-1.36 to 1.60) 0.87
Social deprivation 0.002 (-0.73 to 0.73) 0.99
Grace risk score -0.013 (-1.36 to 1.60) 0.57
ACS type -0.590 (-1.93 to 0.75) 0.39
Aspirin pre-admission -1.439 (-3.19 to 0.31) 0 .1 1
Beta blockers pre-admission 2.198 (0.55 to 3.85) 0.009*
Anxiety in hospital 0.246 (0.09 to 0.41) 0.003*
History of depression 1.427 (-0.06 to 2.92) 0.060
Symptom recurrence 4.400 (2.77 to 6.03) 0 .0 0 1 *
Emotional triggering of ACS 2.097 (0.85 to 3.34) 0 .0 0 1 *
*Significant difference, p < 0.05.
10.3.2 Triggering and physical health status at 12 months
The SF36 physical health status (PHS) scores averaged 63.2 ± 26.2 at 12 months, 
while the physical vitality score averaged 55.7 ± 21.7. Physical health status at 12 
months was worse in socially deprived patients and in those who experienced symptom 
recurrence. Additionally, physical activity habits before ACS were associated with
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physical health status at 12 months (mean PHS scores 58.7, 68.7 and 72.3 for inactive, 
low activity and high activity groups respectively, adjusted for age and gender, p = 
0 .011).
Exertion during the trigger period was predicted by lower physical health status 
scores at 12 months, independently of age, gender, social deprivation, Grace risk score, 
ACS type, anxiety in hospital, history of depression, and physical activity levels (B = - 
16.5, C.I.-33.0 to -0.44, p = 0.044). However, when symptom recurrence was added to 
the model, the association was no longer significant (p = 0.064). Mean scores adjusted 
for covariates were 50.8 ± 24 in the exertion, and 65.6 ± 26.1 in the no exertion group. 
By contrast, vitality at 12 months was predicted by exertion during the trigger period 
independently of all covariates (p = 0.019, Table 10.3). Physical vitality scores adjusted 
for covariates averaged 41.8 ± 28.4 in the exertion and 57.3 ± 20.6 in the non-exertion 
groups. Other independent predictors of 12 month vitality were a history of clinical 
depression and symptom recurrence over the 12 month period. Neither of the physical 
health measures at 12 months was associated with emotional triggering of ACS.
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Table 10.3 Predictors of 12 month physical vitality
Regression coefficient (B) p 
(95% C.I.)
Age -0.016 (-0.59 to 0.56) 0.96
Gender -4.601 (-12.58 to 3.38) 0.26
Social deprivation -1.839 (-5.79 to 2.17) 0.36
Grace risk score -0.018 (-0.26 to 0 .2 2 ) 0 . 8 8
ACS type 3.791 (-3.49 to 11.07) 0.31
Anxiety in hospital -0.627 (-1.49 to 0.23) 0.15
History of depression -10.70 (-18.70 to -2.71) 0.009*
Symptom recurrence -14.08 (-22.90 to -5.26) 0 .0 0 2 *
Physical exertion triggering of ACS -15.45 (-28.35 to -2.56) 0.019*
♦Significant difference, p < 0.05.
10.3.3 Triggering and adaptation at 36 months
HAD anxiety score averaged 5.52 ± 4.2 at 36 months, while the SF36 mental 
health scale averaged 72.7 ± 27.2, and the physical health status measure averaged 48.1 ±
19.7. Anxiety at 36 months was no longer related to ACS type or medication pre­
admission, but it was predicted by symptom recurrence over the 3 years period (p < 
0.001). Emotional triggering continued to be a predictor of anxiety at 36 months 
independently of age, gender, social deprivation, Grace risk score, anxiety in hospital,
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history of depression and symptom recurrence (Table 10.4). Other independent 
predictors were anxiety in hospital and symptom recurrence. Mean levels of anxiety at 
36 months adjusted for covariates, were 6.22 ± 4.6 for the emotional trigger and 4.76 ±
3.9 for the non-trigger patients. Similarly, mental health scores at 36 months were 
predicted by emotional triggering independently of covariates (adjusted means 69.0 ±
20.0 and 76.7 ±21.5 for emotional trigger and no trigger groups, p = 0.047).
Physical health status was associated with triggering by physical exertion, but 
was not predicted by emotional triggering (Table 10.4). Patients who exerted themselves 
physically during the one hour before ACS onset had substantially lower physical health 
status scores at 3 years (adjusted means 31.5 ± 11.5) than those who had not been 
physically active (mean 50.1± 20.9, p = 0.019). The other independent predictor of 
physical health status at 36 months was symptom recurrence. Vitality scores at 36 
months were not predicted by physical or emotional triggers.
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Table 10.4 Predictors of anxiety and physical health status at 36 months
Regression coefficient (B) (95% p 
C.I.)
HAD anxiety (36 months)
Age 0.016 (-3.03 to 6.56) 0.83
Gender 0.397 (-1.28 to 2.80) 0.64
Social deprivation 0.231 (-0.66 to 1.12) 0.61
Grace risk score -0.013 (-0.07 to 0.41) 0.64
Anxiety in hospital 0.305 (0.12 to 0.49) 0.002*
History of depression 1.300 (-0.48 to 3.08) 0.15
Symptom recurrence 2.993 (1.08 to 4.91) 0.002*
Emotional triggering of ACS 1.465 (0.01 to 2.92) 0.049*
SF36 physical health status 
(36 months)
Age 0.228 (-0.53 to 0.99) 0.55
Gender -3.188 (-12.24 to 5.87) 0.49
Social deprivation -1.804 (-6.59 to 2.98) 0.46
Grace risk score -0.225 (-.52 to 0.07) 0.14
Anxiety in hospital 0.086 (-0.92 to 1.09) 0.87
History of depression -8.657 (-18.15 to 0.84) 0.074
Symptom recurrence -12.41 (-22.58 t o -2.23) 0.017*
Physical exertion triggering of ACS -18.61 (-34.04 t o -3.18) 0.019*
*Significant difference, p < 0.05.
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10.4 Discussion
The purpose of this study was to discover whether acute triggering of ACS has 
long term implications for adaptation and quality of life. We discovered that mental 
well-being at 12 and 36 months was predicted by the presence of acute emotional stress 
in the 2 hours before symptom onset. The effect was substantial, with the odds of HADS 
anxiety above the clinical threshold being 6 times greater in patients who experienced 
emotional triggering, after adjustment for socio-demographic factors such as age, gender 
and SES, clinical risk as defined by the GRACE risk score, type of ACS, medication, 
anxiety in hospital, history of depression and symptom recurrence. Effects persisted at 
36 months, and were confirmed with 2 independent measures of mental well-being. 
Emotional triggers were not associated with long term physical health status. 
Conversely, physical exertion during the hour before symptom onset predicted reduced 
physical health status at 12 and 36 months, but was not related to mental well-being.
These findings suggest that acute triggers do have long term consequences for 
adaptation and quality of life in cardiac patients, with differential responses depending 
on whether patients experience a physical or emotional trigger. The absence of cross­
influences between the physical and emotional domains adds credence to the findings, 
indicating that they are not due to the experience of triggers stimulating generalised 
impairment in quality of life.
It should be noted that both physical health status and mental well-being were 
markedly impaired on average both at 12 and 36 months. SF36 physical health status 
scores averaged 63.2 and 48.1 at the two time points, while 32.5% and 30% respectively 
scored above the threshold for moderate anxiety. However, there was wide variation in
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these responses, with some patients showing very little impairment in quality of life at 
follow up.
Anxiety and mental health score at 12 months following hospital discharge were 
positively associated with anxiety measured 7-10 days after hospitalisation, and with a 
history of clinical depression. These results confirm previous findings that psychological 
distress following hospitalisation for ACS predicts poor mental health longitudinally 
(Lane et al., 2001; Beck et al., 2001). Anxiety at 12 months was also higher in those 
admitted with NSTEMI/UA rather than a STEMI. This may be because of the uncertain 
prognosis of unstable angina or the more aggressive clinical treatment of STEMI’s, that 
may lead to more complete symptom relief and sense of cure. Mental health at 12 
months was also poorer in lower SES patients, as has frequently been described in the 
past (Lorant et al., 2003). Interestingly, the use of beta blockers prior to ACS was an 
independent predictor of lower anxiety 12 months later. The explanation is not clear. 
Patients who were prescribed beta blockers were no less likely to report emotional 
triggers or physical exertion than others, but it is possible that the intensity of the 
experience was attenuated. Symptom recurrence was a strong predictor of quality of life 
both at 12 and 36 months, presumably because patients who experienced symptoms were 
more worried that they might suffer a new cardiac event (Heller et al., 1997).
Physical health status at 12 months was predicted by lower SES, sedentary 
behaviour prior to ACS onset, and symptom recurrence. The association between 
physical exertion during the hour before symptom onset, and later physical health status, 
was not as strong as the relationship between emotional triggering and mental well­
being. The probable reason is that this analysis had limited power, since only 5.9% 
patients’ reported physical exertion during the hazard period. Nonetheless, effects were
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significant and persisted at 36 months, when a 19-point difference in SF36 physical 
health status scores was observed between exertion and non-exertion groups.
The long term impact with physical exertion during the trigger period may again 
be due to patients’ attributions. Patients who believe their ACS was triggered by 
physical exertion may become reluctant to become active in the future, fearing a 
recurrence. This will lead to inactivity and de-conditioning, so that sense of vitality and 
ability to carry out every day physical task will be impaired. This process is of 
considerable clinical concern, since regular physical activity following ACS is important 
to future cardiac health, and will increase confidence in ability to resume work and 
normal activities (Balady at al., 2007).
10.S Strengths and limitations
The strengths of this study include its prospective design, the use of systematic 
measures to assess triggering and later quality of life and, as in chapter 9, the inclusion of 
different type of ACS and the characterisation of patients in terms of multivariate clinical 
risk.
The study has a number of limitations. It involved a relatively young sample of 
patients (mean age 61.2 years), with a higher proportion of STEMI than NSTEMI/UA 
and a greater number of men than women compared with recent cohort studies (Hasdai et 
al., 2002). Exclusion of patients with co-morbidities likely to influence symptom 
presentation or mood may have restricted the sample to individuals with lower risk 
profiles. Patients in the study had to recall a specific time of onset, so the ACS events 
were not representative of all emergency cardiac admissions and there was the potential
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for recall bias. Because of the limited sample size, it was not possible to investigate the 
intensity of triggers experiences. Emotional experiences during the 2 hours before 
symptom onset varied from moderate to very intense, and this could have contributed to 
the likelihood of later poor mental well-being. There were too few patients reporting 
both physical exertion and emotional stress to analyse separately, but they may be a 
particularly vulnerable subset. Additionally, we lost 24.5% of patients to 12 months 
follow up. Younger, lower SES patients were less likely to be included in follow up 
assessment, but crucially, trigger and non trigger patients were not differentially retained 
in the study. Nevertheless, the pattern of results might have been different in patients 
who were not included in follow up.
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Chapter 11: Discussion
11.1 Mood in relation to CAD
My thesis presents three studies that address different aspects of the relationship 
between emotional factors and coronary artery disease (CAD).
The three studies were carried out with the following aims:
a) To evaluate the influence o f emotional triggers on cardiac health acutely, on a moment 
to moment basis, in daily life.
b) To evaluate the influence of emotional acute triggers on the long term adaptation after 
an established coronary event or procedure, in terms of psychological adaptation and 
functional recovery.
c) To understand the psychophysiological basis for such effects.
In general, results from these studies suggest that psychological factors relate 
directly to physiological responses (heart rate variability and neuroendocrine function), 
relevant to the onset of acute cardiac events in patients with suspected CAD. 
Additionally, acute emotional triggers of acute coronary syndrome (ACS) have been 
found to relate to later adaptation and quality of life in established ACS patients. I will 
discuss these findings in turn, in relation to the hypotheses described in chapter 3.
An overview of the key relationships are discussed and illustrated in Figure 11.1.
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SIS study: influence o f emotional factors on cardiac health in daily life.
* In patients with definite CAD, depressed mood was associated with decreased 
high frequency and increased low frequency heart rate variability (HRV), suggestive of 
parasympathetic withdrawal. This was not true of the non-CAD patients, though in the 
complete sample, greater parasympathetic control (increased high and decreased low 
frequency power) was present in patients reporting more positive affect (PA).
* The cortisol slope over the day was flatter in patients with CAD who were more 
depressed.
* Episodes of transient ischaemia and/or arrhythmia were also associated with 
increased negative affect (NA), but their incidence was low in the sample, primarily 
because most patients were medicated with beta blockers.
A C C E N T  stu d ies: in flu en ce  o f  e m o tio n a l f a c to r s  on la ter  adapta tion  to  A C S
* Failure to resume work was associated with cardiac factors on admission (heart 
failure, arrhythmia), cardiac complications during the intervening months, and 
depression scores during hospitalisation. It was not related to age, gender, socio­
economic status, type of ACS, cardiac history, acute clinical management, or type D 
personality. In multivariate analyses, the likelihood of returning to work was negatively 
associated with depression independently of clinical and demographic factors.
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* Emotional triggers predicted elevated anxiety and poor mental health status at 12 
months independently of age, gender, socio-economic status, ACS presentation, pre­
admission medication, anxiety in hospital, depression history and symptom recurrence. 
Effects persisted at 36 months. Emotional triggers were not related to physical health 
status at follow-up. By contrast, impaired physical health status was predicted by 
vigorous exertion during the trigger period independently of covariates.
Figure 11.1 Overview of the three studies.
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11.2 Mood and cardiovascular function: Association between mood and transient 
myocardial ischaemia and heart rate variability in CAD and non-CAD patients
Hypothesis 1: Episodes o f silent myocardial ischaemia or arrhythmia triggered during 
ambulatory monitoring will be positively associated with negative mood states.
Hypothesis 2: Trait measures o f depressed affect as measured by validated scales and 
moment to moment negative mood states over the day will be associated with reduced 
heart rate variability.
The findings from both chapters 5 and chapter 7 support both hypothesis 1 and 2 
to some extent. I will first discuss the findings from chapter 7, which support hypothesis
1. Specifically, episodes of transient myocardial ischaemia (TMI) or arrhythmia 
triggered during ambulatory monitoring (as evidenced by ST depression or VT on ECG) 
were positively associated with the negative mood state of worry, a reduction in 
happiness and an increase in negative combined mood (sum of less positive affect and 
more depression, worry, tiredness and anger). There were no associations seen with the 
other negative mood states of anger, tiredness and hostility. Depression showed a trend 
towards an association with TMI with results approaching significance.
Additionally, acute changes in HR and HRV were associated with the TMI 
episodes, in terms of an increased HR and reduced LFn power just prior to the onset of 
the ischaemic episode. No significant associations were seen between any of the other 
HRV indices (HFn power, VLF power, RMSSD) and ischaemic episodes.
Furthermore, in the group of participants who had potentially dangerous ECG 
changes, a significant association was seen between mood and HRV surrounding the 
TMI episodes; specifically an increase in PA was shown to be associated with a smaller
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increase in HR and a reduction in LFn power, in other words, a reduction in sympathetic 
drive. Significant associations were also seen with negative mood states, since an 
increase in worry and greater depressed mood was associated with a reduction in IBI (or 
an increase in HR) and therefore a decrease in parasympathetic drive. The HR and HRV 
findings relating to these negative mood states are the opposite of the findings related to 
the positive mood states.
The results from chapter 5 supported hypothesis 2. There are significant 
associations between mood and HRV, with depressed mood being associated with a 
reduced HRV in the CAD patient group only, while PA in the total sample of 
participants was associated with an increased HRV.
The SIS study findings thus support results from previous studies in which 
negative emotions have been shown to precede the onset of ischaemic episodes. For 
example, Gullette et al. (1997) showed an association between the negative emotions of 
tension, frustration, and sadness and an increase in the relative risk of ischaemia in the 
subsequent hour in CAD patients. There were advantages to the new method used to 
characterise daily experience over diary studies previously used. By using the DRM, it 
was possible to carry out a fine tuned analysis of subtle and fluctuating mood changes 
that occur in daily life, in relation to cardiac episodes. In the analysis of the SIS study, 
mood was assessed in the 15 minute period prior to the onset of the ischaemic episode, 
not in the hour before as in the study by Gullette et al. (1997), and participants displayed 
a significant drop in positive affect, and an increase in worry and combined negative 
mood (less positive affect/more negative affect) just prior to the onset of the episode. 
The change in the magnitude of emotion just prior the onset of the ischaemic episode is 
interesting and has not been shown before. Previous naturalistic studies have also shown 
various emotions to be related to arrhythmia or ECG changes such as anger (Lampert et
al., 2004), depression, or stress (Bacon et al., 2004; Blumenthal et al., 1992), however 
unfortunately our study did not show associations with other such negative mood states.
One reason for this may be because of inadequate levels of arousal of such 
negative emotions during the period of monitoring. The majority of the sample was a 
retired population. Results obtained may have been different if an employed sample had 
been recruited, in which there may have been an increased frequency and intensity of 
emotions to provoke an increase in the frequency and duration of episodes of ischaemia, 
as found in previous studies (Legault et al., 1995). Another factor influencing the 
arousal level is the presence of the beta blocker medication taken by the majority of 
cardiac patients. This may block the sympathetic drive associated with feelings of anger, 
hostility that can provoke TMI episodes (Krantz, 1987, Ratey, 1992).
These positive associations between emotion and the onset of acute ischaemic 
episodes leads onto a discussion of the relationship between the onset of ischaemic 
episodes and the acute changes in heart rate variability (HRV). Previous studies have 
indicated that TMI episodes are often preceded by changes in the autonomic nervous 
system (ANS) consistent with vagal withdrawal and ST depression in a variety of 
subtypes of cardiac patients (Pozzati et al., 1996; Ponikowski et al., 1996).
In the SIS study, a reduction of LFn power and an increase in HR was found in 
the minutes just prior to the onset of ischaemic episodes with a prompt return to baseline 
levels afterwards, suggesting a reduction in the balance between 
sympathetic/parasympathetic drive prior to the onset of the ischaemic episode. No 
associations were seen with HFn and VLF power. This finding supports a previous study 
by Kop et al. (2001), which examined the changes in HRV one hour before and after 
ischaemic events recorded on ambulatory 24 hour ECG’s. Kop et al. (2001) found a 
reduction in LF power prior to the onset of TMI and an increase in HR 60 to 20 minutes
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prior to the TMI episode. The SIS study suggested a reduced parasympathetic drive 
preceding TMI in the minutes before the ischaemic episode, and then a rapid return to 
the original baseline level. It is feasible that the acute changes indicate a possible vagal 
withdrawal preceding the onset of TMI, but then a prompt compensatory mechanism of 
rapidly increasing vagal tone (or decreasing sympathetic tone) to return to the optimal 
baseline level of HRV functioning, in order to limit the severity of the ischaemic 
episode.
In the study by Pozzati et al. (1996), reduced HRV was seen in the 5 minutes 
preceding ischaemic episodes in angina patients, and was thought to be a significant 
predictor of ischaemic death. Huikuri et al. (1999) proposed that a reduced HRV 
accelerates the progression of coronary atherosclerosis rather than being a consequence 
of CAD. This is supported by findings from the SIS study of a reduced HRV, just prior 
to the ischaemic episodes, which in the long term could lead on to acceleration in 
atherosclerosis and ischaemic death. Although no significant relationships were found 
between the group with ECG changes and HRV indices when compared to the remainder 
of the sample, differences were seen when detailed analysis surrounding each of the 
individual ischemic episodes were carried out.
So in conclusion, there is a significant association between increased negative 
mood in the 15 minutes prior to the onset of TMI with changes in HR and HRV shown 
even more acutely in the few minutes prior to ischaemic episodes. The possibility that 
mood can influence HRV changes has been suggested by the association between more 
positive mood and smaller increases in HR and a reduced LFn, independent of 
medication. The converse was seen with worry and depression. This indicates that a 
reduction in the sympathetic drive or an increase in vagal tone were associated with 
positive mood states, and this greater parasympathetic influence may be one biological
mechanism by which positive affect may benefit cardiac health in terms of morbidity and 
mortality.
Hypothesis 2 is to some extent supported by results from chapter 5; changes in 
HRV were related to mood as assessed by the DRM, but not when assessed by the BDI. 
HRV may be influenced more by moment to moment changes in mood, than static traits 
such as those measured by the BDI. Specifically, results from chapter 5 show that 
depressed mood was associated with reduced HRV (decreased HF and increased LF 
power) in CAD patients only. A reduced IBI at night was seen only amongst the CAD 
patient group. Additionally, positive mood was associated with increased HRV 
(increased HF and decreased LF power) in the total sample of patients, not just those 
with CAD. No significant relationships were seen between HRV and depressed mood 
(as measured by the BDI) in either the total or the CAD patient sample.
The absence of associations between HRV and the BDI scores contrasts with 
many other studies in which a reduced HRV is associated with depression, as measured 
by a variety of depression scales (Kim et al., 2005; Moser et al., 1998; Stein et al., 2000; 
Carney et al., 2001; Yeragani et al., 1993, 1995; Krittayaphong et al., 1997). However, a 
significant relationship was seen between negative affect, assessed by the DRM, and 
HRV. It may be that differences were not detected using the BDI, due to inadequate 
demarcation between those who were depressed, and those who were not. A score of 10 
was chosen as the cut-off point, but this meant that a score of 11 would be classified as 
the ‘depressed group’, while those scoring 9 would be allocated to the ‘non-depressed’ 
group, despite the scores being similar. An alternative grouping would be to divide the 
two groups in a more extreme way, into those who scored less than 10 on the BDI, as the 
‘non-depressed’ group, and those who scored above 15, as the ‘depressed’ group. The 
DRM appears to be a more precise tool for measuring moment to moment changes in
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emotions, and possibly more suitable for correlating transient changes in mood with 
transient cardiac changes. There was a good correlation between high BDI scores and 
increased scores for negative affect with the DRM.
The findings that depressed mood (measured by the DRM) was related to 
reductions in HRV in stable CAD patients supports results from previous studies (Carney 
et al., 1995, 2001; Stein et al., 2000). Earlier work has shown a higher HR to be 
associated with depression, consistent with altered ANS function in healthy participants 
but not in cardiac patients. Elevated HR is a risk factor for sudden cardiac death in the 
general population (Kannel et al., 1987). An elevated HR also increases the risk of 
progression to atherosclerosis (Palatini et al., 1999), ischaemia (Palatini et al., 1997) and 
plaque disruption in ACS (Heidland et al., 2001). Findings from the SIS study, of an 
elevated HR at night in the CAD group only, supports the notion of a reduced 
parasympathetic tone at night predisposing the group of patients with cardiac disease to 
cardiac arrhythmia and sudden death. This is a feasible biological mechanism to account 
for the circadian pattern of MI seen in early morning (Willich et al., 1987, Muller et al., 
1989; Krantz et al., 1996).
The fact that depressed affect had a significant association with reduced HRV 
adds to the evidence that the underlying mechanisms linking depression to CAD, include 
dysregulation of the cardiac ANS, with an increase in sympathetic tone and/or reduction 
in vagal tone. The DRM results provide some clarification to the temporal sequence of 
events preceding TMI, since heightened negative affect was recorded prior to the onset 
of ischaemic episodes. This suggests that the negative moods may be contributing to the 
alterations in autonomic control, rather than altered autonomic function leading to 
negative moods in these cardiac patients. However, it should be emphasised that 
significant increases in depressed mood did not precede the onset of TMI in the SIS
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study. The low levels of depressed mood detected with the DRM may have been 
responsible for this.
The significant association between positive affect (measured by the DRM) and 
increased HRV (increased HF and decreased LF power) was found in the complete 
sample of patients, that is both CAD and non-CAD patients. This finding may be due 
the numbers in the CAD group being too small, or that the frequency of positive mood 
being too low in the period of monitoring for an association to be found in the CAD 
group. The findings support a study by McCraty et al. (1995), which showed that the 
positive emotion of appreciation was associated with a spectral shift towards MF/HF 
activity in 24 healthy men and women. The SIS study findings do not, however, fit with 
the study by Bacon et al. (2004). The latter study showed that higher levels of positive 
emotion were related to an increase in LF power in 135 CAD patients. There is little 
evidence in the literature relating positive emotions and HRV, but our results suggest 
that greater PA may provide protection against adverse cardiac changes by increasing the 
HRV.
It should be emphasised that interpreting HRV results is not straightforward. The 
underlying presumption is that a reciprocal sympatho-vagal balance is present, is critical 
to the cardiac ANS, and can be only be deciphered via these calculations. HF power 
appears to be a satisfactory measure of vagal control, whereas LF components reflect 
both sympathetic and parasympathetic modulation, and these measures are typically 
taken without taking patterns o f respiration into account. In addition, both LF and VLF 
power are predominantly caused by fluctuations in the vasomotor tone and systemic 
vascular resistance and are influenced by neural, humoral, endothelial and 
thermoregulation factors, making interpretation of results difficult. Normalisation of HF 
and LF power to total variability and/or using a ratio of these two oscillations help to
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increase the reliability of spectral parameters reflecting parasympathetic/sympathetic 
cardiac modulation. However, it can be argued that transforming variables to better 
correspond to an anticipated physiological response does not necessarily create a more 
valid measure. Cardiovascular variability should not be considered as definitive 
quantitative measures of autonomic outflow, due to its complex physiology.
However, in general, the results from chapters 5 and 7 show that negative 
emotions in daily life are associated with both the onset of TMI and altered HRV. HRV 
may be a potential biological mechanism by which emotion can relate to cardiac health. 
The findings also provide further evidence that the DRM may be a useful tool for the 
characterisation of momentary mood and correlates with the acute cardiac changes.
11.3 Mood and neuroendocrine function
Hypothesis 3 : Episodes o f silent myocardial ischaemia or arrhythmia triggered during 
ambulatory monitoring will be positively associated with lower cortisol awakening 
response.
Hypothesis 4 : Trait measures o f depressed affect as measured by validated scales will 
be associated with flattened cortisol slopes over the day, and with an exaggerated 
cortisol waking response in patients with coronary artery disease.
Hypothesis 3 was supported by results from chapter 7; patients who had episodes 
of ischaemia or arrhythmia had a reduced cortisol awakening response (CAR). 
Hypothesis 4 was supported by results from chapter 6 ; participants with CAD exhibited
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an increased CAR, independent of depression. Additionally, the patients who were 
depressed, as measured by the BDI, demonstrated a flatter cortisol slope after adjustment 
for confounders.
The current literature relating the CAR to negative mood has been mixed and it is 
difficult to determine the significance of the CAR, as it is a distinct and dynamic part of 
the circadian cortisol profile, with further work needed to clarify its main role and 
importance for cardiovascular health. Cross-sectional associations between chronic 
stress and self-reported depression and an increased CAR are seen in studies by 
Pruessner et al. (2003), Steptoe et al. (2004), and Schulz et al. (1998).
The SIS study demonstrated an increased CAR in the CAD patient group only, 
independent of depression. These findings reject the latter part of hypothesis 4. As an 
increased CAR has been shown to be associated with depression in the literature, it is 
plausible that an altered CAR response in patients with CAD may be a mediating 
biological mechanism, which accounts for the prevalence of depression seen in cardiac 
patients (Nicholson et al., 2006). However, these associations infer no direction as to the 
causality, that is, depression could cause the altered CAR response by dysregulation of 
the HPA axis and subsequent elevation o f inflammatory markers or adverse haemostatic 
effects (Girod & Brotman, 2004). Alternatively, the altered CAR response can lead to 
anti-inflammatory and cytokine effects that may subsequently cause depressed mood 
(Steptoe & Brydon, 2007).
There is also evidence to suggest that burnout is associated with an attenuated 
CAR (Pruessner et al., 1999). A reduced CAR is seen to be associated with increasing 
age and a range of health problems (Kudielka & Kirschbaum, 2003) and negative 
markers of cardiovascular health, such as intimae media thickness of arteries in females 
(Eller et al., 2003).
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It appears to be an inconsistency that a heightened CAR can be regarded as 
maladaptive and that a reduced CAR, as associated with burnout (Pruessner et al., 1999), 
can be seen as maladaptive. Similarly, the SIS findings were, on the one hand showing 
an increased CAR in the CAD patients, independent of depression and yet on the other 
hand, showing a reduced CAR in the group of patients displaying ECG changes. 
Additionally, the mean cortisol values were lower in the group displaying ischaemic 
changes on ECG, independent of depression. Higher, rather than lower mean cortisol 
values as in the SIS study, have been shown to be associated with coronary stenosis 
(Bain et al., 1989). Troxler et al. (1977) found significant correlations between elevated 
serial plasma cortisol values in the morning and moderate to severe coronary 
atherosclerosis. One interpretation of such contradictory findings is based on the theory 
proposed by Adam et al. (2007) in that the CAR is seen as an adaptive response designed 
to provide the individual with a boost needed to meet the anticipated demands of the day. 
When this mechanism becomes exhausted over time, by chronic stressful daily events 
and depression or other mood states in cardiac patients, dysregulation of the HPA ensues.
To account for the SIS study findings, one theory is that the patients at a very 
early stage of cardiac disease have an increased CAR, independent of depression, to meet 
the demands of the day. With the daily stresses, strains and negative emotions, an 
increase in the CAR is seen as the CAR is modulated by anticipatory stressful demands 
o f the day. Over a prolonged period, with accumulative stresses, this disruption of the 
natural diurnal cortisol rhythm eventually gives rise to long term metabolic disturbances. 
Eventually, as the regulatory mechanisms fail, the CAR response is no longer elevated, 
but attenuated in at-risk individuals with consequent ischaemic changes that present on 
the ECG. These physiological changes encourage advanced cardiac disease and possibly 
go on to influence mood, particular depression, in established cardiac patients.
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Findings from chapter 6  showed an altered cortisol slope to be associated both 
with depressed mood and heart disease. Specifically, the results support hypothesis 4 in 
that a flatter cortisol slope was found in only the depressed (as measured by the BDI) 
CAD patients. This finding was notably absent from the depressed but cardiac disease- 
free group. The flatter slope was demonstrated by reduced cortisol levels early in the 
day and increased evening levels amongst the depressed CAD patient group.
These SIS study results relating to the cortisol slope supports much of the 
previous literature. A flattened slope has been found in association with work/home load 
stress in a sample of 156 healthy female adults (Adam et al., 2001). A flattened slope 
has also been found in 156 older adults in another study by Adam et al. (2006), in which 
feelings of tension and anger were concurrently associated with a flatter diurnal cortisol 
rhythm mainly resulting from evening cortisol levels.
There have been fewer studies on cortisol measures and mood in cardiac patients. 
The findings from the SIS study are consistent with some of the results from previous 
studies. Otte et al. (2004) has shown greater mean urinary cortisol levels over 24 hours 
in depressed cardiac out-patients compared with non-depressed cardiac out-patients, but 
no relationship was seen with the cortisol slope in this study. However, in the study by 
Nijm et al. (2007), 30 CAD patients were found to have a higher 24 hour cortisol 
secretion and a flattened diurnal slope with significantly higher cortisol values in the 
evening, compared with clinically healthy controls.
The association of a flatter slope associated with the depressed CAD patient 
group only found in the cross-sectional analysis does not determine the causal direction 
between depression and cortisol. There are a number of possible causes of this 
relationship:
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a) Does depression lead to an alteration in the cortisol profile and then onto cardiac 
ischaemia? It is possible that affect will influence the way these participants cope with 
stress resulting in a flatter cortisol slope, which has various metabolic, inflammatory, and 
haemostatic consequences for cardiovascular health over the long term.
b) Do increased cortisol levels found in CAD patients contribute to greater depressive 
symptoms commonly seen in those with cardiac disease?
c) Is there another unmeasured factor that induces cortisol release in the evening and 
thereby a flatter slope and depression?
In conclusion, the results add to the evidence that disturbance of the cortisol 
profile may be the mediating mechanism by which depression is associated with CAD 
but the causal nature of this relationship has yet to be elucidated in further work.
11.4 Adaptation to ACS
Hypothesis 5 : Acute emotional state during hospitalisation for ACS will predict 
resumption o f work 13 months later independent o f both socio-demographic and 
cardiological variables.
Hypothesis 6 : Acute emotional triggers o f ACS are predictive in greater longer term 
adaptation to ACS. Psychological and physical triggers in the hours immediately before 
the symptom onset o f ACS will differentially predict mental and physical health 
adaptation 12 and 36 months later.
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The results from chapter 9 support hypothesis 5; depression independently 
predicts return to work, irrespective of any clinical or socio-demographic factors.
Return to work was regarded as a major indicator of success of recovery from 
acute myocardial infarction in the 1970’s and 1980’s (Mital et al., 2004; Soderman et al., 
2003), but has been relatively neglected over the past decade in favour of more subtle 
measures of quality of life. However, resumption of work remains an important marker 
of the success of medical and rehabilitation services in equipping people to maintain 
economic independence (Boudrez & de Backer, 2000). It cannot be assumed that factors 
identified over 25 years ago, as predictors of return to work, will be relevant in the 
modern era. The concept of ACS has evolved and is no longer limited to acute 
myocardial infarction. Treatment has substantially changed with the use of PCI and 
thrombolysis, and rapid restoration of activities for patients is encouraged. The average 
duration of hospitalisation following ACS has reduced substantially and some authorities 
recommend discharge of patients with uncomplicated ACS within 4 days (Boudrez et al., 
1994).
An inconsistent relationship between depressed mood and return to work has 
been reported in previous investigations. Cross-sectionally, individuals who are not 
working post-ACS are more depressed than those who are employed (Mital et al., 2004). 
However, because causal conclusions cannot be drawn from cross-sectional results, it is 
possible that depression impairs the ability to resume and maintain paid employment. 
The reverse may also be true since lack of work and unemployment is a strong predictor 
of depression (Kaul et al., 2004).
An association between depressed mood measured 4-6 months post-discharge 
and return to work has been described (Cay et al., 1973; Soderman et al., 2003), but 
depressed mood soon after hospital admission is particularly important for two reasons.
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First, clinical depression and dysphoria in the immediate post-ACS period are predictors 
of cardiovascular morbidity and mortality (Alter et al., 2006). Second, depressed mood 
can be conveniently measured before patients are discharged, so provides important early 
information about risks to long term recovery (Dooley et al., 1996). No associations 
between depression and anxiety measured during hospitalisation and return to work were 
found by Petrie et al. (1996) and Mayou (1984), though studies have shown positive 
associations in Sweden and Japan (Soejima et al., 1999; Maeland et al., 1987).
In conclusion, the results indicate that depressed mood in the acute aftermath of 
ACS admission is a powerful predictor of failure to resume work one year later. Its 
influence is independent of clinical and demographic factors. Depressed mood is an 
easily measured and potentially modifiable factor, and is consistently associated with 
other adverse outcomes in CAD. These data indicate that it is relevant to the resumption 
of economic activity as well as other aspects of recovery and rehabilitation.
The results from chapter 10 support hypothesis 6 . Multivariate analyses revealed 
that both anxiety at 1 2  and 36 months were predicted by acute emotional triggering of 
ACS but not by physical triggering. Physical vitality at 12 months and physical health 
status at 36 months were predicted by physical triggers but not by emotional triggers of 
ACS.
The mechanisms through which emotional triggers predict later mental well­
being are not certain. The association is not due to emotional trigger patients being more 
distressed in hospital or having a worse psychiatric history. It is conceivable that some 
unmeasured factors were related both to emotional triggering and later impaired well­
being, but a wide range of socio-demographic and clinical cardiological factors were 
tested. One possibility is that the experience of ACS is more distressing in patients who 
report emotional triggers. The Psychobiology Group at UCL have previously found that
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intense fear of dying was greater among patients who experience emotional stress in the 
two hours before symptom onset (Whitehead et al., 2005). Retrieval of emotional 
memories is influenced by the emotional context at the time of memory consolidation 
(Buchanan, 2007) so stress during the trigger period may contribute to the development 
of post-traumatic symptoms, leading to impaired mental well-being.
Alternatively, patients may attribute their ACS to stress and negative emotions, 
and become worried that similar occurrences will trigger future cardiac events. Cardiac 
patients develop cognitive models of the causes of their illness, in which stress often 
figures prominently (Cameron et al., 2005). Vulnerable individuals may have poor 
coping resources leading to preoccupation with emotional state and vigilance for the 
recurrence of situations and feelings they believe would provoke new cardiac illness. 
Causal attributions have previously been related to other outcomes in coronary heart 
disease, including maladaptive health behaviours (Day et al., 2005; Martin et al., 2005).
These data suggest that acute triggers have long term clinical and psychological 
ramifications beyond the first major concern about avoiding future ACS. Greater 
attention to understanding patients’ views of the immediate causes of their cardiac events 
may lead to wider recognition of the importance of triggers. For example, there is 
evidence that triggering by physical exertion is reduced in those who are usually 
physically active (Servoss et al., 2002). Therefore, the appropriate response to triggering 
by physical exertion is to engage in a regular activity program, and not become more 
sedentary. Similarly, some patients have maladaptive beliefs about the need to avoid 
excitement in their lives and this is shown to predict later poor quality of life (Furze et 
al., 2005). Programmes to educate patients in developing an understanding that 
emotional upset and distress are inevitable and rarely lead to ACS could prove valuable, 
although stress management methods may be required for patients with inappropriate
emotional expression (Tofler & Muller, 2006). By identifying differential predictors of 
adaptation, cardiac rehabilitation programmes could focus more effectively on 
optimizing quality of life and well-being for individuals.
11.5 General study limitations
S IS  s tu dy
11.5.1 SIS study - General
A limitation of the SIS study is the relatively small sample size, although it is 
comparable with many previous investigations of TMI, HRV, and cortisol in everyday 
life (see chapter 2). The study also has no age and sex matched healthy controls free 
from cardiac disease and medication. Such a control group may have confirmed our 
findings, showing that effects were specific to people being investigated for heart 
disease, and that fewer associations between mood and biological markers would have 
occurred in healthy individuals.
However, I felt that a more interesting comparison could be made with 
participants who have normal coronary arteries, despite being in the same clinical 
situation as the CAD patients. In our study, a proportion of the sample had normal 
coronary arteries forming a natural control group. When analysing the influence of 
negative emotion on biological markers, findings are difficult to interpret because 
medications such as beta blockers have such profound effects on biological responses, 
such as HR, HRV and TMI. In addition, being investigated clinically for a serious 
condition such as CAD may have an impact on psychological state.
343
O f the total sample recruited, 68.2 % were male, 31.8 % were female and only
16.5 % were diabetic. It would have been interesting to recruit a wider range of ethnic 
groups, a larger percentage of women and participants with a greater range of cardiac 
risk factors, but such individuals did not attend the outpatient clinics from which I 
recruited. In the SIS study, all patients were recruited from teaching hospitals so there 
was no expected difference in the types of patients that were recruited to all three 
hospitals. However, it should be remembered that there is a possibility that more cases 
of chest pain are likely to be invasively managed in these types of hospitals and so the 
patients may not be representative of general cardiac population. This is because in 
tertiary hospitals there is a wider range of operating theatres and advanced surgical 
equipment, which may influence the decision making processes of the clinician and 
lower the threshold for invasive methods of treatment (for example angiography, 
percutaneous coronary intervention) than in a district general hospital.
11.5.2 Questionnaire
With any questionnaire data, there is a possibility of self-report bias, as people 
may respond in the way that they would like themselves to be perceived, particularly 
when measuring health behaviours. There is also the possibility of interpretation bias in 
the meanings of words. Measurements of trait affect were made using a well-validated 
BDI scale. An alternative method to assessing depression could have been by structured 
clinical interview. Measures o f hostility and anger were omitted from the baseline 
questionnaire due to space limitations and the requirement to restrict the questionnaire to 
an acceptable length. There is well established evidence relating hostility to the 
development of CAD (Barefoot et al., 1983). These emotions were, however, measured 
by the DRM but were reported at generally a low frequency and intensity.
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11.5.3 Clinical aspects
Ejection fraction
I did not collect data on ejection fraction (EF). The EF is the fraction of blood 
pumped out of a ventricle with each heart beat. Studies have shown that HRV is reduced 
in those individuals with a reduced EF, that is those patients with poor left ventricular 
function (LVF) or heart failure (Nolan et al., 1998). Although, the participants were 
screened for exclusion of chronic disease or cardiac failure, objective measurements of 
cardiac status using the EF would have confirmed this. Unfortunately, the three hospitals 
varied in their reporting of ejection fraction data within the angiogram report.
ECG
I chose to use 3 channel, 6  patient cable lead instead of a 12 patient cable lead in 
the interest of balancing the highest probability of detecting ischaemic episodes on the 
ECG recording, versus the acceptability and comfort of wearing the number of electrodes 
for 24 hours. The ECG monitor was lightweight to carry on a belt, but awkward to wear 
at night time. A minority of participants developed an allergic skin reaction to the 
electrode gel pads, despite purchase of a specific type for sensitive skin (‘skin sensor’ 
pads) and two participants’ electrodes were displaced during recordings by their daily 
physical activity. Fortunately, with these cases, ECG information was still available 
from the remaining electrodes.
Use o f beta blocker medication
The ECG recordings revealed a lower frequency of ST ischaemic episodes than 
would be expected for patients with symptoms awaiting an angiogram. O f the SIS study 
sample, only nine people had ST depression or TMI on ECG. One reason may be that 
67% of the sample was on beta blocker medication, which leads to an increase in the
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parasympathetic drive, reduction in blood pressure, and prevents cardiac ischaemia. To 
increase the frequency of detection of ischaemic changes and HRV, it may have been 
better to increase the length of the monitoring period to 48 hours but this would be less 
acceptable to the patients. An alternative would have been to recruit the participants off 
cardiac medication like beta blockers; however, this would have been not ethically 
acceptable. The TMI studies of post MI patients have been with patients who are 
medication-free (Barry et al., 1998, Gabbay et al., 1996, Krantz et al., 1994, Gullette et 
al. 1997), but these studies were carried out in the late 1980’s and 1990’s, and ethical 
guidelines have changed since then. All patients recruited in the study were suspected of 
CAD, awaiting confirmatory angiography, and hence put on beta blocker medication to 
reduce the frequency of angina symptoms, control risk factors, and reduce the risk of a 
full blown cardiac event prior to the angiogram.
HRV measures
There are multiple measures of HRV that are available and a selection of time 
and frequency domain measures were used to reflect a range of HRV measures that 
would be consistent with each other. The Task Force (1996) recommendations state that 
for 24 hour ECG recordings, the results of time domain measures are equivalent to those 
of frequency domain measures. A limitation in the findings of the SIS study is that the 
effects described in the frequency domain, for example a reduction in LF prior to the 
ischaemic episodes, are not supported by consistent findings in the time domain 
measures, such as RMSSD. This may be due to the small sample size. Although there is 
good evidence relating alteration in HRV with development of CAD and prognosis post 
MI, when interpreting these HRV measures, it must be remembered that the relative 
contributions of sympathetic and parasympathetic activity to these HRV indices cannot 
be precisely specified as they are influenced by other physiological factors. In contrast
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to healthy people, in HRV studies of cardiac patients, HF power can be confounded by 
non-respiratory arrhythmia thus exaggerating the magnitude of HF and thus not reflect 
vagal moderation of HR (Stein et al., 1999).
Definition o f CAD
Another slight limitation with this study was the exact definition of the groups 
‘CAD positive’ and ‘CAD negative’. CAD positive patients were those defined as 
having symptoms, positive tests and an angiogram showing one or more vessels stenosed 
at greater than 50%. Other participants showed angiogram findings of only mild 
atheroma, or two or three diseased vessels. With a larger sample, it would have been 
feasible to classify these findings according to the number of diseased vessels. A 
proportion of the sample did not eventually undergo an angiogram procedure due to not 
having any further symptoms or changing their mind about having the procedure done. 
If these patients had no prior history of CAD and declined the procedure, it was assumed 
they were CAD negative. There is a possibility that including them in the data set may 
have overestimated the number of CAD negative people. Additionally, the CAD 
positive patients did not necessarily consist o f the same group of patients who exhibited 
ECG ischaemic changes.
A proportion of patients were found to have normal angiogram results despite 
reporting symptoms of chest pain or undergoing positive exercise tests or a positive 
myocardial perfusion scan. Whilst this is not a limitation to the study, it highlights how 
variable the sensitivity and specificity of the exercise ECG treadmill tests (ETT) and 
myocardial perfusion scans are (Fleischmann et al., 1998; Marwick et al., 1992).
347
11.5.4 Physical activity
In order to assess the relative impact of affective states on cardiac function, the 
effect of physical activity needs to be statistically controlled, as everyday physical 
activity has been associated with ischaemic episodes (Gullette et al., 1997; Gabbay et al., 
1996). Time constraints have prevented physical activity from being taken into account 
in this study in the analysis o f ischaemic changes. However, these analyses are planned 
for the near future. Actogram data will be used to statistically control for physical 
activity and it is possible that the association between negative mood and ischaemic ECG 
changes will be accentuated independent of physical activity. Additionally, the DRM 
did provide data regarding activity and mood throughout the monitoring period, which 
will be used to confirm findings on the actogram in future analyses.
11.5.5 DRM
The new DRM tool, whilst having the advantages of reducing participant burden 
in the study and not missing important incidents in the day, is dependent on accurate 
recall of activities and emotional experiences. It has been argued that affective 
experience as assessed by the DRM is less dependent on comparison standards and 
global prototypic evaluations than by questionnaire measures (Kahneman et al., 2004). 
For example, when people are asked to make global judgements such as how much they 
enjoy spending time with their children, they make prototypical positive evaluations. 
However, the DRM reveals that the time actually spent with children is often not rated as 
enjoyable or satisfying on a day to day basis, and that other activities are rated far more 
positively (Kahneman et al., 2006). It is possible that the interaction with the interviewer 
(researcher) face to face will have influenced affective descriptions for certain activities 
(for example, argument with spouse, school run with child).
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Although, the DRM burdened the participants less than studies using diary 
methods (Gullette et al., 1997; Gabbay et al., 1996), the one hour DRM interview was 
found to be time consuming, laborious and repetitive by some of the participants. An 
alternative method of carrying out the DRM would be for an on-line computer 
questionnaire in which the participants completed it in their own time and with no 
influence from the interviewer.
A longer ECG recording or DRM interview assessing mood over 48 hours may 
have picked up more changes in HRV with relation to various emotions. In addition, 
because of the simultaneous occurrences of multiple activities during daily life, 
particularly those activities being reported together (for example, cooking with friends), 
it may be difficult to specify independent emotional triggers relating to HRV. Another 
limitation to the study is that DRM analyses on data concerning activities and social 
interaction measures have not been carried out. All the analyses are based on mood, but 
the DRM also provides rich data on how people spent their time, and how they felt when 
they were involved in different activities.
11 .5 .6  C o rtiso l
Salivary sampling of cortisol nine times over a 24-hour period is satisfactory and
was acceptable to the majority o f patients. However, it would have been interesting to
have taken samples on more than one day to assess the CAR on two consecutive
mornings, to measure the consistency of the diurnal pattern. Discrepancies can occur
between studies measuring cortisol values and depression, as depressed individuals may
be less inclined to accurately adhere to protocols. There was an absence of adherence
monitoring of the salivary cortisol sampling. While the actigraph can confirm to a high
degree, the time of awakening, there is no comparable assessment of whether the saliva
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sample was collected within the appropriate time periods and whether the patient stayed 
in bed for the first sample of the day. An alternative approach would be to place the 
salivette in a MemsCap bottle which records the date/time of opening, and thereby 
provides a better index of adherence than self-report.
It has also been shown that a potential confounding factor for the CAR is 
sensitivity to light (Clow et al., 2004). These samples were collected from participants 
across a whole range of seasons in which the different environmental exposure to light 
for the participants may have affected the results.
A strength of the study is that patients were studied prior to a diagnosis of CAD, 
so both investigator and research participant were blind to the final diagnosis of their 
symptoms. However, each of these patients was being referred for cardiac 
catheterization which may have affected mood prior to this procedure. It could be 
anticipated that some degree o f anxiety or stress was in process, causing the associated 
neuroendocrine activation. For others, it may be reassuring that something active was 
being done about their problem. So despite not knowing the angiogram results, it is not 
guaranteed that mood was unaffected prior to knowledge of actual disease, in these 
patients with suspected CAD.
ACCENT study
11.5 .7  F o llo w  up
A satisfactory follow up rate is important to ensure the findings are not biased 
and are representative across the patient sample. For instance, it is possible that the more 
depressed people after an MI declined follow up and dropped out of the study. If so, 
analysis of the remaining sample may have underestimated the effect that depression has
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on cardiac prognosis. Follow up of patients proved to be particularly difficult, especially 
as the time from the initial phase of the study had increased. A substantial proportion of 
the patients had either passed away from cardiac or non-cardiac causes or moved 
address. A few participants declined to take part in further follow up or had difficulty 
completing the questionnaire due to increasing ill health. Following up non respondents 
was addressed by searching computerised patient records at the hospital of their original 
admission for ACS.
11.5 .8  R etu rn  to  w o r k
In the return to work analysis, the main outcome measure was whether 
participants were working or not at 12 months follow up. Information was collected 
about whether the participants’ level o f work commitments had changed because of the 
ACS, and about exactly when they returned to work. These factors were not associated 
with depression in hospital, but the quality of data was somewhat suspect. Patients were 
asked about timing at 12 months, and they may not accurately have recalled exactly 
when they resumed work. It should also be emphasised that the return to work measure 
was self-reported, and I was not able to corroborate it with objective measures.
11.5 .9  T r ig g er in g  o f  A C S
All patients’ description of possible triggers in the hour or two prior to the MI 
were self-reported with no objective outside verification, for example, by a spouse. In 
addition, only a very small number of physical exertion trigger cases were reported and 
so this may have biased results in the follow up analysis of emotional and physical 
triggers of ACS and later adaptation.
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11.6 K ey  m essa g e  
F igu re  11.2: K ey  m essa g es
T M I
In c r e a s e  in n eg a t iv e  
c o m b in e d  m o o d  a n d  
worry prior to  o n s e t  
of TMI.
D e c r e a s e  in positive 
affect prior to  o n s e t  
TMI.
C O R T I S O L
D e p r e s s io n  a s s o c i a t e d  with flatter 
cort isol s lo p e  in CAD p a t ien ts  only. 
CAD p a t ie n t s  s h o w  a n  e x a g g e r a te d  
CAR, i n d e p e n d e n t  of d e p re s s io n .  
R e d u c e d  CAR a s s o c i a t e d  with 
i s c h a e m ic  e p i s o d e s  on  EC G .
H R V
D e p r e s s e d  m ood  
a s s o c ia t e d  with red u c e d  
HRV a n d  HR in c re a s e  at 
night in CAD patien ts. 
Positive  affect a s s o c ia t e d  
with in c re a s e d  HRV in 
total s am p le .
S / S  s t u d y  p a tien ts  w ith  ear ly  s u s p e c t e d  CAD in da ily  life
A C C E N T  s tu d y
p a tien ts  w ith e s ta b lis h e d  CAD a t 12  an d  36 m o n th s  after ACS
D e p re s s io n  p red ic ts  re turn  to 
work a t  12-13 m o n th s  later, 
in d e p e n d e n t  of clinical a n d  
d e m o g ra p h ic  factors .
E m otiona l  tr iggers  of A C S  predict long 
te rm  em o tio n a l  a d a p ta t io n  to A C S  a t  12 
a n d  36  m o n th s ,  in d e p e n d e n t  of clinical, 
d e m o g r a p h ic  fac to rs  a n d  m edication .
S u m m a r y :  N e g a t i v e  e m o t i o n  a s s o c i a t e d  w i t h  r e d u c e d  H R V ,  a l t e r e d  c o r t i s o l  p r o f i l e  a n d  
T M I  i n  d a i l y  l i f e  i n  t h e  e a r l y  s t a g e s  o f  C A D ,  a n d  w i t h  e m o t i o n a l  a d a p t a t i o n  t o  A C S  i n  t h e  
l o n g  t e r m  i n  e s t a b l i s h e d  C A D  P o s i t i v e  e m o t i o n  a s s o c i a t e d  w i t h  i n c r e a s e d  H R V . ____________
11.7 F u tu re  p lan s
To build on the present findings from these three studies, I would like to focus on 
a number of areas.
The SIS study utilised cross-sectional data and therefore associations between 
mood and reduced HRV and ischaemic episodes cannot infer causality and a preferable 
methodology is follow up longitudinal studies or case-control designs.
It would be interesting to repeat the study with a much larger sample of patients 
and comparable healthy participants and analyse the associations between a wider range 
of variables (time and frequency domains) and the specific emotions as assessed by the 
DRM.
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I think it would be interesting to further our study by analysing different types of 
CAD patients; that is comparing HRV changes associated with ischaemia and mood in 
these SIS patients with established CAD patients post ACS or after cardiac surgery or 
patients with congestive heart failure. HRV changes may only occur in specific types / 
subgroups of cardiac patients and not others. Additionally, gender differences (Thayer et 
al., 1996) and ethnicity differences (Liao et al., 1995; Wang et al., 2005) in HRV have 
been found, and this is an area to explore further.
It would be interesting to further examine the cohort of patients in the SIS study 
prospectively, to see if reduced HRV associated with negative affect in daily life in the 
participants predicts cardiac mortality/morbidity at one or three year follow up, although 
this study may not have a big enough patient sample to show any statistical differences.
As differing symptoms (cognitive versus somatic) of depression were found to 
differentially relate to variables of HRV (De Jonge et al., 2007); an intervention trial 
could be undertaken in which the patient group who showed an increase in depressive 
symptoms could be recruited and divided into two groups. One group could undertake a 
12 week course of antidepressant treatment and another group could undergo cognitive 
behavioural therapy. HRV and cortisol measures could be assessed along with DRM 
mood after 3 months to see if there is any improvement in HRV or cortisol profiles.
The cortisol diurnal profile was analysed in relation to mood as measured by the 
BDI but not related to the mood profile as measured by the DRM in the day. Previous 
studies have examined cortisol profiles in relation to daily negative events in 
predominantly healthy people. In the study by Peeters et al. (2003), patients with a 
major depressive disorder were investigated by ESM. In contrast to healthy participants, 
the depressed group showed a blunted response to daily negative events. In a study by 
Smyth et al. (1998), increased negative affect in response to current daily stress or
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anticipated stress was associated with elevated cortisol levels and conversely, increased 
positive affect was associated with decreased cortisol levels. It would be interesting to 
analyse associations between cortisol values and the cortisol awakening response and 
aggregate scores of specific emotional states as measured by the DRM in daily life, in 
both cardiac patients and age and sex matched healthy controls from a GP database.
The HPA response to daily stressors over a long period of time remains to be 
demonstrated. Whilst there have been plenty of cross-sectional studies linking cortisol to 
mood and stress in daily life, there have been few prospective studies determining 
whether daily emotional stress predicts future health outcomes. Negative affect may 
mediate the association seen between stress and cortisol, either by affect influencing the 
perception of daily events or being related to a heightened physiological effect of stress 
(Van Eck et al., 1996, Smyth et al., 1998). Two questionnaires were completed-the first 
just before the interview and the second at 6 months. To detect any longer term 
adaptation after the CAD diagnosis, the SIS study patients could be followed up 
prospectively at one year and three years by repeat questionnaire, along with the 
measurements of related physiological correlates such as the ANS, and salivary cortisol 
assessment. This would show whether repeated daily alterations in the HRV indices or 
cortisol slope over time are associated with an alteration in trait BDI score with a 
consequent long term effect on cardiovascular health, in terms of new cardiac events or 
re-admission or change in quality of life.
Finally, the SIS study investigated temporal variation in HRV, cortisol and mood 
across the day, focusing on differences between depressed and non-depressed individuals 
and between groups of CAD and non-CAD patients. However, all the results from the 
S is  study so far, are based on between-person analyses. DRM analyses could include 
the relationship between the patient’s activities and who they were with at the time of the
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ischaemic episode. These data lend themselves well to within-person analyses using 
multilevel modelling, looking at co-variation between mood, activities and physiology.
11.8 Clinical implications
The clinical implications o f identifying emotional stimuli as triggers of ACS 
either at an early stage of CAD before an MI has occurred, or at an advanced stage of 
disease in which patients have been hospitalised for ACS, are related both to prognosis 
and prevention. From the prognostic perspective, emotional triggering may imply a 
special vulnerability to interpersonal events, which places certain types of patients at 
high risk.
A range of clinical management strategies can be directed against the risk of 
triggering of ACS, by reducing exposure to known emotional or physical triggers in 
daily life, either in patients with early suspected CAD or in patients recovering from an 
ACS event. Precautions could be taken that heighten alertness to high risk situations to 
ameliorate the impact of these triggers. A good example is regular physical exercise 
training for reducing the risk of triggering by physical exertion (Willich et al., 1993; 
Mittleman et al., 1993). The onset of ACS during vigorous exercise is greatly lessened 
in people who are physically fit and exercise regularly.
Prevention of emotional triggering is more difficult than physical triggers. This 
is because the absolute rates are of low intensity especially in daily life. So even in high 
risk cases, the chances of a trigger stimulus actually inducing an ACS on any particular 
occasion are low. Informing patients about the possible dangers of emotional triggers 
must be handled delicately, since it is important not to give the impression that all
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excitement and intense emotion should be avoided (for example, attending a football 
match), or that the patient should withdraw into a restricted style of living (Thompson et 
al., 2000). Patients should be reassured that the absolute risk levels are low even though 
relative risk may be high.
Nevertheless, there are cognitive behavioural therapies that can assist people with 
the inappropriate or excessive expression of emotions, such as anxiety, worry, and 
distress. High levels of worry predicted a worse physical health status at 6 months 
independently of covariates (chapter 8 SIS study 6 month follow up results) whereas 
anxiety at both 12 and 36 months was predicted by emotional triggering of ACS. 
Anxiety management programmes can help people escape from the cycle of negative 
thoughts, identify unreasonable fears and encourage a more realistic appraisal of the 
situation with its probable risks, and replace it with more measured methods of coping. 
Similarly, stress management training can help people cope with apparently 
overwhelming demands by more effective time management, prioritising, and reappraisal 
of the importance of different pressures. A study by Blumenthal et al. (2002) was carried 
out in which 94 male CAD out-patients were randomly assigned to a stress management 
programme, exercise regime, or usual care. After 5 years, stress management was 
associated with a significant reduction in clinical CAD events compared with usual care 
over each of the first two years and after five years.
Pharmacological methods may also be appropriate, including beta blockers. 
Depressed mood has been associated with reduced HRV. Activity induced changes in 
the sympatho-vagal balance have been implicated in triggering of ischaemia. The SIS 
study showed a reduced frequency of ischaemic episodes possibly due to patients being 
on beta blocker medication. Beta blockade may thus, in theory, be beneficial in 
treatment by reducing cardiac demand. Reduction of the sympathetic drive by beta
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blockers may also attenuate the natural haemodynamic responses evoked by anxiety or 
panic. However, the use of pharmacological methods requires fuller evaluation; while 
some studies suggest that emotional triggering is less common in patients taking beta 
blockers (Culic et al., 2004), this is not a universal finding (Strike et al., 2006).
11.9 Conclusion
In combination, the SIS study and the two studies from the ACCENT study add 
to the literature relating emotional factors to cardiac health. They suggest that negative 
emotions in daily life as measured by a new tool, the DRM, and negative trait affect 
contribute both to the onset of acute cardiac events in susceptible patients and that 
negative emotions are related to impaired long term adaptation following ACS.
The studies indicate that the pathophysiological processes underlying emotional 
triggering include the neuroendocrine and autonomic processes stimulating rhythm 
disturbances, which may promote plaque rupture, thrombosis formation, and cardiac 
ischaemia.
The results from these studies promises important insight into the timing of acute 
cardiac events and implications for rapid recovery after ACS, opening up possibilities for 
new methods o f clinical management. The effectiveness of such techniques in clinical 
practice remains to be demonstrated empirically. By further understanding how 
emotional factors relate to cardiac health, clinicians can risk-stratify psychologically 
vulnerable individuals and apply a more individually tailored management programme 
(both pharmacological and non pharmacological). Focusing on the psychological
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environment of the patient in addition to treating the standard biological risk factors will 
ultimately provide greater benefit to the patients’ cardiac health and well being.
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Appendix 1: Patient information sheet
Royal Free and University College Medical School
UNIVERSITY COLLEGE LONDON
DEPARTMENT OF CARDIOLOGY, ROYAL FREE HOSPITAL 
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH, UCL
Study of Emotion and Heart Disease
PATIENT INFORMATION SHEET (Confidential)
You are being invited to take part in a research study. Before you decide it is important for you to 
understand why the research is being done and what it will involve. Please take time to read the 
following information carefully and discuss it with others if  you wish. Ask us if  there is anything 
that is not clear or if  you would like more information. Take time to decide whether or not you 
wish to take part.
Thank you for reading this.
W hat is the purpose o f the study?
Disease in the coronary blood vessels develops over many years, but exactly what triggers 
symptoms and heart attacks is not well understood. We are trying to find out whether lifestyle 
and emotional state make a contribution in some patients. We are studying the relationship 
between emotion and the heart in everyday life, and how our responses to emotional events in the 
day may relate to physical symptoms, adaptation to heart disease and quality o f life. We are 
particularly interested in linking the psychological factors with the underlying biology o f heart 
disease, to see whether there are differences in the various chemicals in the body that are 
involved in heart attacks and angina.
W ho is organising and funding the research?
This research study is funded by the British Heart Foundation, and its purpose is to learn more 
about how our emotions and behaviour influence the cardiovascular system in health and disease. 
The results will help advance our knowledge o f  the links between the mind and the body, and 
develop new methods o f  improving patient care. The study is being carried out by Dr  
, a Consultant Cardiologist at the Royal Free Hospital, in collaboration with Professor 
Andrew Steptoe from the Department o f  Epidemiology and Public Health at University College 
London. The researchers, who are contracted by the British Heart Foundation and will carry out 
the work, are Dr Mimi Bhattacharyya and Dr *******.
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Why have 1 been chosen?
We are looking to see how emotional state affects the heart. To increase the likelihood o f finding 
any significant relationship between emotion and heart disease, we need to study patients who 
are having symptoms o f possible heart disease.
You have been chosen as you have been having symptoms o f chest pain requiring your 
attendance to hospital and your exercise test shows some changes on the ECG that could indicate 
a possibility o f  heart disease.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form to keep. If you decide to 
take part you are still free to withdraw at any time and without giving a reason. A decision to 
withdraw at any time, or a decision not to take part, will not affect the standard o f  care you will 
receive.
W hat will happen to me if  I take part? How You Can Help?
We would like to record the electrical activity in your heart (the ECG) by asking you to wear a 
monitor for 24 hours. This is like wearing a walkman. It is comfortable, discreet to wear and 
should not interfere in your daily activities. We also need to know about the effect that physical 
activity has on your heart, so we would like you to wear a special watch on your wrist which 
measures physical activity. After the 24 hour period, we will interview you about what has been 
happening in your life during the period o f  monitoring. This will take about one hour, and will 
take place in the Cardiac Department at the Royal Free or at University College London. We 
will also ask you to fill in some questionnaires in your own time. These concern how you are 
feeling about life, and how you cope with stress. This should take no longer than 30 minutes to 
complete. Analysis o f the 24 hour ECG tape from the monitor will clarify the link between 
emotional events in the day and what is happening to your heart at the same time.
The second part o f  the study involves measurement o f  chemicals in your saliva (spit). There are 
several hormones that affect the way the body works, and fortunately these can be measured in 
saliva. Several times over a day o f  ECG monitoring, we will ask you to put a cotton dental swab 
in your mouth for a couple o f  minutes, then return it to a storage tube. We would like to do this 
both on the day o f  ECG monitoring, and then again after 6 months and 12 months. The samples 
you collect at home can be posted back to us (we will provide the postage and packing).
W hat else do I have to do?
There are no lifestyle restrictions. As we are studying emotion and heart disease in everyday life 
you should do everything as usual including, if  applicable, taking your regular medication.
W hat are the possible disadvantages o f taking part?
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If analysis o f your ECG brings up a condition that requires management, for example a 
significant arrhythmia, we will inform both you and staff at the clinic.
W hat are the possible benefits o f taking part?
There are no direct immediate clinical benefits from taking part in the study. We can provide you 
with personal information regarding your ECG and heart rate. The information we get from this 
study may help us to treat future patients with coronary heart disease better. Your participation to 
help further this research would be appreciated.
W ill my taking part in this study be kept confidential?
We want to emphasise that all results obtained will be strictly confidential and will only be used 
for medical research purposes. All information about you which leaves the hospital will have 
your name and address removed so that you cannot be recognised from it. We will inform your 
GP by letter about the study and your agreed participation in it with your consent.
W hat if something goes wrong?
We do not expect you to suffer any adverse effects from this study since we are not testing any 
medicines or procedures and it will not affect your clinical outcome. There are no special 
compensation arrangements. If you are harmed due to som eone’s negligence, then you may have 
grounds for legal action but you may have to pay for it. Regardless o f this, if  you wish to 
complain, or have any concerns about any aspect o f  the way you have been approached or treated 
during the course
o f this study, the normal National Health Service complaints mechanisms should be available to 
you. You will be able to contact the research team in the first instance.
W hat will happen to the results o f the research study?
The study will recruit 100 participants over a 2 year period. The results will be statistically 
analysed and findings subsequently published in peer reviewed journals. You will not be 
identified in any publication.
W ho has reviewed the study?
The local research ethics committee at the Royal Free Hospital and Medical School have 
reviewed the study and given a favourable ethical opinion.
Contact for further Inform ation
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Many thanks for reading this. We hope you feel able to take part in our study, which will help us 
understand more about the causes o f  heart disease and how to manage it better.
If you have any questions, please contact Dr.Mimi Bhattacharyya, Department o f Epidemiology 
and Public Health, University College London, . 
Telephone  or email 
408
Appendix 2: SIS study patient consent form
Royal Free and University College Medical School
  
DEPARTMENT OF CARDIOLOGY, ROYAL FREE HOSPITAL 
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH, UCL
Study N um ber:
P atien t Id en tifica tion  N u m b er
CONSENT FORM (Confidential)
T itle  o f  pro ject: A Study of Emotion and Heart Disease
N am e o f  R esearchers: D r , P ro fe sso r A n d rew  S tep toe , D r M  B h a ttach ary y a , D r 
A ny qu estio n s to  D r.M  B h attacharyya, D e p a rtm en t o f  E p id em io lo g y  and Pub lic  H ealth , U n iversity  C ollege 
L ondon , 
Please initial
1. I con firm  that I have read and u n d e rs to o d  the  in fo rm atio n  shee t for the above  study and have 
had the  oppo rtu n ity  to  ask questions.
2. I und erstan d  th at m y p a rtic ip a tio n  is v o lu n ta ry  and  th at I am  free  to  w ithd raw  at any tim e, 
w ithou t g iv in g  any  reaso n , w ith o u t m y m ed ical care  or legal righ ts be ing  affected .
3. I un d erstan d  th a t sec tio n s  o f  any  o f  m y m edical notes m ay be looked at by reg u la to ry  
au th o ritie s  w h e re  it is re le v an t to  m y tak in g  part in research . I give pe rm iss io n  for these  
in d iv iduals to  h ave  access to  m y records. I a lso  give perm ission  for m y G P to  be in form ed  o f  
m y p a rtic ip a tio n  in th e  study .
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4. I agree to take part in the above study.
N am e o f  pa tien t D ate S ignatu re
N am e o f  P erson  tak in g  consent D ate S igna tu re
( if  d ifferen t from  researcher)
R esearcher D ate S ignature
1 for Patient; 1 for R esearch er; 1 to  be kep t w ith  h o sp ita l no tes
Appendix 3: Day Reconstruction Method interview
DIARY OF EVENTS YESTERDAY
We would like to learn what you did and how you felt yesterday. Not all days are the 
same-some are better, some are worse and others are pretty typical. Here we are only 
asking you about yesterday. Because many people find it difficult to remember what 
exactly they did and experienced i.e. your mood and how you felt about those episodes 
we will do this in three steps.
First I shall ask when you woke up and when you went to sleep yesterday (A)
Then, we’d like you to reconstruct what your day was like as a continuous series of 
episodes in a film (B). Think about where you were? What did you do and experience? 
How did you feel? For each episode I shall ask the approximate time at which episode 
began and ended(usually between 15mins and 2  hours).Indications of an end of an 
episode may be going to a different location, ending an activity or change of people with 
whom you were interacting.
The day will be divided up into morning (M) (waking till before lunch), afternoon (A) 
(12-6pm), Evening (E) (6 pm till you went to bed).Try to remember each episode in detail 
and what you felt and how was your mood at the time.
Finally the third step involves that after reconstructing the episodes of the day, we will 
ask several questions about how you fe lt and moods experienced for every episode 
recorded (C)
We will ask you to fill out a time table of events in the day to jog your memory.
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i) Interview (Answers to questions asked inputted directly into SPSS software 
programme)
About what time did you wake up yesterday?
And when did you go to sleep?
Morning
a) Episode: Please select the earliest episode you noted in the Morning: Describe it
b) When did the first episode begin and end. Please try to remember the times as 
precisely as you can.
c) This is episode number 1M which began at —  and ended at
D) What were you doing?
-commuting
-shopping
-doing housework
-eating
-prayer
-socialising
-nap/rest
-relaxing
-other
-self care
-working
-preparing food
-taking care of children
-watching TV
-computer/internet/email
-on phone
-exercising
-intimate relations
-driving
-walking
e) Where were you?
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-At home -at work -somewhere else
f) Were you interacting with anyone else (including phone)? 
-No one -'^ sk ip  n ex t question
If you were interacting with someone (please check all that apply) 
-Spouse/significant other -my children
-Friends -parents/relatives
-Co-workers -boss
-Clients/customers -other people not listed
-students
ii) Timetable that patients are asked to complete to aid participation in DRM
Time of 
day
What were you 
doing?
Where were 
you
If with
someone,
who?
Beginning 
time(B)/end 
time episode 
(E)(number)
0600-0700
0700-0800
0800-0900
0900-1000
1000-1100
1100-1200
1200-1300
1300-1400
1400-1500
1500-1600
1600-1700
1700-1800
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Time of 
day
What were you 
doing?
Where were 
you
If with
someone,
who?
Beginning 
time(B)/end 
time episode 
(E)(number)
1800-1900
1900-2000
2000-2100
2100-2200
2200-2300
2300-0000
Episode number in total- Morning
Afternoon
Evening
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iii) Ratings of emotion for each episode
How did you feel during this episode?
Please rate each fe e lin g  on the scale given.
*A rating of 0 means that you did not experience that feeling at all.
*A rating of 6 means that this feeling was a very important part of the experience. 
*Please circle the number between 0 and 6 that best describes how you felt.
Not at all Very Much
Impatient for it to end?  0
Happy?..................................  0
Frustrated/annoyed?  0
Depressed/blue?.................... 0
Warm/friendly?.....................  0
Angry/hostile?........................  0
Worried/anxious?..................  0
Tired?...................................... 0
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
Appendix 4: SIS study pre interview questionnaire pack
Pt No:Name:
Medical Research Study 
Emotion and Heart Disease
T hank  you very  m uch  fo r p a rtic ip a tin g  in o u r study o f  em o tio n s and  h eart d isease. In 
add ition  to  the  sa liva  sam p les w e have  ask ed  you to  co llec t, w e  w o u ld  like you to  
co m ple te  th is q u estio n n a ire  ab o u t y o u r life sty le , y o u r a ttitu d es and  o p in ions, the w ay 
you feel ab o u t y o u rse lf  and  th e  w ay  yo u  feel ab o u t y o u r h eart p rob lem . Y ou m ay feel 
that som e o f  the qu estio n s do not ap p ly  to  you , bu t p lease  an sw er each  question  w ith 
the an sw er that m ost c losely  fits the  w ay  y ou  feel.
T he answ ers you prov ide in th is q u e stio n n a ire  w ill be kep t strictly confidential. T he 
in fo rm ation  w ill go into the s ta tis tics  fo r  the study , and it w ill not be p o ssib le  to 
identify  you personally  in any reports . U n d e r no  c ircu m stan ces w ill any o f  the 
in fo rm ation  you give us be m ade  av a ilab le  to  an yone  else.
Most of the questions can be answered by circling the appropriate 
answer.
F or exam ple:
“I can sit at ease and feel relaxed”
Definitely Usually Not often Not at all
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Please be sure to read the instructions to each section carefully.
What do you think caused your medical problem?
Serious illnesses like heart disease may be caused by many different factors. We would 
like to find out what factors you think were involved with your own illness. Listed 
below are a series of factors that patients in the past have thought helped to cause their 
heart disease symptoms. Please think about each item, then circle the answer that 
indicates how much you agree or disagree with each statement.
Factors that might have helped cause my illness
My illness is hereditary -  it runs in my family No Maybe Yes
Smoking played a major role in causing my illness No Maybe Yes
My illness was brought on by other medical problems No Maybe Yes
Stress was a major factor in my illness No Maybe Yes
Being overweight caused my illness No Maybe Yes
High blood pressure was an important factor in my illness No Maybe Yes
Diet played a major role in causing my illness No Maybe Yes
I became ill because I over-exerted myself No Maybe Yes
It was just by chance and bad luck that I became ill No Maybe Yes
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My illness was caused by poor medical care in the past No Maybe Yes
Lack of exercise was a cause of my illness No Maybe Yes
My illness was brought on by tiredness and exhaustion No Maybe Yes
Genetic factors (genes) caused my illness No Maybe Yes
My state of mind played a major part in causing my illness No Maybe Yes
Working too hard caused my illness No Maybe Yes
A germ or virus caused my illness No Maybe Yes
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This part of the questionnaire is about your emotions and how you are feeling. 
Read each item and circle the reply which comes closest to how you have been 
feeling in the past week.
1. I feel tense or ‘wound up’:
Most of the time A lot of the time From time to time, Not at all
occasionally
2. I get a sort of frightened feeling as if something awful is about to happen:
Very definitely and Yes, but not too badly A little, but it doesn’t Not at all
quite badly worry me
3. Worrying thoughts go through my mind:
A great deal of the time A lot of the time From time to time Only
occasionally
but not too
often
4. I can sit at ease and feel relaxed:
Definitely Usually Not often Not at all
5. I get a sort of frightened feeling like ‘butterflies ‘ in the stomach:
Not at all Occasionally Quite often Very often
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6. I feel restless as if I have to be on the move:
Very much indeed Quite a lot Not very much Not at all
7. I get sudden feelings of panic:
Very often indeed Quite often Not very often Not at all
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The following questions are about your health and daily activities. Read each 
item and circle one answer for each question.
1. In general would you say your health is:
Excellent Very Good Good Fair Poor
2. Compared to one year ago, how would you rate your health in general now?
Much better now Somewhat better About the same Somewhat worse Much worse
than one year ago now than one year now than one year now than oneas one year ago
ago ago year ago
3. The following questions are about the activities you might do during a typical 
day.
Does your health now limit you in these activities? If so how much?
• Vigorous activities -  such as running, lifting heavy objects, participating in a 
strenuous sport
Yes, limited a lot Yes, limited a 
little
No, not limited at 
all
Moderate activities -  such as moving a table, pushing a vacuum
bowling, or playing golf.
Yes, limited a lot Yes, limited a No, not limited at
little all
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Lifting or carrying groceries.
Yes, limited a lot Yes, limited a 
little
No, not limited at
Climbing several flights of stairs.
Yes, limited a No, not limited atYes, limited a lot
Climbing one flight of stairs.
Yes, limited a lot Yes, limited a 
little
No, not limited at 
all
Bending, kneeling, or stooping.
Yes. limited a No. not limited atYes, limited a lot
Walking more than a mile.
Yes, limited a No, not limited atYes, limited a lot
Walking half a mile.
Yes, limited a lot Yes, limited a 
little
No, not limited at 
all
• Walking one hundred yards.
Yes, limited a lot Yes, limited a 
little
No, not limited at 
all
• Bathing or dressing yourself.
Yes, limited a lot Yes, limited a 
little
No, not limited at 
all
4. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health?
• Cut down the amount of time you spent on work or other activities.
No
Yes
• Accomplished less than you would like.
No
Yes
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• Were limited in the kind of work or other activities.
No
Yes
• Had difficulty performing the work or other activities (for example, it took extra 
effort).
No
Yes
5. During the past 4 weeks, have you had any of the following problems with your
work or other regular daily activities as a result of any emotional problems
(such
as feeling depressed or anxious)?
• Cut down on the amount of time you spent on work or other activities:
No
Yes
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• Accomplished less than you would like:
No
Yes
• Didn’t do work or other activities as carefully as usual:
No
Yes
6. During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbours, or groups?
Not at all Slightly Moderately Quite a bit Extremely
7. How much bodily pain have you had during the past 4 weeks?
None Very mild Mild Moderate Severe Very severe
8 . During the past 4 weeks, how much did pain interfere with your normal work 
(including both work
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outside the home and housework)?
Not at all A little bit Moderately Quite a bit Extremely
9. These questions are about how you feel and how things have been with you 
during the past 4 weeks. For each question, please give the one answer that 
comes closest to the way you have been feeling. How much of the time during 
the past 4 weeks:
• Did you feel full of life?
All of the Most of the A good bit of Some of the A little bit of None of the
time time the time time the time time
• Have you been a very nervous person?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Have you felt so down in the dumps that nothing could cheer you up?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
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• Have you felt calm and peaceful?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Did you have a lot of energy?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Have you felt downhearted and low?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Did you feel worn out?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Have you been a happy person?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
• Did you feel tired?
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All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
10. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, 
relatives, etc.)?
All of the time Most of the A good bit of Some of the A little bit of None of the
time the time time the time time
11. How TRUE or FALSE is each of the following statements for you?
• I seem to get ill more easily than other people.
Definitely
True
Mostly True Don’t Know Mostly False Definitely
False
• I am as healthy as anybody I know.
Definitely
True
Mostly True Don’t Know Mostly False Definitely
False
• I expect my health to get worse.
Definitely
True
Mostly True Don’t Know Mostly False Definitely
False
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• My health is excellent.
Definitely
True
Mostly True Don’t Know Mostly False Definitely
False
T he fo llow ing  sta tem en ts concern  your a ttitu d es and  op in ions. P lease  in d ica te  the  ex ten t you agree w ith 
each o f  the fo llow ing  sta tem ents. P lease  tick  one an sw er for each  s ta tem en t. T h ere  are no righ t or w rong  
answ ers.
S trong ly
D isag ree
D isag ree N eu tra l A gree Strongly
A gree
1 In uncertain  tim es,
I usually  expect the best
2 I t’s easy  for m e to  re lax
3 If  so m eth ing  can  go w ro n g  
for m e, it w ill
4 I ’m alw ays o p tim istic  
abou t m y fu tu re
5 I en jo y  m y friends a lot
6 It’s im p ortan t for m e 
to  keep busy
7 I hard ly  ev er expect 
th ings to  go m y way
8 I d o n ’t get upset 
too  easily
9 I ra re ly  co u n t on good 
th in g s h ap p en in g  to  m e
10 O v erall, I exp ec t m ore 
good  th in g s to  happen  
to  m e than  bad
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This part of the questionnaire consists of 21 groups of statements. After reading 
each group of statements carefully, circle the number (0, 1, 2, or 3) next to the one 
statement in each group which best describes the way you have been feeling the 
past week, including today. If several statements within a group seem to apply 
equally well, circle each one. Be sure to read all the statements in each group 
before making your choice.
1. 0 I do not feel sad.
1 I feel sad.
2 I am sad all the time and I can’t snap out of it.
3 I am so sad or unhappy that I can’t stand it.
2. 0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel that the future is hopeless and that things cannot improve.
3. 0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
4. 0 I get as much satisfaction out of things as I used to.
1 I don’t enjoy things the way I used to.
2 I don’t get real satisfaction out of anything anymore.
3 I am dissatisfied or bored with everything.
5. 0 I don’t feel particularly guilty.
1 I feel guilty a good part of the time.
2 I feel guilty most of the time.
3 I feel guilty all of the time.
6 . 0 I don’t feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7. 0 I don’t feel disappointed in myself.
1 I am disappointed in myself.
2 I am disgusted with myself.
3 I hate myself.
8 . 0 I don’t feel I am any worse than anybody else.
1 I am critical of myself for my weaknesses or mistakes.
2  1 blame myself all the time for my faults.
3 I blame myself for everything bad that happens.
9. 0 I don’t have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would not carry them out.
2 I would like to kill myself.
3 I would kill myself if I had the chance.
10. 0 I don’t cry any more than usual.
1 I cry more now than I used to.
2 I cry all the time now.
3 I used to be able to cry, but now I can’t cry even though I want to.
11. 0 I am no more irritated now than 1 ever am.
1 I get annoyed or irritated more easily than I used to.
2 I feel irritated all the time now.
3 I don’t get irritated at all by the things that used to irritate me.
12. 0 I have not lost interest in other people.
1 I am less interested in other people than I used to be.
2 I have lost most of my interest in other people.
3 I have lost all of my interest in other people.
13. 0 I make decisions about as well as I ever could.
1 I put off making decisions more than I used to.
2 I have greater difficulty in making decisions than before.
3 I can’t make decisions at all any more.
14. 0 I don’t feel I look any worse than I used to.
1 I am worried that I am looking old or unattractive.
2 I feel that there are permanent changes in my appearance that
make me look unattractive.
3 I believe that I look ugly.
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15. 0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can’t do any work at all.
16. 0 I can sleep as well as usual.
1 I don’t sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
3 I wake up several hours earlier than I used to and cannot get back to sleep.
17. 0 I don’t get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18. 0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19. 0 I haven’t lost much weight, if any, lately.
1 I have lost more than 5 pounds.
2 I have lost more than 10 pounds.
3 I have lost more than 15 pounds.
I am purposely trying to lose weight by eating less. Y es________No_______
20. 0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and pains; or upset 
stomach; or constipation.
2 I am very worried about physical problems and it’s hard to think of much 
else.
3 I am so worried about my physical problems that I cannot think about
anything else.
21. 0 I have not noticed any recent change in my interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely
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That is the end o f the questionnaire. Please check that you have answered all of the 
questions and then post the questionnaire back to us. Thank you very much for taking the 
time to make this important contribution to our study of emotion and heart disease. We 
may be in touch with you regarding a follow up stage of the study, in which case we look 
forward to speaking with you soon.
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Appendix 5: SIS Study -  6 month telephone follow up
Patient name
SIS no
Interviewer
Date o f Fitting o f  Monitor
Date o f Removal 
Monitor/Interview
Date o f telephone follow up
Subsequent problems? YES / NO - specify
Re -  admission? YES / NO
Coronary Angiogram? YES/NO
Result?
■ Normal
■ Angioplasty
■ Stent
- CABG
■ Complications/Miscell
Date o f coronary angiogram if  
still awaiting?
Other medical problems
Recurrence o f  symptoms? YES / NO
Seen GP since discharge? Y E S / N O
GP checked cholesterol? YES / NO
GP checked BP? YES / NO
GP checked blood sugar ( if  
appropriate)
YES / NO
Attended rehab course?(if MI) Y E S / N O Where?
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No. o f sessions attended e.g 6/8
Found rehab course useful? YES / NO
Did you receive advice about the following either in hospital or subsequently on a cardiac rehab 
course? YES/NO?
Subject Advice given? Advice implemented? Comments?
Exercise Y E S / N O YES / NO / PARTIAL
Weight Y E S / N O YES / NO / PARTIAL
Stress Y E S / N O YES / NO / PARTIAL
Alcohol YES / NO YES / NO / PARTIAL
Diet Y E S / N O YES / NO / PARTIAL (fruit/veg/oily fish/lowfat)
Were you a smoker before your heart pro 3lem? YES / NO
Were you advised to stop YES / NO
Advice implemented YES / NO / PARTIAL - specify
Relapsed? - reason?
How many a day do you smoke now?
What medication are you currently taking? Any problem with medication?
I forget to take my medicine ALWAYS/OFTEN/SOMETIMES/RARELY/NEVER
I alter the dose o f my medications ALWAYS/OFTEN/SOMETIMES/RA RELY/NEVER
I stop taking my medicines for a while ALWAYS/OFTEN/SOMETIMES/RARELY/NEVER
I decide to miss out a dose ALWAYS/OFTEN/SOMETIMES/RARELY/NEVER
I take less than instructed ALWAYS/OFTEN/SOMETIMES/RARELY/NEVER
I never forget to take my medicine ALWAYS/OFTEN/SOMETIMES/RA RELY/NEVER
Thank you. Mention questionnaire pack.
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Appendix 6: SIS study 6 month follow up questionnaire
Pt N oName
Medical Research Study 
Emotion and Heart Disease
Thank you very much for participating in our study o f emotions and heart 
disease. In addition to the saliva samples we have asked you to collect, we 
would like you to complete this questionnaire about your lifestyle, your 
attitudes and opinions, the way you feel about yourself and the way you feel 
about your heart problem. You may feel that some o f  the questions do not 
apply to you, but please answer each question with the answer that most closely 
fits the way you feel.
The answers you provide in this questionnaire will be kept strictly 
confidential. The information will go into the statistics for the study, and it 
will not be possible to identify you personally in any reports. Under no 
circumstances will any o f  the information you give us be made available to 
anyone else.
Most o f the questions can be answered by circling the appropriate answer.
For example:
“ I can  sit a t ease  and  feel re la x e d ’'
D efinitely Usually N ot often Not at all
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Please be sure to read the instructions to each section carefully.
Serious heart disease may be caused by many different factors. We would  
like to find out what factors you think were involved with your own illness. 
Listed below are a series o f  factors that patients in the past have thought 
helped to cause their heart disease symptoms. Please think about each item, 
then circle the answer that indicates how much you agree or disagree with 
each statement.
1. What do you think caused your symptoms?
Factors that might have helped cause my illness
My illness is hereditary -  it runs in my family No Maybe Yes
Smoking played a major role in causing my illness No Maybe Yes
My illness was brought on by other medical problems No Maybe Yes
Stress was a major factor in my illness No Maybe Yes
Being overweight caused my illness No Maybe Yes
High blood pressure was an important factor in my illness No Maybe Yes
Diet played a major role in causing my illness No Maybe Yes
I became ill because I over-exerted m yself No Maybe Yes
It was just by chance and bad luck that I becam e ill No Maybe Yes
My illness was caused by poor medical care in the past No Maybe Yes
Lack o f  exercise was a cause o f  my illness No Maybe Yes
My illness was brought on by tiredness and exhaustion No Maybe Yes
Genetic factors (genes) caused my illness No Maybe Yes
My state o f  mind played a major part in causing my illness No Maybe Yes
Working too hard caused my illness No Maybe Yes
A germ or virus caused my illness No Maybe Yes
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2. This part o f  the questionnaire is about your emotions and how you 
are feeling. Read each item and circle the reply which comes closest to 
how you have been feeling in the past week.
I feel tense or ‘wound up ’:
Most o f the time A lot o f  the time From time to time, Not at all
occasionally
I get a sort o f  frightened feeling as if  something awful is about to happen:
Very definitely and Yes, but not too A little, but it Not at all
quite badly badly doesn’t worry me
W orrying thoughts go through my mind:
A great deal o f the A lot o f  the time From time to time Only
time occasionally
but not too
often
I can sit at ease and feel relaxed:
Definitely Usually Not often Not at all
I get a sort o f  frightened feeling like ‘butterflies ‘ in the stomach:
439
Not at all Occasionally Quite often Very often
I feel restless as i f  I have to be on the move:
Very much indeed Quite a lot Not very much Not at all
I get sudden feelings o f  panic:
Very often indeed Quite often Not very often Not at all
3. The following questions are about your health and daily 
activities. Read each item and circle one answer for each question.
1. In general would you say your health is:
Excellent Very Good Good Fair Poor
2. Compared to one year ago, how  would you rate your health in general 
now?
Much better Somewhat better About the Somewhat Much worse
now than one now than one same as one worse now than now than one
year ago year ago year ago one year ago year ago
3. The follow ing questions are about the activities you might do during 
a typical day.
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D oes your health now limit you in these activities? If so how  
much?
• Vigorous activities -  such as running, lifting heavy objects, 
participating in a strenuous sport
Yes, limited a Y es, limited a No, not limited
lot little at all
Moderate activities -  such as m oving a table, pushing a vacuum  
cleaner, bowling, or playing golf.
Yes, limited a Yes, limited a N o, not limited
lot little at all
•  Lifting or carrying groceries.
Yes, limited a Y es, limited a N o, not limited
lot little at all
•  Climbing several flights o f  stairs.
Y es, limited a Y es, limited a N o, not limited
lot little at all
•  Climbing one flight o f  stairs.
Yes, limited a Y es, limited a N o, not limited
lot little at all
•  Bending, kneeling, or stooping.
Y es, limited a Yes, limited a No, not limited
lot little at all
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• Walking more than a mile.
Yes, limited a 
lot
Yes, limited a 
little
No, not limited 
at all
•  Walking half a mile.
Yes, limited a Y es, limited a N o, not limited
lot little at all
• Walking one hundred yards.
Yes, limited a Y es, limited a N o, not limited
lot little at all
•  Bathing or dressing yourself.
Yes, limited a Y es, lim ited a N o, not limited
lot little at all
4. During the past 4 weeks, have you had any o f  the following  
problems with your work or other regular daily activities as a result of 
your physical health?
•  Cut down the amount of time you spent on work or other activities.
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N o
Yes
• Accomplished less than you would like.
N o
Yes
• Were limited in the kind o f  work or other activities.
N o
Yes
• Had difficulty performing the work or other activities (for example, it 
took extra effort).
N o
Yes
5. During the past 4 weeks, have you had any o f  the following  
problems with your
work or other regular daily activities as a result of any emotional 
problems (such
as feeling depressed or anxious)?
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• Cut down on the amount of time you spent on work or other activities:
N o
Yes
• Accomplished less than you w ould like:
N o
Yes
• D idn’t do work or other activities as carefully as usual:
N o
Yes
6. During the past 4 weeks, to what extent has your physical health or 
emotional problems interfered with your normal social activities 
with family, friends, neighbours, or groups?
Not at all Slightly Moderately Quite a bit Extremely
7. How much bodily pain have you had during the past 4 weeks?
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None Very mild Mild Moderate Severe Very
severe
8. During the past 4 weeks, how much did pain interfere with your normal 
work (including both work outside the home and housework)?
Not at all A little bit Moderately Quite a bit Extremely
9. These questions are about how you feel and how things have been 
with you during the past 4 weeks. For each question, please give  
the one answer that com es closest to the way you have been 
feeling. How much o f  the time during the past 4 weeks:
•  Did you feel full o f  life?
All o f  the Most o f  the A good bit Some o f A  little bit None o f  the
time time o f  the time the time o f  the time time
• Have you been a very nervous person?
All o f  the M ost o f  the A  good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Have you felt so down in the dumps that nothing could cheer you up?
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All o f  the M ost o f  the A good bit Som e o f A  little bit None o f  the
time time o f  the time the time o f  the time time
•  Have you felt calm and peaceful?
All o f  the Most o f  the A good bit Som e o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Did you have a lot o f  energy?
All o f  the M ost o f  the A  good bit Som e o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Have you felt downhearted and low?
All o f  the M ost o f  the A  good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Did you feel worn out?
A ll o f  the M ost o f  the A  good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Have you been a happy person?
All o f  the M ost o f  the A good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
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• Did you feel tired?
All o f  the M ost o f  the A  good bit Som e o f A  little bit None o f  the
time time o f  the time the time o f  the time time
10. During the past 4 weeks, how much o f  the time has your physical 
health or emotional problems interfered with your social activities 
(like visiting friends, relatives, etc.)?
All o f  the Most o f  the A good bit Som e o f A little bit None o f  the
time time o f  the time the time o f  the time time
11. How TRUE or FALSE is each o f  the follow ing statements for you?
• I seem to get ill more easily than other people.
Definitely Mostly D on ’t M ostly Definitely
True True Know False False
• I am as healthy as anybody I know.
D efinitely M ostly D on’t M ostly Definitely
True True Know False False
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• I expect my health to get worse.
Definitely Mostly D on’t M ostly Definitely
True True Know False False
• My health is excellent.
Definitely M ostly D on’t M ostly Definitely
True True Know False False
12. This section o f  the questionnaire is concerned with how many people 
you see or talk to on a regular basis including family, friends, workmates, 
neighbours, etc. Please circle your answer to each question.
1. Do you have children?
If Yes, how often do you see or talk on the phone to your children?
Never Once a month Once every two Once a week Every day
w eeks
2. Are either o f  your parents living?
If your mother is living, how often do you see or talk on the phone to
her?
Never Once a month Once every two Once a week Every day
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weeks
If your father is living, how often do you see or talk on the phone to
him?
Never Once a month Once every two Once a week Every day
weeks
3. If you are married or living with your partner, are either o f  your in­
laws (spouse’s parents) living?
If your mother-in-law is living, how often do you see or talk on the 
phone to her?
Never Once a month Once every two Once a week Every day
w eeks
If your father-in-law is living, how often do you see or talk on the 
phone to him?
Never Once a month Once every two Once a week Every day
weeks
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4. Are there other relatives who you feel close to?
If Yes, how often do you see or talk on the phone to these relatives?
Never Once a month Once every two Once a w eek Every day
weeks
5. Do you have friends who you feel close to (i.e., people you feel at 
ease with, can talk to about private matters, and can call on for help)?
If Yes, how often do you see or talk on the phone to these friends?
Never Once a month Once every two Once a week Every day
w eeks
6. D o you belong to a church, temple, mosque or other religious group?
If Yes, how often do you talk to members o f  this religious group?
Never Once a month Once every two Once a week Every day
weeks
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7. Do you attend any classes (school, university, technical training, or 
adult education) on a regular basis?
If Yes, how often do you talk to fellow  students or teachers?
Never Once a month Once every two Once a week Every day
weeks
8. If you are currently working, how often do you talk to people (other 
than those you supervise) at work?
Never Once a month Once every two Once a week Every day
weeks
9. How often do you visit or talk to your neighbours?
Never Once a month Once every two Once a week Every day
weeks
10. Are you currently involved in any regular volunteer work?
If Y es, how  often do you talk to people involved in this work?
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Never Once a month Once every two Once a week Every day
weeks
11. Do you belong to any non-religious groups? Examples include social 
clubs, recreational groups, trades unions, etc.
If Yes, how often do you talk to fellow  group members?
Never Once a month Once every two Once a week Every day
weeks
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13. The scale below is made up of a list of statements each of which may
or may not be true of you. Please read each item and decide whether the 
statement is TRUE or FALSE as it pertains to you personally and circle 
your choice. This is not a test so there are no right or wrong answers.
1. There is at least one person I know w hose advice I 
really trust
TRUE FALSE
2. There is no one I can trust to give me good advice about 
money matters
TRUE FALSE
3. There is no one I know who w ill tell me honestly about 
how I’m handling my problems
TRUE FALSE
4. When I need suggestions about how to deal with a 
personal problem I know there is som eone I can turn to
TRUE FALSE
5. I feel that there is no one with whom  I can share my 
most private worries and fears
TRUE FALSE
6. If I had to go away for a few  w eeks, som eone I know  
would look after my house
TRUE FALSE
7. If I were sick and needed som eone to drive me to the 
doctor, I w ould have trouble finding someone.
TRUE FALSE
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8. There are several different people with whom  I enjoy 
spending time
TRUE FALSE
9. I don’t often get invited to do things with others TRUE FALSE
10. If I were sick, there would be almost no one I could find 
to help me with my daily chores
TRUE FALSE
11. If I had to post an important letter at the post office by 5 
o ’clock and couldn’t make it, there is som eone who  
could do it for me
TRUE FALSE
12. If I needed a lift to the airport very early in the morning, 
I would have a hard time finding anyone to take me
TRUE FALSE
14. Below are some statements which describe people’s beliefs and 
attitudes and the way they might react to some situations. If the 
statement applies to you or describes you in general, tick the True 
column. If the statement does not describe you, indicate False.
TRUE FALSE
0
I think a great many people exaggerate their 
misfortunes to gain the sympathy and help o f  others.
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01 I think most people would lie to get ahead.
When someone does me wrong I feel I should pay him  
g  back if  I can, just for the principle o f  the thing.
Most people are honest chiefly through fear o f  being 
Q  caught.
M ost people w ill use som ewhat unfair means to gain 
profit or an advantage rather than to lose it.
It takes a lot o f  argument to convince most people o f  
the truth.
I don’t blame anyone for trying to grab everything 
he/she can get in this world.
_  N o one cares much what happens to you.n
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_  It is safer to trust nobody.
9
I
n
Most people make friends because friends are likely to 
be useful to them.
Most people inwardly dislike putting them selves out to 
help other people.
I am often inclined to go out o f  my way to w in a point 
with someone who has opposed me.
f f l  I do not blame a person for taking advantage o f  
som eone who lays h im self open to it.
People generally demand more respect for their own 
Q  rights than they are w illing to allow for others.
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15. Listed below is a series o f  statements concerning the ways in which 
people think about their heart problem. Read each item carefully, and 
indicate how far you agree with it, using the scale on the right hand 
side. For example, i f  you agree with statement 3 quite strongly, you 
would circle number 5.
Strongly Disagree Slightly Slightly Agree Strongly
disagree somewhat disagree Agree som ewhat Agree
1 2 3 4 5 6
1. If my heart problem worsens 1 2 3 4 5 6
it is my own behaviour which
determines how soon I feel 
better again.
2. Most things that affect my heart 1 2 3 4 5 6
problem happen to me by chance.
3. If I see my doctor regularly, I am 1 2 3 4 5 6
less likely to have problems with
my heart problem.
4. I am directly responsible for my 1 2 3 4 5 6
heart problem getting better or
worse.
5. Luck plays a big part in 1 2 3 4 5 6
determining how  my heart
problem improves.
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6. Other people play a big role in 1 2 3 4 5 6
whether my heart problem
improves, stays the same, or 
gets worse.
7. Whatever goes wrong with my 1 2 3 4 5 6
heart problem is my own fault.
8. Whatever improvement occurs 1 2 3 4 5 6
with my heart problem is largely
a matter o f  good fortune.
9. Follow ing doctor’s orders to the 1 2 3 4 5 6
letter is the best way to keep my
heart problem from getting worse.
10. The main thing which affects my 1 2 3 4 5 6
my heart problem is what I
m yself do.
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11. If my heart problem worsens, 1 2 3 4 5 6
it’s a matter o f  fate.
12. The type o f  help I receive from 1 2 3 4 5 6
other people determines how soon
my heart problem improves.
13. If my heart problem takes a turn 1 2 3 4 5 6
for the worse, it is because I have
not been taking proper care o f  
myself.
14. I f I am lucky, my heart problem 1 2 3 4 5 6
w ill get better.
15. Whenever my heart problem 1 2 3 4 5 6
worsens, I should consult a
medically trained professional.
16. I deserve the credit when my 1 2 3 4 5 6
heart problem improves and the
blame when it gets worse.
17. A s to my heart problem, what 1 2 3 4 5 6
w ill be w ill be.
459
18. In order for my heart problem 1 2 3 4 5 6
to improve, it is up to other people 
to see that the right things happen.
16. This part o f  the questionnaire consists o f  21 groups o f  statements. 
After reading each group o f  statements carefully, circle the number (0, 
1, 2, or 3) next to the one statement in each group which best describes 
the way you have been feeling the past week, including today. If 
several statements within a group seem to apply equally w ell, circle 
each one. Be sure to read all the statements in each group before 
making your choice.
1. 0 I do not feel sad.
1 I feel sad.
2 I am sad all the time and I can’t snap out of it.
3 I am so sad or unhappy that I can’t stand it.
2. 0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel that the future is hopeless and that things cannot improve.
3. 0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
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01
2
3
0
1
2
3
0
1
2
3
0
1
2
3
0
1
2
3
0
1
2
I get as much satisfaction out o f things as I used to.
I don’t enjoy things the way I used to.
I don’t get real satisfaction out of anything anymore.
I am dissatisfied or bored with everything.
I don’t feel particularly guilty.
I feel guilty a good part of the time.
I feel guilty most of the time.
I feel guilty all of the time.
I don’t feel I am being punished.
I feel I may be punished.
I expect to be punished.
I feel I am being punished.
I don’t feel disappointed in myself.
I am disappointed in myself.
I am disgusted with myself.
I hate myself.
I don’t feel I am any worse than anybody else.
I am critical of myself for my weaknesses or mistakes.
I blame myself all the time for my faults.
I blame myself for everything bad that happens.
I don’t have any thoughts of killing myself.
I have thoughts of killing myself, but I would not carry them out. 
I would like to kill myself.
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I would kill m yself if I had the chance.
I don’t cry any more than usual.
I cry more now than I used to.
I cry all the time now.
I used to be able to cry, but now I can’t cry even though I want to.
I am no more irritated now than I ever am.
I get annoyed or irritated more easily than I used to.
I feel irritated all the time now.
I don’t get irritated at all by the things that used to irritate me.
I have not lost interest in other people.
I am less interested in other people than I used to be.
I have lost most of my interest in other people.
I have lost all of my interest in other people.
I make decisions about as well as I ever could.
I put off making decisions more than I used to.
I have greater difficulty in making decisions than before.
I can’t make decisions at all any more.
I don’t feel I look any worse than I used to.
I am worried that I am looking old or unattractive.
I feel that there are permanent changes in my appearance that 
make me look unattractive.
I believe that I look ugly.
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0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can’t do any work at all.
0 I can sleep as well as usual.
1 I don’t sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and find it hard to get back to sleep.
3 I wake up several hours earlier than I used to and cannot get back to sleep.
0 I don’t get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
0 I haven’t lost much weight, if any, lately.
1 I have lost more than 5 pounds.
2 I have lost more than 10 pounds.
3 I have lost more than 15 pounds.
0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and pains; or upset 
stomach; or constipation.
2 I am very worried about physical problems and it’s hard to think of much 
else.
3 I am so worried about my physical problems that I cannot think about
anything else.
21. 0 I have not noticed any recent change in my interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
That is the end o f  the questionnaire. Please check that you have 
answered all o f  the questions and then post the questionnaire back to 
us. Thank you very much for taking the time to make this important 
contribution to our study o f  em otion and heart disease. W e may be 
in touch with you regarding a follow  up stage o f  the study, in which  
case w e look forward to speaking with you soon.
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Appendix 7: ACCENT invitation letter to patient for taking part in 36 month 
follow up.
Royal Free and University College Medical School
UNIVERSITY COLLEGE LONDON
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH
Gower Street Campus 
 
D ear
I have taken  over from  D r * * * * * an d  D r ****** w hom  you m ay recall w h en  you  to o k  part in 
our research  study, ap p ro x im ate ly  3 y ears ago  w h en  you w ere  in itially  ad m itted  to  hosp ital for a heart 
problem . I enclose  the p a tien t in fo rm atio n  sh ee t on the study  to  jo g  y o u r m em ory .
A s d iscu ssed  on the  te lep h o n e , I w o u ld  be so  ap p rec ia tiv e  i f  you  w o u ld  co n sid e r tak in g  part in 
the  very  final phase  o f  our study o f  stress and  h eart d isease . W e w o u ld  like you to  co m p le te  the 
en clo sed  q uestionnaire  pack, w hich  co n ta in s so m e q u estio n s you an sw ered  in h osp ita l, but w hich  we 
need to  ask  you again  as a m eans o f  f in d in g  out how  you are feeling  now .
Please  use the enclosed  FREEPOST e n v e lo p e  to  send  back  the q u estio n n a ire  pack.
W e have a telephone n um ber reco rd ed  fo r you bu t i f  th is is due to  be changed , 1 w ou ld  be 
g ratefu l i f  you could  w rite  it on the q u estio n n a ire  by y o u r n am e i f  you are ag reed  to  this.
T h an k  you once again  for y our help , I h o p e  all is w ell. Feel free  to ring  on the telephone  
ex ten sio n  be lo w  if  you have any queries w h a tso ev er.
Y ours S in cere ly ,
D r M im i B h a ttach a ry y a  
C lin ical R e se a rc h  Fellow
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Appendix 8: ACCENT patient information sheet
Royal Free and University College Medical School
UNIVERSITY COLLEGE LONDON
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH
Study of Emotional Factors and Quality of Life in Heart Disease 
PATIENT INFORMATION SHEET (Confidential)
This research study is funded by the British Heart Foundation to try and explore how our 
emotions and behaviour influence the cardiovascular system in health and disease. The results 
of this study will help advance our knowledge o f  the links between the mind and the body. 
This exciting and important area o f  medical science will contribute to the understanding of  
heart disease, and aims to improve both the prevention and the treatment o f  this common 
illness. The study was being carried out by Professor Andrew Steptoe from the Department 
o f Epidemiology and Public Health at University College London, in collaboration with Dr 
 from the Department o f  Clinical Cardiology. The researchers who will carry 
out the work are Dr******, Dr ******* and Dr ******* and Dr Mimi Bhattacharyya.
Exactly what triggers heart attacks and unstable angina is unknown. We still don’t know why 
people have a heart attack on one specific day and not on the day before or the day after. It is 
likely to represent a complex interaction o f  several factors. We are trying to find out whether 
lifestyle and emotional state make a contribution in some patients. We also want to learn 
more about how people respond emotionally to coming into hospital with a heart problem, 
and how these responses may relate to physical recovery and quality o f  life. We are 
particularly interested in linking the psychological factors with the underlying biology o f  
heart disease, to see whether there are differences in the various chemicals in the blood that 
are involved in heart attacks and angina.
How You Can Help
You may rem em ber taking part in a research study a while back in which we 
interviewed you about what has been happening in your life over the last six months, 
right up until you came into hospital. We also asked you to fill in some questionnaires in 
your own time. These concern how you are feeling about life, and how you cope with 
stress. W e would like to follow this up three years after being in hospital. This would
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involve a telephone interview and filling out a questionnaire sim ilar to the one you have 
previously completed for us one year after being in hospital.
We want to emphasise that all results obtained will be strictly confidential and will only be 
used for medical research purposes. You will be free to withdraw from the study at any time 
without giving a reason. Taking part or deciding not to take part will not affect your medical 
treatment in any way.
Many thanks for reading this.
We hope you feel able to take part in our study, which will help us understand more about the 
causes o f heart disease and how to manage it better.
Any questions to Dr.Mimi Bhattacharyya, Department o f Epidemiology and Public Health, 
University College London   
Appendix 9: ACCENT patient consent form
Royal Free and University College Medical School
U NIV ERSITY  COLLEGE LONDON
DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH
Study N um ber
CONSENT FORM (Confidential)
Title  o f  p ro ject: A Study of the Emotional and Behavioural Factors in Acute Coronary Syndromes
N am e o f  R esearchers: P ro fesso r A n d rew  S tep to e , D r.* * * * * , Dr. *****Dr Mimi Bhattacharyya.
Any questions to Dr. Bhattacharyya, Department of Epidemiology and Public 
Health, University College London   
Please initial
1. 1 confirm  th at I have read and u n d e rs to o d  the in fo rm ation  shee t for the  above  study and have 
had the o p p ortun ity  to  ask  q u estio n s .
2. I u nderstand  th a t m y p a r tic ip a tio n  is v o lun tary  and  th at I am  free to  w ithd raw  at any tim e,
w ithout g iv in g  any  reaso n , w ith o u t m y m edical care  or legal righ ts b e ing  affected .
3. I u n d e rstan d  th at sec tio n s o f  any o f  m y m edical notes m ay be looked at by regu latory
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au thoritie s w here  it is re lev an t to  m y tak in g  part in research . I g ive p erm ission  for these 
ind iv iduals to have access to  m y records.
4. I agree  to  take  part in the above study  and be invo lved  in fo llo w  up fo r th ree  years a fter the 
initial study.
N am e o f  patient D ate S ig natu re
R esearcher D ate S ignatu re
1 for Patient; 1 for R esearcher; 1 to  be kep t w ith  hosp ital no tes
469
Appendix 10: ACCENT study 12 and 36 month telephone questionnaire
Patient name
EMOT no
Interviewer
Date o f admission
Date o f telephone follow up
Subsequent heart problems? YES / NO - specify
Severity (circle) Mild Moderate Severe
Other major med probs?
Re -  admission? YES /N O
Revascularisation procedure? Y E S / N O
Recurrence o f symptoms? YES /N O
Limiting Angina? YES / NO
Seen GP last 3 months? YES / NO
GP checked cholesterol? YES / NO
Cholesterol level Mmol/1
GP checked BP? YES / NO
GP checked blood sugar (if  
appropriate)
Y E S / N O
Attended rehab course? YES / NO Where?
No. o f  sessions attended e.g 6/8
Found rehab course useful? Y E S / N O
Do you feel that your lifestyle has changed since your heart problem?
How?
Did you receive advice about the following either in hospital or subsequently on a cardiac 
rehab course?
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Subject Advice given? Advice implemented? Comments?
Exercise YES / NO YES / NO / PARTIAL
Weight YES / NO YES / NO / PARTIAL
Stress YES / NO Y E S / N O / P A R T I A L
Alcohol Y E S / N O Y E S / N O / P A R T I A L
Diet Y E S / N O YES / NO / PARTIAL
Were you a smoker before your heart problem? YES / NO
Were you advised to stop YES / NO
Advice implemented YES / NO / PARTIAL - specify
Relapsed? - reason?
How many a day do you smoke now?
What medication are you currently taking?
Any problems with meds? YES / NO - specify
Do you take all your tablets every day?
How often do you miss a dose?
Working pre heart problem? YES / NO
Back to work? Y E S / N O
When returned to work
Full / part time / light duties?
Do you have any further thoughts about anything that may have triggered o ff your heart 
problem?
Thank you. Mention questionnaire pack.
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Appendix 11: 12 and 36 month questionnaire
Name: Pt No
Medical Research Study 
Emotion and Heart Disease
T h an k  you very  m uch  for p a rtic ip a tin g  in th e  th ird  p h ase  o f  ou r study  o f  em otions 
and heart d isease. W e w o u ld  like  you  to  c o m p le te  th is  q u estio n n a ire  about your 
lifesty le, your a ttitudes and o p in io n s , the  w ay  you  feel ab o u t y o u rse lf  and the  w ay 
you feel about your heart p ro b lem . Y ou  m ay  feel th at som e o f  the qu estio n s do  not 
app ly  to  you, but p lease  an sw er each  q u estio n  w ith  th e  an sw er that m ost c losely  fits 
the  w ay you feel.
T he answ ers you p rov ide  in th is  q u e s tio n n a ire  w ill be kep t strictly confidential. 
T h e  in fo rm ation  w ill go  in to  th e  s ta tis tic s  fo r the  study , and  it w ill not be possib le  to  
iden tify  you perso n ally  in any  rep o rts . U n d e r no  c ircu m stan ces w ill any  o f  the 
in fo rm ation  you g ive us be m ad e  a v a ilab le  to  an yone  else.
M ost o f  the qu estio n s can  be an sw e red  by c irc lin g  the ap p ro p ria te  answ er.
For example:
“ I can  sit at ease  and  feel re lax ed "
D efinitely Usually N ot often Not at all
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Please be sure to read the instructions to each section
carefully.
What do you think caused your heart problem?
Serious heart disease may be caused by many different factors. We 
would like to find out what factors you think were involved with your 
own illness. Listed below are a series o f  factors that patients in the past 
have thought helped to cause their heart disease symptoms. Please think 
about each item, then circle the answer that indicates how much you 
agree or disagree with each statement.
Factors that might have helped cause my illness:
My illness is hereditary -  it runs in my family No Maybe Yes
Smoking played a major role in causing my illness No Maybe Yes
My illness was brought on by other medical problems No Maybe Yes
Stress was a major factor in my illness No Maybe Yes
Being overweight caused my illness No Maybe Yes
High blood pressure was an important factor in my illness No Maybe Yes
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Diet played a major role in causing my illness No Maybe Yes
I became ill because I over-exerted m yself No Maybe Yes
It was just by chance and bad luck that I became ill No Maybe Yes
My illness was caused by poor medical care in the past No Maybe Yes
Lack o f  exercise was a cause o f  my illness No Maybe Yes
My illness was brought on by tiredness and exhaustion No Maybe Yes
Genetic factors (genes) caused my illness No Maybe Yes
My state o f  mind played a major part in causing my illness No Maybe Yes
Working too hard caused my illness No Maybe Yes
A germ or virus caused my illness No Maybe Yes
This part o f  the questionnaire is about your emotions and how you 
are feeling. Read each item and circle the reply which comes closest 
to how you have been feeling in the past week.
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2. I feel tense o r ‘wound up’:
Most o f  the time A lot o f  the time From time to time, Not at all
occasionally
8. I get a sort o f  frightened feeling as i f  som ething awful is about to 
happen:
Very definitely and Yes, but not too A little, but it Not at all
quite badly badly doesn’t worry me
9. Worrying thoughts go through my mind:
A great deal o f  the 
time
A lot o f  the time From time to time Only 
occasionally 
but not too 
often
10.1 can sit at ease and feel relaxed:
Definitely U sually Not often Not at all
11.1 get a sort o f  frightened feeling like ‘butterflies ‘ in the stomach:
Not at all O ccasionally Quite often Very often
12.1 feel restless as i f  I have to be on the move:
Very much indeed Quite a lot N ot very much Not at all
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13.1 get sudden feelings of panic:
Very often indeed Quite often Not very often Not at all
The following questions are about your health and daily 
activities. Read each item and circle one answer for each 
question.
1. In general would you say your health is:
Very G ood Good Fair Poor
__Fyppllpnt__
2. Compared to one year ago, how would you rate your health in general 
now?
Much better Som ewhat better About the Somewhat Much worse
now than one now  than one same as one worse now than now than one
year ago year ago year ago one year ago year ago
3. The follow ing questions are about the activities you might do 
during a typical day D oes your health now limit you in these 
activities? I f  so how  much?
• Vigorous activities -  such as running, lifting heavy objects, 
participating in a strenuous sport
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Yes, limited a Yes, limited a N o, not limited
lot little at all
•  Moderate activities -  such as m oving a table, pushing a vacuum  
cleaner, bowling, or playing golf.
Yes, limited a Y es, limited a N o, not limited
lot little at all
Lifting or carrying groceries.
Yes, limited a Y es, limited a N o, not limited
lot little at all
•  Climbing several flights o f  stairs.
Yes, limited a Y es, limited a No, not limited
lot little at all
• Climbing one flight o f  stairs.
Yes, limited a Y es, limited a No, not limited
lot little at all
• Bending, kneeling, or stooping.
Y es, lim ited a Y es, limited a N o, not limited
lot little at all
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Walking more than a mile.
Yes, limited a Yes, limited a N o, not limited
lot little at all
• Walking half a mile.
Yes, limited a Y es, lim ited a N o, not limited
lot little at all
•  Walking one hundred yards.
Yes, limited a Y es, limited a N o, not limited
lot little at all
•  Bathing or dressing yourself.
Yes, limited a Y es, lim ited a No, not limited
lot little at all
4. During the past 4 weeks, have you had any o f  the following  
problems with your work or other regular daily activities as a result 
of your physical health?
Cut down the amount of time you spent on work or other activities.
N o
Yes
• Accomplished less than you w ould like.
N o
Yes
• Were limited in the kind o f  work or other activities.
N o
Yes
• Had difficulty performing the work or other activities (for example, it 
took extra effort).
N o
Y es
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5. During the past 4 weeks, have you had any o f  the following 
problems with your work or other regular daily activities as a result 
of any emotional problems (such as feeling depressed or anxious)?
• Cut down on the amount of time you spent on work or other 
activities:
N o
Y es
• Accomplished less than you would like:
N o
Yes
• D idn’t do work or other activities as carefully as usual:
N o
Y es
6. During the past 4 weeks, to what extent has your physical health 
or emotional problems interfered with your normal social 
activities with family, friends, neighbours, or groups?
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Not at all Slightly Moderately Quite a bit Extremely
7. How much bodily pain have you had during the past 4 weeks?
None Very mild M ild Moderate Severe Very
severe
8. During the past 4 weeks, how  much did pain interfere with your 
normal work (including both work outside the home and 
housework)?
Not at all A little bit M oderately Quite a bit Extremely
9. These questions are about how  you feel and how things have been 
with you during the past 4 weeks. For each question, please 
give the one answer that com es closest to the way you have been 
feeling. How much o f  the time during the past 4 weeks:
•  Did you feel lull o f  life?
All o f  the M ost o f  the A  good bit Some o f A little bit N one o f  the
time time o f  the time the time o f  the time time
• Have you been a very nervous person?
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All o f  the M ost o f  the A good bit Som e o f A  little bit None o f  the
time time o f  the time the time o f  the time time
• Have you felt so down in the dumps that nothing could cheer you up?
All o f  the Most o f  the A  good bit Som e o f A little bit None o f  the
time time o f  the time the time o f  the time time
•  Have you felt calm and peaceful?
All o f  the Most o f  the A  good bit Som e o f A  little bit N one o f  the
time time o f  the time the time o f  the time time
• Did you have a lot o f  energy?
All o f  the Most o f  the A  good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Have you felt downhearted and low?
All o f  the Most o f  the A  good bit Some o f A  little bit None o f  the
time time o f  the time the time o f  the time time
• Did you feel worn out?
All o f  the M ost o f  the A good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
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• Have you been a happy person?
All o f  the Most o f  the A good bit Som e o f A little bit None o f  the
time time o f  the time the time o f  the time time
• Did you feel tired?
All o f  the Most o f  the A good bit Some o f A little bit N one o f  the
time time o f  the time the time o f  the time time
10. During the past 4 weeks, how much o f  the time has your 
physical health or emotional problems interfered with your social 
activities (like visiting friends, relatives, etc.)?
All o f  the Most o f  the A  good bit Some o f A little bit None o f  the
time time o f  the time the time o f  the time time
11. How TRUE or FALSE is each o f  the follow ing statements for you?
• I seem  to get ill more easily than other people.
D efinitely M ostly D on’t M ostly Definitely
True True Know False False
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• I am as healthy as anybody I know.
Definitely M ostly D on’t M ostly Definitely
True True Know False False
• I expect my health to get worse.
Definitely M ostly D on’t M ostly D efinitely
True True Know False False
• My health is excellent.
Definitely M ostly D on’t M ostly Definitely
True True Know False False
These questions relate to thoughts and/or feelings you may have 
experienced over the last few  months since you had the acute heart 
symptoms which led to your hospital admission. Please circle 
whichever answer seem s to apply closest you.
1. Have you had upsetting thoughts or images that related to your 
heart problem and that came into your head when you didn’t want 
them to?
Not at all Once per w eek or 2 - 4  times per 5 or more times
less w eek per week
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2. Have you been having bad dreams or nightmares about your heart 
problem?
Not at all Once per w eek or 2 - 4  tim es per 5 or more times
less w eek per week
3. Have you had the experience o f  reliving the tim e when your acute 
heart symptoms occurred, acting or feeling as i f  it were happening 
again?
Not at all A  little bit Somewhat Very much
4. Have you felt very em otionally upset when reminded o f  the time 
your acute heart symptom s came on, such as becom ing very 
scared, angry, sad?
N ot at all Once in a w hile Somewhat Very much
5. Have you been having physical reactions i f  reminded o f  when your 
heart symptoms first occurred, for example heart beating fast, 
breaking out in a cold sweat etc?
Not at all Once per w eek  or 2 - 4  times per 5 or more times
less w eek per week
6. Have you been trying not to think about or have feelings associated 
with your heart problem?
N ot at all Once in a while Somewhat Very much
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7. Have you been making efforts to avoid activities, situations, or 
places that remind you o f  when the symptom s that led to your 
being admitted to hospital started?
Not at all Once in a while Som ewhat Very much
8. Have you been unable to remember any important parts o f  the time
when your heart problem started and when you got into hospital?
Not at all A  little bit Som ewhat Very much
9. Have you found that you have not been interested in 
used to enjoy doing?
things you
Not at all A little bit Somewhat Very much
10.Have you felt distant or cut o f f  from others?
N ot at all Once in a w hile Som ewhat Very much
1 l.H ave you felt em otionally numb, for example, felt sad but couldn’t
cry, unable to have loving feelings?
Not at all Once in a w hile Somewhat Very much
12.Have you felt that any future plans or hopes have changed because
o f  the heart problem that led to your going into hospital?
Not at all Once in a while Somewhat Very much
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13.Have you been having problems falling or staying asleep?
Not at all Once per w eek or 2 - 4  tim es per 5 or more times
less w eek per week
14.Have you been more irritable or had outbursts o f  anger?
Not at all Once per w eek or 2 - 4  times per 5 or more times
less week per week
15.Have you been having difficulty concentrating, for example 
drifting in and out o f  conversations, losing track o f  the story on 
television, difficulty remembering what you have read?
Not at all Once in a w hile Somewhat Very much
16.Have you been overly alert, for exam ple checking to see who is 
around you?
Not at all A  little bit H alf o f  the time Alm ost always
17.Have you been jumpier or more easily startled?
Not at all A  little bit H alf o f  the time Almost always
This part o f  the questionnaire consists o f  21 groups o f  statements. 
After reading each group o f  statements carefully, circle the number
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(0, 1, 2, or 3) next to the one statement in each group which best 
describes the way you have been feeling the past week, including 
today. If several statements within a group seem  to apply equally 
well, circle each one. Be sure to read all the statements in each 
group before making your choice.
1. 0 I do not feel sad.
1 I feel sad.
2 I am sad all the time and I can’t snap out of it.
3 I am so sad or unhappy that I can’t stand it.
2. 0 I am not particularly discouraged about the future.
1 I feel discouraged about the future.
2 I feel I have nothing to look forward to.
3 I feel that the future is hopeless and that things cannot improve.
3. 0 I do not feel like a failure.
1 I feel I have failed more than the average person.
2 As I look back on my life, all I can see is a lot of failures.
3 I feel I am a complete failure as a person.
4. 0 I get as much satisfaction out of things as I used to.
1 I don’t enjoy things the way I used to.
2 I don’t get real satisfaction out of anything anymore.
3 I am dissatisfied or bored with everything.
5. 0 I don’t feel particularly guilty.
1 I feel guilty a good part of the time.
2 I feel guilty most of the time.
3 I feel guilty all of the time.
6 . 0 I don’t feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7. 0 I d on ’t fee l disappointed in m yself.
1 I am disappointed in m yself.
2 I am d isgusted  with m yself.
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I hate myself.
I don’t feel I am any worse than anybody else.
I am critical of myself for my weaknesses or mistakes.
I blame myself all the time for my faults.
1 blame myself for everything bad that happens.
I don’t have any thoughts of killing myself.
I have thoughts of killing myself, but I would not carry them out.
I would like to kill myself.
I would kill myself if I had the chance.
I don’t cry any more than usual.
I cry more now than I used to.
I cry all the time now.
I used to be able to cry, but now I can’t cry even though I want to.
I am no more irritated now than I ever am.
I get annoyed or irritated more easily than I used to.
I feel irritated all the time now.
1 don’t get irritated at all by the things that used to irritate me.
I have not lost interest in other people.
I am less interested in other people than I used to be.
I have lost most of my interest in other people.
I have lost all of my interest in other people.
I make decisions about as well as I ever could.
I put off making decisions more than I used to.
I have greater difficulty in making decisions than before.
I can’t make decisions at all any more.
I don’t feel I look any worse than I used to.
I am worried that I am looking old or unattractive.
I feel that there are permanent changes in my appearance that make me 
look unattractive.
I believe that I look ugly.
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15. 0 I can work about as well as before.
1 It takes an extra effort to get started at doing something.
2 I have to push myself very hard to do anything.
3 I can’t do any work at all.
16. 0 I can sleep as well as usual.
1 I don’t sleep as well as I used to.
2 I wake up 1-2 hours earlier than usual and find it hard to get back to
sleep.
3 I wake up several hours earlier than I used to and cannot get back to
sleep.
17. 0 I don’t get more tired than usual.
1 I get tired more easily than I used to.
2 I get tired from doing almost anything.
3 I am too tired to do anything.
18. 0 My appetite is no worse than usual.
1 My appetite is not as good as it used to be.
2 My appetite is much worse now.
3 I have no appetite at all anymore.
19. 0 I haven’t lost much weight, if any, lately.
1 I have lost more than 5 pounds.
2 I have lost more than 10 pounds.
3 I have lost more than 15 pounds.
I am purposely trying to lose weight by eating less. Yes _______
No_______
20. 0 I am no more worried about my health than usual.
1 I am worried about physical problems such as aches and pains; or upset
stomach; or constipation.
2 I am very worried about physical problems and it’s hard to think of
much else.
3 I am so worried about my physical problems that I cannot think about 
anything else.
21. 0 I have not noticed any recent change in my interest in sex.
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1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
That is the end o f  the questionnaire. Please check that you 
have answered all o f  the questions and then post the 
questionnaire back to us. This is the final questionnaire in 
this study. Thank you very much for taking the time to 
make this important contribution to our research o f  
emotions and heart disease.
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